data_1exk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1exk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 109.905 -0.405 . . . . 10.0 109.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -138.16 144.22 40.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.844 1.257 . . . . 10.0 108.059 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.95 142.95 45.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.0 t -76.58 87.26 3.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -41.67 -41.86 2.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.567 1.947 . . . . 10.0 111.751 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -51.67 -45.69 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 10.0 111.443 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.79 18.49 18.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.768 0.713 . . . . 10.0 110.599 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.83 35.95 25.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.26 1.424 . . . . 10.0 110.166 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.86 3.06 58.77 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.144 -1.364 . . . . 10.0 115.02 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -80.05 -75.22 0.27 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.012 1.906 . . . . 10.0 110.388 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.89 -19.25 0.76 Allowed Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.628 1.585 . . . . 10.0 112.308 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.71 151.53 26.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.596 1.698 . . . . 10.0 111.087 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -52.82 151.59 8.13 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.182 0.901 . . . . 10.0 111.92 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -50.51 137.23 40.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.54 2.827 . . . . 10.0 112.06 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.82 -51.8 2.75 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.598 1.094 . . . . 10.0 111.1 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -68.56 70.42 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.235 2.614 . . . . 10.0 108.904 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -56.76 158.43 8.68 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.383 0.673 . . . . 10.0 112.656 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.59 145.21 60.08 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.69 1.593 . . . . 10.0 109.287 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -84.6 123.01 29.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -50.78 121.35 5.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.914 0.886 . . . . 10.0 109.624 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.92 116.9 33.7 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.898 -0.778 . . . . 10.0 108.898 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.27 -38.46 6.66 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.582 1.521 . . . . 10.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.58 -39.71 7.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.289 1.836 . . . . 10.0 113.272 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -115.4 17.0 16.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.926 0.89 . . . . 10.0 111.568 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 47.1 49.71 14.77 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.0 0.92 . . . . 10.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.67 2.92 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.779 1.18 . . . . 10.0 115.247 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -90.12 2.84 54.86 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.843 1.321 . . . . 10.0 113.107 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.99 -8.82 5.83 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.776 1.07 . . . . 10.0 115.776 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.98 130.75 52.99 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.068 1.434 . . . . 10.0 110.031 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 m -87.95 143.85 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.658 -1.608 . . . . 10.0 106.658 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -98.33 110.67 23.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.93 -1.137 . . . . 10.0 107.93 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.6 tpt -75.79 73.29 2.73 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -69.44 55.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.064 2.146 . . . . 10.0 112.981 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.27 64.29 4.13 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.764 1.226 . . . . 10.0 108.414 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 -126.91 31.88 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -53.59 -47.83 69.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.306 1.042 . . . . 10.0 113.284 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -79.67 58.17 2.69 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.983 0.513 . . . . 10.0 111.143 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 59.0 2.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.261 0.625 . . . . 10.0 112.527 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.65 175.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -115.42 171.12 7.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -141.63 154.64 45.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.827 -1.916 . . . . 10.0 105.827 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -65.65 136.08 55.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 39.1 t -71.04 116.57 47.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.848 0.749 . . . . 10.0 109.649 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -38.99 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.874 1.716 . . . . 10.0 111.251 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -47.21 -41.14 17.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.004 1.322 . . . . 10.0 113.101 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.3 p -116.02 20.63 14.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.139 0.976 . . . . 10.0 111.299 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 46.8 42.92 12.58 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.374 1.07 . . . . 10.0 111.6 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.95 -4.09 11.18 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.433 0.933 . . . . 10.0 115.433 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -78.86 -5.5 53.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.644 1.722 . . . . 10.0 113.041 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.94 5.64 5.77 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.39 0.995 . . . . 10.0 114.642 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 p -129.14 132.41 47.34 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.773 1.229 . . . . 10.0 111.322 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -104.56 120.26 40.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.391 1.077 . . . . 10.0 110.111 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -78.01 65.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.356 1.462 . . . . 10.0 107.429 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -56.83 -45.43 82.34 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.296 0.57 . . . . 10.0 109.479 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -114.02 100.03 51.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.981 1.712 . . . . 10.0 108.475 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.72 131.04 19.13 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.925 1.75 . . . . 10.0 112.34 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.47 100.21 0.48 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -40.73 -50.37 3.1 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.63 1.572 . . . . 10.0 112.805 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -45.21 -40.0 6.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.861 1.265 . . . . 10.0 112.973 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -118.45 19.78 13.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.286 0.634 . . . . 10.0 111.004 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 46.5 42.92 11.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.647 1.179 . . . . 10.0 110.827 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.73 29.3 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.236 -1.313 . . . . 10.0 116.279 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -65.99 -55.95 14.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.278 2.039 . . . . 10.0 110.293 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.69 -9.62 16.51 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.718 1.151 . . . . 10.0 114.415 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.73 156.36 41.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.34 -1.356 . . . . 10.0 107.34 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.14 166.51 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.155 0.582 . . . . 10.0 109.69 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.57 136.59 36.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.817 -1.92 . . . . 10.0 105.817 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -51.11 116.19 1.89 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.414 -0.588 . . . . 10.0 109.414 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 124.334 1.054 . . . . 10.0 108.247 -177.748 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -118.05 147.09 43.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.79 138.34 58.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.406 0.441 . . . . 10.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.03 100.09 4.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.057 -1.461 . . . . 10.0 107.057 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.16 -43.38 20.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.563 . . . . 10.0 111.577 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.7 -29.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.277 1.431 . . . . 10.0 112.445 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.31 19.84 8.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.816 0.846 . . . . 10.0 110.808 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 44.93 42.44 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.344 1.458 . . . . 10.0 111.314 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.29 -11.26 38.34 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.165 1.226 . . . . 10.0 116.165 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.8 p -70.32 -68.72 0.4 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 120.036 1.918 . . . . 10.0 110.816 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.74 -5.5 5.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.863 2.173 . . . . 10.0 109.205 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.54 131.32 35.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.519 1.16 . . . . 10.0 109.159 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -54.69 159.41 3.53 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -42.5 137.35 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.983 3.122 . . . . 10.0 114.68 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.41 10.92 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.789 1.185 . . . . 10.0 114.157 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 m -127.36 136.07 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 146.12 33.26 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 124.12 0.968 . . . . 10.0 110.319 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -68.75 158.21 58.75 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 106.839 -2.023 . . . . 10.0 106.839 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -89.96 114.22 26.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -48.07 124.13 7.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.381 1.072 . . . . 10.0 109.866 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.53 115.39 17.96 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.74 -36.94 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.815 1.676 . . . . 10.0 110.725 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.61 -39.93 8.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.682 1.593 . . . . 10.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 p -114.6 12.65 17.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.788 . . . . 10.0 111.667 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.89 41.93 23.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.024 0.93 . . . . 10.0 109.895 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.53 -7.81 8.18 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.246 -0.752 . . . . 10.0 114.846 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -68.14 -9.06 43.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.499 1.65 . . . . 10.0 113.898 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.25 54.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.356 0.979 . . . . 10.0 113.68 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.4 143.55 30.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.509 1.154 . . . . 10.0 110.404 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.34 152.03 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.1 1.76 . . . . 10.0 107.534 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -125.66 118.94 26.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 89.6 mtp -104.02 121.48 43.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.873 1.269 . . . . 10.0 108.505 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -95.28 112.18 23.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.568 1.147 . . . . 10.0 108.914 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.82 53.73 2.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.43 -71.25 0.35 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.341 0.972 . . . . 10.0 112.427 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -80.56 -68.49 0.68 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 10.0 110.099 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.94 174.31 7.23 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.269 0.628 . . . . 10.0 110.058 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.14 43.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.703 0.801 . . . . 10.0 109.443 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 164.58 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 124.644 1.177 . . . . 10.0 108.576 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.56 152.63 43.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.113 0.965 . . . . 10.0 111.621 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.1 160.04 41.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -59.75 136.74 58.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.4 t -72.05 117.14 55.58 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.812 0.733 . . . . 10.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.09 -40.44 6.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.086 1.857 . . . . 10.0 111.357 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -45.85 -36.87 5.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.651 1.18 . . . . 10.0 113.013 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.4 p -121.43 21.49 10.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.877 0.871 . . . . 10.0 111.595 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 44.86 42.99 6.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.407 1.083 . . . . 10.0 111.705 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -4.76 9.13 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.699 1.04 . . . . 10.0 115.699 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -77.62 -7.8 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.425 1.612 . . . . 10.0 112.932 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.82 -2.21 2.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.105 0.86 . . . . 10.0 114.14 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 135.28 49.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.657 1.583 . . . . 10.0 109.876 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -101.88 119.79 39.35 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.773 1.229 . . . . 10.0 108.252 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.0 66.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 10.0 108.351 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -63.43 -35.51 80.68 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.786 -0.571 . . . . 10.0 110.22 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -109.64 77.05 0.96 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 127.795 2.438 . . . . 10.0 110.086 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.81 124.52 13.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.222 2.614 . . . . 10.0 115.591 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.99 94.89 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.495 1.518 . . . . 10.0 107.989 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -39.54 -47.83 1.95 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.476 1.51 . . . . 10.0 113.273 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -45.97 -43.29 13.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.972 0.909 . . . . 10.0 112.7 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.43 19.69 16.72 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 122.923 0.489 . . . . 10.0 110.461 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.08 40.85 18.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.436 1.094 . . . . 10.0 110.314 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.44 20.56 45.61 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.388 -0.673 . . . . 10.0 114.325 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -67.69 0.65 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.145 1.473 . . . . 10.0 107.371 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.92 -45.04 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.475 -0.65 . . . . 10.0 111.475 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.29 161.36 26.0 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.167 0.987 . . . . 10.0 110.237 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.7 149.78 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.226 1.011 . . . . 10.0 110.107 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.2 71.55 2.23 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.321 1.048 . . . . 10.0 109.371 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 67.14 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.906 2.083 . . . . 10.0 109.044 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.451 -0.422 0 C-N-CA 125.875 1.67 . . . . 10.0 111.724 -175.552 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.3 0.095 . . . . 10.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -129.82 156.26 44.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.731 1.612 . . . . 10.0 108.243 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.18 137.08 58.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.197 0.599 . . . . 10.0 109.783 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 t -76.6 81.63 3.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -46.18 -38.19 8.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.419 1.487 . . . . 10.0 111.502 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.04 -42.5 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.359 1.464 . . . . 10.0 111.776 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.8 p -110.36 20.19 18.03 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.511 0.724 . . . . 10.0 110.34 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 49.93 38.01 15.17 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.418 1.487 . . . . 10.0 110.27 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.84 0.54 14.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.544 -1.142 . . . . 10.0 115.384 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -73.77 -57.88 3.68 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 120.123 1.961 . . . . 10.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.85 5.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.433 1.968 . . . . 10.0 109.829 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 129.57 40.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.215 1.008 . . . . 10.0 112.172 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -42.2 145.59 0.76 Allowed Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.556 1.943 . . . . 10.0 111.729 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -39.13 132.08 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.725 2.95 . . . . 10.0 113.139 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.46 15.27 23.85 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.13 -0.817 . . . . 10.0 114.307 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -119.21 157.51 27.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.783 1.233 . . . . 10.0 107.717 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.99 152.63 43.77 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.1 1.36 . . . . 10.0 109.019 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.83 -177.9 4.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.149 1.899 . . . . 10.0 108.996 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -117.64 125.93 51.61 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -47.01 122.33 4.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.305 1.042 . . . . 10.0 110.897 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.61 115.79 27.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 -36.76 9.04 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.603 1.535 . . . . 10.0 110.887 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -46.32 -38.88 9.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.951 1.7 . . . . 10.0 112.985 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.21 19.99 13.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.089 0.956 . . . . 10.0 111.261 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 46.65 42.68 11.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.357 1.063 . . . . 10.0 111.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.41 -6.31 11.87 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.691 -1.061 . . . . 10.0 115.615 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.3 p -68.12 -44.48 76.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.073 1.936 . . . . 10.0 112.069 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.59 2.51 34.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.264 1.411 . . . . 10.0 111.136 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -128.82 130.07 46.46 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.714 1.257 . . . . 10.0 110.19 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.51 132.73 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -116.92 116.53 27.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.9 mmt -68.98 158.48 34.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -144.28 41.34 1.37 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.769 0.828 . . . . 10.0 109.854 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -163.69 0.59 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.015 1.726 . . . . 10.0 107.754 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.25 3.24 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.975 -0.85 . . . . 10.0 110.975 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -158.07 -60.74 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.295 0.547 . . . . 10.0 110.915 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -135.77 156.15 49.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.211 1.404 . . . . 10.0 107.404 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.7 63.03 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -78.34 172.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 123.412 0.685 . . . . 10.0 111.005 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.1 164.24 30.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.421 0.526 . . . . 10.0 112.421 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -144.6 161.69 38.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.718 1.207 . . . . 10.0 108.272 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -62.41 134.17 56.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.52 117.1 40.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 119.031 0.832 . . . . 10.0 109.748 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.88 -39.8 5.86 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.819 1.679 . . . . 10.0 111.241 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.88 -39.88 27.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.501 1.12 . . . . 10.0 113.635 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.8 p -113.12 16.23 19.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.196 0.998 . . . . 10.0 111.384 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 48.07 44.57 19.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 10.0 110.608 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.57 -2.36 16.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -78.63 -2.67 40.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.028 1.914 . . . . 10.0 113.343 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.54 -0.28 2.22 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.176 0.893 . . . . 10.0 114.279 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -125.71 128.59 48.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.628 1.571 . . . . 10.0 109.971 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.41 144.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.588 -1.264 . . . . 10.0 107.588 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mm -108.62 73.74 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.515 1.126 . . . . 10.0 109.334 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -66.14 -27.82 68.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.968 . . . . 10.0 108.719 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 80.23 0.42 Allowed Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 127.392 2.277 . . . . 10.0 110.061 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.36 121.69 9.01 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.292 2.661 . . . . 10.0 114.716 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.0 t -68.55 91.65 0.43 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.339 -1.726 . . . . 10.0 106.339 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -40.87 -44.19 2.23 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 125.347 1.459 . . . . 10.0 112.596 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -44.16 -37.22 3.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.08 0.952 . . . . 10.0 112.599 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -124.22 14.01 9.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.009 . . . . 10.0 111.243 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m80 45.73 43.24 9.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.46 1.104 . . . . 10.0 110.612 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.3 38.27 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.64 -37.82 59.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.011 1.906 . . . . 10.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.99 34.02 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.406 1.003 . . . . 10.0 114.925 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.77 155.37 45.61 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 119.162 1.481 . . . . 10.0 110.367 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.6 m -134.19 155.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 125.136 1.374 . . . . 10.0 108.676 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.91 148.33 23.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.533 0.733 . . . . 10.0 109.424 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -75.56 49.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.795 0.838 . . . . 10.0 110.623 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.452 -0.336 0 O-C-N 121.077 -1.014 . . . . 10.0 111.021 -177.329 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -134.02 146.12 50.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.627 1.171 . . . . 10.0 108.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.68 144.2 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.466 -0.568 . . . . 10.0 109.466 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.51 91.31 5.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -46.69 -38.9 10.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.415 1.486 . . . . 10.0 111.814 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.5 t -49.59 -43.01 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.392 1.477 . . . . 10.0 111.278 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 20.22 18.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.952 0.501 . . . . 10.0 110.688 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 52.84 38.56 27.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.152 1.381 . . . . 10.0 110.099 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.99 -3.11 47.6 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.411 -1.216 . . . . 10.0 115.167 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -78.0 -74.51 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.144 1.972 . . . . 10.0 111.36 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.9 -18.0 1.09 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.626 1.108 . . . . 10.0 111.847 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.73 140.9 31.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.662 1.731 . . . . 10.0 109.587 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 157.6 2.47 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.008 0.744 . . . . 10.0 113.008 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -41.67 136.72 2.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.643 3.562 . . . . 10.0 115.337 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -60.25 2.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.582 0.611 . . . . 10.0 112.227 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 m -70.91 79.69 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.327 0.584 . . . . 10.0 109.928 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.78 162.95 4.43 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.183 0.993 . . . . 10.0 111.865 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.55 153.54 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.86 1.707 . . . . 10.0 110.215 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -98.49 135.0 40.67 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.797 -0.445 . . . . 10.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -50.82 124.93 12.14 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.058 0.943 . . . . 10.0 110.738 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -68.19 115.85 33.22 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 118.597 0.635 . . . . 10.0 109.445 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.25 -34.75 12.39 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.43 1.42 . . . . 10.0 110.806 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -46.25 -38.26 8.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.624 1.569 . . . . 10.0 113.22 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.23 15.29 13.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.315 1.046 . . . . 10.0 110.718 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 50.0 40.59 21.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.973 0.909 . . . . 10.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.06 10.34 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.851 0.739 . . . . 10.0 114.654 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.4 m -64.29 -28.29 69.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.918 1.359 . . . . 10.0 113.339 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 -16.79 57.56 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.483 1.04 . . . . 10.0 114.776 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 146.75 52.47 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.946 1.373 . . . . 10.0 110.455 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.23 155.14 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.271 1.428 . . . . 10.0 107.146 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -126.54 114.71 18.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.2 mtp -76.53 73.17 3.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.87 60.69 0.17 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.144 1.378 . . . . 10.0 112.408 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 48.29 0.63 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.504 1.122 . . . . 10.0 110.797 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.2 -61.78 2.22 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.344 -0.847 . . . . 10.0 112.432 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -102.35 -72.66 0.68 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.981 0.89 . . . . 10.0 113.359 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -73.64 68.99 1.25 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.568 -0.708 . . . . 10.0 111.553 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 59.74 0.63 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.424 1.09 . . . . 10.0 111.35 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.0 m -78.6 151.96 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 C-N-CA 123.138 0.575 . . . . 10.0 111.295 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.1 150.88 24.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.414 1.086 . . . . 10.0 111.921 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -145.13 151.11 37.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -60.5 135.93 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.51 116.38 48.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.001 0.819 . . . . 10.0 109.29 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.02 -38.38 7.3 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.156 1.904 . . . . 10.0 111.33 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -45.3 -42.52 9.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.961 1.704 . . . . 10.0 112.258 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -115.21 20.79 14.69 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.195 0.998 . . . . 10.0 112.077 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 46.92 41.9 11.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.53 1.132 . . . . 10.0 111.354 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.22 -7.04 6.42 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.409 0.923 . . . . 10.0 115.409 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.34 -9.33 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.61 1.705 . . . . 10.0 113.443 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.02 3.33 10.63 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.568 -0.707 . . . . 10.0 112.941 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.78 133.11 47.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.078 1.751 . . . . 10.0 109.933 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.04 122.68 43.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.207 1.403 . . . . 10.0 109.905 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.5 mm -81.02 67.14 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.637 1.575 . . . . 10.0 107.092 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -57.56 -38.03 74.11 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.562 0.579 . . . . 10.0 112.562 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -125.98 84.25 61.56 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.283 1.433 . . . . 10.0 110.44 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.53 132.34 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.959 3.773 . . . . 10.0 115.914 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.1 t -74.62 95.15 2.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -37.4 -50.05 1.04 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.76 1.624 . . . . 10.0 113.009 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -45.13 -36.15 3.54 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.397 1.079 . . . . 10.0 113.508 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -122.59 15.55 10.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.477 0.711 . . . . 10.0 110.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 43.98 45.33 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.939 1.295 . . . . 10.0 111.15 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.78 -3.1 13.51 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 116.291 1.277 . . . . 10.0 116.291 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -66.84 -36.88 83.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.14 1.97 . . . . 10.0 111.132 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.48 56.17 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 123.99 0.805 . . . . 10.0 113.333 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -135.93 160.93 37.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.453 1.126 . . . . 10.0 110.14 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.71 157.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.344 1.457 . . . . 10.0 107.895 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.29 126.97 50.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.861 0.864 . . . . 10.0 109.096 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -77.09 62.93 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.454 -0.249 0 O-C-N 121.463 -0.773 . . . . 10.0 110.919 -177.317 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -109.0 128.36 54.89 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.226 1.811 . . . . 10.0 107.656 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 128.89 39.06 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.573 0.749 . . . . 10.0 109.84 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 t -79.48 88.99 5.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.032 -0.729 . . . . 10.0 109.032 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -49.3 -36.01 19.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.064 1.346 . . . . 10.0 111.418 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -49.47 -48.29 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.796 1.238 . . . . 10.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.1 p -103.21 23.45 12.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.411 0.624 . . . . 10.0 111.001 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 53.33 37.14 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.259 1.424 . . . . 10.0 110.604 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.45 47.37 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.592 -1.115 . . . . 10.0 115.109 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -84.52 -69.57 0.64 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.751 1.775 . . . . 10.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.58 -24.89 1.51 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.205 1.859 . . . . 10.0 109.994 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.99 131.86 40.95 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.804 0.802 . . . . 10.0 111.063 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.7 143.34 6.01 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.849 -0.596 . . . . 10.0 111.741 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -22.27 126.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 1 C-N-CA 127.321 5.347 . . . . 10.0 117.163 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.1 -48.25 2.39 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.848 0.737 . . . . 10.0 112.831 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.89 128.74 38.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.246 1.418 . . . . 10.0 109.772 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.56 152.47 63.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 122.032 -0.418 . . . . 10.0 111.481 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 179.28 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.072 1.848 . . . . 10.0 108.941 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -121.5 131.72 54.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -50.49 125.32 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.056 0.942 . . . . 10.0 112.088 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.36 116.08 45.6 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.5 -38.79 7.86 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.353 1.368 . . . . 10.0 110.589 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -45.2 -39.42 6.25 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.314 1.846 . . . . 10.0 113.06 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.37 30.68 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.744 0.818 . . . . 10.0 110.641 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 39.78 47.96 1.89 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.305 1.442 . . . . 10.0 113.261 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 -4.17 39.61 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 116.279 1.272 . . . . 10.0 116.279 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 p -84.14 -68.99 0.67 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.127 1.964 . . . . 10.0 111.939 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.19 -5.28 0.65 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.261 -1.299 . . . . 10.0 116.277 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 143.55 47.32 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.46 2.13 . . . . 10.0 112.459 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -99.4 130.38 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.611 1.564 . . . . 10.0 108.153 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -103.21 106.31 16.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.045 0.538 . . . . 10.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.3 tpp -77.44 72.76 4.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.4 65.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.38 2.272 . . . . 10.0 112.98 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -79.25 70.07 5.58 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -136.96 27.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.945 -1.262 . . . . 10.0 109.945 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -55.1 -34.93 64.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.074 0.95 . . . . 10.0 112.128 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -74.29 72.13 1.76 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.743 0.817 . . . . 10.0 110.164 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 58.5 0.51 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.544 1.138 . . . . 10.0 111.544 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 m -81.47 157.35 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.538 0.735 . . . . 10.0 109.791 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.25 164.97 29.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.227 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.69 153.38 42.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.043 1.337 . . . . 10.0 108.021 -175.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.7 m -60.44 136.4 58.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.74 116.77 51.39 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.42 -39.21 7.44 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.08 1.853 . . . . 10.0 112.116 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.42 -36.88 45.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.1 p -112.82 16.69 19.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.077 0.951 . . . . 10.0 111.28 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 47.77 42.9 16.43 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.987 1.315 . . . . 10.0 110.813 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.78 1.07 53.5 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -87.8 5.65 39.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.623 1.711 . . . . 10.0 113.583 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.42 -3.88 0.75 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.091 0.853 . . . . 10.0 115.009 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -121.81 125.96 47.7 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.417 1.487 . . . . 10.0 111.255 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.68 152.59 23.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.89 85.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -66.89 -23.05 65.96 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -111.62 68.3 0.75 Allowed Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 128.294 2.638 . . . . 10.0 109.973 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.31 133.74 27.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.269 2.646 . . . . 10.0 115.491 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.0 t -70.24 93.16 0.82 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.336 -1.357 . . . . 10.0 107.336 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -40.62 -45.4 2.33 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.693 1.597 . . . . 10.0 112.582 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -42.35 -40.01 2.35 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.348 1.459 . . . . 10.0 112.464 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -124.83 23.08 8.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.906 0.883 . . . . 10.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 46.22 40.96 8.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.987 1.315 . . . . 10.0 111.069 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.04 14.89 48.09 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 118.814 -0.992 . . . . 10.0 115.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.02 -23.57 44.24 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.726 1.763 . . . . 10.0 110.578 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.97 3.18 80.09 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.649 1.595 . . . . 10.0 114.38 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 153.1 31.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.304 1.052 . . . . 10.0 109.288 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.09 140.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 107.752 -1.203 . . . . 10.0 107.752 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -66.16 134.2 52.26 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.727 -0.608 . . . . 10.0 110.646 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -77.47 65.21 2.96 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.674 -0.862 . . . . 10.0 108.674 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.342 1.057 . . . . 10.0 109.045 -179.224 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -132.23 124.58 29.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.034 1.733 . . . . 10.0 108.15 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -62.43 135.05 57.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.291 0.636 . . . . 10.0 110.02 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.75 114.56 8.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -54.77 -42.78 72.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.228 0.611 . . . . 10.0 111.018 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -54.08 -49.59 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.346 1.058 . . . . 10.0 112.447 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.65 -0.44 51.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.609 0.64 . . . . 10.0 112.061 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 66.74 40.52 3.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.766 1.227 . . . . 10.0 109.437 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.39 -3.51 39.98 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.151 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.5 p -75.68 -69.22 0.5 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.073 1.937 . . . . 10.0 110.362 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.26 -8.47 4.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.08 2.752 . . . . 10.0 109.443 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.7 133.93 39.37 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.141 0.971 . . . . 10.0 110.728 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -44.91 142.6 2.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.258 1.423 . . . . 10.0 110.69 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.92 141.68 45.41 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.659 2.239 . . . . 10.0 110.906 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.75 21.04 34.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.642 0.639 . . . . 10.0 113.144 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -134.03 160.56 37.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.7 148.7 51.34 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.197 0.999 . . . . 10.0 111.825 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.09 -179.05 5.09 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.15 2.566 . . . . 10.0 108.395 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -117.23 129.71 56.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -49.02 123.53 7.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.745 1.218 . . . . 10.0 110.845 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.2 t -65.68 115.83 26.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.85 -35.69 11.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.646 1.564 . . . . 10.0 111.092 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.71 -38.24 9.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.767 1.627 . . . . 10.0 112.997 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -117.45 15.59 14.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 111.333 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.7 40.91 21.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.18 0.992 . . . . 10.0 110.376 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.18 -11.79 7.88 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.628 0.632 . . . . 10.0 114.535 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -66.98 -11.85 58.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.997 1.398 . . . . 10.0 114.302 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.66 41.23 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.795 -0.566 . . . . 10.0 113.384 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 125.56 33.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.536 1.134 . . . . 10.0 109.163 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.32 131.3 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.72 111.5 21.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.0 mmm -74.24 72.35 1.75 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.003 1.321 . . . . 10.0 108.274 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -66.21 62.48 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.519 1.928 . . . . 10.0 112.704 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 51.86 1.01 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.648 1.179 . . . . 10.0 110.435 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.06 -67.28 0.48 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.27 0.938 . . . . 10.0 113.291 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -98.23 -72.51 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.76 1.224 . . . . 10.0 112.655 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -77.35 69.72 3.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.179 0.899 . . . . 10.0 110.881 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.8 59.68 0.9 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.805 0.842 . . . . 10.0 111.546 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.22 163.59 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.14 0.576 . . . . 10.0 110.246 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -125.04 171.17 10.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.23 154.04 45.58 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -62.21 133.52 55.31 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.37 117.16 56.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.849 0.75 . . . . 10.0 109.62 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.16 -36.38 5.76 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.166 1.911 . . . . 10.0 111.286 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -39.57 24.09 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.529 1.132 . . . . 10.0 112.543 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.7 p -117.62 20.12 13.61 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.249 1.019 . . . . 10.0 110.806 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 42.92 45.49 4.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.437 1.495 . . . . 10.0 112.177 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -9.2 5.36 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.237 0.855 . . . . 10.0 115.237 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -73.57 -8.44 55.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.257 1.529 . . . . 10.0 112.363 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 -13.06 0.55 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.533 1.063 . . . . 10.0 115.167 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.79 133.52 55.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.833 1.653 . . . . 10.0 110.904 -174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.0 116.91 28.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.17 66.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.633 1.573 . . . . 10.0 108.438 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -62.61 -34.08 76.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.255 0.55 . . . . 10.0 109.713 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -107.98 79.91 0.96 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.145 2.578 . . . . 10.0 109.69 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 125.79 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.477 2.118 . . . . 10.0 114.998 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.32 87.13 0.43 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -38.64 -44.7 1.01 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.218 1.807 . . . . 10.0 112.83 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -44.7 -41.42 6.76 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.801 1.24 . . . . 10.0 112.362 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.99 27.4 8.09 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.668 0.787 . . . . 10.0 109.963 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 45.62 37.72 3.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.937 1.695 . . . . 10.0 111.827 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.91 9.46 46.7 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 114.98 0.752 . . . . 10.0 114.98 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.66 -32.16 69.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.299 1.55 . . . . 10.0 109.563 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.44 -23.71 32.49 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.19 1.376 . . . . 10.0 113.525 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.32 151.5 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.267 1.034 . . . . 10.0 109.736 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.26 154.67 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.965 1.306 . . . . 10.0 107.662 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.42 142.89 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.577 -0.702 . . . . 10.0 110.216 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -69.42 70.84 0.28 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.734 1.214 . . . . 10.0 109.515 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 125.771 1.628 . . . . 10.0 110.653 -176.211 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 111.555 0.206 . . . . 10.0 111.555 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -119.22 144.35 46.78 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.463 1.505 . . . . 10.0 109.929 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.78 135.74 56.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -77.98 87.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -46.46 -38.53 9.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.55 1.54 . . . . 10.0 111.312 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.69 -43.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.897 1.279 . . . . 10.0 111.029 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.64 13.99 29.06 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.845 0.458 . . . . 10.0 111.802 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 53.79 33.15 16.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 10.0 110.496 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.23 3.8 33.14 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.777 -1.013 . . . . 10.0 114.861 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 p -83.93 -24.55 30.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.602 1.701 . . . . 10.0 112.208 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.74 -9.99 74.73 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 119.029 -0.873 . . . . 10.0 110.927 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.6 139.11 33.98 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.862 1.331 . . . . 10.0 111.267 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -50.5 155.46 1.82 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.277 0.631 . . . . 10.0 111.56 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -28.53 121.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 125.308 4.005 . . . . 10.0 116.292 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.86 16.39 1.18 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.165 1.841 . . . . 10.0 116.021 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -93.08 119.51 32.39 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.193 1.496 . . . . 10.0 108.615 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.09 128.28 84.93 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.516 -0.754 . . . . 10.0 111.085 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -68.31 -175.97 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.522 2.148 . . . . 10.0 111.618 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -122.33 120.64 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.774 1.63 . . . . 10.0 107.295 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -48.97 124.77 9.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.621 1.168 . . . . 10.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.2 117.32 48.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.62 -38.5 8.02 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.432 1.421 . . . . 10.0 110.898 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -40.1 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.962 1.705 . . . . 10.0 113.221 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.2 21.84 12.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.822 0.849 . . . . 10.0 111.174 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 45.52 43.63 9.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.354 1.062 . . . . 10.0 111.676 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.91 -4.03 25.13 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.422 -1.21 . . . . 10.0 115.987 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -68.53 -58.05 4.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.197 1.998 . . . . 10.0 111.609 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.77 3.31 7.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.233 1.873 . . . . 10.0 110.85 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 131.06 33.03 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.803 1.301 . . . . 10.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -87.09 157.92 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.684 1.193 . . . . 10.0 108.558 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -123.81 112.7 17.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.683 1.193 . . . . 10.0 108.132 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.28 73.08 3.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -68.68 64.41 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.04 1.336 . . . . 10.0 111.885 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.99 59.03 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.437 1.095 . . . . 10.0 110.439 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.69 -66.3 1.08 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.253 0.93 . . . . 10.0 113.028 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -109.68 -65.94 1.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.86 0.864 . . . . 10.0 112.743 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.77 68.49 1.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.911 -0.493 . . . . 10.0 111.324 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.26 63.96 1.06 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.605 1.162 . . . . 10.0 112.077 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.1 m -75.08 160.28 5.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 123.12 0.568 . . . . 10.0 111.707 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -117.91 152.46 35.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.935 0.894 . . . . 10.0 112.907 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -147.1 154.98 41.78 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.366 1.067 . . . . 10.0 108.564 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -60.7 139.38 57.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.37 116.72 57.27 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.54 -37.73 5.19 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.913 1.742 . . . . 10.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.53 -38.93 32.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.958 1.303 . . . . 10.0 113.37 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.4 p -115.7 23.21 12.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.507 1.123 . . . . 10.0 110.988 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 41.25 49.22 3.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.485 1.514 . . . . 10.0 111.987 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.45 -3.55 11.22 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.449 1.34 . . . . 10.0 116.449 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -73.81 -31.34 63.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.173 1.986 . . . . 10.0 112.318 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -6.86 83.16 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.572 -0.611 . . . . 10.0 111.572 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.6 p -116.65 122.87 45.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.708 1.203 . . . . 10.0 111.628 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.4 mt -91.23 171.61 9.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.695 -1.594 . . . . 10.0 106.695 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.53 126.59 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -67.52 -37.63 83.06 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.293 -1.003 . . . . 10.0 108.293 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -109.62 76.79 0.93 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.689 2.396 . . . . 10.0 108.855 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.75 157.06 61.71 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.894 2.396 . . . . 10.0 113.614 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.23 85.71 0.57 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.982 0.913 . . . . 10.0 109.307 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -36.94 -47.38 0.7 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.357 1.863 . . . . 10.0 112.606 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -40.9 -39.53 1.17 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.946 1.698 . . . . 10.0 112.597 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.2 p -127.21 25.1 6.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.823 0.849 . . . . 10.0 110.927 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 49.39 35.96 8.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.613 0.765 . . . . 10.0 110.237 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.6 21.85 29.98 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.78 -1.011 . . . . 10.0 114.64 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -27.52 60.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.397 1.599 . . . . 10.0 111.29 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.99 -8.79 65.44 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.63 1.11 . . . . 10.0 111.976 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -139.46 153.66 47.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.094 0.947 . . . . 10.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.36 173.71 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 127.027 2.131 . . . . 10.0 106.914 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.75 139.9 39.43 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.525 -0.734 . . . . 10.0 111.434 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -71.19 67.79 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.944 2.098 . . . . 10.0 108.109 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.942 1.697 . . . . 10.0 110.703 -175.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -139.53 150.77 45.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.397 1.479 . . . . 10.0 107.463 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -79.58 137.37 37.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.014 0.526 . . . . 10.0 109.587 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.36 89.22 3.18 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.474 -0.936 . . . . 10.0 108.474 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -44.18 -39.78 4.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.912 1.685 . . . . 10.0 112.153 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -49.25 -42.35 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.457 1.503 . . . . 10.0 111.83 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.1 p -108.32 18.72 20.73 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.828 0.851 . . . . 10.0 110.386 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 52.57 36.49 20.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.209 1.404 . . . . 10.0 110.086 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.95 -0.87 35.21 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.393 -1.226 . . . . 10.0 114.982 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -73.27 -67.22 0.6 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.066 1.933 . . . . 10.0 111.194 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.66 -17.36 3.27 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.267 1.889 . . . . 10.0 110.031 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.98 154.12 38.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.509 1.155 . . . . 10.0 108.92 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -54.99 167.9 0.58 Allowed Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 119.871 1.214 . . . . 10.0 113.38 -174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -39.99 122.98 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.899 3.066 . . . . 10.0 114.325 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.61 26.22 7.39 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.806 1.193 . . . . 10.0 114.461 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.0 m -113.92 145.94 40.78 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.269 -1.382 . . . . 10.0 107.269 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -92.26 151.05 41.23 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 117.947 0.339 . . . . 10.0 110.744 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.59 -179.37 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.235 1.957 . . . . 10.0 108.067 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -110.11 125.5 53.05 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -49.42 124.73 9.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.142 0.977 . . . . 10.0 110.343 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.47 116.72 39.98 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 -37.78 6.95 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.844 1.696 . . . . 10.0 110.915 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.58 -40.82 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.1 1.76 . . . . 10.0 112.957 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.8 16.64 18.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.034 0.934 . . . . 10.0 111.534 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.26 42.3 13.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.301 1.041 . . . . 10.0 110.594 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.18 -4.95 5.49 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.475 -1.181 . . . . 10.0 115.775 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.6 p -67.53 -36.32 80.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.452 2.126 . . . . 10.0 111.972 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.36 50.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.506 1.05 . . . . 10.0 112.651 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -134.02 150.17 51.22 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.993 1.397 . . . . 10.0 111.0 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.4 130.07 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -115.67 110.47 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.522 0.677 . . . . 10.0 109.796 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 62.3 mmm -73.25 79.96 1.32 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.106 1.362 . . . . 10.0 107.328 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.73 67.72 0.81 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.008 0.923 . . . . 10.0 110.012 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.37 70.3 0.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.725 1.21 . . . . 10.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 -63.63 2.07 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.421 1.01 . . . . 10.0 111.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.72 -35.84 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.364 0.666 . . . . 10.0 112.707 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -75.46 59.59 1.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.538 1.063 . . . . 10.0 109.991 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 128.58 36.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.741 0.816 . . . . 10.0 111.275 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.52 155.88 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 106.868 -1.53 . . . . 10.0 106.868 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.81 161.48 37.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.775 0.657 . . . . 10.0 112.775 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.63 163.86 31.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.631 1.172 . . . . 10.0 108.57 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -61.78 137.51 58.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -69.98 117.29 52.49 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.861 0.755 . . . . 10.0 109.148 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 -40.31 5.18 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.124 1.882 . . . . 10.0 111.479 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.09 -39.58 20.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.798 1.239 . . . . 10.0 113.284 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.4 p -116.08 21.73 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.102 0.961 . . . . 10.0 111.48 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 44.1 44.97 6.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.561 1.145 . . . . 10.0 111.517 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 -6.14 8.26 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.214 1.246 . . . . 10.0 116.214 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -76.69 -8.72 57.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.361 2.08 . . . . 10.0 112.672 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.08 6.12 23.87 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.496 -0.752 . . . . 10.0 112.449 -174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.87 131.28 38.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.748 1.219 . . . . 10.0 111.574 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.87 122.26 32.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.532 1.533 . . . . 10.0 107.699 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 mm -75.74 77.33 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 124.694 1.198 . . . . 10.0 108.815 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -37.2 -51.51 1.02 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.805 2.042 . . . . 10.0 111.792 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 119.01 10.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.854 1.662 . . . . 10.0 106.673 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 126.46 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.34 2.027 . . . . 10.0 113.782 -174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.65 94.63 0.8 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.597 1.159 . . . . 10.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -38.25 -48.98 1.35 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.346 1.458 . . . . 10.0 112.727 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -43.93 -38.23 3.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.7 p -122.2 11.7 10.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.438 0.695 . . . . 10.0 110.882 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 m80 45.83 45.79 11.71 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.791 1.236 . . . . 10.0 111.495 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.86 28.58 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.06 -0.855 . . . . 10.0 114.838 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -11.53 60.48 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.349 1.574 . . . . 10.0 110.567 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 -49.11 3.56 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.564 0.602 . . . . 10.0 112.333 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.59 168.2 9.64 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.158 0.983 . . . . 10.0 110.797 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.51 157.94 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.559 1.944 . . . . 10.0 106.383 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -99.3 132.78 44.38 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.077 -1.082 . . . . 10.0 108.077 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -68.98 76.13 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.149 1.379 . . . . 10.0 110.569 -174.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 111.587 0.217 . . . . 10.0 111.587 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -106.12 131.19 53.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.86 124.89 20.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.728 1.211 . . . . 10.0 109.699 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -78.99 87.23 4.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.23 -36.28 13.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.563 1.545 . . . . 10.0 111.549 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -49.75 -49.46 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.725 1.21 . . . . 10.0 110.303 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -99.86 19.2 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.116 0.484 . . . . 10.0 110.945 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 56.39 34.4 24.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.651 1.181 . . . . 10.0 109.687 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 -1.98 34.66 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.791 -1.005 . . . . 10.0 115.086 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -76.04 -67.4 0.68 Allowed 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.671 1.735 . . . . 10.0 110.67 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.37 -22.51 2.05 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.869 1.223 . . . . 10.0 111.804 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.85 147.75 23.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.963 1.382 . . . . 10.0 109.991 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 154.01 1.62 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -34.35 128.43 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 125.503 4.136 . . . . 10.0 115.902 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.49 -49.4 1.97 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.867 0.746 . . . . 10.0 113.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -75.31 69.25 2.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.471 1.109 . . . . 10.0 109.355 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.04 156.67 18.92 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.105 1.762 . . . . 10.0 110.328 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.63 176.64 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.283 1.988 . . . . 10.0 111.168 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -112.87 136.87 52.04 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -54.0 123.55 12.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.539 0.735 . . . . 10.0 111.176 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.62 119.32 70.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.982 -1.118 . . . . 10.0 107.982 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.67 -37.47 9.33 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.608 1.539 . . . . 10.0 111.399 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.55 -49.14 27.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.305 1.442 . . . . 10.0 112.61 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.08 11.85 37.8 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.618 0.767 . . . . 10.0 111.611 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 51.38 46.73 26.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.528 0.731 . . . . 10.0 109.306 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.47 -2.33 1.21 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.38 0.991 . . . . 10.0 114.703 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -90.46 11.72 20.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.736 1.268 . . . . 10.0 113.426 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -26.54 0.61 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 116.417 1.327 . . . . 10.0 116.417 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.75 136.1 53.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.657 1.229 . . . . 10.0 110.908 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 m -87.67 158.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -135.17 114.59 12.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 75.83 3.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -68.33 63.19 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.504 1.521 . . . . 10.0 113.426 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 52.79 0.99 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.586 0.754 . . . . 10.0 110.345 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.14 -68.44 0.34 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.353 0.978 . . . . 10.0 113.417 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -96.39 -71.47 0.67 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.909 1.283 . . . . 10.0 112.4 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -77.04 68.9 3.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.237 0.926 . . . . 10.0 110.94 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.8 0.96 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.211 1.004 . . . . 10.0 110.633 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.8 m -75.48 140.32 17.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.757 0.789 . . . . 10.0 112.691 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -91.77 154.44 18.93 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.504 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.27 152.04 42.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 m -65.5 131.88 47.52 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.52 117.43 55.14 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 119.087 0.858 . . . . 10.0 109.616 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.15 -38.44 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.754 1.636 . . . . 10.0 111.051 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.86 -37.54 2.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.408 1.483 . . . . 10.0 113.259 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 p -127.41 25.75 6.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.192 0.997 . . . . 10.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 41.94 48.5 3.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.813 1.245 . . . . 10.0 112.196 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.98 -8.77 7.44 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 115.564 0.985 . . . . 10.0 115.564 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -75.29 -8.87 57.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.792 1.796 . . . . 10.0 113.406 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.14 0.29 4.23 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.873 0.749 . . . . 10.0 114.588 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.48 129.46 51.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.144 1.377 . . . . 10.0 110.58 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.52 107.16 16.61 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.86 -1.904 . . . . 10.0 105.86 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.67 74.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.788 1.235 . . . . 10.0 108.68 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -40.42 -50.76 2.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.357 1.863 . . . . 10.0 112.501 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -142.87 99.99 5.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.875 1.67 . . . . 10.0 107.585 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.04 141.4 57.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.387 2.725 . . . . 10.0 116.113 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.9 t -77.76 93.81 4.37 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.357 1.463 . . . . 10.0 107.679 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -41.25 -45.59 2.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.956 1.703 . . . . 10.0 112.544 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -43.35 -38.8 2.84 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.171 1.788 . . . . 10.0 112.685 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.2 p -123.22 23.37 9.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.067 0.947 . . . . 10.0 110.653 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.0 39.01 5.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.312 1.445 . . . . 10.0 111.388 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.68 -2.59 39.22 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.578 -1.124 . . . . 10.0 115.75 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.32 -29.97 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 120.283 2.041 . . . . 10.0 111.906 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.95 7.84 60.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.829 1.204 . . . . 10.0 114.027 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.15 150.51 29.95 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.147 0.974 . . . . 10.0 109.331 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.05 132.13 60.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.31 101.57 12.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.393 0.677 . . . . 10.0 109.18 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -79.84 60.86 3.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.149 -0.685 . . . . 10.0 109.149 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.457 -0.105 0 C-N-CA 124.894 1.278 . . . . 10.0 108.613 -179.831 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.231 0.092 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.25 139.91 49.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.713 1.605 . . . . 10.0 107.922 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.46 140.32 48.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.26 93.95 4.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.065 -1.087 . . . . 10.0 108.065 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.56 -37.26 17.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.43 1.492 . . . . 10.0 111.628 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.08 -40.94 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.269 1.028 . . . . 10.0 110.9 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.5 p -106.05 20.31 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.573 0.624 . . . . 10.0 110.748 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.81 35.19 23.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.847 1.259 . . . . 10.0 110.197 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 7.86 67.44 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.206 -1.33 . . . . 10.0 114.848 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.1 p -85.5 -74.06 0.42 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.943 1.872 . . . . 10.0 110.401 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -20.15 1.04 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.982 1.753 . . . . 10.0 112.242 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.98 154.18 20.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.241 1.521 . . . . 10.0 110.584 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -49.63 148.51 5.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 118.41 0.55 . . . . 10.0 112.458 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.1 135.76 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 125.129 3.886 . . . . 10.0 114.692 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.73 -52.91 2.02 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.233 0.921 . . . . 10.0 112.653 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 m -73.6 79.77 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.881 0.872 . . . . 10.0 109.203 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.11 156.48 13.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.904 0.882 . . . . 10.0 111.369 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.89 168.39 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.78 2.32 . . . . 10.0 113.231 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -90.26 121.8 32.6 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -52.44 124.62 13.92 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.911 0.884 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.65 118.49 54.81 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 -37.61 9.95 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.567 1.512 . . . . 10.0 111.505 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -46.57 -47.59 19.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.084 1.354 . . . . 10.0 113.161 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.0 p -100.73 6.41 43.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.75 0.82 . . . . 10.0 111.139 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 54.31 39.56 30.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.702 -0.851 . . . . 10.0 108.702 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.66 13.57 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.731 0.681 . . . . 10.0 113.943 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -72.0 4.86 3.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.602 1.704 . . . . 10.0 115.602 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.05 -28.93 0.95 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 115.821 1.089 . . . . 10.0 115.821 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.65 154.46 46.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.22 1.01 . . . . 10.0 109.61 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.29 147.32 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.46 109.34 18.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.1 tpp -102.41 139.72 37.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.428 1.491 . . . . 10.0 109.331 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -90.65 107.77 19.38 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 58.88 1.36 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.294 0.569 . . . . 10.0 111.503 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.43 -44.19 2.18 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.124 -0.985 . . . . 10.0 111.624 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -114.02 -72.54 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.884 1.274 . . . . 10.0 111.672 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -102.54 163.06 12.44 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 124.845 1.258 . . . . 10.0 112.9 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.75 128.9 34.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.799 1.24 . . . . 10.0 109.924 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.57 148.63 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.68 1.192 . . . . 10.0 108.553 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.84 145.25 28.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.525 0.73 . . . . 10.0 111.778 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.28 142.48 41.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 m -57.63 135.21 56.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.397 0.544 . . . . 10.0 110.013 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.2 t -75.97 117.9 67.23 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.885 -0.783 . . . . 10.0 108.885 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 -37.85 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.25 1.967 . . . . 10.0 112.062 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -38.82 22.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.796 1.239 . . . . 10.0 113.143 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.3 p -115.43 21.42 14.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.849 1.26 . . . . 10.0 111.189 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 44.01 45.4 6.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.922 1.289 . . . . 10.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.49 -9.71 7.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.52 -1.156 . . . . 10.0 115.986 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -67.21 -45.41 76.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.32 2.06 . . . . 10.0 111.285 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.13 46.66 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.897 1.237 . . . . 10.0 110.523 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 p -114.05 131.37 56.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.97 1.708 . . . . 10.0 111.709 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.03 113.5 25.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.48 69.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 108.068 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -59.35 -44.08 92.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.034 0.445 . . . . 10.0 110.64 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -120.73 82.86 34.95 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 127.318 2.247 . . . . 10.0 109.421 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.12 139.95 69.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.855 3.036 . . . . 10.0 116.617 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.6 t -74.0 89.94 1.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -41.72 -43.33 2.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.138 1.375 . . . . 10.0 112.915 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -46.32 -43.85 16.26 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 10.0 112.31 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.6 p -112.86 24.49 12.35 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.308 0.643 . . . . 10.0 110.208 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.59 43.02 12.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.083 1.353 . . . . 10.0 111.047 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.63 7.39 27.62 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.777 -1.013 . . . . 10.0 115.349 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -59.4 3.22 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.597 1.698 . . . . 10.0 108.872 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.75 11.83 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.956 1.265 . . . . 10.0 114.056 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.47 153.06 40.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.9 -1.519 . . . . 10.0 106.9 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.35 161.58 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.204 1.001 . . . . 10.0 109.524 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.04 149.79 32.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.258 -0.645 . . . . 10.0 109.258 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ttp-105 -75.86 52.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.034 1.334 . . . . 10.0 108.448 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.452 -0.356 0 O-C-N 121.143 -0.973 . . . . 10.0 111.079 -176.741 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.49 -0.559 . . . . 10.0 109.49 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.97 150.32 42.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.938 2.095 . . . . 10.0 106.808 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.81 143.06 51.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.05 91.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.62 -37.29 12.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.49 1.516 . . . . 10.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.06 -48.73 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.572 1.149 . . . . 10.0 110.205 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.61 22.0 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.159 0.504 . . . . 10.0 111.006 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.31 35.37 22.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.9 1.28 . . . . 10.0 110.436 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.37 -0.76 46.64 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.628 -1.096 . . . . 10.0 114.84 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -77.7 -71.02 0.44 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.773 1.787 . . . . 10.0 110.571 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.77 -17.06 2.2 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.065 1.793 . . . . 10.0 110.766 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.28 135.83 33.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.799 1.299 . . . . 10.0 109.862 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -50.26 147.06 7.87 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 -175.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -22.54 126.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 1 C-N-CA 127.513 5.475 . . . . 10.0 117.913 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.48 -42.67 0.85 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.556 1.074 . . . . 10.0 113.801 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -72.44 82.82 1.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.693 1.197 . . . . 10.0 108.195 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.03 155.1 16.82 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 122.789 0.436 . . . . 10.0 111.711 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.88 152.63 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 107.804 -1.652 . . . . 10.0 107.804 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -89.52 118.89 29.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.136 -1.431 . . . . 10.0 107.136 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -50.51 123.16 8.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.806 0.842 . . . . 10.0 109.105 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.65 115.49 15.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.24 -35.59 8.36 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.572 1.515 . . . . 10.0 110.348 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.67 -39.46 11.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.565 1.546 . . . . 10.0 112.806 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.5 p -115.18 16.8 16.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.341 0.656 . . . . 10.0 111.632 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.13 48.39 15.82 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.44 1.096 . . . . 10.0 110.384 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.89 -47.91 2.27 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.207 -0.774 . . . . 10.0 113.239 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.6 -45.4 0.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.756 2.422 . . . . 10.0 115.971 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.13 5.28 43.86 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.425 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.83 152.1 50.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.683 1.741 . . . . 10.0 112.235 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.12 158.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.769 1.627 . . . . 10.0 107.72 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -113.83 105.41 13.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.893 0.877 . . . . 10.0 110.027 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 tpt -72.28 93.3 1.47 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.079 -1.823 . . . . 10.0 106.079 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -92.64 121.22 33.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.196 2.598 . . . . 10.0 109.588 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.37 55.25 0.74 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.83 -77.61 0.21 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.792 1.187 . . . . 10.0 112.301 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -81.52 -65.95 0.95 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.774 0.829 . . . . 10.0 109.932 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -83.9 162.96 20.33 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.65 154.16 20.07 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.18 165.99 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 107.84 -1.171 . . . . 10.0 107.84 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -123.71 137.66 54.66 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.617 0.767 . . . . 10.0 110.521 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 162.03 37.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.706 0.629 . . . . 10.0 109.513 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 m -55.49 137.18 49.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 10.0 110.84 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.21 116.28 45.27 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.8 -0.619 . . . . 10.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.35 -39.38 7.38 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.843 1.695 . . . . 10.0 111.159 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -35.63 5.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.832 1.253 . . . . 10.0 113.204 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.1 p -125.16 25.87 7.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.089 0.956 . . . . 10.0 111.058 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 41.49 45.35 2.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.184 1.394 . . . . 10.0 112.316 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.91 -7.04 3.29 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.625 1.01 . . . . 10.0 115.625 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -69.49 -28.44 66.06 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.508 1.654 . . . . 10.0 110.952 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -9.59 76.54 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.799 0.714 . . . . 10.0 112.315 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 p -116.06 131.81 56.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.954 1.701 . . . . 10.0 113.455 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.14 100.59 12.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.0 mt -82.93 71.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.87 -24.64 67.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.959 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -124.44 75.52 62.11 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.894 2.078 . . . . 10.0 110.999 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.92 133.5 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.223 3.282 . . . . 10.0 116.295 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.48 88.81 2.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.653 -1.24 . . . . 10.0 107.653 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -36.96 -47.84 0.73 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.156 1.782 . . . . 10.0 112.98 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.37 -43.71 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.518 1.527 . . . . 10.0 112.415 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.6 p -116.99 22.26 12.7 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.725 0.81 . . . . 10.0 110.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 47.0 40.95 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.867 1.267 . . . . 10.0 110.241 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.81 10.57 13.8 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.882 1.113 . . . . 10.0 115.882 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.3 82.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.784 1.792 . . . . 10.0 109.319 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.17 59.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.563 2.03 . . . . 10.0 113.544 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.91 155.39 41.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.036 0.934 . . . . 10.0 108.668 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.87 152.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 125.296 1.438 . . . . 10.0 108.402 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.73 138.33 58.44 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.849 0.46 . . . . 10.0 110.152 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -78.83 61.31 3.04 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.532 0.263 0 O-C-N 121.522 -0.736 . . . . 10.0 110.582 -178.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.379 -0.23 . . . . 10.0 110.379 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.33 145.49 47.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.217 1.407 . . . . 10.0 108.194 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -72.47 131.6 42.77 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.298 0.639 . . . . 10.0 110.145 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.94 86.21 4.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.591 0.71 . . . . 10.0 109.14 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -48.1 -35.82 12.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.307 1.443 . . . . 10.0 111.38 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.44 -45.43 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.009 1.324 . . . . 10.0 110.835 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -102.29 17.2 24.04 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.269 0.486 . . . . 10.0 111.087 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.47 34.43 23.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.365 1.066 . . . . 10.0 109.17 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 -4.21 20.94 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.552 -1.138 . . . . 10.0 115.583 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -71.77 -61.17 1.88 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.293 2.046 . . . . 10.0 110.589 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.34 -12.31 6.36 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.65 2.072 . . . . 10.0 109.215 -173.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 141.71 33.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.63 1.215 . . . . 10.0 109.247 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -51.26 152.28 4.36 Favored Pre-proline 0 CA--C 1.551 1.003 0 CA-C-N 119.031 0.832 . . . . 10.0 112.415 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.26 129.7 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.076 3.85 . . . . 10.0 116.205 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.46 12.73 3.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.105 1.336 . . . . 10.0 115.248 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.9 m -110.58 125.45 53.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.893 1.346 . . . . 10.0 107.59 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.52 144.36 98.61 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 122.935 0.494 . . . . 10.0 111.302 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.34 164.68 34.53 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 N-CA-C 106.829 -2.027 . . . . 10.0 106.829 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.54 115.62 27.73 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.609 -0.682 . . . . 10.0 109.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -48.42 124.14 7.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.413 1.085 . . . . 10.0 110.452 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -65.6 115.82 25.83 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -35.55 8.0 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.319 1.346 . . . . 10.0 110.1 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -39.27 7.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.613 1.565 . . . . 10.0 113.181 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.77 17.09 13.55 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.435 0.694 . . . . 10.0 111.22 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 47.95 48.85 17.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.036 0.934 . . . . 10.0 110.201 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.68 -46.71 2.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.408 -0.808 . . . . 10.0 113.271 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -29.94 -40.59 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.976 2.91 . . . . 10.0 116.5 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.68 0.16 52.69 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.65 1.119 . . . . 10.0 115.811 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.28 151.65 40.78 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.815 1.307 . . . . 10.0 109.609 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -113.75 133.56 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.889 1.676 . . . . 10.0 108.178 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -107.92 91.08 3.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.435 1.094 . . . . 10.0 109.065 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.0 mmm -81.82 57.7 3.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.994 0.739 . . . . 10.0 112.994 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 176.12 165.15 0.41 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.083 2.153 . . . . 10.0 108.864 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.9 147.15 9.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.259 1.024 . . . . 10.0 108.77 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.96 40.22 6.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.168 0.89 . . . . 10.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -174.24 -149.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.444 -2.428 . . . . 10.0 104.444 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.36 73.45 2.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.526 1.057 . . . . 10.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.6 68.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.834 1.654 . . . . 10.0 112.124 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.99 160.35 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 124.134 0.974 . . . . 10.0 109.785 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -146.34 160.83 41.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 123.438 0.461 . . . . 10.0 111.367 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 163.14 34.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.088 0.955 . . . . 10.0 108.621 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.6 m -55.8 137.95 48.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.042 0.937 . . . . 10.0 109.471 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.69 118.69 68.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 118.569 0.622 . . . . 10.0 109.471 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.99 -38.6 7.09 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.186 1.924 . . . . 10.0 111.387 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -47.52 -42.29 22.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.586 1.554 . . . . 10.0 112.838 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.7 p -112.82 20.89 16.05 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.314 1.046 . . . . 10.0 111.585 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 44.18 44.45 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.799 1.24 . . . . 10.0 111.176 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.26 -7.02 5.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.486 -1.174 . . . . 10.0 115.976 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -68.42 -39.32 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 120.288 2.044 . . . . 10.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.27 -19.21 46.52 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.326 0.965 . . . . 10.0 110.711 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 132.4 54.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.524 1.93 . . . . 10.0 111.712 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -92.45 120.05 32.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.869 1.268 . . . . 10.0 108.11 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.86 63.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.95 -35.23 79.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.141 0.576 . . . . 10.0 111.212 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -111.45 74.49 1.17 Allowed Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.268 2.227 . . . . 10.0 109.083 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.67 133.92 38.7 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.657 2.904 . . . . 10.0 116.632 -172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.2 90.66 2.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.494 1.518 . . . . 10.0 107.212 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -39.51 -46.88 1.79 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.433 1.493 . . . . 10.0 112.489 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.17 -44.68 5.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.588 1.155 . . . . 10.0 112.643 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -113.89 14.2 18.5 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.204 0.602 . . . . 10.0 111.072 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.92 36.02 20.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.757 0.823 . . . . 10.0 109.919 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.09 15.19 49.51 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.127 -0.818 . . . . 10.0 114.393 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -2.02 40.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.326 1.563 . . . . 10.0 111.895 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.09 -43.77 2.28 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.384 -0.823 . . . . 10.0 113.091 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 168.84 9.44 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.283 1.433 . . . . 10.0 110.851 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.15 144.16 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 125.721 1.608 . . . . 10.0 107.722 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -87.84 105.54 17.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -71.94 81.73 0.92 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 126.455 1.902 . . . . 10.0 109.837 -178.282 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -120.34 145.5 47.06 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.108 1.363 . . . . 10.0 110.041 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -54.09 134.79 43.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.187 0.995 . . . . 10.0 111.642 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -77.43 103.93 7.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -46.84 -42.85 17.95 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.212 1.405 . . . . 10.0 111.126 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.11 -38.62 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.524 1.13 . . . . 10.0 111.928 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -106.75 4.2 27.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.085 0.857 . . . . 10.0 111.812 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.93 33.54 12.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.733 0.813 . . . . 10.0 108.935 174.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.78 -11.82 44.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.326 -1.263 . . . . 10.0 114.628 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.4 p -71.5 -71.59 0.26 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.066 1.933 . . . . 10.0 111.213 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.31 -24.66 2.2 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.814 2.15 . . . . 10.0 109.458 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 150.27 43.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.747 0.774 . . . . 10.0 110.017 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.21 165.1 2.98 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 122.086 -0.384 . . . . 10.0 111.133 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -40.48 127.68 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.908 3.072 . . . . 10.0 114.956 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.7 19.86 5.26 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.938 1.256 . . . . 10.0 114.786 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -108.12 135.16 49.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.606 -1.628 . . . . 10.0 106.606 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -79.94 147.55 66.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 118.466 0.576 . . . . 10.0 111.161 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.63 -173.32 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.152 -1.903 . . . . 10.0 107.152 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -126.05 123.17 37.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -45.54 124.85 5.3 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.813 1.245 . . . . 10.0 111.922 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -68.89 117.53 52.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.32 -36.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.796 1.664 . . . . 10.0 110.756 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.54 -46.49 19.35 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.664 1.585 . . . . 10.0 112.363 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -105.44 14.93 27.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.796 0.839 . . . . 10.0 111.634 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 49.22 40.39 17.84 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.961 0.904 . . . . 10.0 110.68 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -5.37 7.07 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.854 -0.97 . . . . 10.0 115.412 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.0 p -69.48 -26.61 64.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 120.096 1.948 . . . . 10.0 112.804 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.43 71.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 133.2 35.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.463 1.131 . . . . 10.0 110.482 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.47 157.55 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.282 1.433 . . . . 10.0 107.99 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -108.38 117.78 35.05 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.951 -1.499 . . . . 10.0 106.951 172.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.36 92.21 2.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.699 -2.704 . . . . 10.0 103.699 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -65.73 40.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.574 1.694 . . . . 10.0 115.574 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -78.61 55.66 1.69 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.299 -1.501 . . . . 10.0 111.043 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 26.15 -92.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 128.046 2.736 . . . . 10.0 114.064 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -36.74 -44.96 0.5 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.603 1.961 . . . . 10.0 112.678 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -129.68 56.6 1.71 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.07 69.1 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.187 0.995 . . . . 10.0 111.376 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 169.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.602 1.161 . . . . 10.0 112.491 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -109.2 149.8 28.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.487 1.115 . . . . 10.0 111.415 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -141.58 151.51 43.24 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.568 1.547 . . . . 10.0 108.037 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 m -58.25 138.09 56.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.863 0.756 . . . . 10.0 109.957 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.76 117.75 63.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.874 0.761 . . . . 10.0 108.998 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.99 -41.66 3.8 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.795 1.664 . . . . 10.0 111.16 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -47.66 -42.03 23.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.864 1.265 . . . . 10.0 113.547 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.21 21.66 15.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.66 0.784 . . . . 10.0 111.456 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 45.96 46.74 12.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.619 1.167 . . . . 10.0 111.369 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.31 -6.81 9.61 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.652 1.021 . . . . 10.0 115.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -68.18 -25.57 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.866 1.833 . . . . 10.0 112.652 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 1.51 87.07 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.38 0.514 . . . . 10.0 112.601 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.5 p -118.12 125.7 50.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.463 1.505 . . . . 10.0 111.304 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.65 151.67 22.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.26 90.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -64.88 -27.46 68.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -106.77 69.57 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.946 2.498 . . . . 10.0 109.856 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.26 128.74 22.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.195 1.93 . . . . 10.0 113.457 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.3 91.73 0.17 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -33.3 -51.54 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.011 2.124 . . . . 10.0 113.894 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -44.54 -45.63 9.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.187 1.395 . . . . 10.0 112.624 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.9 p -111.45 15.79 21.08 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.112 0.565 . . . . 10.0 110.45 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 54.14 34.08 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.222 1.009 . . . . 10.0 110.382 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.21 15.21 60.59 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 119.39 -0.672 . . . . 10.0 113.938 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -77.35 -4.41 44.98 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.036 1.418 . . . . 10.0 111.765 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.51 -43.5 2.1 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.028 -1.045 . . . . 10.0 114.242 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -134.5 155.52 50.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.162 0.985 . . . . 10.0 110.235 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.66 158.41 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 C-N-CA 124.748 1.219 . . . . 10.0 109.922 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -69.6 139.51 53.65 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -74.0 55.97 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.533 1.533 . . . . 10.0 110.634 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.453 -0.32 0 O-C-N 121.273 -0.892 . . . . 10.0 110.929 -178.384 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.076 0.398 . . . . 10.0 112.076 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -128.67 150.54 50.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.779 1.232 . . . . 10.0 108.399 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.13 135.14 56.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.794 0.838 . . . . 10.0 111.2 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -80.02 87.49 5.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 10.0 108.167 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -48.67 -37.01 17.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 10.0 111.528 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -49.98 -53.52 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.657 1.183 . . . . 10.0 110.157 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -93.38 18.6 9.45 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.264 0.484 . . . . 10.0 111.255 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 54.24 35.92 23.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.986 0.914 . . . . 10.0 109.898 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.54 4.63 61.55 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.282 -1.288 . . . . 10.0 115.452 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -87.0 -81.34 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.811 1.805 . . . . 10.0 111.382 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.7 -8.39 0.07 OUTLIER Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.616 -1.102 . . . . 10.0 114.61 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.44 157.77 20.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.702 1.751 . . . . 10.0 109.961 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -49.95 163.65 0.4 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.89 1.07 . . . . 10.0 113.89 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.23 135.99 24.87 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.107 2.538 . . . . 10.0 112.733 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 -57.7 2.65 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.992 -0.338 . . . . 10.0 112.417 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.1 m -72.68 64.67 0.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.804 1.242 . . . . 10.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 159.57 27.31 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.759 0.823 . . . . 10.0 112.331 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.57 176.06 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 10.0 110.946 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -117.74 124.76 49.24 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -44.3 124.0 3.78 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 10.0 111.807 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.67 116.71 40.44 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -38.06 7.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.63 1.554 . . . . 10.0 110.952 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -42.65 12.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.776 1.63 . . . . 10.0 112.861 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.0 p -112.18 18.17 18.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.813 0.845 . . . . 10.0 111.454 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.67 41.56 13.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.949 0.9 . . . . 10.0 111.172 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.17 0.08 55.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.283 -1.287 . . . . 10.0 115.801 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.7 p -69.56 -61.08 1.93 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 120.461 2.13 . . . . 10.0 111.321 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.31 10.34 7.37 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.115 2.293 . . . . 10.0 110.86 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 151.18 47.95 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.127 1.464 . . . . 10.0 110.48 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.44 144.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.342 1.457 . . . . 10.0 108.042 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -106.34 110.09 22.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.632 -0.877 . . . . 10.0 108.632 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.8 ttm -77.65 90.34 3.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.111 -1.07 . . . . 10.0 108.111 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -73.37 69.22 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.327 0.651 . . . . 10.0 110.517 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 45.44 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.45 -73.0 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.069 1.318 . . . . 10.0 115.059 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.74 -42.64 73.66 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.777 0.831 . . . . 10.0 110.438 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -120.48 170.64 9.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.705 1.202 . . . . 10.0 107.886 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 63.98 1.11 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.113 0.565 . . . . 10.0 109.694 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.65 176.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 110.465 -0.198 . . . . 10.0 110.465 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.44 159.27 41.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.526 0.33 . . . . 10.0 111.363 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.84 164.85 28.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.678 1.191 . . . . 10.0 108.429 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 m -63.87 140.76 58.9 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.64 116.0 45.4 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 118.849 0.75 . . . . 10.0 109.587 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.42 -38.81 7.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.043 1.829 . . . . 10.0 111.274 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.14 -34.22 5.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.245 . . . . 10.0 113.287 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.9 p -123.86 21.83 9.02 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.006 0.922 . . . . 10.0 111.189 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 45.5 42.21 7.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 10.0 111.928 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.38 -1.57 19.36 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.263 0.865 . . . . 10.0 115.263 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -79.32 -4.48 51.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.277 1.538 . . . . 10.0 111.744 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.59 -12.57 0.71 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.426 1.013 . . . . 10.0 113.978 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -122.03 132.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 10.0 111.094 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.13 106.03 7.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.895 -2.261 . . . . 10.0 104.895 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.14 77.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.259 1.423 . . . . 10.0 108.054 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -43.06 2.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.579 1.952 . . . . 10.0 111.022 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -145.2 144.99 25.15 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 104.441 -2.429 . . . . 10.0 104.441 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.0 125.39 3.11 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.187 1.925 . . . . 10.0 112.15 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -71.03 85.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -39.88 -46.03 1.92 Allowed 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 125.899 1.68 . . . . 10.0 113.172 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -42.61 -40.2 2.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.525 1.13 . . . . 10.0 112.683 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.16 18.73 12.31 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.539 0.736 . . . . 10.0 111.256 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 45.74 42.53 8.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.487 1.115 . . . . 10.0 109.537 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 51.96 25.41 16.62 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.528 1.537 . . . . 10.0 116.328 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -79.04 -38.88 35.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.588 1.694 . . . . 10.0 108.754 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.27 -0.91 55.96 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.095 1.807 . . . . 10.0 113.791 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 151.4 44.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.83 142.65 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.045 0.938 . . . . 10.0 110.47 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -77.53 78.29 4.05 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -76.19 60.27 1.46 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.452 1.101 . . . . 10.0 111.537 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 10.0 108.657 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.804 0.811 . . . . 10.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.81 127.62 33.41 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.437 1.895 . . . . 10.0 110.422 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.56 126.65 28.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.601 0.76 . . . . 10.0 110.593 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.19 89.84 3.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.28 -38.54 19.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.302 1.441 . . . . 10.0 111.319 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -50.27 -41.81 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.776 1.23 . . . . 10.0 111.618 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.4 p -107.56 19.28 20.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.916 0.486 . . . . 10.0 110.662 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.38 38.74 18.76 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.059 1.344 . . . . 10.0 110.163 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.63 24.16 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.445 -1.197 . . . . 10.0 115.561 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -72.7 -66.24 0.69 Allowed 'General case' 0 C--N 1.341 0.207 0 CA-C-N 120.098 1.949 . . . . 10.0 111.057 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.15 -8.13 4.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.226 2.346 . . . . 10.0 110.183 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.39 138.87 40.67 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.902 1.351 . . . . 10.0 111.031 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -51.76 144.45 18.92 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.817 0.735 . . . . 10.0 110.695 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -49.26 -37.0 38.97 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.298 2.665 . . . . 10.0 113.792 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.41 12.23 68.84 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.017 -1.435 . . . . 10.0 115.113 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -155.66 147.1 22.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.126 2.463 . . . . 10.0 110.938 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.77 157.73 66.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.823 -0.608 . . . . 10.0 109.495 176.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.62 169.64 19.45 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.281 1.987 . . . . 10.0 108.057 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -101.41 115.78 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 119.127 -0.463 . . . . 10.0 110.207 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -42.92 122.23 2.34 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.561 1.144 . . . . 10.0 111.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -65.61 115.57 23.49 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.66 -36.09 6.94 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.823 1.682 . . . . 10.0 110.709 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.38 -39.83 7.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.681 1.593 . . . . 10.0 112.883 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.3 p -114.86 12.48 16.92 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.094 0.958 . . . . 10.0 111.751 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.77 42.46 23.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.013 0.925 . . . . 10.0 109.995 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.08 -8.44 8.36 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 114.805 0.682 . . . . 10.0 114.805 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -68.27 -8.61 40.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.425 1.612 . . . . 10.0 114.045 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 14.66 55.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.602 1.096 . . . . 10.0 113.769 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -145.04 142.29 29.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.145 0.972 . . . . 10.0 110.088 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.11 133.15 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.625 1.57 . . . . 10.0 106.93 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.54 109.61 22.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.03 0.532 . . . . 10.0 110.428 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.99 88.5 0.4 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.331 1.052 . . . . 10.0 108.59 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -73.89 62.3 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.67 0.788 . . . . 10.0 110.238 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 43.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.632 1.173 . . . . 10.0 112.729 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.17 -64.45 1.3 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.684 -0.635 . . . . 10.0 112.391 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.99 -78.23 0.37 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.122 0.969 . . . . 10.0 113.09 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -84.11 98.15 9.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.536 0.734 . . . . 10.0 111.455 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 58.84 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.375 0.67 . . . . 10.0 111.266 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.02 162.36 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 O-C-N 121.878 -0.514 . . . . 10.0 110.05 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.39 171.97 7.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.812 1.041 . . . . 10.0 113.812 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 153.13 47.37 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.645 -1.983 . . . . 10.0 105.645 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 m -58.86 135.76 57.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.85 116.99 49.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.908 0.776 . . . . 10.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.15 -38.05 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.027 1.818 . . . . 10.0 111.367 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.41 -39.49 22.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.599 1.16 . . . . 10.0 113.174 -177.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.49 18.66 15.85 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.094 . . . . 10.0 111.47 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 47.01 43.51 13.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.341 1.056 . . . . 10.0 111.113 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.34 6.43 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.44 0.936 . . . . 10.0 115.44 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -74.54 -7.38 52.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.918 1.859 . . . . 10.0 112.737 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.39 1.21 7.26 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.403 -0.811 . . . . 10.0 113.216 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -133.18 132.91 42.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.17 1.388 . . . . 10.0 109.783 -174.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.74 118.58 27.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.875 1.27 . . . . 10.0 108.323 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -78.4 61.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.976 1.31 . . . . 10.0 108.435 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.74 -34.4 77.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.588 0.709 . . . . 10.0 109.752 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.79 78.14 1.18 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.011 2.924 . . . . 10.0 109.108 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.07 136.65 35.39 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.296 2.664 . . . . 10.0 116.342 -173.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.8 t -74.15 87.95 1.94 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.466 -1.679 . . . . 10.0 106.466 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.96 -40.79 4.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.97 1.308 . . . . 10.0 111.859 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -46.45 -38.66 9.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.932 0.893 . . . . 10.0 112.123 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.6 p -122.26 22.93 9.99 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.534 0.734 . . . . 10.0 110.477 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 45.87 39.81 5.88 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 10.0 110.949 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.07 17.7 31.13 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.249 0.86 . . . . 10.0 115.249 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -36.73 64.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.151 1.475 . . . . 10.0 110.328 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.04 -23.85 17.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.557 1.075 . . . . 10.0 112.031 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.73 159.17 44.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.141 0.97 . . . . 10.0 110.321 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.48 145.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 124.952 1.301 . . . . 10.0 109.865 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -69.77 139.45 53.27 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.905 -0.497 . . . . 10.0 109.876 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -64.61 71.37 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.093 1.757 . . . . 10.0 109.862 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 125.576 1.55 . . . . 10.0 110.633 -176.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -120.16 156.4 31.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.873 1.669 . . . . 10.0 110.383 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.66 129.13 19.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 112.081 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -77.24 89.59 3.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -49.09 -38.02 23.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.784 1.233 . . . . 10.0 111.313 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.8 -31.43 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.249 1.42 . . . . 10.0 112.221 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -123.24 22.52 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 10.0 110.13 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 45.01 41.71 5.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.589 1.556 . . . . 10.0 111.238 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.53 -4.44 27.65 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.803 1.081 . . . . 10.0 115.803 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -73.17 -68.95 0.45 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.742 1.771 . . . . 10.0 109.164 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.13 -6.52 4.35 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.58 2.038 . . . . 10.0 109.105 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 128.12 34.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.924 1.362 . . . . 10.0 109.673 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 156.42 2.6 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -38.76 133.59 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.408 3.406 . . . . 10.0 114.794 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.58 19.52 9.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.968 1.27 . . . . 10.0 114.498 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -126.11 140.9 52.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.68 153.44 42.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 122.809 0.444 . . . . 10.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.97 168.67 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 107.768 -1.666 . . . . 10.0 107.768 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.98 119.29 33.24 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -51.15 124.37 11.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.893 0.877 . . . . 10.0 109.362 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -64.23 115.18 17.52 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 118.702 0.683 . . . . 10.0 109.397 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.0 -35.85 8.4 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.632 1.555 . . . . 10.0 110.587 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -45.37 -38.34 5.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 10.0 113.056 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.35 13.95 13.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.241 1.016 . . . . 10.0 111.471 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.3 41.89 21.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.886 0.874 . . . . 10.0 110.195 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.8 -8.08 8.27 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 119.233 -0.76 . . . . 10.0 114.979 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -65.39 -15.7 62.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.563 1.682 . . . . 10.0 113.955 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 4.61 68.47 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.864 0.745 . . . . 10.0 113.651 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.97 156.74 44.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.94 1.37 . . . . 10.0 110.611 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.99 141.64 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 126.451 1.9 . . . . 10.0 107.391 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -124.55 115.47 20.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.16 165.43 24.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.427 1.091 . . . . 10.0 108.399 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -131.33 46.06 2.72 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.274 0.63 . . . . 10.0 112.434 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -78.74 64.0 3.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.874 0.845 . . . . 10.0 109.399 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 37.03 -104.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.439 2.447 . . . . 10.0 113.18 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -47.82 -35.19 9.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.251 1.42 . . . . 10.0 113.591 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -124.43 57.87 1.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.025 0.375 . . . . 10.0 111.227 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.99 66.48 0.38 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.443 1.097 . . . . 10.0 110.589 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.74 167.01 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.49 1.116 . . . . 10.0 112.885 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -126.44 156.86 39.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.063 0.945 . . . . 10.0 111.474 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.18 162.39 35.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.502 1.121 . . . . 10.0 108.94 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 m -62.4 140.99 58.56 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.777 0.831 . . . . 10.0 108.968 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.9 117.48 61.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 118.752 0.706 . . . . 10.0 109.605 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.31 -40.49 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.079 1.853 . . . . 10.0 111.46 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -44.73 -40.11 5.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.992 1.317 . . . . 10.0 112.625 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.59 22.54 11.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 10.0 112.05 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 44.39 43.11 5.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.535 1.134 . . . . 10.0 111.641 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.56 -6.16 6.42 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.757 1.063 . . . . 10.0 115.757 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -78.8 -2.73 40.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.674 1.737 . . . . 10.0 112.775 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.8 -8.97 0.73 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.205 0.907 . . . . 10.0 114.671 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -125.1 135.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.684 1.593 . . . . 10.0 110.655 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.6 mt -97.77 120.58 38.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.883 1.273 . . . . 10.0 108.073 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.5 mm -78.13 63.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.536 1.135 . . . . 10.0 108.23 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -69.36 -26.23 64.57 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.663 -0.648 . . . . 10.0 110.69 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -111.28 72.85 0.93 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 127.253 2.221 . . . . 10.0 109.46 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -62.99 129.42 25.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.019 2.479 . . . . 10.0 115.536 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.2 92.38 0.76 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.989 1.716 . . . . 10.0 106.543 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -37.23 -49.01 0.91 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.272 1.829 . . . . 10.0 112.613 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.73 -38.12 4.21 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.11 1.364 . . . . 10.0 112.812 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.0 p -121.85 16.29 10.97 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.893 0.877 . . . . 10.0 111.069 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 48.23 37.84 9.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.382 1.073 . . . . 10.0 110.836 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.52 6.76 43.51 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 118.955 -0.914 . . . . 10.0 115.058 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -44.0 87.01 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.78 1.79 . . . . 10.0 110.643 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.81 30.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.816 1.198 . . . . 10.0 113.405 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -146.25 154.61 41.92 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.481 1.64 . . . . 10.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 155.77 33.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 125.771 1.629 . . . . 10.0 109.298 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.53 141.56 51.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.286 -0.635 . . . . 10.0 109.286 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.97 67.28 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.756 2.022 . . . . 10.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.457 -0.096 0 C-N-CA 125.906 1.682 . . . . 10.0 108.288 176.368 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -112.84 124.5 52.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.487 1.115 . . . . 10.0 108.959 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.63 125.21 15.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.233 1.013 . . . . 10.0 110.584 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -81.1 89.04 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 109.688 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -49.5 -38.04 28.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.516 1.126 . . . . 10.0 111.016 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.07 -36.42 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.46 1.504 . . . . 10.0 111.655 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 p -117.52 23.92 11.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.078 0.551 . . . . 10.0 110.791 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.5 p80 46.03 42.35 9.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.64 1.576 . . . . 10.0 111.486 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.0 -3.72 27.46 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -77.84 -67.82 0.69 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 120.099 1.95 . . . . 10.0 110.196 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.65 -3.54 3.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.184 1.849 . . . . 10.0 110.496 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.49 140.23 30.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.008 1.904 . . . . 10.0 111.196 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -48.42 140.72 9.78 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.067 0.947 . . . . 10.0 111.625 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -36.28 133.41 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 125.165 3.91 . . . . 10.0 113.942 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.77 -45.72 1.64 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.236 0.922 . . . . 10.0 112.456 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 68.97 0.64 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.542 2.337 . . . . 10.0 108.503 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.55 151.76 28.42 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.178 0.991 . . . . 10.0 112.419 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.09 146.93 53.29 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.294 1.329 . . . . 10.0 108.786 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -83.06 140.38 32.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -57.71 123.26 15.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.547 0.739 . . . . 10.0 109.734 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -67.61 116.3 36.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.264 0.938 . . . . 10.0 108.981 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.64 -38.35 10.85 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 120.557 1.235 . . . . 10.0 110.777 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.22 -40.31 11.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.388 1.875 . . . . 10.0 113.134 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 p -121.3 27.68 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.821 0.849 . . . . 10.0 110.598 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 45.39 42.12 7.2 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.724 1.21 . . . . 10.0 112.788 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.46 58.29 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.328 -1.262 . . . . 10.0 116.196 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.6 p -81.31 -66.27 0.91 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.991 1.895 . . . . 10.0 112.02 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.43 -6.31 0.78 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.556 -1.135 . . . . 10.0 115.761 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.06 132.93 43.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.095 1.947 . . . . 10.0 111.67 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -75.99 138.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.1 114.69 23.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.7 mtp -77.49 73.72 4.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -68.71 62.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.292 1.437 . . . . 10.0 112.299 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.12 51.4 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.385 1.474 . . . . 10.0 110.489 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.23 -65.98 0.73 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.386 0.993 . . . . 10.0 113.332 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -100.91 -69.68 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.835 1.254 . . . . 10.0 112.122 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -74.52 68.69 1.63 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.573 -0.704 . . . . 10.0 111.213 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.24 59.24 0.75 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.21 1.004 . . . . 10.0 112.16 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.35 169.93 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 124.614 1.166 . . . . 10.0 110.7 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -146.84 159.52 43.41 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.621 0.6 . . . . 10.0 112.621 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.59 158.69 43.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.832 1.253 . . . . 10.0 108.572 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -53.55 134.44 40.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.062 0.545 . . . . 10.0 110.209 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.7 t -75.93 116.97 60.42 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.865 -0.588 . . . . 10.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.67 -39.01 7.2 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.169 1.913 . . . . 10.0 111.336 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -44.84 -43.41 8.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.997 1.719 . . . . 10.0 112.552 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.06 23.0 12.53 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.083 0.953 . . . . 10.0 111.699 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 44.21 44.68 6.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.781 1.232 . . . . 10.0 111.713 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -5.09 17.48 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -81.26 -8.32 59.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.308 2.054 . . . . 10.0 113.43 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.04 -7.63 3.05 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 121.459 -0.775 . . . . 10.0 113.192 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 133.61 55.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.747 2.019 . . . . 10.0 111.874 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.63 119.56 33.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.216 1.406 . . . . 10.0 108.854 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.31 81.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.79 1.636 . . . . 10.0 108.856 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -42.44 -49.95 5.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.415 1.486 . . . . 10.0 111.294 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -149.03 128.45 6.34 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.17 136.35 31.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.769 2.313 . . . . 10.0 114.848 -171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.5 t -73.68 90.82 1.84 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.673 1.589 . . . . 10.0 106.831 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -39.41 -45.39 1.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.73 1.612 . . . . 10.0 112.685 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.12 -39.32 2.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.827 1.251 . . . . 10.0 112.731 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.8 24.63 8.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.886 0.875 . . . . 10.0 110.631 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 47.99 35.59 5.23 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.296 1.038 . . . . 10.0 110.849 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.52 21.0 53.5 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.973 0.749 . . . . 10.0 114.973 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.42 -40.46 57.7 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.881 1.34 . . . . 10.0 110.367 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.72 -13.73 14.87 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.471 1.51 . . . . 10.0 112.073 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.62 145.5 29.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.155 0.978 . . . . 10.0 109.686 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.49 138.14 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.98 124.28 33.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -68.76 73.27 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.076 1.35 . . . . 10.0 108.406 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.631 1.973 . . . . 10.0 109.662 -176.643 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.69 132.78 54.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.229 1.812 . . . . 10.0 107.448 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.21 129.79 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -75.54 88.43 2.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -48.06 -39.48 20.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.831 1.252 . . . . 10.0 111.292 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -49.83 -33.44 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.143 1.377 . . . . 10.0 112.224 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.66 27.19 8.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.62 0.645 . . . . 10.0 110.656 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 44.69 41.97 5.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.47 1.508 . . . . 10.0 111.499 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 -3.52 30.95 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.131 -1.372 . . . . 10.0 116.044 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -80.9 -71.63 0.46 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 120.024 1.912 . . . . 10.0 110.661 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.43 -10.44 1.72 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.934 1.255 . . . . 10.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.63 137.81 33.64 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.222 2.011 . . . . 10.0 109.225 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 152.33 4.59 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 118.882 0.764 . . . . 10.0 112.071 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -46.82 141.77 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.122 3.214 . . . . 10.0 114.322 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.6 -58.32 3.78 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.783 0.706 . . . . 10.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 81.82 1.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.588 0.709 . . . . 10.0 109.852 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -56.49 157.32 9.91 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.636 1.174 . . . . 10.0 112.475 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.95 -174.72 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.328 2.019 . . . . 10.0 109.397 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -119.24 156.52 29.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -65.66 131.29 45.98 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.525 -1.359 . . . . 10.0 110.493 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -75.03 114.9 39.63 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.312 0.96 . . . . 10.0 109.389 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.1 -37.55 8.22 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.607 1.538 . . . . 10.0 110.558 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.96 -38.63 7.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.818 1.647 . . . . 10.0 112.964 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.3 p -119.06 20.45 12.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.797 0.839 . . . . 10.0 111.334 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 46.0 44.08 11.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.478 1.111 . . . . 10.0 111.483 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.13 -1.19 34.72 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.315 -1.269 . . . . 10.0 115.737 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.8 p -70.33 -63.2 1.13 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 120.336 2.068 . . . . 10.0 111.256 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.71 7.11 4.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.474 1.988 . . . . 10.0 111.529 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -134.7 146.93 49.93 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.426 1.613 . . . . 10.0 111.759 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 m -111.93 145.61 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.546 1.538 . . . . 10.0 108.336 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -107.91 113.33 26.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.072 -1.085 . . . . 10.0 108.072 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.7 tpp -75.15 73.95 2.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -70.76 60.98 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.655 1.582 . . . . 10.0 112.023 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -76.99 56.59 1.24 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.258 1.423 . . . . 10.0 110.861 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.68 -71.3 0.38 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.503 1.049 . . . . 10.0 112.847 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -98.63 -63.76 1.1 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.058 0.943 . . . . 10.0 112.025 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -77.49 60.73 2.14 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.895 0.878 . . . . 10.0 111.059 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.14 60.38 0.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.736 1.214 . . . . 10.0 113.096 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.29 -179.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.806 0.842 . . . . 10.0 110.013 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.6 160.08 40.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.46 166.6 24.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.513 1.125 . . . . 10.0 108.722 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 m -63.98 141.13 58.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.3 t -75.62 115.34 44.94 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 118.613 0.642 . . . . 10.0 109.707 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.45 -37.83 9.35 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.263 1.975 . . . . 10.0 111.052 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -45.38 -33.42 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.831 1.652 . . . . 10.0 112.538 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.07 21.79 6.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.9 0.88 . . . . 10.0 111.746 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.83 40.42 8.94 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.134 0.974 . . . . 10.0 112.263 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.29 53.62 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.114 0.805 . . . . 10.0 115.114 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -82.69 -7.77 59.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.966 1.383 . . . . 10.0 112.405 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.03 -6.49 2.97 Favored Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.465 -0.772 . . . . 10.0 113.041 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.56 127.04 52.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.184 1.793 . . . . 10.0 112.172 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.57 116.89 10.5 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.699 1.6 . . . . 10.0 107.482 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 mm -72.07 74.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 126.121 1.768 . . . . 10.0 109.291 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -42.47 -47.75 5.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.17 1.788 . . . . 10.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.22 94.96 5.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.87 1.268 . . . . 10.0 109.263 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.61 123.22 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 1 C-N-CA 125.573 4.182 . . . . 10.0 117.553 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.97 91.41 2.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.187 1.795 . . . . 10.0 107.142 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -36.98 -48.27 0.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.198 1.799 . . . . 10.0 112.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -43.37 -42.68 4.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.678 1.591 . . . . 10.0 112.639 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.28 16.87 14.81 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 123.756 0.823 . . . . 10.0 110.795 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 51.25 35.02 12.54 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.54 1.136 . . . . 10.0 110.27 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.64 14.25 57.45 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.688 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -75.05 -27.28 59.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.184 1.492 . . . . 10.0 111.627 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.56 -34.26 4.84 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.578 1.085 . . . . 10.0 113.718 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 144.37 50.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.123 0.969 . . . . 10.0 108.72 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.37 145.39 34.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.154 0.982 . . . . 10.0 109.412 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -80.47 138.69 36.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -67.79 72.09 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.034 1.334 . . . . 10.0 109.291 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 125.48 1.512 . . . . 10.0 110.625 -176.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -129.56 150.39 50.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.16 0.984 . . . . 10.0 109.531 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 131.44 43.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.808 1.643 . . . . 10.0 112.412 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.3 t -76.99 101.13 5.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.195 -1.78 . . . . 10.0 106.195 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -48.8 -41.97 34.44 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.288 1.435 . . . . 10.0 111.518 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.5 t -52.23 -33.38 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.103 1.361 . . . . 10.0 111.89 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.76 19.54 14.43 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.404 0.547 . . . . 10.0 110.925 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.08 38.31 16.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.019 1.327 . . . . 10.0 111.242 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.34 60.19 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.593 -1.115 . . . . 10.0 115.382 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.6 p -79.28 -67.88 0.71 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.89 1.845 . . . . 10.0 110.909 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.11 -9.47 3.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.981 2.705 . . . . 10.0 110.028 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 126.63 30.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.209 1.003 . . . . 10.0 111.739 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -44.76 141.49 2.92 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.916 1.687 . . . . 10.0 111.258 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.13 145.35 65.2 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.641 2.227 . . . . 10.0 110.185 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.05 39.06 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.44 0.543 . . . . 10.0 113.118 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -137.87 169.77 17.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 150.68 75.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 118.933 0.788 . . . . 10.0 111.047 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.86 168.05 10.98 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.236 2.624 . . . . 10.0 108.506 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -105.37 126.09 51.72 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 122.191 -0.318 . . . . 10.0 110.647 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -50.13 121.92 6.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 10.0 110.573 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.85 115.8 26.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -70.21 -36.27 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.642 1.561 . . . . 10.0 110.754 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.14 -40.26 10.8 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.679 1.592 . . . . 10.0 112.907 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 p -115.73 18.14 15.86 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 10.0 111.32 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 47.79 42.0 15.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.249 1.02 . . . . 10.0 110.722 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.37 -2.95 8.81 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.385 -1.231 . . . . 10.0 115.518 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -45.41 82.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.324 2.062 . . . . 10.0 111.322 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.06 3.24 28.06 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.365 1.459 . . . . 10.0 111.262 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -135.12 143.11 46.39 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.074 1.437 . . . . 10.0 112.079 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 m -99.46 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 126.096 1.758 . . . . 10.0 107.679 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -126.68 118.7 25.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.01 -1.478 . . . . 10.0 107.01 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -107.77 135.62 48.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.698 1.199 . . . . 10.0 108.843 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -99.05 115.26 28.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.767 1.227 . . . . 10.0 108.234 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 58.05 3.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.585 -0.895 . . . . 10.0 108.585 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 -66.7 2.07 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -101.23 -76.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.841 1.256 . . . . 10.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.46 172.84 6.61 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.475 0.579 . . . . 10.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.34 152.24 40.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.784 -0.573 . . . . 10.0 109.718 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.43 156.87 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.419 1.088 . . . . 10.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 158.85 23.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.595 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -147.03 155.13 41.97 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.231 -1.396 . . . . 10.0 107.231 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -63.76 133.99 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.34 117.35 56.07 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 119.178 0.899 . . . . 10.0 109.087 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.26 -37.04 8.47 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.95 1.767 . . . . 10.0 111.422 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -39.25 25.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.779 1.231 . . . . 10.0 113.566 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -116.26 19.63 14.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.892 1.277 . . . . 10.0 110.892 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 46.59 44.59 13.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.631 1.172 . . . . 10.0 111.319 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.84 -8.18 6.39 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.451 0.94 . . . . 10.0 115.451 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -74.94 -17.65 60.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.775 1.787 . . . . 10.0 112.714 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.2 12.64 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.843 -0.536 . . . . 10.0 112.385 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -106.54 130.49 54.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.703 1.601 . . . . 10.0 112.069 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.6 mt -81.63 115.82 21.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -75.68 67.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.321 1.048 . . . . 10.0 108.192 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.91 -24.59 67.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.078 0.551 . . . . 10.0 109.575 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -118.35 80.18 15.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 128.396 2.678 . . . . 10.0 110.655 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.6 122.17 11.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.962 2.442 . . . . 10.0 115.191 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.43 89.42 0.69 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.367 -1.345 . . . . 10.0 107.367 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -39.26 -46.31 1.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.283 1.833 . . . . 10.0 112.848 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -45.59 -36.79 4.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.274 1.03 . . . . 10.0 112.555 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.1 26.07 6.58 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.822 0.849 . . . . 10.0 110.182 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 43.44 40.13 2.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.549 1.54 . . . . 10.0 112.117 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.97 37.32 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.198 -0.939 . . . . 10.0 115.245 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.42 -39.27 88.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.727 1.763 . . . . 10.0 109.547 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.26 -9.08 67.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.213 1.863 . . . . 10.0 114.333 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.74 44.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.865 1.332 . . . . 10.0 109.271 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.72 147.9 30.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.558 1.143 . . . . 10.0 110.419 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 79.88 1.99 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.351 1.06 . . . . 10.0 108.439 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -79.48 50.28 1.1 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.396 1.079 . . . . 10.0 110.764 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.455 -0.218 0 O-C-N 121.513 -0.742 . . . . 10.0 109.888 -179.418 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -110.78 127.01 55.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.766 1.626 . . . . 10.0 107.566 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.4 127.11 30.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.795 1.238 . . . . 10.0 109.798 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.1 85.23 4.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.289 0.566 . . . . 10.0 110.041 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -46.77 -38.7 10.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.258 1.423 . . . . 10.0 111.708 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -49.16 -38.48 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.798 1.639 . . . . 10.0 111.712 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.14 19.52 17.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.147 0.579 . . . . 10.0 110.585 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 51.89 36.27 17.82 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.218 1.407 . . . . 10.0 109.772 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 3.66 42.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.43 1.014 . . . . 10.0 115.546 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -75.34 -66.3 0.78 Allowed 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.61 1.705 . . . . 10.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.89 -9.91 3.64 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.978 2.228 . . . . 10.0 109.82 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.18 139.65 46.46 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.355 1.578 . . . . 10.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -56.13 146.4 50.84 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.438 -0.791 . . . . 10.0 109.407 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -32.81 -66.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 1 C-N-CA 125.349 4.033 . . . . 10.0 115.68 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.29 44.5 3.06 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.583 -0.698 . . . . 10.0 113.074 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -158.13 158.65 35.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.673 1.236 . . . . 10.0 107.975 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 147.25 36.73 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.105 1.362 . . . . 10.0 108.662 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.21 160.15 42.84 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.413 2.075 . . . . 10.0 107.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -105.32 126.18 51.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -36.75 116.92 0.46 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.949 1.3 . . . . 10.0 113.073 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.6 115.52 44.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.14 -31.75 18.26 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.649 1.566 . . . . 10.0 110.589 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -43.56 29.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.151 1.38 . . . . 10.0 112.062 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -108.04 11.55 27.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.081 0.953 . . . . 10.0 111.28 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 52.15 37.93 23.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.272 1.029 . . . . 10.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 -8.35 19.18 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.799 -0.563 . . . . 10.0 113.993 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 m -71.38 -8.7 55.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.989 1.394 . . . . 10.0 114.438 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.92 -18.78 11.35 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.064 0.847 . . . . 10.0 113.729 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -133.61 131.62 39.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.246 1.023 . . . . 10.0 109.566 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 m -73.8 150.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.337 1.455 . . . . 10.0 107.291 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.51 107.22 14.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.341 0.657 . . . . 10.0 109.889 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.32 114.87 22.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -97.95 133.12 42.87 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.578 1.151 . . . . 10.0 109.984 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.07 80.94 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.902 1.681 . . . . 10.0 107.606 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.37 -64.2 2.5 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.996 0.807 . . . . 10.0 111.704 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.71 -66.69 0.82 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.258 1.023 . . . . 10.0 109.416 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -59.92 155.33 16.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.981 0.512 . . . . 10.0 109.715 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.01 157.21 43.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.418 0.287 . . . . 10.0 110.83 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.92 148.57 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.429 1.092 . . . . 10.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.83 144.76 30.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.883 0.873 . . . . 10.0 112.177 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -140.15 143.81 36.36 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.302 1.441 . . . . 10.0 107.843 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -53.09 135.39 37.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.253 0.933 . . . . 10.0 111.489 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.2 t -79.53 116.89 64.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.97 -41.94 3.59 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.133 1.889 . . . . 10.0 111.259 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.2 -29.83 2.59 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.95 1.092 . . . . 10.0 113.95 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.2 p -127.46 29.95 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.759 0.824 . . . . 10.0 111.594 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 38.78 49.83 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.239 1.416 . . . . 10.0 111.945 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.54 -11.03 3.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.203 1.241 . . . . 10.0 116.203 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -74.08 -13.82 60.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.106 1.953 . . . . 10.0 113.574 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.35 7.2 86.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.559 -0.578 . . . . 10.0 114.339 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -132.03 119.05 20.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.444 1.122 . . . . 10.0 110.565 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.03 150.19 43.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.002 1.321 . . . . 10.0 110.209 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -112.72 73.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 125.557 1.543 . . . . 10.0 109.961 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -68.45 -24.67 64.74 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.275 -0.891 . . . . 10.0 109.613 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -107.4 79.14 0.73 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.942 2.497 . . . . 10.0 110.323 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 118.09 5.06 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.296 2.664 . . . . 10.0 115.801 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.6 t -65.6 95.49 0.23 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.481 -1.674 . . . . 10.0 106.481 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -38.79 -48.81 1.56 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.869 1.668 . . . . 10.0 112.776 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -42.93 -39.89 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.725 1.21 . . . . 10.0 112.752 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.01 19.5 10.03 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.594 0.757 . . . . 10.0 111.047 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 46.38 41.93 9.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.653 1.181 . . . . 10.0 110.776 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.13 15.46 44.04 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.409 0.924 . . . . 10.0 115.409 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.83 -44.63 31.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.625 1.712 . . . . 10.0 109.009 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.75 -7.43 13.41 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.906 1.717 . . . . 10.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.62 152.85 32.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.881 -1.364 . . . . 10.0 109.688 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.08 146.45 13.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -98.59 137.69 36.86 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.344 -0.613 . . . . 10.0 109.344 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -78.26 59.98 2.41 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.064 -1.087 . . . . 10.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.31 1.044 . . . . 10.0 110.86 -178.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.457 0 N-CA-C 108.519 -1.833 . . . . 10.0 108.519 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.78 -23.68 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.504 1.122 . . . . 10.0 111.825 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -65.81 -35.9 81.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.906 2.082 . . . . 10.0 110.974 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -93.91 -49.61 5.73 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.378 1.071 . . . . 10.0 108.496 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.29 65.71 1.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.564 1.546 . . . . 10.0 108.292 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.5 pt -70.02 73.09 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.182 0.993 . . . . 10.0 112.142 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 55.36 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.08 2.152 . . . . 10.0 113.484 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.58 86.77 52.0 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.713 -1.588 . . . . 10.0 106.713 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -42.62 138.56 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.355 3.37 . . . . 10.0 115.297 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.57 146.27 14.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.358 -1.719 . . . . 10.0 106.358 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.59 147.7 23.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.907 0.483 . . . . 10.0 109.905 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -138.16 144.22 40.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.844 1.257 . . . . 10.0 108.059 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.95 142.95 45.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.0 t -76.58 87.26 3.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -41.67 -41.86 2.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.567 1.947 . . . . 10.0 111.751 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -51.67 -45.69 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 10.0 111.443 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.79 18.49 18.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.768 0.713 . . . . 10.0 110.599 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.83 35.95 25.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.26 1.424 . . . . 10.0 110.166 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.86 3.06 58.77 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.144 -1.364 . . . . 10.0 115.02 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -80.05 -75.22 0.27 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.012 1.906 . . . . 10.0 110.388 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.89 -19.25 0.76 Allowed Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.628 1.585 . . . . 10.0 112.308 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.71 151.53 26.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.596 1.698 . . . . 10.0 111.087 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -52.82 151.59 8.13 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.182 0.901 . . . . 10.0 111.92 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -50.51 137.23 40.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.54 2.827 . . . . 10.0 112.06 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.82 -51.8 2.75 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.598 1.094 . . . . 10.0 111.1 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -68.56 70.42 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.235 2.614 . . . . 10.0 108.904 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -56.76 158.43 8.68 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.383 0.673 . . . . 10.0 112.656 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.59 145.21 60.08 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.69 1.593 . . . . 10.0 109.287 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -84.6 123.01 29.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -50.78 121.35 5.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.914 0.886 . . . . 10.0 109.624 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.92 116.9 33.7 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.898 -0.778 . . . . 10.0 108.898 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.27 -38.46 6.66 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.582 1.521 . . . . 10.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.58 -39.71 7.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.289 1.836 . . . . 10.0 113.272 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -115.4 17.0 16.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.926 0.89 . . . . 10.0 111.568 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 47.1 49.71 14.77 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.0 0.92 . . . . 10.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.67 2.92 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.779 1.18 . . . . 10.0 115.247 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -90.12 2.84 54.86 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.843 1.321 . . . . 10.0 113.107 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.99 -8.82 5.83 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.776 1.07 . . . . 10.0 115.776 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.98 130.75 52.99 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.068 1.434 . . . . 10.0 110.031 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 m -87.95 143.85 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.658 -1.608 . . . . 10.0 106.658 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -98.33 110.67 23.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.93 -1.137 . . . . 10.0 107.93 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.6 tpt -75.79 73.29 2.73 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -69.44 55.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.064 2.146 . . . . 10.0 112.981 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.27 64.29 4.13 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.764 1.226 . . . . 10.0 108.414 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 -126.91 31.88 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -53.59 -47.83 69.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.306 1.042 . . . . 10.0 113.284 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -79.67 58.17 2.69 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.983 0.513 . . . . 10.0 111.143 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 59.0 2.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.261 0.625 . . . . 10.0 112.527 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.65 175.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -115.42 171.12 7.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -141.63 154.64 45.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.827 -1.916 . . . . 10.0 105.827 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -65.65 136.08 55.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 39.1 t -71.04 116.57 47.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.848 0.749 . . . . 10.0 109.649 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -38.99 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.874 1.716 . . . . 10.0 111.251 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -47.21 -41.14 17.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.004 1.322 . . . . 10.0 113.101 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.3 p -116.02 20.63 14.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.139 0.976 . . . . 10.0 111.299 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 46.8 42.92 12.58 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.374 1.07 . . . . 10.0 111.6 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.95 -4.09 11.18 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.433 0.933 . . . . 10.0 115.433 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -78.86 -5.5 53.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.644 1.722 . . . . 10.0 113.041 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.94 5.64 5.77 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.39 0.995 . . . . 10.0 114.642 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 p -129.14 132.41 47.34 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.773 1.229 . . . . 10.0 111.322 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -104.56 120.26 40.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.391 1.077 . . . . 10.0 110.111 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -78.01 65.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.356 1.462 . . . . 10.0 107.429 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -56.83 -45.43 82.34 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.296 0.57 . . . . 10.0 109.479 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -114.02 100.03 51.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.981 1.712 . . . . 10.0 108.475 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.72 131.04 19.13 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.925 1.75 . . . . 10.0 112.34 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.47 100.21 0.48 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -40.73 -50.37 3.1 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.63 1.572 . . . . 10.0 112.805 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -45.21 -40.0 6.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.861 1.265 . . . . 10.0 112.973 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -118.45 19.78 13.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.286 0.634 . . . . 10.0 111.004 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 46.5 42.92 11.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.647 1.179 . . . . 10.0 110.827 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.73 29.3 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.236 -1.313 . . . . 10.0 116.279 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -65.99 -55.95 14.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.278 2.039 . . . . 10.0 110.293 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.69 -9.62 16.51 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.718 1.151 . . . . 10.0 114.415 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.73 156.36 41.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.34 -1.356 . . . . 10.0 107.34 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.14 166.51 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.155 0.582 . . . . 10.0 109.69 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.57 136.59 36.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.817 -1.92 . . . . 10.0 105.817 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -51.11 116.19 1.89 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.414 -0.588 . . . . 10.0 109.414 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 124.334 1.054 . . . . 10.0 108.247 -177.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.788 0 N-CA-C 111.011 -0.836 . . . . 10.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.72 -42.69 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.607 0.763 . . . . 10.0 109.955 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -166.83 -166.64 0.85 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -167.92 -159.16 0.28 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.418 1.887 . . . . 10.0 107.074 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -75.67 65.92 1.92 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.555 -0.716 . . . . 10.0 109.936 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 62.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.942 0.897 . . . . 10.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 62.03 2.79 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.077 -1.014 . . . . 10.0 108.516 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mm -78.72 135.94 59.45 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 105.722 -1.955 . . . . 10.0 105.722 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.11 91.08 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.544 2.163 . . . . 10.0 108.609 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 62.51 0.25 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.558 1.943 . . . . 10.0 112.469 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.9 mt -68.28 109.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.998 -0.438 . . . . 10.0 109.845 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -118.05 147.09 43.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.79 138.34 58.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.406 0.441 . . . . 10.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.03 100.09 4.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.057 -1.461 . . . . 10.0 107.057 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.16 -43.38 20.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.563 . . . . 10.0 111.577 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.7 -29.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.277 1.431 . . . . 10.0 112.445 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.31 19.84 8.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.816 0.846 . . . . 10.0 110.808 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 44.93 42.44 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.344 1.458 . . . . 10.0 111.314 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.29 -11.26 38.34 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.165 1.226 . . . . 10.0 116.165 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.8 p -70.32 -68.72 0.4 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 120.036 1.918 . . . . 10.0 110.816 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.74 -5.5 5.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.863 2.173 . . . . 10.0 109.205 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.54 131.32 35.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.519 1.16 . . . . 10.0 109.159 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -54.69 159.41 3.53 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -42.5 137.35 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.983 3.122 . . . . 10.0 114.68 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.41 10.92 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.789 1.185 . . . . 10.0 114.157 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 m -127.36 136.07 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 146.12 33.26 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 124.12 0.968 . . . . 10.0 110.319 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -68.75 158.21 58.75 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 106.839 -2.023 . . . . 10.0 106.839 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -89.96 114.22 26.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -48.07 124.13 7.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.381 1.072 . . . . 10.0 109.866 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.53 115.39 17.96 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.74 -36.94 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.815 1.676 . . . . 10.0 110.725 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.61 -39.93 8.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.682 1.593 . . . . 10.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 p -114.6 12.65 17.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.788 . . . . 10.0 111.667 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.89 41.93 23.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.024 0.93 . . . . 10.0 109.895 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.53 -7.81 8.18 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.246 -0.752 . . . . 10.0 114.846 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -68.14 -9.06 43.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.499 1.65 . . . . 10.0 113.898 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.25 54.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.356 0.979 . . . . 10.0 113.68 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.4 143.55 30.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.509 1.154 . . . . 10.0 110.404 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.34 152.03 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.1 1.76 . . . . 10.0 107.534 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -125.66 118.94 26.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 89.6 mtp -104.02 121.48 43.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.873 1.269 . . . . 10.0 108.505 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -95.28 112.18 23.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.568 1.147 . . . . 10.0 108.914 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.82 53.73 2.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.43 -71.25 0.35 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.341 0.972 . . . . 10.0 112.427 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -80.56 -68.49 0.68 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 10.0 110.099 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.94 174.31 7.23 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.269 0.628 . . . . 10.0 110.058 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.14 43.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.703 0.801 . . . . 10.0 109.443 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 164.58 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 124.644 1.177 . . . . 10.0 108.576 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.56 152.63 43.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.113 0.965 . . . . 10.0 111.621 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.1 160.04 41.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -59.75 136.74 58.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.4 t -72.05 117.14 55.58 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.812 0.733 . . . . 10.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.09 -40.44 6.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.086 1.857 . . . . 10.0 111.357 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -45.85 -36.87 5.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.651 1.18 . . . . 10.0 113.013 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.4 p -121.43 21.49 10.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.877 0.871 . . . . 10.0 111.595 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 44.86 42.99 6.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.407 1.083 . . . . 10.0 111.705 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -4.76 9.13 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.699 1.04 . . . . 10.0 115.699 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -77.62 -7.8 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.425 1.612 . . . . 10.0 112.932 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.82 -2.21 2.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.105 0.86 . . . . 10.0 114.14 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 135.28 49.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.657 1.583 . . . . 10.0 109.876 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -101.88 119.79 39.35 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.773 1.229 . . . . 10.0 108.252 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.0 66.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 10.0 108.351 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -63.43 -35.51 80.68 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.786 -0.571 . . . . 10.0 110.22 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -109.64 77.05 0.96 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 127.795 2.438 . . . . 10.0 110.086 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.81 124.52 13.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.222 2.614 . . . . 10.0 115.591 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.99 94.89 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.495 1.518 . . . . 10.0 107.989 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -39.54 -47.83 1.95 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.476 1.51 . . . . 10.0 113.273 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -45.97 -43.29 13.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.972 0.909 . . . . 10.0 112.7 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.43 19.69 16.72 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 122.923 0.489 . . . . 10.0 110.461 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.08 40.85 18.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.436 1.094 . . . . 10.0 110.314 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.44 20.56 45.61 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.388 -0.673 . . . . 10.0 114.325 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -67.69 0.65 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.145 1.473 . . . . 10.0 107.371 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.92 -45.04 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.475 -0.65 . . . . 10.0 111.475 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.29 161.36 26.0 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.167 0.987 . . . . 10.0 110.237 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.7 149.78 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.226 1.011 . . . . 10.0 110.107 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.2 71.55 2.23 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.321 1.048 . . . . 10.0 109.371 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 67.14 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.906 2.083 . . . . 10.0 109.044 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.451 -0.422 0 C-N-CA 125.875 1.67 . . . . 10.0 111.724 -175.552 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 108.93 -1.668 . . . . 10.0 108.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.25 -49.78 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.6 p -78.35 68.35 4.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -49.7 -37.37 28.71 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.922 1.289 . . . . 10.0 111.856 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -73.23 63.7 0.74 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.951 1.3 . . . . 10.0 110.279 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.0 pt -73.53 53.93 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.56 1.144 . . . . 10.0 111.986 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -98.36 36.56 1.59 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.586 1.154 . . . . 10.0 108.747 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -157.15 155.65 28.29 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 128.627 2.771 . . . . 10.0 104.591 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.38 74.76 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.977 3.118 . . . . 10.0 111.072 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -78.23 67.32 4.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.177 1.391 . . . . 10.0 108.391 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 mt -101.72 142.3 33.26 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.938 1.295 . . . . 10.0 110.903 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -129.82 156.26 44.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.731 1.612 . . . . 10.0 108.243 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.18 137.08 58.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.197 0.599 . . . . 10.0 109.783 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 t -76.6 81.63 3.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -46.18 -38.19 8.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.419 1.487 . . . . 10.0 111.502 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.04 -42.5 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.359 1.464 . . . . 10.0 111.776 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.8 p -110.36 20.19 18.03 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.511 0.724 . . . . 10.0 110.34 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 49.93 38.01 15.17 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.418 1.487 . . . . 10.0 110.27 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.84 0.54 14.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.544 -1.142 . . . . 10.0 115.384 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -73.77 -57.88 3.68 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 120.123 1.961 . . . . 10.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.85 5.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.433 1.968 . . . . 10.0 109.829 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 129.57 40.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.215 1.008 . . . . 10.0 112.172 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -42.2 145.59 0.76 Allowed Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.556 1.943 . . . . 10.0 111.729 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -39.13 132.08 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.725 2.95 . . . . 10.0 113.139 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.46 15.27 23.85 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.13 -0.817 . . . . 10.0 114.307 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -119.21 157.51 27.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.783 1.233 . . . . 10.0 107.717 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.99 152.63 43.77 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.1 1.36 . . . . 10.0 109.019 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.83 -177.9 4.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.149 1.899 . . . . 10.0 108.996 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -117.64 125.93 51.61 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -47.01 122.33 4.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.305 1.042 . . . . 10.0 110.897 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.61 115.79 27.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 -36.76 9.04 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.603 1.535 . . . . 10.0 110.887 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -46.32 -38.88 9.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.951 1.7 . . . . 10.0 112.985 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.21 19.99 13.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.089 0.956 . . . . 10.0 111.261 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 46.65 42.68 11.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.357 1.063 . . . . 10.0 111.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.41 -6.31 11.87 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.691 -1.061 . . . . 10.0 115.615 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.3 p -68.12 -44.48 76.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.073 1.936 . . . . 10.0 112.069 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.59 2.51 34.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.264 1.411 . . . . 10.0 111.136 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -128.82 130.07 46.46 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.714 1.257 . . . . 10.0 110.19 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.51 132.73 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -116.92 116.53 27.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.9 mmt -68.98 158.48 34.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -144.28 41.34 1.37 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.769 0.828 . . . . 10.0 109.854 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -163.69 0.59 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.015 1.726 . . . . 10.0 107.754 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.25 3.24 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.975 -0.85 . . . . 10.0 110.975 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -158.07 -60.74 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.295 0.547 . . . . 10.0 110.915 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -135.77 156.15 49.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.211 1.404 . . . . 10.0 107.404 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.7 63.03 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -78.34 172.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 123.412 0.685 . . . . 10.0 111.005 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.1 164.24 30.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.421 0.526 . . . . 10.0 112.421 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -144.6 161.69 38.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.718 1.207 . . . . 10.0 108.272 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -62.41 134.17 56.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.52 117.1 40.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 119.031 0.832 . . . . 10.0 109.748 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.88 -39.8 5.86 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.819 1.679 . . . . 10.0 111.241 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.88 -39.88 27.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.501 1.12 . . . . 10.0 113.635 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.8 p -113.12 16.23 19.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.196 0.998 . . . . 10.0 111.384 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 48.07 44.57 19.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 10.0 110.608 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.57 -2.36 16.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -78.63 -2.67 40.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.028 1.914 . . . . 10.0 113.343 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.54 -0.28 2.22 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.176 0.893 . . . . 10.0 114.279 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -125.71 128.59 48.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.628 1.571 . . . . 10.0 109.971 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.41 144.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.588 -1.264 . . . . 10.0 107.588 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mm -108.62 73.74 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.515 1.126 . . . . 10.0 109.334 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -66.14 -27.82 68.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.968 . . . . 10.0 108.719 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 80.23 0.42 Allowed Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 127.392 2.277 . . . . 10.0 110.061 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.36 121.69 9.01 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.292 2.661 . . . . 10.0 114.716 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.0 t -68.55 91.65 0.43 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.339 -1.726 . . . . 10.0 106.339 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -40.87 -44.19 2.23 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 125.347 1.459 . . . . 10.0 112.596 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -44.16 -37.22 3.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.08 0.952 . . . . 10.0 112.599 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -124.22 14.01 9.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.009 . . . . 10.0 111.243 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m80 45.73 43.24 9.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.46 1.104 . . . . 10.0 110.612 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.3 38.27 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.64 -37.82 59.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.011 1.906 . . . . 10.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.99 34.02 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.406 1.003 . . . . 10.0 114.925 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.77 155.37 45.61 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 119.162 1.481 . . . . 10.0 110.367 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.6 m -134.19 155.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 125.136 1.374 . . . . 10.0 108.676 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.91 148.33 23.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.533 0.733 . . . . 10.0 109.424 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -75.56 49.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.795 0.838 . . . . 10.0 110.623 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.452 -0.336 0 O-C-N 121.077 -1.014 . . . . 10.0 111.021 -177.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 109.143 -1.583 . . . . 10.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -54.42 -34.82 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -63.08 -33.09 74.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.816 2.046 . . . . 10.0 112.302 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -85.25 -41.28 15.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.353 1.061 . . . . 10.0 109.44 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -56.8 145.69 28.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.02 0.928 . . . . 10.0 109.495 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt -71.22 66.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.782 0.833 . . . . 10.0 113.018 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -79.11 56.86 2.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.139 0.975 . . . . 10.0 109.644 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 pt -70.7 132.3 87.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.397 -0.811 . . . . 10.0 108.908 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.85 103.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.118 3.212 . . . . 10.0 112.965 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 m -134.05 129.21 35.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.4 mt -76.28 136.32 39.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.305 0.502 . . . . 10.0 109.667 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -134.02 146.12 50.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.627 1.171 . . . . 10.0 108.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.68 144.2 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.466 -0.568 . . . . 10.0 109.466 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.51 91.31 5.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -46.69 -38.9 10.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.415 1.486 . . . . 10.0 111.814 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.5 t -49.59 -43.01 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.392 1.477 . . . . 10.0 111.278 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 20.22 18.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.952 0.501 . . . . 10.0 110.688 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 52.84 38.56 27.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.152 1.381 . . . . 10.0 110.099 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.99 -3.11 47.6 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.411 -1.216 . . . . 10.0 115.167 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -78.0 -74.51 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.144 1.972 . . . . 10.0 111.36 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.9 -18.0 1.09 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.626 1.108 . . . . 10.0 111.847 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.73 140.9 31.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.662 1.731 . . . . 10.0 109.587 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 157.6 2.47 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.008 0.744 . . . . 10.0 113.008 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -41.67 136.72 2.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.643 3.562 . . . . 10.0 115.337 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -60.25 2.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.582 0.611 . . . . 10.0 112.227 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 m -70.91 79.69 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.327 0.584 . . . . 10.0 109.928 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.78 162.95 4.43 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.183 0.993 . . . . 10.0 111.865 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.55 153.54 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.86 1.707 . . . . 10.0 110.215 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -98.49 135.0 40.67 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.797 -0.445 . . . . 10.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -50.82 124.93 12.14 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.058 0.943 . . . . 10.0 110.738 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -68.19 115.85 33.22 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 118.597 0.635 . . . . 10.0 109.445 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.25 -34.75 12.39 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.43 1.42 . . . . 10.0 110.806 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -46.25 -38.26 8.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.624 1.569 . . . . 10.0 113.22 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.23 15.29 13.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.315 1.046 . . . . 10.0 110.718 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 50.0 40.59 21.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.973 0.909 . . . . 10.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.06 10.34 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.851 0.739 . . . . 10.0 114.654 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.4 m -64.29 -28.29 69.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.918 1.359 . . . . 10.0 113.339 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 -16.79 57.56 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.483 1.04 . . . . 10.0 114.776 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 146.75 52.47 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.946 1.373 . . . . 10.0 110.455 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.23 155.14 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.271 1.428 . . . . 10.0 107.146 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -126.54 114.71 18.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.2 mtp -76.53 73.17 3.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.87 60.69 0.17 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.144 1.378 . . . . 10.0 112.408 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 48.29 0.63 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.504 1.122 . . . . 10.0 110.797 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.2 -61.78 2.22 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.344 -0.847 . . . . 10.0 112.432 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -102.35 -72.66 0.68 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.981 0.89 . . . . 10.0 113.359 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -73.64 68.99 1.25 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.568 -0.708 . . . . 10.0 111.553 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 59.74 0.63 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.424 1.09 . . . . 10.0 111.35 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.0 m -78.6 151.96 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 C-N-CA 123.138 0.575 . . . . 10.0 111.295 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.1 150.88 24.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.414 1.086 . . . . 10.0 111.921 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -145.13 151.11 37.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -60.5 135.93 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.51 116.38 48.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.001 0.819 . . . . 10.0 109.29 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.02 -38.38 7.3 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.156 1.904 . . . . 10.0 111.33 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -45.3 -42.52 9.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.961 1.704 . . . . 10.0 112.258 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -115.21 20.79 14.69 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.195 0.998 . . . . 10.0 112.077 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 46.92 41.9 11.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.53 1.132 . . . . 10.0 111.354 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.22 -7.04 6.42 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.409 0.923 . . . . 10.0 115.409 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.34 -9.33 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.61 1.705 . . . . 10.0 113.443 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.02 3.33 10.63 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.568 -0.707 . . . . 10.0 112.941 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.78 133.11 47.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.078 1.751 . . . . 10.0 109.933 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.04 122.68 43.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.207 1.403 . . . . 10.0 109.905 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.5 mm -81.02 67.14 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.637 1.575 . . . . 10.0 107.092 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -57.56 -38.03 74.11 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.562 0.579 . . . . 10.0 112.562 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -125.98 84.25 61.56 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.283 1.433 . . . . 10.0 110.44 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.53 132.34 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.959 3.773 . . . . 10.0 115.914 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.1 t -74.62 95.15 2.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -37.4 -50.05 1.04 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.76 1.624 . . . . 10.0 113.009 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -45.13 -36.15 3.54 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.397 1.079 . . . . 10.0 113.508 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -122.59 15.55 10.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.477 0.711 . . . . 10.0 110.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 43.98 45.33 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.939 1.295 . . . . 10.0 111.15 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.78 -3.1 13.51 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 116.291 1.277 . . . . 10.0 116.291 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -66.84 -36.88 83.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.14 1.97 . . . . 10.0 111.132 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.48 56.17 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 123.99 0.805 . . . . 10.0 113.333 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -135.93 160.93 37.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.453 1.126 . . . . 10.0 110.14 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.71 157.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.344 1.457 . . . . 10.0 107.895 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.29 126.97 50.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.861 0.864 . . . . 10.0 109.096 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -77.09 62.93 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.454 -0.249 0 O-C-N 121.463 -0.773 . . . . 10.0 110.919 -177.317 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 109.192 -1.563 . . . . 10.0 109.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.46 152.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 117.193 0.497 . . . . 10.0 109.921 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t -64.85 154.32 37.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.029 0.442 . . . . 10.0 110.069 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.49 -28.26 69.07 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.08 57.76 2.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.801 -0.562 . . . . 10.0 111.476 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 pt -66.11 -15.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.892 0.377 . . . . 10.0 111.351 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -76.56 51.76 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.342 1.857 . . . . 10.0 108.851 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -55.48 138.11 68.81 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.078 0.551 . . . . 10.0 110.222 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.59 51.79 3.09 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.301 2.668 . . . . 10.0 112.88 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -81.11 55.82 2.63 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.1 mt -140.02 137.13 34.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.361 1.464 . . . . 10.0 108.687 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -109.0 128.36 54.89 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.226 1.811 . . . . 10.0 107.656 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 128.89 39.06 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.573 0.749 . . . . 10.0 109.84 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 t -79.48 88.99 5.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.032 -0.729 . . . . 10.0 109.032 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -49.3 -36.01 19.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.064 1.346 . . . . 10.0 111.418 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -49.47 -48.29 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.796 1.238 . . . . 10.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.1 p -103.21 23.45 12.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.411 0.624 . . . . 10.0 111.001 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 53.33 37.14 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.259 1.424 . . . . 10.0 110.604 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.45 47.37 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.592 -1.115 . . . . 10.0 115.109 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -84.52 -69.57 0.64 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.751 1.775 . . . . 10.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.58 -24.89 1.51 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.205 1.859 . . . . 10.0 109.994 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.99 131.86 40.95 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.804 0.802 . . . . 10.0 111.063 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.7 143.34 6.01 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.849 -0.596 . . . . 10.0 111.741 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -22.27 126.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 1 C-N-CA 127.321 5.347 . . . . 10.0 117.163 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.1 -48.25 2.39 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.848 0.737 . . . . 10.0 112.831 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.89 128.74 38.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.246 1.418 . . . . 10.0 109.772 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.56 152.47 63.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 122.032 -0.418 . . . . 10.0 111.481 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 179.28 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.072 1.848 . . . . 10.0 108.941 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -121.5 131.72 54.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -50.49 125.32 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.056 0.942 . . . . 10.0 112.088 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.36 116.08 45.6 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.5 -38.79 7.86 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.353 1.368 . . . . 10.0 110.589 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -45.2 -39.42 6.25 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.314 1.846 . . . . 10.0 113.06 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.37 30.68 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.744 0.818 . . . . 10.0 110.641 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 39.78 47.96 1.89 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.305 1.442 . . . . 10.0 113.261 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 -4.17 39.61 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 116.279 1.272 . . . . 10.0 116.279 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 p -84.14 -68.99 0.67 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.127 1.964 . . . . 10.0 111.939 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.19 -5.28 0.65 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.261 -1.299 . . . . 10.0 116.277 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 143.55 47.32 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.46 2.13 . . . . 10.0 112.459 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -99.4 130.38 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.611 1.564 . . . . 10.0 108.153 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -103.21 106.31 16.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.045 0.538 . . . . 10.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.3 tpp -77.44 72.76 4.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.4 65.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.38 2.272 . . . . 10.0 112.98 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -79.25 70.07 5.58 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -136.96 27.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.945 -1.262 . . . . 10.0 109.945 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -55.1 -34.93 64.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.074 0.95 . . . . 10.0 112.128 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -74.29 72.13 1.76 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.743 0.817 . . . . 10.0 110.164 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 58.5 0.51 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.544 1.138 . . . . 10.0 111.544 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 m -81.47 157.35 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.538 0.735 . . . . 10.0 109.791 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.25 164.97 29.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.227 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.69 153.38 42.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.043 1.337 . . . . 10.0 108.021 -175.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.7 m -60.44 136.4 58.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.74 116.77 51.39 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.42 -39.21 7.44 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.08 1.853 . . . . 10.0 112.116 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.42 -36.88 45.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.1 p -112.82 16.69 19.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.077 0.951 . . . . 10.0 111.28 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 47.77 42.9 16.43 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.987 1.315 . . . . 10.0 110.813 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.78 1.07 53.5 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -87.8 5.65 39.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.623 1.711 . . . . 10.0 113.583 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.42 -3.88 0.75 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.091 0.853 . . . . 10.0 115.009 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -121.81 125.96 47.7 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.417 1.487 . . . . 10.0 111.255 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.68 152.59 23.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.89 85.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -66.89 -23.05 65.96 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -111.62 68.3 0.75 Allowed Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 128.294 2.638 . . . . 10.0 109.973 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.31 133.74 27.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.269 2.646 . . . . 10.0 115.491 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.0 t -70.24 93.16 0.82 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.336 -1.357 . . . . 10.0 107.336 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -40.62 -45.4 2.33 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.693 1.597 . . . . 10.0 112.582 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -42.35 -40.01 2.35 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.348 1.459 . . . . 10.0 112.464 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -124.83 23.08 8.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.906 0.883 . . . . 10.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 46.22 40.96 8.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.987 1.315 . . . . 10.0 111.069 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.04 14.89 48.09 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 118.814 -0.992 . . . . 10.0 115.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.02 -23.57 44.24 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.726 1.763 . . . . 10.0 110.578 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.97 3.18 80.09 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.649 1.595 . . . . 10.0 114.38 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 153.1 31.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.304 1.052 . . . . 10.0 109.288 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.09 140.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 107.752 -1.203 . . . . 10.0 107.752 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -66.16 134.2 52.26 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.727 -0.608 . . . . 10.0 110.646 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -77.47 65.21 2.96 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.674 -0.862 . . . . 10.0 108.674 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.342 1.057 . . . . 10.0 109.045 -179.224 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.856 0 N-CA-C 110.114 -1.194 . . . . 10.0 110.114 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.15 174.57 7.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.32 1.448 . . . . 10.0 107.952 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.9 p -74.6 61.12 0.94 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.26 1.024 . . . . 10.0 111.433 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -94.37 -44.32 7.97 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.625 1.17 . . . . 10.0 108.124 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.08 51.02 0.94 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.305 0.642 . . . . 10.0 111.475 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.37 61.62 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.764 0.792 . . . . 10.0 109.871 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -79.73 71.98 6.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.4 mt -42.56 135.19 2.66 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.455 1.502 . . . . 10.0 108.669 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.1 62.19 1.95 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.831 3.02 . . . . 10.0 113.878 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m -142.41 54.62 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.038 -2.208 . . . . 10.0 105.038 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.3 mt -141.43 155.43 45.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.815 1.646 . . . . 10.0 108.11 -177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -132.23 124.58 29.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.034 1.733 . . . . 10.0 108.15 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -62.43 135.05 57.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.291 0.636 . . . . 10.0 110.02 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.75 114.56 8.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -54.77 -42.78 72.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.228 0.611 . . . . 10.0 111.018 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -54.08 -49.59 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.346 1.058 . . . . 10.0 112.447 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.65 -0.44 51.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.609 0.64 . . . . 10.0 112.061 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 66.74 40.52 3.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.766 1.227 . . . . 10.0 109.437 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.39 -3.51 39.98 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.151 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.5 p -75.68 -69.22 0.5 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.073 1.937 . . . . 10.0 110.362 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.26 -8.47 4.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.08 2.752 . . . . 10.0 109.443 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.7 133.93 39.37 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.141 0.971 . . . . 10.0 110.728 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -44.91 142.6 2.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.258 1.423 . . . . 10.0 110.69 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.92 141.68 45.41 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.659 2.239 . . . . 10.0 110.906 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.75 21.04 34.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.642 0.639 . . . . 10.0 113.144 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -134.03 160.56 37.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.7 148.7 51.34 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.197 0.999 . . . . 10.0 111.825 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.09 -179.05 5.09 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.15 2.566 . . . . 10.0 108.395 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -117.23 129.71 56.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -49.02 123.53 7.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.745 1.218 . . . . 10.0 110.845 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.2 t -65.68 115.83 26.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.85 -35.69 11.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.646 1.564 . . . . 10.0 111.092 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.71 -38.24 9.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.767 1.627 . . . . 10.0 112.997 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -117.45 15.59 14.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 111.333 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.7 40.91 21.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.18 0.992 . . . . 10.0 110.376 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.18 -11.79 7.88 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.628 0.632 . . . . 10.0 114.535 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -66.98 -11.85 58.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.997 1.398 . . . . 10.0 114.302 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.66 41.23 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.795 -0.566 . . . . 10.0 113.384 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 125.56 33.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.536 1.134 . . . . 10.0 109.163 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.32 131.3 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.72 111.5 21.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.0 mmm -74.24 72.35 1.75 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.003 1.321 . . . . 10.0 108.274 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -66.21 62.48 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.519 1.928 . . . . 10.0 112.704 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 51.86 1.01 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.648 1.179 . . . . 10.0 110.435 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.06 -67.28 0.48 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.27 0.938 . . . . 10.0 113.291 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -98.23 -72.51 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.76 1.224 . . . . 10.0 112.655 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -77.35 69.72 3.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.179 0.899 . . . . 10.0 110.881 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.8 59.68 0.9 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.805 0.842 . . . . 10.0 111.546 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.22 163.59 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.14 0.576 . . . . 10.0 110.246 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -125.04 171.17 10.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.23 154.04 45.58 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -62.21 133.52 55.31 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.37 117.16 56.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.849 0.75 . . . . 10.0 109.62 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.16 -36.38 5.76 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.166 1.911 . . . . 10.0 111.286 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -39.57 24.09 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.529 1.132 . . . . 10.0 112.543 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.7 p -117.62 20.12 13.61 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.249 1.019 . . . . 10.0 110.806 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 42.92 45.49 4.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.437 1.495 . . . . 10.0 112.177 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -9.2 5.36 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.237 0.855 . . . . 10.0 115.237 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -73.57 -8.44 55.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.257 1.529 . . . . 10.0 112.363 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 -13.06 0.55 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.533 1.063 . . . . 10.0 115.167 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.79 133.52 55.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.833 1.653 . . . . 10.0 110.904 -174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.0 116.91 28.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.17 66.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.633 1.573 . . . . 10.0 108.438 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -62.61 -34.08 76.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.255 0.55 . . . . 10.0 109.713 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -107.98 79.91 0.96 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.145 2.578 . . . . 10.0 109.69 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 125.79 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.477 2.118 . . . . 10.0 114.998 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.32 87.13 0.43 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -38.64 -44.7 1.01 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.218 1.807 . . . . 10.0 112.83 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -44.7 -41.42 6.76 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.801 1.24 . . . . 10.0 112.362 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.99 27.4 8.09 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.668 0.787 . . . . 10.0 109.963 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 45.62 37.72 3.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.937 1.695 . . . . 10.0 111.827 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.91 9.46 46.7 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 114.98 0.752 . . . . 10.0 114.98 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.66 -32.16 69.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.299 1.55 . . . . 10.0 109.563 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.44 -23.71 32.49 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.19 1.376 . . . . 10.0 113.525 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.32 151.5 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.267 1.034 . . . . 10.0 109.736 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.26 154.67 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.965 1.306 . . . . 10.0 107.662 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -69.42 142.89 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.577 -0.702 . . . . 10.0 110.216 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -69.42 70.84 0.28 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.734 1.214 . . . . 10.0 109.515 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 125.771 1.628 . . . . 10.0 110.653 -176.211 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 110.501 -1.04 . . . . 10.0 110.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -54.52 71.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.312 2.245 . . . . 10.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -145.55 -78.57 0.18 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.497 1.919 . . . . 10.0 107.312 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -141.22 -56.36 0.49 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.73 2.412 . . . . 10.0 106.126 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.88 72.55 2.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.12 63.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.785 1.634 . . . . 10.0 111.639 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.8 mtm105 -76.55 59.18 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.991 1.316 . . . . 10.0 111.811 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' N ' ' CD ' ' A' ' 9' ' ' PRO 0.278 9.3 mm -60.33 -49.4 90.66 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.106 -0.237 . . . . 10.0 110.77 174.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 8' ' ' ILE . 18.3 Cg_exo -67.88 175.24 6.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.471 3.448 . . . . 10.0 109.761 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -59.73 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.386 2.674 . . . . 10.0 114.346 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.5 mt -132.54 145.75 51.38 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.655 1.182 . . . . 10.0 111.555 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -119.22 144.35 46.78 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.463 1.505 . . . . 10.0 109.929 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.78 135.74 56.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -77.98 87.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -46.46 -38.53 9.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.55 1.54 . . . . 10.0 111.312 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.69 -43.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.897 1.279 . . . . 10.0 111.029 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.64 13.99 29.06 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.845 0.458 . . . . 10.0 111.802 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 53.79 33.15 16.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 10.0 110.496 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.23 3.8 33.14 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.777 -1.013 . . . . 10.0 114.861 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 p -83.93 -24.55 30.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.602 1.701 . . . . 10.0 112.208 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.74 -9.99 74.73 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 119.029 -0.873 . . . . 10.0 110.927 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.6 139.11 33.98 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.862 1.331 . . . . 10.0 111.267 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -50.5 155.46 1.82 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.277 0.631 . . . . 10.0 111.56 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -28.53 121.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 125.308 4.005 . . . . 10.0 116.292 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.86 16.39 1.18 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.165 1.841 . . . . 10.0 116.021 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -93.08 119.51 32.39 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.193 1.496 . . . . 10.0 108.615 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.09 128.28 84.93 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.516 -0.754 . . . . 10.0 111.085 -178.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -68.31 -175.97 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.522 2.148 . . . . 10.0 111.618 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -122.33 120.64 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.774 1.63 . . . . 10.0 107.295 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -48.97 124.77 9.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.621 1.168 . . . . 10.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.2 117.32 48.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.62 -38.5 8.02 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.432 1.421 . . . . 10.0 110.898 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -40.1 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.962 1.705 . . . . 10.0 113.221 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.2 21.84 12.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.822 0.849 . . . . 10.0 111.174 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 45.52 43.63 9.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.354 1.062 . . . . 10.0 111.676 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.91 -4.03 25.13 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.422 -1.21 . . . . 10.0 115.987 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -68.53 -58.05 4.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.197 1.998 . . . . 10.0 111.609 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.77 3.31 7.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.233 1.873 . . . . 10.0 110.85 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 131.06 33.03 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.803 1.301 . . . . 10.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -87.09 157.92 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.684 1.193 . . . . 10.0 108.558 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -123.81 112.7 17.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.683 1.193 . . . . 10.0 108.132 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.28 73.08 3.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -68.68 64.41 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.04 1.336 . . . . 10.0 111.885 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.99 59.03 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.437 1.095 . . . . 10.0 110.439 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.69 -66.3 1.08 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.253 0.93 . . . . 10.0 113.028 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -109.68 -65.94 1.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.86 0.864 . . . . 10.0 112.743 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.77 68.49 1.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.911 -0.493 . . . . 10.0 111.324 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.26 63.96 1.06 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.605 1.162 . . . . 10.0 112.077 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.1 m -75.08 160.28 5.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 123.12 0.568 . . . . 10.0 111.707 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -117.91 152.46 35.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.935 0.894 . . . . 10.0 112.907 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -147.1 154.98 41.78 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.366 1.067 . . . . 10.0 108.564 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -60.7 139.38 57.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.37 116.72 57.27 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.54 -37.73 5.19 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.913 1.742 . . . . 10.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.53 -38.93 32.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.958 1.303 . . . . 10.0 113.37 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.4 p -115.7 23.21 12.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.507 1.123 . . . . 10.0 110.988 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 41.25 49.22 3.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.485 1.514 . . . . 10.0 111.987 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.45 -3.55 11.22 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.449 1.34 . . . . 10.0 116.449 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -73.81 -31.34 63.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.173 1.986 . . . . 10.0 112.318 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -6.86 83.16 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.572 -0.611 . . . . 10.0 111.572 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.6 p -116.65 122.87 45.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.708 1.203 . . . . 10.0 111.628 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.4 mt -91.23 171.61 9.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.695 -1.594 . . . . 10.0 106.695 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.53 126.59 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -67.52 -37.63 83.06 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.293 -1.003 . . . . 10.0 108.293 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -109.62 76.79 0.93 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.689 2.396 . . . . 10.0 108.855 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.75 157.06 61.71 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.894 2.396 . . . . 10.0 113.614 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.23 85.71 0.57 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.982 0.913 . . . . 10.0 109.307 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -36.94 -47.38 0.7 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.357 1.863 . . . . 10.0 112.606 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -40.9 -39.53 1.17 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.946 1.698 . . . . 10.0 112.597 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.2 p -127.21 25.1 6.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.823 0.849 . . . . 10.0 110.927 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 49.39 35.96 8.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.613 0.765 . . . . 10.0 110.237 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.6 21.85 29.98 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.78 -1.011 . . . . 10.0 114.64 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -27.52 60.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.397 1.599 . . . . 10.0 111.29 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.99 -8.79 65.44 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.63 1.11 . . . . 10.0 111.976 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -139.46 153.66 47.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.094 0.947 . . . . 10.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.36 173.71 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 127.027 2.131 . . . . 10.0 106.914 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -77.75 139.9 39.43 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.525 -0.734 . . . . 10.0 111.434 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -71.19 67.79 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.944 2.098 . . . . 10.0 108.109 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.942 1.697 . . . . 10.0 110.703 -175.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 108.668 -1.773 . . . . 10.0 108.668 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -56.17 -29.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.407 0.683 . . . . 10.0 110.365 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 p -55.24 -35.62 65.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.817 1.647 . . . . 10.0 110.922 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.83 -51.09 5.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.81 60.23 1.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.95 0.9 . . . . 10.0 111.061 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 pt -78.71 64.08 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -75.55 61.12 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.523 1.129 . . . . 10.0 110.632 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -138.21 154.51 74.01 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.679 1.992 . . . . 10.0 107.187 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.32 73.26 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.533 3.489 . . . . 10.0 109.803 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 m -71.0 112.06 6.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.597 1.159 . . . . 10.0 109.853 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.61 149.31 34.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -139.53 150.77 45.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.397 1.479 . . . . 10.0 107.463 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -79.58 137.37 37.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.014 0.526 . . . . 10.0 109.587 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.36 89.22 3.18 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.474 -0.936 . . . . 10.0 108.474 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -44.18 -39.78 4.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.912 1.685 . . . . 10.0 112.153 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -49.25 -42.35 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.457 1.503 . . . . 10.0 111.83 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.1 p -108.32 18.72 20.73 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.828 0.851 . . . . 10.0 110.386 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 52.57 36.49 20.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.209 1.404 . . . . 10.0 110.086 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.95 -0.87 35.21 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.393 -1.226 . . . . 10.0 114.982 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -73.27 -67.22 0.6 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.066 1.933 . . . . 10.0 111.194 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.66 -17.36 3.27 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.267 1.889 . . . . 10.0 110.031 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.98 154.12 38.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.509 1.155 . . . . 10.0 108.92 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -54.99 167.9 0.58 Allowed Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 119.871 1.214 . . . . 10.0 113.38 -174.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -39.99 122.98 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.899 3.066 . . . . 10.0 114.325 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.61 26.22 7.39 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.806 1.193 . . . . 10.0 114.461 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.0 m -113.92 145.94 40.78 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.269 -1.382 . . . . 10.0 107.269 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -92.26 151.05 41.23 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 117.947 0.339 . . . . 10.0 110.744 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.59 -179.37 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.235 1.957 . . . . 10.0 108.067 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -110.11 125.5 53.05 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -49.42 124.73 9.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.142 0.977 . . . . 10.0 110.343 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.47 116.72 39.98 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 -37.78 6.95 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.844 1.696 . . . . 10.0 110.915 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.58 -40.82 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.1 1.76 . . . . 10.0 112.957 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.8 16.64 18.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.034 0.934 . . . . 10.0 111.534 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.26 42.3 13.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.301 1.041 . . . . 10.0 110.594 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.18 -4.95 5.49 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.475 -1.181 . . . . 10.0 115.775 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.6 p -67.53 -36.32 80.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.452 2.126 . . . . 10.0 111.972 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.36 50.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.506 1.05 . . . . 10.0 112.651 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -134.02 150.17 51.22 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.993 1.397 . . . . 10.0 111.0 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.4 130.07 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -115.67 110.47 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.522 0.677 . . . . 10.0 109.796 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 62.3 mmm -73.25 79.96 1.32 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.106 1.362 . . . . 10.0 107.328 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.73 67.72 0.81 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.008 0.923 . . . . 10.0 110.012 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.37 70.3 0.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.725 1.21 . . . . 10.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 -63.63 2.07 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.421 1.01 . . . . 10.0 111.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.72 -35.84 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.364 0.666 . . . . 10.0 112.707 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -75.46 59.59 1.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.538 1.063 . . . . 10.0 109.991 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 128.58 36.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.741 0.816 . . . . 10.0 111.275 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.52 155.88 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 106.868 -1.53 . . . . 10.0 106.868 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.81 161.48 37.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.775 0.657 . . . . 10.0 112.775 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.63 163.86 31.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.631 1.172 . . . . 10.0 108.57 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -61.78 137.51 58.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -69.98 117.29 52.49 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.861 0.755 . . . . 10.0 109.148 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 -40.31 5.18 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.124 1.882 . . . . 10.0 111.479 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.09 -39.58 20.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.798 1.239 . . . . 10.0 113.284 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.4 p -116.08 21.73 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.102 0.961 . . . . 10.0 111.48 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 44.1 44.97 6.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.561 1.145 . . . . 10.0 111.517 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 -6.14 8.26 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.214 1.246 . . . . 10.0 116.214 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -76.69 -8.72 57.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.361 2.08 . . . . 10.0 112.672 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.08 6.12 23.87 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.496 -0.752 . . . . 10.0 112.449 -174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.87 131.28 38.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.748 1.219 . . . . 10.0 111.574 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.87 122.26 32.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.532 1.533 . . . . 10.0 107.699 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 mm -75.74 77.33 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 124.694 1.198 . . . . 10.0 108.815 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -37.2 -51.51 1.02 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.805 2.042 . . . . 10.0 111.792 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 119.01 10.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.854 1.662 . . . . 10.0 106.673 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 126.46 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.34 2.027 . . . . 10.0 113.782 -174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.65 94.63 0.8 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.597 1.159 . . . . 10.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -38.25 -48.98 1.35 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.346 1.458 . . . . 10.0 112.727 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -43.93 -38.23 3.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.7 p -122.2 11.7 10.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.438 0.695 . . . . 10.0 110.882 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 m80 45.83 45.79 11.71 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.791 1.236 . . . . 10.0 111.495 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.86 28.58 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.06 -0.855 . . . . 10.0 114.838 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -11.53 60.48 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.349 1.574 . . . . 10.0 110.567 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 -49.11 3.56 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.564 0.602 . . . . 10.0 112.333 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.59 168.2 9.64 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.158 0.983 . . . . 10.0 110.797 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.51 157.94 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.559 1.944 . . . . 10.0 106.383 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -99.3 132.78 44.38 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.077 -1.082 . . . . 10.0 108.077 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -68.98 76.13 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.149 1.379 . . . . 10.0 110.569 -174.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.513 0 N-CA-C 108.856 -1.698 . . . . 10.0 108.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.82 -26.75 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.488 0.715 . . . . 10.0 111.257 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -68.01 -42.43 80.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.681 1.993 . . . . 10.0 110.897 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -79.76 -38.1 33.95 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.535 1.134 . . . . 10.0 110.472 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -72.25 68.85 0.76 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.228 1.011 . . . . 10.0 109.831 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.6 pt -67.49 66.11 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.756 1.622 . . . . 10.0 112.597 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -74.31 60.07 0.81 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.294 1.838 . . . . 10.0 110.604 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.9 mm -56.4 121.23 41.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.168 -0.92 . . . . 10.0 108.544 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.35 74.65 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.598 2.865 . . . . 10.0 110.217 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -79.72 62.8 4.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.45 1.5 . . . . 10.0 108.181 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -79.12 121.08 24.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.473 0.709 . . . . 10.0 111.587 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -106.12 131.19 53.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.86 124.89 20.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.728 1.211 . . . . 10.0 109.699 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -78.99 87.23 4.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.23 -36.28 13.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.563 1.545 . . . . 10.0 111.549 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -49.75 -49.46 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.725 1.21 . . . . 10.0 110.303 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -99.86 19.2 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.116 0.484 . . . . 10.0 110.945 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 56.39 34.4 24.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.651 1.181 . . . . 10.0 109.687 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 -1.98 34.66 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.791 -1.005 . . . . 10.0 115.086 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -76.04 -67.4 0.68 Allowed 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.671 1.735 . . . . 10.0 110.67 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.37 -22.51 2.05 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.869 1.223 . . . . 10.0 111.804 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.85 147.75 23.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.963 1.382 . . . . 10.0 109.991 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 154.01 1.62 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -34.35 128.43 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 125.503 4.136 . . . . 10.0 115.902 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.49 -49.4 1.97 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.867 0.746 . . . . 10.0 113.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -75.31 69.25 2.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.471 1.109 . . . . 10.0 109.355 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.04 156.67 18.92 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.105 1.762 . . . . 10.0 110.328 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.63 176.64 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.283 1.988 . . . . 10.0 111.168 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -112.87 136.87 52.04 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -54.0 123.55 12.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.539 0.735 . . . . 10.0 111.176 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.62 119.32 70.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.982 -1.118 . . . . 10.0 107.982 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.67 -37.47 9.33 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.608 1.539 . . . . 10.0 111.399 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.55 -49.14 27.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.305 1.442 . . . . 10.0 112.61 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.08 11.85 37.8 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.618 0.767 . . . . 10.0 111.611 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 51.38 46.73 26.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.528 0.731 . . . . 10.0 109.306 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.47 -2.33 1.21 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.38 0.991 . . . . 10.0 114.703 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -90.46 11.72 20.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.736 1.268 . . . . 10.0 113.426 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -26.54 0.61 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 116.417 1.327 . . . . 10.0 116.417 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.75 136.1 53.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.657 1.229 . . . . 10.0 110.908 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 m -87.67 158.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -135.17 114.59 12.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 75.83 3.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -68.33 63.19 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.504 1.521 . . . . 10.0 113.426 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 52.79 0.99 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.586 0.754 . . . . 10.0 110.345 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.14 -68.44 0.34 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.353 0.978 . . . . 10.0 113.417 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -96.39 -71.47 0.67 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.909 1.283 . . . . 10.0 112.4 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -77.04 68.9 3.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.237 0.926 . . . . 10.0 110.94 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.8 0.96 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.211 1.004 . . . . 10.0 110.633 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.8 m -75.48 140.32 17.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.757 0.789 . . . . 10.0 112.691 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -91.77 154.44 18.93 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.504 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.27 152.04 42.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 m -65.5 131.88 47.52 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.52 117.43 55.14 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 119.087 0.858 . . . . 10.0 109.616 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.15 -38.44 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.754 1.636 . . . . 10.0 111.051 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.86 -37.54 2.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.408 1.483 . . . . 10.0 113.259 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 p -127.41 25.75 6.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.192 0.997 . . . . 10.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 41.94 48.5 3.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.813 1.245 . . . . 10.0 112.196 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.98 -8.77 7.44 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 115.564 0.985 . . . . 10.0 115.564 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -75.29 -8.87 57.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.792 1.796 . . . . 10.0 113.406 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.14 0.29 4.23 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.873 0.749 . . . . 10.0 114.588 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.48 129.46 51.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.144 1.377 . . . . 10.0 110.58 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.52 107.16 16.61 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.86 -1.904 . . . . 10.0 105.86 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.67 74.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.788 1.235 . . . . 10.0 108.68 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -40.42 -50.76 2.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.357 1.863 . . . . 10.0 112.501 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -142.87 99.99 5.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.875 1.67 . . . . 10.0 107.585 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.04 141.4 57.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.387 2.725 . . . . 10.0 116.113 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.9 t -77.76 93.81 4.37 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.357 1.463 . . . . 10.0 107.679 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -41.25 -45.59 2.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.956 1.703 . . . . 10.0 112.544 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -43.35 -38.8 2.84 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.171 1.788 . . . . 10.0 112.685 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.2 p -123.22 23.37 9.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.067 0.947 . . . . 10.0 110.653 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.0 39.01 5.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.312 1.445 . . . . 10.0 111.388 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.68 -2.59 39.22 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.578 -1.124 . . . . 10.0 115.75 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.32 -29.97 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 120.283 2.041 . . . . 10.0 111.906 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.95 7.84 60.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.829 1.204 . . . . 10.0 114.027 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.15 150.51 29.95 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.147 0.974 . . . . 10.0 109.331 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.05 132.13 60.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.31 101.57 12.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.393 0.677 . . . . 10.0 109.18 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -79.84 60.86 3.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.149 -0.685 . . . . 10.0 109.149 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.457 -0.105 0 C-N-CA 124.894 1.278 . . . . 10.0 108.613 -179.831 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.595 -1.002 . . . . 10.0 110.595 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -50.2 -33.19 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.838 1.255 . . . . 10.0 111.326 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -50.05 -32.72 16.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 10.0 112.078 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -66.2 -29.01 69.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.764 -0.585 . . . . 10.0 111.344 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -78.17 56.13 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.474 0.709 . . . . 10.0 111.424 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.21 -17.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.941 0.897 . . . . 10.0 112.282 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -56.11 -30.32 61.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.008 1.323 . . . . 10.0 110.781 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.2 tt -125.13 85.01 58.6 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 105.876 -1.898 . . . . 10.0 105.876 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.04 179.38 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.332 2.021 . . . . 10.0 112.239 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -163.53 160.24 22.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.503 -2.036 . . . . 10.0 105.503 175.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.5 mt -109.51 144.44 37.78 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.25 139.91 49.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.713 1.605 . . . . 10.0 107.922 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.46 140.32 48.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.26 93.95 4.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.065 -1.087 . . . . 10.0 108.065 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.56 -37.26 17.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.43 1.492 . . . . 10.0 111.628 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.08 -40.94 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.269 1.028 . . . . 10.0 110.9 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.5 p -106.05 20.31 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.573 0.624 . . . . 10.0 110.748 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.81 35.19 23.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.847 1.259 . . . . 10.0 110.197 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 7.86 67.44 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.206 -1.33 . . . . 10.0 114.848 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.1 p -85.5 -74.06 0.42 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.943 1.872 . . . . 10.0 110.401 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -20.15 1.04 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.982 1.753 . . . . 10.0 112.242 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.98 154.18 20.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.241 1.521 . . . . 10.0 110.584 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -49.63 148.51 5.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 118.41 0.55 . . . . 10.0 112.458 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.1 135.76 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 125.129 3.886 . . . . 10.0 114.692 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.73 -52.91 2.02 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.233 0.921 . . . . 10.0 112.653 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 m -73.6 79.77 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.881 0.872 . . . . 10.0 109.203 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.11 156.48 13.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.904 0.882 . . . . 10.0 111.369 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.89 168.39 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.78 2.32 . . . . 10.0 113.231 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -90.26 121.8 32.6 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -52.44 124.62 13.92 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.911 0.884 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.65 118.49 54.81 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 -37.61 9.95 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.567 1.512 . . . . 10.0 111.505 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -46.57 -47.59 19.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.084 1.354 . . . . 10.0 113.161 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.0 p -100.73 6.41 43.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.75 0.82 . . . . 10.0 111.139 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 54.31 39.56 30.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.702 -0.851 . . . . 10.0 108.702 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.66 13.57 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.731 0.681 . . . . 10.0 113.943 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -72.0 4.86 3.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.602 1.704 . . . . 10.0 115.602 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.05 -28.93 0.95 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 115.821 1.089 . . . . 10.0 115.821 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.65 154.46 46.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.22 1.01 . . . . 10.0 109.61 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.29 147.32 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.46 109.34 18.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.1 tpp -102.41 139.72 37.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.428 1.491 . . . . 10.0 109.331 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -90.65 107.77 19.38 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 58.88 1.36 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.294 0.569 . . . . 10.0 111.503 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.43 -44.19 2.18 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.124 -0.985 . . . . 10.0 111.624 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -114.02 -72.54 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.884 1.274 . . . . 10.0 111.672 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -102.54 163.06 12.44 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 124.845 1.258 . . . . 10.0 112.9 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.75 128.9 34.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.799 1.24 . . . . 10.0 109.924 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.57 148.63 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.68 1.192 . . . . 10.0 108.553 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.84 145.25 28.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.525 0.73 . . . . 10.0 111.778 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.28 142.48 41.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 m -57.63 135.21 56.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.397 0.544 . . . . 10.0 110.013 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.2 t -75.97 117.9 67.23 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.885 -0.783 . . . . 10.0 108.885 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 -37.85 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.25 1.967 . . . . 10.0 112.062 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -38.82 22.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.796 1.239 . . . . 10.0 113.143 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.3 p -115.43 21.42 14.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.849 1.26 . . . . 10.0 111.189 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 44.01 45.4 6.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.922 1.289 . . . . 10.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.49 -9.71 7.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.52 -1.156 . . . . 10.0 115.986 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -67.21 -45.41 76.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.32 2.06 . . . . 10.0 111.285 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.13 46.66 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.897 1.237 . . . . 10.0 110.523 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 p -114.05 131.37 56.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.97 1.708 . . . . 10.0 111.709 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.03 113.5 25.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.48 69.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 108.068 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -59.35 -44.08 92.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.034 0.445 . . . . 10.0 110.64 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -120.73 82.86 34.95 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 127.318 2.247 . . . . 10.0 109.421 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.12 139.95 69.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.855 3.036 . . . . 10.0 116.617 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.6 t -74.0 89.94 1.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -41.72 -43.33 2.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.138 1.375 . . . . 10.0 112.915 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -46.32 -43.85 16.26 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 10.0 112.31 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.6 p -112.86 24.49 12.35 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.308 0.643 . . . . 10.0 110.208 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.59 43.02 12.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.083 1.353 . . . . 10.0 111.047 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.63 7.39 27.62 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.777 -1.013 . . . . 10.0 115.349 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -59.4 3.22 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.597 1.698 . . . . 10.0 108.872 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.75 11.83 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.956 1.265 . . . . 10.0 114.056 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.47 153.06 40.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.9 -1.519 . . . . 10.0 106.9 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.35 161.58 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.204 1.001 . . . . 10.0 109.524 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.04 149.79 32.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.258 -0.645 . . . . 10.0 109.258 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ttp-105 -75.86 52.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.034 1.334 . . . . 10.0 108.448 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.452 -0.356 0 O-C-N 121.143 -0.973 . . . . 10.0 111.079 -176.741 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 109.657 -1.377 . . . . 10.0 109.657 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.39 -44.55 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.707 1.203 . . . . 10.0 112.209 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -52.18 -36.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.339 1.856 . . . . 10.0 112.581 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -91.06 -34.07 15.24 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.214 1.006 . . . . 10.0 110.028 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.29 -41.8 94.15 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.057 0.456 . . . . 10.0 111.969 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.7 pt -61.4 125.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -76.7 57.98 1.34 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 10.0 111.806 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.61 129.2 24.45 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 104.55 -2.389 . . . . 10.0 104.55 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -42.0 115.94 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.538 2.825 . . . . 10.0 110.948 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -68.99 59.74 0.1 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.595 1.558 . . . . 10.0 114.044 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt -138.43 161.62 36.52 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.741 1.616 . . . . 10.0 109.49 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.97 150.32 42.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.938 2.095 . . . . 10.0 106.808 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.81 143.06 51.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.05 91.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.62 -37.29 12.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.49 1.516 . . . . 10.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.06 -48.73 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.572 1.149 . . . . 10.0 110.205 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.61 22.0 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.159 0.504 . . . . 10.0 111.006 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.31 35.37 22.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.9 1.28 . . . . 10.0 110.436 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.37 -0.76 46.64 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.628 -1.096 . . . . 10.0 114.84 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -77.7 -71.02 0.44 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.773 1.787 . . . . 10.0 110.571 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.77 -17.06 2.2 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.065 1.793 . . . . 10.0 110.766 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.28 135.83 33.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.799 1.299 . . . . 10.0 109.862 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -50.26 147.06 7.87 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 -175.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -22.54 126.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 1 C-N-CA 127.513 5.475 . . . . 10.0 117.913 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.48 -42.67 0.85 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.556 1.074 . . . . 10.0 113.801 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -72.44 82.82 1.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.693 1.197 . . . . 10.0 108.195 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.03 155.1 16.82 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 122.789 0.436 . . . . 10.0 111.711 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.88 152.63 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 107.804 -1.652 . . . . 10.0 107.804 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -89.52 118.89 29.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.136 -1.431 . . . . 10.0 107.136 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -50.51 123.16 8.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.806 0.842 . . . . 10.0 109.105 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.65 115.49 15.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.24 -35.59 8.36 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.572 1.515 . . . . 10.0 110.348 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.67 -39.46 11.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.565 1.546 . . . . 10.0 112.806 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.5 p -115.18 16.8 16.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.341 0.656 . . . . 10.0 111.632 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.13 48.39 15.82 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.44 1.096 . . . . 10.0 110.384 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.89 -47.91 2.27 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.207 -0.774 . . . . 10.0 113.239 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.6 -45.4 0.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.756 2.422 . . . . 10.0 115.971 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.13 5.28 43.86 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.425 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.83 152.1 50.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.683 1.741 . . . . 10.0 112.235 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.12 158.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.769 1.627 . . . . 10.0 107.72 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -113.83 105.41 13.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.893 0.877 . . . . 10.0 110.027 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 tpt -72.28 93.3 1.47 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.079 -1.823 . . . . 10.0 106.079 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -92.64 121.22 33.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.196 2.598 . . . . 10.0 109.588 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.37 55.25 0.74 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.83 -77.61 0.21 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.792 1.187 . . . . 10.0 112.301 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -81.52 -65.95 0.95 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.774 0.829 . . . . 10.0 109.932 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -83.9 162.96 20.33 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.65 154.16 20.07 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.18 165.99 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 107.84 -1.171 . . . . 10.0 107.84 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -123.71 137.66 54.66 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.617 0.767 . . . . 10.0 110.521 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 162.03 37.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.706 0.629 . . . . 10.0 109.513 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 m -55.49 137.18 49.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 10.0 110.84 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.21 116.28 45.27 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.8 -0.619 . . . . 10.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.35 -39.38 7.38 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.843 1.695 . . . . 10.0 111.159 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -35.63 5.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.832 1.253 . . . . 10.0 113.204 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.1 p -125.16 25.87 7.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.089 0.956 . . . . 10.0 111.058 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 41.49 45.35 2.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.184 1.394 . . . . 10.0 112.316 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.91 -7.04 3.29 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.625 1.01 . . . . 10.0 115.625 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -69.49 -28.44 66.06 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.508 1.654 . . . . 10.0 110.952 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -9.59 76.54 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.799 0.714 . . . . 10.0 112.315 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 p -116.06 131.81 56.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.954 1.701 . . . . 10.0 113.455 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.14 100.59 12.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.0 mt -82.93 71.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.87 -24.64 67.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.959 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -124.44 75.52 62.11 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.894 2.078 . . . . 10.0 110.999 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.92 133.5 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.223 3.282 . . . . 10.0 116.295 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.48 88.81 2.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.653 -1.24 . . . . 10.0 107.653 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -36.96 -47.84 0.73 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.156 1.782 . . . . 10.0 112.98 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.37 -43.71 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.518 1.527 . . . . 10.0 112.415 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.6 p -116.99 22.26 12.7 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.725 0.81 . . . . 10.0 110.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 47.0 40.95 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.867 1.267 . . . . 10.0 110.241 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.81 10.57 13.8 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.882 1.113 . . . . 10.0 115.882 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.3 82.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.784 1.792 . . . . 10.0 109.319 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.17 59.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.563 2.03 . . . . 10.0 113.544 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.91 155.39 41.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.036 0.934 . . . . 10.0 108.668 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.87 152.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 125.296 1.438 . . . . 10.0 108.402 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.73 138.33 58.44 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.849 0.46 . . . . 10.0 110.152 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -78.83 61.31 3.04 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.532 0.263 0 O-C-N 121.522 -0.736 . . . . 10.0 110.582 -178.144 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.596 0 N-CA-C 108.639 -1.784 . . . . 10.0 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.1 t -54.87 -31.57 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.094 0.958 . . . . 10.0 109.282 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 p -46.18 -38.09 7.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.069 1.748 . . . . 10.0 111.58 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -67.42 -30.34 70.06 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.94 0.337 . . . . 10.0 111.856 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -85.39 -41.28 15.59 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.315 1.046 . . . . 10.0 112.531 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 pt -75.91 69.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.517 0.675 . . . . 10.0 109.373 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -76.62 58.07 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.572 1.149 . . . . 10.0 111.106 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -77.08 134.57 67.63 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.79 -1.93 . . . . 10.0 105.79 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.68 51.57 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.221 2.614 . . . . 10.0 112.834 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.5 73.71 5.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.174 -1.417 . . . . 10.0 107.174 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.15 123.26 20.64 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.549 -0.719 . . . . 10.0 110.379 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.33 145.49 47.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.217 1.407 . . . . 10.0 108.194 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -72.47 131.6 42.77 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.298 0.639 . . . . 10.0 110.145 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.94 86.21 4.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.591 0.71 . . . . 10.0 109.14 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -48.1 -35.82 12.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.307 1.443 . . . . 10.0 111.38 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.44 -45.43 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.009 1.324 . . . . 10.0 110.835 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -102.29 17.2 24.04 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.269 0.486 . . . . 10.0 111.087 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.47 34.43 23.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.365 1.066 . . . . 10.0 109.17 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 -4.21 20.94 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.552 -1.138 . . . . 10.0 115.583 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -71.77 -61.17 1.88 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.293 2.046 . . . . 10.0 110.589 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.34 -12.31 6.36 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.65 2.072 . . . . 10.0 109.215 -173.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 141.71 33.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.63 1.215 . . . . 10.0 109.247 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -51.26 152.28 4.36 Favored Pre-proline 0 CA--C 1.551 1.003 0 CA-C-N 119.031 0.832 . . . . 10.0 112.415 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.26 129.7 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.076 3.85 . . . . 10.0 116.205 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.46 12.73 3.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.105 1.336 . . . . 10.0 115.248 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.9 m -110.58 125.45 53.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.893 1.346 . . . . 10.0 107.59 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.52 144.36 98.61 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 122.935 0.494 . . . . 10.0 111.302 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.34 164.68 34.53 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 N-CA-C 106.829 -2.027 . . . . 10.0 106.829 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.54 115.62 27.73 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.609 -0.682 . . . . 10.0 109.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -48.42 124.14 7.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.413 1.085 . . . . 10.0 110.452 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -65.6 115.82 25.83 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -35.55 8.0 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.319 1.346 . . . . 10.0 110.1 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -39.27 7.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.613 1.565 . . . . 10.0 113.181 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.77 17.09 13.55 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.435 0.694 . . . . 10.0 111.22 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 47.95 48.85 17.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.036 0.934 . . . . 10.0 110.201 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.68 -46.71 2.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.408 -0.808 . . . . 10.0 113.271 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -29.94 -40.59 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.976 2.91 . . . . 10.0 116.5 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.68 0.16 52.69 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.65 1.119 . . . . 10.0 115.811 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.28 151.65 40.78 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.815 1.307 . . . . 10.0 109.609 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -113.75 133.56 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.889 1.676 . . . . 10.0 108.178 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -107.92 91.08 3.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.435 1.094 . . . . 10.0 109.065 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.0 mmm -81.82 57.7 3.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.994 0.739 . . . . 10.0 112.994 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 176.12 165.15 0.41 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.083 2.153 . . . . 10.0 108.864 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.9 147.15 9.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.259 1.024 . . . . 10.0 108.77 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.96 40.22 6.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.168 0.89 . . . . 10.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -174.24 -149.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.444 -2.428 . . . . 10.0 104.444 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.36 73.45 2.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.526 1.057 . . . . 10.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.6 68.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.834 1.654 . . . . 10.0 112.124 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.99 160.35 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 124.134 0.974 . . . . 10.0 109.785 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -146.34 160.83 41.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 123.438 0.461 . . . . 10.0 111.367 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 163.14 34.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.088 0.955 . . . . 10.0 108.621 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.6 m -55.8 137.95 48.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.042 0.937 . . . . 10.0 109.471 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.69 118.69 68.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 118.569 0.622 . . . . 10.0 109.471 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.99 -38.6 7.09 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.186 1.924 . . . . 10.0 111.387 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -47.52 -42.29 22.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.586 1.554 . . . . 10.0 112.838 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.7 p -112.82 20.89 16.05 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.314 1.046 . . . . 10.0 111.585 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 44.18 44.45 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.799 1.24 . . . . 10.0 111.176 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.26 -7.02 5.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.486 -1.174 . . . . 10.0 115.976 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -68.42 -39.32 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 120.288 2.044 . . . . 10.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.27 -19.21 46.52 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.326 0.965 . . . . 10.0 110.711 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 132.4 54.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.524 1.93 . . . . 10.0 111.712 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -92.45 120.05 32.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.869 1.268 . . . . 10.0 108.11 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.86 63.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.95 -35.23 79.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.141 0.576 . . . . 10.0 111.212 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -111.45 74.49 1.17 Allowed Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.268 2.227 . . . . 10.0 109.083 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.67 133.92 38.7 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.657 2.904 . . . . 10.0 116.632 -172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.2 90.66 2.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.494 1.518 . . . . 10.0 107.212 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -39.51 -46.88 1.79 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.433 1.493 . . . . 10.0 112.489 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.17 -44.68 5.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.588 1.155 . . . . 10.0 112.643 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -113.89 14.2 18.5 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.204 0.602 . . . . 10.0 111.072 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.92 36.02 20.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.757 0.823 . . . . 10.0 109.919 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.09 15.19 49.51 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.127 -0.818 . . . . 10.0 114.393 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -2.02 40.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.326 1.563 . . . . 10.0 111.895 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.09 -43.77 2.28 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.384 -0.823 . . . . 10.0 113.091 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 168.84 9.44 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.283 1.433 . . . . 10.0 110.851 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.15 144.16 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 125.721 1.608 . . . . 10.0 107.722 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -87.84 105.54 17.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -71.94 81.73 0.92 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 126.455 1.902 . . . . 10.0 109.837 -178.282 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 111.987 -0.445 . . . . 10.0 111.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -74.07 144.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 t -53.46 -21.29 5.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.743 1.016 . . . . 10.0 113.743 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -63.78 -27.1 68.96 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 10.0 110.383 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.83 66.16 2.05 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.178 0.991 . . . . 10.0 109.1 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.45 66.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.817 1.247 . . . . 10.0 112.994 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -75.55 62.41 1.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.394 -0.816 . . . . 10.0 109.39 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -130.65 121.81 19.35 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 125.663 1.585 . . . . 10.0 106.771 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.77 72.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.571 3.514 . . . . 10.0 112.394 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -72.95 146.74 45.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.976 1.311 . . . . 10.0 110.691 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -120.34 145.5 47.06 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.108 1.363 . . . . 10.0 110.041 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -54.09 134.79 43.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.187 0.995 . . . . 10.0 111.642 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -77.43 103.93 7.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -46.84 -42.85 17.95 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.212 1.405 . . . . 10.0 111.126 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.11 -38.62 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.524 1.13 . . . . 10.0 111.928 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -106.75 4.2 27.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.085 0.857 . . . . 10.0 111.812 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.93 33.54 12.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.733 0.813 . . . . 10.0 108.935 174.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.78 -11.82 44.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.326 -1.263 . . . . 10.0 114.628 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.4 p -71.5 -71.59 0.26 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.066 1.933 . . . . 10.0 111.213 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.31 -24.66 2.2 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.814 2.15 . . . . 10.0 109.458 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 150.27 43.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.747 0.774 . . . . 10.0 110.017 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.21 165.1 2.98 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 122.086 -0.384 . . . . 10.0 111.133 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -40.48 127.68 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.908 3.072 . . . . 10.0 114.956 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.7 19.86 5.26 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.938 1.256 . . . . 10.0 114.786 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -108.12 135.16 49.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.606 -1.628 . . . . 10.0 106.606 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -79.94 147.55 66.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 118.466 0.576 . . . . 10.0 111.161 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.63 -173.32 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.152 -1.903 . . . . 10.0 107.152 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -126.05 123.17 37.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -45.54 124.85 5.3 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.813 1.245 . . . . 10.0 111.922 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -68.89 117.53 52.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.32 -36.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.796 1.664 . . . . 10.0 110.756 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.54 -46.49 19.35 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.664 1.585 . . . . 10.0 112.363 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -105.44 14.93 27.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.796 0.839 . . . . 10.0 111.634 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 49.22 40.39 17.84 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.961 0.904 . . . . 10.0 110.68 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -5.37 7.07 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.854 -0.97 . . . . 10.0 115.412 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.0 p -69.48 -26.61 64.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 120.096 1.948 . . . . 10.0 112.804 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.43 71.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 133.2 35.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.463 1.131 . . . . 10.0 110.482 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.47 157.55 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.282 1.433 . . . . 10.0 107.99 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -108.38 117.78 35.05 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.951 -1.499 . . . . 10.0 106.951 172.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.36 92.21 2.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.699 -2.704 . . . . 10.0 103.699 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -65.73 40.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.574 1.694 . . . . 10.0 115.574 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -78.61 55.66 1.69 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.299 -1.501 . . . . 10.0 111.043 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 26.15 -92.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 128.046 2.736 . . . . 10.0 114.064 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -36.74 -44.96 0.5 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.603 1.961 . . . . 10.0 112.678 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -129.68 56.6 1.71 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.07 69.1 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.187 0.995 . . . . 10.0 111.376 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 169.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.602 1.161 . . . . 10.0 112.491 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -109.2 149.8 28.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.487 1.115 . . . . 10.0 111.415 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -141.58 151.51 43.24 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.568 1.547 . . . . 10.0 108.037 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 m -58.25 138.09 56.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.863 0.756 . . . . 10.0 109.957 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.76 117.75 63.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.874 0.761 . . . . 10.0 108.998 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.99 -41.66 3.8 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.795 1.664 . . . . 10.0 111.16 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -47.66 -42.03 23.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.864 1.265 . . . . 10.0 113.547 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.21 21.66 15.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.66 0.784 . . . . 10.0 111.456 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 45.96 46.74 12.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.619 1.167 . . . . 10.0 111.369 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.31 -6.81 9.61 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.652 1.021 . . . . 10.0 115.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -68.18 -25.57 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.866 1.833 . . . . 10.0 112.652 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 1.51 87.07 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.38 0.514 . . . . 10.0 112.601 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.5 p -118.12 125.7 50.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.463 1.505 . . . . 10.0 111.304 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.65 151.67 22.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.26 90.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -64.88 -27.46 68.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -106.77 69.57 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.946 2.498 . . . . 10.0 109.856 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.26 128.74 22.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.195 1.93 . . . . 10.0 113.457 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.3 91.73 0.17 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -33.3 -51.54 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.011 2.124 . . . . 10.0 113.894 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -44.54 -45.63 9.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.187 1.395 . . . . 10.0 112.624 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.9 p -111.45 15.79 21.08 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.112 0.565 . . . . 10.0 110.45 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 54.14 34.08 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.222 1.009 . . . . 10.0 110.382 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.21 15.21 60.59 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 119.39 -0.672 . . . . 10.0 113.938 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -77.35 -4.41 44.98 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.036 1.418 . . . . 10.0 111.765 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.51 -43.5 2.1 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.028 -1.045 . . . . 10.0 114.242 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -134.5 155.52 50.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.162 0.985 . . . . 10.0 110.235 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.66 158.41 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 C-N-CA 124.748 1.219 . . . . 10.0 109.922 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -69.6 139.51 53.65 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -74.0 55.97 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.533 1.533 . . . . 10.0 110.634 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.453 -0.32 0 O-C-N 121.273 -0.892 . . . . 10.0 110.929 -178.384 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.58 0 N-CA-C 109.603 -1.399 . . . . 10.0 109.603 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.31 -31.7 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -159.86 -176.35 5.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 176.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -84.85 -34.22 22.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -75.05 47.91 0.37 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.28 55.51 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.1 mmt-85 4.63 39.9 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.588 1 C-N-CA 132.389 4.276 . . . . 10.0 118.603 -171.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.6 mt -95.19 130.26 32.98 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -44.98 97.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.646 3.564 . . . . 10.0 114.763 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -154.02 59.6 0.72 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 106.148 -1.797 . . . . 10.0 106.148 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.46 119.49 13.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.201 -0.909 . . . . 10.0 112.076 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -128.67 150.54 50.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.779 1.232 . . . . 10.0 108.399 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.13 135.14 56.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.794 0.838 . . . . 10.0 111.2 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -80.02 87.49 5.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 10.0 108.167 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -48.67 -37.01 17.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 10.0 111.528 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -49.98 -53.52 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.657 1.183 . . . . 10.0 110.157 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -93.38 18.6 9.45 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.264 0.484 . . . . 10.0 111.255 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 54.24 35.92 23.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.986 0.914 . . . . 10.0 109.898 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.54 4.63 61.55 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.282 -1.288 . . . . 10.0 115.452 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -87.0 -81.34 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.811 1.805 . . . . 10.0 111.382 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.7 -8.39 0.07 OUTLIER Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.616 -1.102 . . . . 10.0 114.61 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.44 157.77 20.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.702 1.751 . . . . 10.0 109.961 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -49.95 163.65 0.4 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.89 1.07 . . . . 10.0 113.89 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.23 135.99 24.87 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.107 2.538 . . . . 10.0 112.733 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 -57.7 2.65 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.992 -0.338 . . . . 10.0 112.417 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.1 m -72.68 64.67 0.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.804 1.242 . . . . 10.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 159.57 27.31 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.759 0.823 . . . . 10.0 112.331 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.57 176.06 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 10.0 110.946 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -117.74 124.76 49.24 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -44.3 124.0 3.78 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 10.0 111.807 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.67 116.71 40.44 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -38.06 7.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.63 1.554 . . . . 10.0 110.952 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -42.65 12.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.776 1.63 . . . . 10.0 112.861 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.0 p -112.18 18.17 18.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.813 0.845 . . . . 10.0 111.454 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.67 41.56 13.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.949 0.9 . . . . 10.0 111.172 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.17 0.08 55.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.283 -1.287 . . . . 10.0 115.801 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.7 p -69.56 -61.08 1.93 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 120.461 2.13 . . . . 10.0 111.321 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.31 10.34 7.37 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.115 2.293 . . . . 10.0 110.86 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 151.18 47.95 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.127 1.464 . . . . 10.0 110.48 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.44 144.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.342 1.457 . . . . 10.0 108.042 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -106.34 110.09 22.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.632 -0.877 . . . . 10.0 108.632 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.8 ttm -77.65 90.34 3.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.111 -1.07 . . . . 10.0 108.111 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -73.37 69.22 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.327 0.651 . . . . 10.0 110.517 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 45.44 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.45 -73.0 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.069 1.318 . . . . 10.0 115.059 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.74 -42.64 73.66 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.777 0.831 . . . . 10.0 110.438 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -120.48 170.64 9.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.705 1.202 . . . . 10.0 107.886 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 63.98 1.11 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.113 0.565 . . . . 10.0 109.694 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.65 176.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 110.465 -0.198 . . . . 10.0 110.465 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.44 159.27 41.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.526 0.33 . . . . 10.0 111.363 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.84 164.85 28.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.678 1.191 . . . . 10.0 108.429 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 m -63.87 140.76 58.9 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.64 116.0 45.4 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 118.849 0.75 . . . . 10.0 109.587 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.42 -38.81 7.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.043 1.829 . . . . 10.0 111.274 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.14 -34.22 5.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.245 . . . . 10.0 113.287 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.9 p -123.86 21.83 9.02 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.006 0.922 . . . . 10.0 111.189 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 45.5 42.21 7.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 10.0 111.928 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.38 -1.57 19.36 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.263 0.865 . . . . 10.0 115.263 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -79.32 -4.48 51.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.277 1.538 . . . . 10.0 111.744 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.59 -12.57 0.71 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.426 1.013 . . . . 10.0 113.978 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -122.03 132.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 10.0 111.094 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.13 106.03 7.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.895 -2.261 . . . . 10.0 104.895 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.14 77.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.259 1.423 . . . . 10.0 108.054 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -43.06 2.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.579 1.952 . . . . 10.0 111.022 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -145.2 144.99 25.15 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 104.441 -2.429 . . . . 10.0 104.441 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.0 125.39 3.11 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.187 1.925 . . . . 10.0 112.15 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -71.03 85.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -39.88 -46.03 1.92 Allowed 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 125.899 1.68 . . . . 10.0 113.172 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -42.61 -40.2 2.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.525 1.13 . . . . 10.0 112.683 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.16 18.73 12.31 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.539 0.736 . . . . 10.0 111.256 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 45.74 42.53 8.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.487 1.115 . . . . 10.0 109.537 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 51.96 25.41 16.62 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.528 1.537 . . . . 10.0 116.328 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -79.04 -38.88 35.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.588 1.694 . . . . 10.0 108.754 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.27 -0.91 55.96 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.095 1.807 . . . . 10.0 113.791 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 151.4 44.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.83 142.65 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.045 0.938 . . . . 10.0 110.47 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -77.53 78.29 4.05 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -76.19 60.27 1.46 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.452 1.101 . . . . 10.0 111.537 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 10.0 108.657 177.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.0 m -40.95 -48.02 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.987 1.315 . . . . 10.0 112.615 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -52.03 -43.69 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.599 1.56 . . . . 10.0 111.821 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -55.32 -41.25 72.15 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 pt -74.09 56.34 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.7 0.762 . . . . 10.0 111.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -56.47 -38.35 71.57 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.13 -0.981 . . . . 10.0 112.229 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.255 0.2 OUTLIER -117.96 -48.45 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.637 1.975 . . . . 10.0 116.168 -178.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.38 74.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 1 C-N-CA 126.712 4.941 . . . . 10.0 117.209 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 m -152.5 114.84 4.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.45 99.84 12.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.804 0.811 . . . . 10.0 111.185 -175.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.81 127.62 33.41 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.437 1.895 . . . . 10.0 110.422 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.56 126.65 28.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.601 0.76 . . . . 10.0 110.593 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.19 89.84 3.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.28 -38.54 19.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.302 1.441 . . . . 10.0 111.319 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -50.27 -41.81 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.776 1.23 . . . . 10.0 111.618 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.4 p -107.56 19.28 20.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.916 0.486 . . . . 10.0 110.662 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.38 38.74 18.76 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.059 1.344 . . . . 10.0 110.163 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.63 24.16 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.445 -1.197 . . . . 10.0 115.561 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -72.7 -66.24 0.69 Allowed 'General case' 0 C--N 1.341 0.207 0 CA-C-N 120.098 1.949 . . . . 10.0 111.057 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.15 -8.13 4.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.226 2.346 . . . . 10.0 110.183 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.39 138.87 40.67 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.902 1.351 . . . . 10.0 111.031 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -51.76 144.45 18.92 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.817 0.735 . . . . 10.0 110.695 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -49.26 -37.0 38.97 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.298 2.665 . . . . 10.0 113.792 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.41 12.23 68.84 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.017 -1.435 . . . . 10.0 115.113 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -155.66 147.1 22.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.126 2.463 . . . . 10.0 110.938 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.77 157.73 66.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.823 -0.608 . . . . 10.0 109.495 176.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.62 169.64 19.45 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.281 1.987 . . . . 10.0 108.057 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -101.41 115.78 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 119.127 -0.463 . . . . 10.0 110.207 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -42.92 122.23 2.34 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.561 1.144 . . . . 10.0 111.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -65.61 115.57 23.49 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.66 -36.09 6.94 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.823 1.682 . . . . 10.0 110.709 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.38 -39.83 7.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.681 1.593 . . . . 10.0 112.883 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.3 p -114.86 12.48 16.92 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.094 0.958 . . . . 10.0 111.751 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.77 42.46 23.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.013 0.925 . . . . 10.0 109.995 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.08 -8.44 8.36 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 114.805 0.682 . . . . 10.0 114.805 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -68.27 -8.61 40.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.425 1.612 . . . . 10.0 114.045 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 14.66 55.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.602 1.096 . . . . 10.0 113.769 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -145.04 142.29 29.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.145 0.972 . . . . 10.0 110.088 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.11 133.15 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.625 1.57 . . . . 10.0 106.93 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.54 109.61 22.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.03 0.532 . . . . 10.0 110.428 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.99 88.5 0.4 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.331 1.052 . . . . 10.0 108.59 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -73.89 62.3 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.67 0.788 . . . . 10.0 110.238 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 43.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.632 1.173 . . . . 10.0 112.729 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.17 -64.45 1.3 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.684 -0.635 . . . . 10.0 112.391 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.99 -78.23 0.37 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.122 0.969 . . . . 10.0 113.09 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -84.11 98.15 9.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.536 0.734 . . . . 10.0 111.455 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 58.84 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.375 0.67 . . . . 10.0 111.266 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.02 162.36 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 O-C-N 121.878 -0.514 . . . . 10.0 110.05 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.39 171.97 7.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.812 1.041 . . . . 10.0 113.812 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 153.13 47.37 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.645 -1.983 . . . . 10.0 105.645 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 m -58.86 135.76 57.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.85 116.99 49.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.908 0.776 . . . . 10.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.15 -38.05 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.027 1.818 . . . . 10.0 111.367 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.41 -39.49 22.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.599 1.16 . . . . 10.0 113.174 -177.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.49 18.66 15.85 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.094 . . . . 10.0 111.47 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 47.01 43.51 13.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.341 1.056 . . . . 10.0 111.113 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.34 6.43 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.44 0.936 . . . . 10.0 115.44 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -74.54 -7.38 52.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.918 1.859 . . . . 10.0 112.737 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.39 1.21 7.26 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.403 -0.811 . . . . 10.0 113.216 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -133.18 132.91 42.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.17 1.388 . . . . 10.0 109.783 -174.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.74 118.58 27.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.875 1.27 . . . . 10.0 108.323 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -78.4 61.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.976 1.31 . . . . 10.0 108.435 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.74 -34.4 77.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.588 0.709 . . . . 10.0 109.752 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.79 78.14 1.18 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.011 2.924 . . . . 10.0 109.108 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.07 136.65 35.39 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.296 2.664 . . . . 10.0 116.342 -173.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.8 t -74.15 87.95 1.94 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.466 -1.679 . . . . 10.0 106.466 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.96 -40.79 4.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.97 1.308 . . . . 10.0 111.859 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -46.45 -38.66 9.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.932 0.893 . . . . 10.0 112.123 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.6 p -122.26 22.93 9.99 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.534 0.734 . . . . 10.0 110.477 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 45.87 39.81 5.88 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 10.0 110.949 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.07 17.7 31.13 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.249 0.86 . . . . 10.0 115.249 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -36.73 64.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.151 1.475 . . . . 10.0 110.328 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.04 -23.85 17.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.557 1.075 . . . . 10.0 112.031 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.73 159.17 44.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.141 0.97 . . . . 10.0 110.321 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.48 145.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 124.952 1.301 . . . . 10.0 109.865 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -69.77 139.45 53.27 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.905 -0.497 . . . . 10.0 109.876 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -64.61 71.37 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.093 1.757 . . . . 10.0 109.862 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 125.576 1.55 . . . . 10.0 110.633 -176.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 108.546 -1.822 . . . . 10.0 108.546 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.95 -31.93 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.026 0.53 . . . . 10.0 110.198 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p -48.82 -33.67 10.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.763 2.025 . . . . 10.0 111.737 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -67.17 -30.87 70.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.862 0.465 . . . . 10.0 111.027 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -89.56 -56.58 3.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.389 1.09 . . . . 10.0 111.374 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 pt -76.47 71.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.542 -1.208 . . . . 10.0 110.379 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -72.68 58.47 0.44 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 10.0 111.578 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.91 138.64 61.5 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.05 76.32 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.691 2.927 . . . . 10.0 109.685 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m -87.41 101.85 13.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.062 1.745 . . . . 10.0 108.982 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.25 120.1 23.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -120.16 156.4 31.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.873 1.669 . . . . 10.0 110.383 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.66 129.13 19.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 112.081 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -77.24 89.59 3.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -49.09 -38.02 23.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.784 1.233 . . . . 10.0 111.313 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.8 -31.43 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.249 1.42 . . . . 10.0 112.221 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -123.24 22.52 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 10.0 110.13 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 45.01 41.71 5.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.589 1.556 . . . . 10.0 111.238 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.53 -4.44 27.65 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.803 1.081 . . . . 10.0 115.803 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -73.17 -68.95 0.45 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.742 1.771 . . . . 10.0 109.164 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.13 -6.52 4.35 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.58 2.038 . . . . 10.0 109.105 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 128.12 34.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.924 1.362 . . . . 10.0 109.673 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 156.42 2.6 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -38.76 133.59 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.408 3.406 . . . . 10.0 114.794 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.58 19.52 9.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.968 1.27 . . . . 10.0 114.498 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -126.11 140.9 52.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.68 153.44 42.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 122.809 0.444 . . . . 10.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.97 168.67 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 107.768 -1.666 . . . . 10.0 107.768 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.98 119.29 33.24 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -51.15 124.37 11.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.893 0.877 . . . . 10.0 109.362 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -64.23 115.18 17.52 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 118.702 0.683 . . . . 10.0 109.397 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.0 -35.85 8.4 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.632 1.555 . . . . 10.0 110.587 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -45.37 -38.34 5.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 10.0 113.056 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.35 13.95 13.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.241 1.016 . . . . 10.0 111.471 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.3 41.89 21.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.886 0.874 . . . . 10.0 110.195 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.8 -8.08 8.27 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 119.233 -0.76 . . . . 10.0 114.979 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -65.39 -15.7 62.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.563 1.682 . . . . 10.0 113.955 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 4.61 68.47 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.864 0.745 . . . . 10.0 113.651 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.97 156.74 44.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.94 1.37 . . . . 10.0 110.611 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.99 141.64 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 126.451 1.9 . . . . 10.0 107.391 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -124.55 115.47 20.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.16 165.43 24.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.427 1.091 . . . . 10.0 108.399 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -131.33 46.06 2.72 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.274 0.63 . . . . 10.0 112.434 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -78.74 64.0 3.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.874 0.845 . . . . 10.0 109.399 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 37.03 -104.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.439 2.447 . . . . 10.0 113.18 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -47.82 -35.19 9.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.251 1.42 . . . . 10.0 113.591 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -124.43 57.87 1.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.025 0.375 . . . . 10.0 111.227 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.99 66.48 0.38 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.443 1.097 . . . . 10.0 110.589 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.74 167.01 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.49 1.116 . . . . 10.0 112.885 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -126.44 156.86 39.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.063 0.945 . . . . 10.0 111.474 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.18 162.39 35.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.502 1.121 . . . . 10.0 108.94 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 m -62.4 140.99 58.56 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.777 0.831 . . . . 10.0 108.968 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.9 117.48 61.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 118.752 0.706 . . . . 10.0 109.605 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.31 -40.49 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.079 1.853 . . . . 10.0 111.46 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -44.73 -40.11 5.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.992 1.317 . . . . 10.0 112.625 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.59 22.54 11.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 10.0 112.05 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 44.39 43.11 5.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.535 1.134 . . . . 10.0 111.641 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.56 -6.16 6.42 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.757 1.063 . . . . 10.0 115.757 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -78.8 -2.73 40.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.674 1.737 . . . . 10.0 112.775 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.8 -8.97 0.73 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.205 0.907 . . . . 10.0 114.671 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -125.1 135.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.684 1.593 . . . . 10.0 110.655 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.6 mt -97.77 120.58 38.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.883 1.273 . . . . 10.0 108.073 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.5 mm -78.13 63.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.536 1.135 . . . . 10.0 108.23 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -69.36 -26.23 64.57 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.663 -0.648 . . . . 10.0 110.69 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -111.28 72.85 0.93 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 127.253 2.221 . . . . 10.0 109.46 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -62.99 129.42 25.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.019 2.479 . . . . 10.0 115.536 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.2 92.38 0.76 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.989 1.716 . . . . 10.0 106.543 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -37.23 -49.01 0.91 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.272 1.829 . . . . 10.0 112.613 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.73 -38.12 4.21 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.11 1.364 . . . . 10.0 112.812 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.0 p -121.85 16.29 10.97 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.893 0.877 . . . . 10.0 111.069 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 48.23 37.84 9.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.382 1.073 . . . . 10.0 110.836 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.52 6.76 43.51 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 118.955 -0.914 . . . . 10.0 115.058 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -44.0 87.01 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.78 1.79 . . . . 10.0 110.643 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.81 30.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.816 1.198 . . . . 10.0 113.405 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -146.25 154.61 41.92 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.481 1.64 . . . . 10.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 155.77 33.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 125.771 1.629 . . . . 10.0 109.298 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.53 141.56 51.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.286 -0.635 . . . . 10.0 109.286 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.97 67.28 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.756 2.022 . . . . 10.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.457 -0.096 0 C-N-CA 125.906 1.682 . . . . 10.0 108.288 176.368 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.47 167.01 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.042 0.537 . . . . 10.0 111.969 -177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -71.03 66.3 0.38 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.435 1.894 . . . . 10.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -162.03 -41.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 130.221 3.409 . . . . 10.0 106.414 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.36 80.14 1.02 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.04 -1.096 . . . . 10.0 108.04 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.93 62.15 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.635 1.174 . . . . 10.0 111.402 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -55.73 -37.37 68.36 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.776 0.83 . . . . 10.0 111.683 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.14 139.24 45.53 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.975 1.31 . . . . 10.0 110.589 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.1 84.65 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.181 3.254 . . . . 10.0 110.146 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 134.88 57.47 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.409 1.883 . . . . 10.0 112.013 -174.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.13 126.11 34.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -112.84 124.5 52.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.487 1.115 . . . . 10.0 108.959 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.63 125.21 15.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.233 1.013 . . . . 10.0 110.584 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -81.1 89.04 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 109.688 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -49.5 -38.04 28.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.516 1.126 . . . . 10.0 111.016 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.07 -36.42 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.46 1.504 . . . . 10.0 111.655 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 p -117.52 23.92 11.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.078 0.551 . . . . 10.0 110.791 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.5 p80 46.03 42.35 9.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.64 1.576 . . . . 10.0 111.486 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.0 -3.72 27.46 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -77.84 -67.82 0.69 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 120.099 1.95 . . . . 10.0 110.196 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.65 -3.54 3.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.184 1.849 . . . . 10.0 110.496 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.49 140.23 30.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.008 1.904 . . . . 10.0 111.196 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -48.42 140.72 9.78 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.067 0.947 . . . . 10.0 111.625 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -36.28 133.41 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 125.165 3.91 . . . . 10.0 113.942 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.77 -45.72 1.64 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.236 0.922 . . . . 10.0 112.456 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 68.97 0.64 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.542 2.337 . . . . 10.0 108.503 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.55 151.76 28.42 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.178 0.991 . . . . 10.0 112.419 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.09 146.93 53.29 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.294 1.329 . . . . 10.0 108.786 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -83.06 140.38 32.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -57.71 123.26 15.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.547 0.739 . . . . 10.0 109.734 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -67.61 116.3 36.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.264 0.938 . . . . 10.0 108.981 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.64 -38.35 10.85 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 120.557 1.235 . . . . 10.0 110.777 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.22 -40.31 11.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.388 1.875 . . . . 10.0 113.134 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 p -121.3 27.68 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.821 0.849 . . . . 10.0 110.598 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 45.39 42.12 7.2 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.724 1.21 . . . . 10.0 112.788 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.46 58.29 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.328 -1.262 . . . . 10.0 116.196 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.6 p -81.31 -66.27 0.91 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.991 1.895 . . . . 10.0 112.02 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.43 -6.31 0.78 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.556 -1.135 . . . . 10.0 115.761 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.06 132.93 43.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.095 1.947 . . . . 10.0 111.67 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -75.99 138.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.1 114.69 23.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.7 mtp -77.49 73.72 4.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -68.71 62.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.292 1.437 . . . . 10.0 112.299 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.12 51.4 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.385 1.474 . . . . 10.0 110.489 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.23 -65.98 0.73 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.386 0.993 . . . . 10.0 113.332 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -100.91 -69.68 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.835 1.254 . . . . 10.0 112.122 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -74.52 68.69 1.63 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.573 -0.704 . . . . 10.0 111.213 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.24 59.24 0.75 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.21 1.004 . . . . 10.0 112.16 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.35 169.93 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 124.614 1.166 . . . . 10.0 110.7 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -146.84 159.52 43.41 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.621 0.6 . . . . 10.0 112.621 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.59 158.69 43.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.832 1.253 . . . . 10.0 108.572 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -53.55 134.44 40.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.062 0.545 . . . . 10.0 110.209 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.7 t -75.93 116.97 60.42 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.865 -0.588 . . . . 10.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.67 -39.01 7.2 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.169 1.913 . . . . 10.0 111.336 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -44.84 -43.41 8.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.997 1.719 . . . . 10.0 112.552 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.06 23.0 12.53 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.083 0.953 . . . . 10.0 111.699 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 44.21 44.68 6.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.781 1.232 . . . . 10.0 111.713 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -5.09 17.48 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -81.26 -8.32 59.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.308 2.054 . . . . 10.0 113.43 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.04 -7.63 3.05 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 121.459 -0.775 . . . . 10.0 113.192 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 133.61 55.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.747 2.019 . . . . 10.0 111.874 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.63 119.56 33.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.216 1.406 . . . . 10.0 108.854 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.31 81.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.79 1.636 . . . . 10.0 108.856 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -42.44 -49.95 5.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.415 1.486 . . . . 10.0 111.294 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -149.03 128.45 6.34 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.17 136.35 31.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.769 2.313 . . . . 10.0 114.848 -171.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.5 t -73.68 90.82 1.84 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.673 1.589 . . . . 10.0 106.831 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -39.41 -45.39 1.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.73 1.612 . . . . 10.0 112.685 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.12 -39.32 2.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.827 1.251 . . . . 10.0 112.731 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.8 24.63 8.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.886 0.875 . . . . 10.0 110.631 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 47.99 35.59 5.23 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.296 1.038 . . . . 10.0 110.849 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.52 21.0 53.5 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.973 0.749 . . . . 10.0 114.973 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.42 -40.46 57.7 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.881 1.34 . . . . 10.0 110.367 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.72 -13.73 14.87 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.471 1.51 . . . . 10.0 112.073 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.62 145.5 29.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.155 0.978 . . . . 10.0 109.686 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.49 138.14 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.98 124.28 33.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -68.76 73.27 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.076 1.35 . . . . 10.0 108.406 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.631 1.973 . . . . 10.0 109.662 -176.643 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.22 -14.87 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.044 0.538 . . . . 10.0 110.161 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 p -67.77 70.34 0.13 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.521 2.328 . . . . 10.0 110.343 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -163.97 -169.11 1.77 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.675 1.59 . . . . 10.0 107.708 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.75 138.04 57.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt -75.95 56.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.836 0.827 . . . . 10.0 112.115 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -158.33 43.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.093 1.757 . . . . 10.0 106.46 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.3 tt -53.02 116.45 9.27 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 123.787 0.835 . . . . 10.0 111.251 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.32 76.72 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.054 2.503 . . . . 10.0 107.619 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 m -74.79 64.1 1.23 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.927 1.291 . . . . 10.0 111.305 -173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.86 143.66 27.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.219 1.008 . . . . 10.0 109.755 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.69 132.78 54.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.229 1.812 . . . . 10.0 107.448 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.21 129.79 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -75.54 88.43 2.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -48.06 -39.48 20.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.831 1.252 . . . . 10.0 111.292 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -49.83 -33.44 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.143 1.377 . . . . 10.0 112.224 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.66 27.19 8.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.62 0.645 . . . . 10.0 110.656 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 44.69 41.97 5.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.47 1.508 . . . . 10.0 111.499 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 -3.52 30.95 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.131 -1.372 . . . . 10.0 116.044 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -80.9 -71.63 0.46 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 120.024 1.912 . . . . 10.0 110.661 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.43 -10.44 1.72 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.934 1.255 . . . . 10.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.63 137.81 33.64 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.222 2.011 . . . . 10.0 109.225 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 152.33 4.59 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 118.882 0.764 . . . . 10.0 112.071 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -46.82 141.77 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.122 3.214 . . . . 10.0 114.322 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.6 -58.32 3.78 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.783 0.706 . . . . 10.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 81.82 1.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.588 0.709 . . . . 10.0 109.852 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -56.49 157.32 9.91 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.636 1.174 . . . . 10.0 112.475 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.95 -174.72 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.328 2.019 . . . . 10.0 109.397 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -119.24 156.52 29.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -65.66 131.29 45.98 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.525 -1.359 . . . . 10.0 110.493 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -75.03 114.9 39.63 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.312 0.96 . . . . 10.0 109.389 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.1 -37.55 8.22 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.607 1.538 . . . . 10.0 110.558 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.96 -38.63 7.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.818 1.647 . . . . 10.0 112.964 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.3 p -119.06 20.45 12.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.797 0.839 . . . . 10.0 111.334 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 46.0 44.08 11.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.478 1.111 . . . . 10.0 111.483 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.13 -1.19 34.72 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.315 -1.269 . . . . 10.0 115.737 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.8 p -70.33 -63.2 1.13 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 120.336 2.068 . . . . 10.0 111.256 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.71 7.11 4.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.474 1.988 . . . . 10.0 111.529 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -134.7 146.93 49.93 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.426 1.613 . . . . 10.0 111.759 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 m -111.93 145.61 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.546 1.538 . . . . 10.0 108.336 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -107.91 113.33 26.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.072 -1.085 . . . . 10.0 108.072 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.7 tpp -75.15 73.95 2.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -70.76 60.98 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.655 1.582 . . . . 10.0 112.023 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -76.99 56.59 1.24 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.258 1.423 . . . . 10.0 110.861 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.68 -71.3 0.38 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.503 1.049 . . . . 10.0 112.847 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -98.63 -63.76 1.1 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.058 0.943 . . . . 10.0 112.025 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -77.49 60.73 2.14 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.895 0.878 . . . . 10.0 111.059 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.14 60.38 0.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.736 1.214 . . . . 10.0 113.096 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.29 -179.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.806 0.842 . . . . 10.0 110.013 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.6 160.08 40.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.46 166.6 24.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.513 1.125 . . . . 10.0 108.722 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 m -63.98 141.13 58.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.3 t -75.62 115.34 44.94 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 118.613 0.642 . . . . 10.0 109.707 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.45 -37.83 9.35 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.263 1.975 . . . . 10.0 111.052 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -45.38 -33.42 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.831 1.652 . . . . 10.0 112.538 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.07 21.79 6.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.9 0.88 . . . . 10.0 111.746 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.83 40.42 8.94 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.134 0.974 . . . . 10.0 112.263 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.29 53.62 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.114 0.805 . . . . 10.0 115.114 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -82.69 -7.77 59.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.966 1.383 . . . . 10.0 112.405 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.03 -6.49 2.97 Favored Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.465 -0.772 . . . . 10.0 113.041 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.56 127.04 52.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.184 1.793 . . . . 10.0 112.172 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.57 116.89 10.5 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.699 1.6 . . . . 10.0 107.482 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 mm -72.07 74.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 126.121 1.768 . . . . 10.0 109.291 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -42.47 -47.75 5.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.17 1.788 . . . . 10.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.22 94.96 5.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.87 1.268 . . . . 10.0 109.263 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.61 123.22 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 1 C-N-CA 125.573 4.182 . . . . 10.0 117.553 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.97 91.41 2.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.187 1.795 . . . . 10.0 107.142 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -36.98 -48.27 0.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.198 1.799 . . . . 10.0 112.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -43.37 -42.68 4.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.678 1.591 . . . . 10.0 112.639 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.28 16.87 14.81 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 123.756 0.823 . . . . 10.0 110.795 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 51.25 35.02 12.54 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.54 1.136 . . . . 10.0 110.27 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.64 14.25 57.45 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.688 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -75.05 -27.28 59.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.184 1.492 . . . . 10.0 111.627 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.56 -34.26 4.84 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.578 1.085 . . . . 10.0 113.718 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 144.37 50.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.123 0.969 . . . . 10.0 108.72 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.37 145.39 34.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.154 0.982 . . . . 10.0 109.412 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -80.47 138.69 36.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -67.79 72.09 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.034 1.334 . . . . 10.0 109.291 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 125.48 1.512 . . . . 10.0 110.625 -176.055 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 109.386 -1.486 . . . . 10.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.52 -22.33 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.5 p -71.0 69.1 0.46 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.991 2.116 . . . . 10.0 108.709 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -136.38 -149.69 0.34 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.435 1.094 . . . . 10.0 109.551 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.27 58.84 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.352 1.061 . . . . 10.0 111.981 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.0 pt -77.74 59.19 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.463 0.705 . . . . 10.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -77.75 64.95 3.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.46 0.704 . . . . 10.0 109.125 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.79 154.35 80.46 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 126.242 1.817 . . . . 10.0 107.368 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.49 75.26 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.8 2.334 . . . . 10.0 110.799 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 m -73.43 65.78 0.93 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.572 0.749 . . . . 10.0 110.683 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.51 120.93 15.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.643 -0.661 . . . . 10.0 110.214 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -129.56 150.39 50.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.16 0.984 . . . . 10.0 109.531 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 131.44 43.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.808 1.643 . . . . 10.0 112.412 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.3 t -76.99 101.13 5.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.195 -1.78 . . . . 10.0 106.195 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -48.8 -41.97 34.44 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.288 1.435 . . . . 10.0 111.518 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.5 t -52.23 -33.38 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.103 1.361 . . . . 10.0 111.89 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.76 19.54 14.43 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.404 0.547 . . . . 10.0 110.925 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.08 38.31 16.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.019 1.327 . . . . 10.0 111.242 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.34 60.19 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.593 -1.115 . . . . 10.0 115.382 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.6 p -79.28 -67.88 0.71 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.89 1.845 . . . . 10.0 110.909 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.11 -9.47 3.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.981 2.705 . . . . 10.0 110.028 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 126.63 30.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.209 1.003 . . . . 10.0 111.739 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -44.76 141.49 2.92 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.916 1.687 . . . . 10.0 111.258 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.13 145.35 65.2 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.641 2.227 . . . . 10.0 110.185 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.05 39.06 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.44 0.543 . . . . 10.0 113.118 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -137.87 169.77 17.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 150.68 75.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 118.933 0.788 . . . . 10.0 111.047 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.86 168.05 10.98 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.236 2.624 . . . . 10.0 108.506 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -105.37 126.09 51.72 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 122.191 -0.318 . . . . 10.0 110.647 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -50.13 121.92 6.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 10.0 110.573 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.85 115.8 26.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -70.21 -36.27 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.642 1.561 . . . . 10.0 110.754 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.14 -40.26 10.8 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.679 1.592 . . . . 10.0 112.907 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 p -115.73 18.14 15.86 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 10.0 111.32 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 47.79 42.0 15.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.249 1.02 . . . . 10.0 110.722 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.37 -2.95 8.81 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.385 -1.231 . . . . 10.0 115.518 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -45.41 82.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.324 2.062 . . . . 10.0 111.322 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.06 3.24 28.06 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.365 1.459 . . . . 10.0 111.262 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -135.12 143.11 46.39 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.074 1.437 . . . . 10.0 112.079 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 m -99.46 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 126.096 1.758 . . . . 10.0 107.679 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -126.68 118.7 25.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.01 -1.478 . . . . 10.0 107.01 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -107.77 135.62 48.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.698 1.199 . . . . 10.0 108.843 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -99.05 115.26 28.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.767 1.227 . . . . 10.0 108.234 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 58.05 3.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.585 -0.895 . . . . 10.0 108.585 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 -66.7 2.07 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -101.23 -76.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.841 1.256 . . . . 10.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.46 172.84 6.61 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.475 0.579 . . . . 10.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.34 152.24 40.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.784 -0.573 . . . . 10.0 109.718 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.43 156.87 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.419 1.088 . . . . 10.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 158.85 23.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.595 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -147.03 155.13 41.97 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.231 -1.396 . . . . 10.0 107.231 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -63.76 133.99 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.34 117.35 56.07 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 119.178 0.899 . . . . 10.0 109.087 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.26 -37.04 8.47 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.95 1.767 . . . . 10.0 111.422 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -39.25 25.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.779 1.231 . . . . 10.0 113.566 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -116.26 19.63 14.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.892 1.277 . . . . 10.0 110.892 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 46.59 44.59 13.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.631 1.172 . . . . 10.0 111.319 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.84 -8.18 6.39 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.451 0.94 . . . . 10.0 115.451 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -74.94 -17.65 60.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.775 1.787 . . . . 10.0 112.714 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.2 12.64 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.843 -0.536 . . . . 10.0 112.385 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -106.54 130.49 54.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.703 1.601 . . . . 10.0 112.069 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.6 mt -81.63 115.82 21.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -75.68 67.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.321 1.048 . . . . 10.0 108.192 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.91 -24.59 67.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.078 0.551 . . . . 10.0 109.575 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -118.35 80.18 15.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 128.396 2.678 . . . . 10.0 110.655 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.6 122.17 11.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.962 2.442 . . . . 10.0 115.191 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.43 89.42 0.69 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.367 -1.345 . . . . 10.0 107.367 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -39.26 -46.31 1.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.283 1.833 . . . . 10.0 112.848 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -45.59 -36.79 4.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.274 1.03 . . . . 10.0 112.555 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.1 26.07 6.58 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.822 0.849 . . . . 10.0 110.182 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 43.44 40.13 2.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.549 1.54 . . . . 10.0 112.117 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.97 37.32 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.198 -0.939 . . . . 10.0 115.245 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.42 -39.27 88.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.727 1.763 . . . . 10.0 109.547 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.26 -9.08 67.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.213 1.863 . . . . 10.0 114.333 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.74 44.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.865 1.332 . . . . 10.0 109.271 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.72 147.9 30.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.558 1.143 . . . . 10.0 110.419 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 79.88 1.99 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.351 1.06 . . . . 10.0 108.439 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -79.48 50.28 1.1 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.396 1.079 . . . . 10.0 110.764 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.455 -0.218 0 O-C-N 121.513 -0.742 . . . . 10.0 109.888 -179.418 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 109.999 -1.24 . . . . 10.0 109.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.8 m -46.48 -30.75 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.86 1.664 . . . . 10.0 113.836 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p -55.95 -38.95 71.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.179 0.991 . . . . 10.0 110.64 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -94.43 -50.9 5.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.303 1.041 . . . . 10.0 108.192 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.8 65.44 1.93 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.906 1.283 . . . . 10.0 109.1 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -58.11 -8.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.82 66.38 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.21 158.4 10.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.938 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -56.16 69.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 1 C-N-CA 125.321 4.014 . . . . 10.0 115.027 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -92.24 88.43 6.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.708 -1.96 . . . . 10.0 105.708 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.4 mt -96.59 132.62 42.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.549 1.14 . . . . 10.0 111.795 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -110.78 127.01 55.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.766 1.626 . . . . 10.0 107.566 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.4 127.11 30.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.795 1.238 . . . . 10.0 109.798 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.1 85.23 4.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.289 0.566 . . . . 10.0 110.041 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -46.77 -38.7 10.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.258 1.423 . . . . 10.0 111.708 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -49.16 -38.48 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.798 1.639 . . . . 10.0 111.712 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.14 19.52 17.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.147 0.579 . . . . 10.0 110.585 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 51.89 36.27 17.82 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.218 1.407 . . . . 10.0 109.772 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 3.66 42.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.43 1.014 . . . . 10.0 115.546 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -75.34 -66.3 0.78 Allowed 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.61 1.705 . . . . 10.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.89 -9.91 3.64 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.978 2.228 . . . . 10.0 109.82 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.18 139.65 46.46 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.355 1.578 . . . . 10.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -56.13 146.4 50.84 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.438 -0.791 . . . . 10.0 109.407 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -32.81 -66.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 1 C-N-CA 125.349 4.033 . . . . 10.0 115.68 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.29 44.5 3.06 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.583 -0.698 . . . . 10.0 113.074 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -158.13 158.65 35.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.673 1.236 . . . . 10.0 107.975 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 147.25 36.73 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.105 1.362 . . . . 10.0 108.662 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.21 160.15 42.84 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.413 2.075 . . . . 10.0 107.247 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -105.32 126.18 51.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -36.75 116.92 0.46 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.949 1.3 . . . . 10.0 113.073 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.6 115.52 44.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.14 -31.75 18.26 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.649 1.566 . . . . 10.0 110.589 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -43.56 29.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.151 1.38 . . . . 10.0 112.062 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -108.04 11.55 27.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.081 0.953 . . . . 10.0 111.28 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 52.15 37.93 23.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.272 1.029 . . . . 10.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 -8.35 19.18 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.799 -0.563 . . . . 10.0 113.993 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 m -71.38 -8.7 55.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.989 1.394 . . . . 10.0 114.438 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.92 -18.78 11.35 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.064 0.847 . . . . 10.0 113.729 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -133.61 131.62 39.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.246 1.023 . . . . 10.0 109.566 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 m -73.8 150.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.337 1.455 . . . . 10.0 107.291 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.51 107.22 14.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.341 0.657 . . . . 10.0 109.889 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.32 114.87 22.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -97.95 133.12 42.87 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.578 1.151 . . . . 10.0 109.984 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.07 80.94 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.902 1.681 . . . . 10.0 107.606 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.37 -64.2 2.5 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.996 0.807 . . . . 10.0 111.704 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.71 -66.69 0.82 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.258 1.023 . . . . 10.0 109.416 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -59.92 155.33 16.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.981 0.512 . . . . 10.0 109.715 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.01 157.21 43.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.418 0.287 . . . . 10.0 110.83 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.92 148.57 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.429 1.092 . . . . 10.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.83 144.76 30.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.883 0.873 . . . . 10.0 112.177 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -140.15 143.81 36.36 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.302 1.441 . . . . 10.0 107.843 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -53.09 135.39 37.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.253 0.933 . . . . 10.0 111.489 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.2 t -79.53 116.89 64.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.97 -41.94 3.59 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.133 1.889 . . . . 10.0 111.259 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.2 -29.83 2.59 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.95 1.092 . . . . 10.0 113.95 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.2 p -127.46 29.95 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.759 0.824 . . . . 10.0 111.594 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 38.78 49.83 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.239 1.416 . . . . 10.0 111.945 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.54 -11.03 3.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.203 1.241 . . . . 10.0 116.203 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -74.08 -13.82 60.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.106 1.953 . . . . 10.0 113.574 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.35 7.2 86.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.559 -0.578 . . . . 10.0 114.339 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -132.03 119.05 20.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.444 1.122 . . . . 10.0 110.565 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.03 150.19 43.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.002 1.321 . . . . 10.0 110.209 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -112.72 73.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 125.557 1.543 . . . . 10.0 109.961 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -68.45 -24.67 64.74 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.275 -0.891 . . . . 10.0 109.613 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -107.4 79.14 0.73 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.942 2.497 . . . . 10.0 110.323 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 118.09 5.06 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.296 2.664 . . . . 10.0 115.801 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.6 t -65.6 95.49 0.23 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.481 -1.674 . . . . 10.0 106.481 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -38.79 -48.81 1.56 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.869 1.668 . . . . 10.0 112.776 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -42.93 -39.89 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.725 1.21 . . . . 10.0 112.752 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.01 19.5 10.03 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.594 0.757 . . . . 10.0 111.047 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 46.38 41.93 9.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.653 1.181 . . . . 10.0 110.776 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.13 15.46 44.04 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.409 0.924 . . . . 10.0 115.409 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.83 -44.63 31.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.625 1.712 . . . . 10.0 109.009 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.75 -7.43 13.41 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.906 1.717 . . . . 10.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.62 152.85 32.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.881 -1.364 . . . . 10.0 109.688 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.08 146.45 13.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -98.59 137.69 36.86 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.344 -0.613 . . . . 10.0 109.344 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -78.26 59.98 2.41 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.064 -1.087 . . . . 10.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.31 1.044 . . . . 10.0 110.86 -178.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 109.905 -0.405 . . . . 10.0 109.905 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -138.16 144.22 40.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.844 1.257 . . . . 10.0 108.059 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.95 142.95 45.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.0 t -76.58 87.26 3.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -41.67 -41.86 2.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.567 1.947 . . . . 10.0 111.751 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -51.67 -45.69 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 10.0 111.443 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.79 18.49 18.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.768 0.713 . . . . 10.0 110.599 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.83 35.95 25.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.26 1.424 . . . . 10.0 110.166 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.86 3.06 58.77 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.144 -1.364 . . . . 10.0 115.02 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -80.05 -75.22 0.27 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.012 1.906 . . . . 10.0 110.388 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.89 -19.25 0.76 Allowed Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.628 1.585 . . . . 10.0 112.308 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.71 151.53 26.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.596 1.698 . . . . 10.0 111.087 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -52.82 151.59 8.13 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.182 0.901 . . . . 10.0 111.92 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -50.51 137.23 40.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.54 2.827 . . . . 10.0 112.06 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.82 -51.8 2.75 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.598 1.094 . . . . 10.0 111.1 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -68.56 70.42 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.235 2.614 . . . . 10.0 108.904 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -56.76 158.43 8.68 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.383 0.673 . . . . 10.0 112.656 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.59 145.21 60.08 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.69 1.593 . . . . 10.0 109.287 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -84.6 123.01 29.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -50.78 121.35 5.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.914 0.886 . . . . 10.0 109.624 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.92 116.9 33.7 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.898 -0.778 . . . . 10.0 108.898 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.27 -38.46 6.66 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.582 1.521 . . . . 10.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.58 -39.71 7.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.289 1.836 . . . . 10.0 113.272 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -115.4 17.0 16.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.926 0.89 . . . . 10.0 111.568 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 47.1 49.71 14.77 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.0 0.92 . . . . 10.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.67 2.92 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.779 1.18 . . . . 10.0 115.247 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -90.12 2.84 54.86 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.843 1.321 . . . . 10.0 113.107 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.99 -8.82 5.83 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.776 1.07 . . . . 10.0 115.776 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.98 130.75 52.99 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.068 1.434 . . . . 10.0 110.031 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 m -87.95 143.85 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.658 -1.608 . . . . 10.0 106.658 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -98.33 110.67 23.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.93 -1.137 . . . . 10.0 107.93 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.6 tpt -75.79 73.29 2.73 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -69.44 55.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.064 2.146 . . . . 10.0 112.981 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.27 64.29 4.13 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.764 1.226 . . . . 10.0 108.414 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 -126.91 31.88 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -53.59 -47.83 69.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.306 1.042 . . . . 10.0 113.284 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -79.67 58.17 2.69 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.983 0.513 . . . . 10.0 111.143 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 59.0 2.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.261 0.625 . . . . 10.0 112.527 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.65 175.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -115.42 171.12 7.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -141.63 154.64 45.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.827 -1.916 . . . . 10.0 105.827 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -65.65 136.08 55.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 39.1 t -71.04 116.57 47.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.848 0.749 . . . . 10.0 109.649 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -38.99 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.874 1.716 . . . . 10.0 111.251 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -47.21 -41.14 17.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.004 1.322 . . . . 10.0 113.101 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.3 p -116.02 20.63 14.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.139 0.976 . . . . 10.0 111.299 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 46.8 42.92 12.58 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.374 1.07 . . . . 10.0 111.6 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.95 -4.09 11.18 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.433 0.933 . . . . 10.0 115.433 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -78.86 -5.5 53.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.644 1.722 . . . . 10.0 113.041 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.94 5.64 5.77 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.39 0.995 . . . . 10.0 114.642 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 p -129.14 132.41 47.34 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.773 1.229 . . . . 10.0 111.322 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -104.56 120.26 40.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.391 1.077 . . . . 10.0 110.111 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -78.01 65.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.356 1.462 . . . . 10.0 107.429 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -56.83 -45.43 82.34 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.296 0.57 . . . . 10.0 109.479 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -114.02 100.03 51.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.981 1.712 . . . . 10.0 108.475 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.72 131.04 19.13 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.925 1.75 . . . . 10.0 112.34 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.47 100.21 0.48 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -40.73 -50.37 3.1 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.63 1.572 . . . . 10.0 112.805 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -45.21 -40.0 6.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.861 1.265 . . . . 10.0 112.973 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -118.45 19.78 13.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.286 0.634 . . . . 10.0 111.004 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 46.5 42.92 11.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.647 1.179 . . . . 10.0 110.827 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.73 29.3 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.236 -1.313 . . . . 10.0 116.279 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -65.99 -55.95 14.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.278 2.039 . . . . 10.0 110.293 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.69 -9.62 16.51 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.718 1.151 . . . . 10.0 114.415 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.73 156.36 41.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.34 -1.356 . . . . 10.0 107.34 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.14 166.51 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.155 0.582 . . . . 10.0 109.69 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.57 136.59 36.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.817 -1.92 . . . . 10.0 105.817 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -51.11 116.19 1.89 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.414 -0.588 . . . . 10.0 109.414 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 124.334 1.054 . . . . 10.0 108.247 -177.748 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -118.05 147.09 43.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.79 138.34 58.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.406 0.441 . . . . 10.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.03 100.09 4.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.057 -1.461 . . . . 10.0 107.057 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.16 -43.38 20.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.563 . . . . 10.0 111.577 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.7 -29.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.277 1.431 . . . . 10.0 112.445 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.31 19.84 8.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.816 0.846 . . . . 10.0 110.808 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 44.93 42.44 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.344 1.458 . . . . 10.0 111.314 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.29 -11.26 38.34 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.165 1.226 . . . . 10.0 116.165 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.8 p -70.32 -68.72 0.4 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 120.036 1.918 . . . . 10.0 110.816 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.74 -5.5 5.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.863 2.173 . . . . 10.0 109.205 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.54 131.32 35.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.519 1.16 . . . . 10.0 109.159 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -54.69 159.41 3.53 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -42.5 137.35 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.983 3.122 . . . . 10.0 114.68 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.41 10.92 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.789 1.185 . . . . 10.0 114.157 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 m -127.36 136.07 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.406 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -90.86 146.12 33.26 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 124.12 0.968 . . . . 10.0 110.319 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -68.75 158.21 58.75 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 106.839 -2.023 . . . . 10.0 106.839 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -89.96 114.22 26.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -48.07 124.13 7.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.381 1.072 . . . . 10.0 109.866 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.53 115.39 17.96 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.74 -36.94 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.815 1.676 . . . . 10.0 110.725 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.61 -39.93 8.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.682 1.593 . . . . 10.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 p -114.6 12.65 17.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.788 . . . . 10.0 111.667 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.89 41.93 23.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.024 0.93 . . . . 10.0 109.895 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.53 -7.81 8.18 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.246 -0.752 . . . . 10.0 114.846 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -68.14 -9.06 43.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.499 1.65 . . . . 10.0 113.898 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.25 54.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.356 0.979 . . . . 10.0 113.68 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.4 143.55 30.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.509 1.154 . . . . 10.0 110.404 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.34 152.03 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.1 1.76 . . . . 10.0 107.534 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -125.66 118.94 26.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 89.6 mtp -104.02 121.48 43.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.873 1.269 . . . . 10.0 108.505 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -95.28 112.18 23.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.568 1.147 . . . . 10.0 108.914 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.82 53.73 2.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.43 -71.25 0.35 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.341 0.972 . . . . 10.0 112.427 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -80.56 -68.49 0.68 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 10.0 110.099 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.94 174.31 7.23 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.269 0.628 . . . . 10.0 110.058 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.14 43.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.703 0.801 . . . . 10.0 109.443 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 164.58 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 124.644 1.177 . . . . 10.0 108.576 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.56 152.63 43.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.113 0.965 . . . . 10.0 111.621 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.1 160.04 41.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -59.75 136.74 58.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.4 t -72.05 117.14 55.58 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.812 0.733 . . . . 10.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.09 -40.44 6.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.086 1.857 . . . . 10.0 111.357 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -45.85 -36.87 5.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.651 1.18 . . . . 10.0 113.013 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.4 p -121.43 21.49 10.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.877 0.871 . . . . 10.0 111.595 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 44.86 42.99 6.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.407 1.083 . . . . 10.0 111.705 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -4.76 9.13 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.699 1.04 . . . . 10.0 115.699 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -77.62 -7.8 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.425 1.612 . . . . 10.0 112.932 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.82 -2.21 2.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.105 0.86 . . . . 10.0 114.14 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 135.28 49.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.657 1.583 . . . . 10.0 109.876 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -101.88 119.79 39.35 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.773 1.229 . . . . 10.0 108.252 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.0 66.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 10.0 108.351 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -63.43 -35.51 80.68 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.786 -0.571 . . . . 10.0 110.22 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -109.64 77.05 0.96 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 127.795 2.438 . . . . 10.0 110.086 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.81 124.52 13.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.222 2.614 . . . . 10.0 115.591 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.99 94.89 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.495 1.518 . . . . 10.0 107.989 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -39.54 -47.83 1.95 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.476 1.51 . . . . 10.0 113.273 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -45.97 -43.29 13.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.972 0.909 . . . . 10.0 112.7 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.43 19.69 16.72 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 122.923 0.489 . . . . 10.0 110.461 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.08 40.85 18.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.436 1.094 . . . . 10.0 110.314 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.44 20.56 45.61 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.388 -0.673 . . . . 10.0 114.325 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -67.69 0.65 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.145 1.473 . . . . 10.0 107.371 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.92 -45.04 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.475 -0.65 . . . . 10.0 111.475 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.29 161.36 26.0 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.167 0.987 . . . . 10.0 110.237 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.7 149.78 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.226 1.011 . . . . 10.0 110.107 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.2 71.55 2.23 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.321 1.048 . . . . 10.0 109.371 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 67.14 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.906 2.083 . . . . 10.0 109.044 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.451 -0.422 0 C-N-CA 125.875 1.67 . . . . 10.0 111.724 -175.552 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.3 0.095 . . . . 10.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -129.82 156.26 44.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.731 1.612 . . . . 10.0 108.243 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.18 137.08 58.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.197 0.599 . . . . 10.0 109.783 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 t -76.6 81.63 3.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -46.18 -38.19 8.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.419 1.487 . . . . 10.0 111.502 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.04 -42.5 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.359 1.464 . . . . 10.0 111.776 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.8 p -110.36 20.19 18.03 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.511 0.724 . . . . 10.0 110.34 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 49.93 38.01 15.17 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.418 1.487 . . . . 10.0 110.27 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.84 0.54 14.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.544 -1.142 . . . . 10.0 115.384 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -73.77 -57.88 3.68 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 120.123 1.961 . . . . 10.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.85 5.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.433 1.968 . . . . 10.0 109.829 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 129.57 40.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.215 1.008 . . . . 10.0 112.172 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -42.2 145.59 0.76 Allowed Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.556 1.943 . . . . 10.0 111.729 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -39.13 132.08 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.725 2.95 . . . . 10.0 113.139 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.46 15.27 23.85 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.13 -0.817 . . . . 10.0 114.307 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -119.21 157.51 27.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.783 1.233 . . . . 10.0 107.717 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.99 152.63 43.77 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.1 1.36 . . . . 10.0 109.019 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.83 -177.9 4.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.149 1.899 . . . . 10.0 108.996 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -117.64 125.93 51.61 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -47.01 122.33 4.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.305 1.042 . . . . 10.0 110.897 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.61 115.79 27.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 -36.76 9.04 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.603 1.535 . . . . 10.0 110.887 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -46.32 -38.88 9.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.951 1.7 . . . . 10.0 112.985 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.21 19.99 13.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.089 0.956 . . . . 10.0 111.261 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 46.65 42.68 11.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.357 1.063 . . . . 10.0 111.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.41 -6.31 11.87 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.691 -1.061 . . . . 10.0 115.615 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.3 p -68.12 -44.48 76.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.073 1.936 . . . . 10.0 112.069 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.59 2.51 34.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.264 1.411 . . . . 10.0 111.136 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -128.82 130.07 46.46 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.714 1.257 . . . . 10.0 110.19 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.51 132.73 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -116.92 116.53 27.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.9 mmt -68.98 158.48 34.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -144.28 41.34 1.37 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.769 0.828 . . . . 10.0 109.854 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -163.69 0.59 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.015 1.726 . . . . 10.0 107.754 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.25 3.24 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.975 -0.85 . . . . 10.0 110.975 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -158.07 -60.74 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.295 0.547 . . . . 10.0 110.915 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -135.77 156.15 49.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.211 1.404 . . . . 10.0 107.404 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.7 63.03 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -78.34 172.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 123.412 0.685 . . . . 10.0 111.005 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.1 164.24 30.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.421 0.526 . . . . 10.0 112.421 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -144.6 161.69 38.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.718 1.207 . . . . 10.0 108.272 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -62.41 134.17 56.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.52 117.1 40.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 119.031 0.832 . . . . 10.0 109.748 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.88 -39.8 5.86 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.819 1.679 . . . . 10.0 111.241 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.88 -39.88 27.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.501 1.12 . . . . 10.0 113.635 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.8 p -113.12 16.23 19.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.196 0.998 . . . . 10.0 111.384 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 48.07 44.57 19.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 10.0 110.608 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.57 -2.36 16.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -78.63 -2.67 40.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.028 1.914 . . . . 10.0 113.343 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.54 -0.28 2.22 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.176 0.893 . . . . 10.0 114.279 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -125.71 128.59 48.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.628 1.571 . . . . 10.0 109.971 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.41 144.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.588 -1.264 . . . . 10.0 107.588 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mm -108.62 73.74 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.515 1.126 . . . . 10.0 109.334 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -66.14 -27.82 68.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.968 . . . . 10.0 108.719 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 80.23 0.42 Allowed Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 127.392 2.277 . . . . 10.0 110.061 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.36 121.69 9.01 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.292 2.661 . . . . 10.0 114.716 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.0 t -68.55 91.65 0.43 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.339 -1.726 . . . . 10.0 106.339 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -40.87 -44.19 2.23 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 125.347 1.459 . . . . 10.0 112.596 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -44.16 -37.22 3.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.08 0.952 . . . . 10.0 112.599 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -124.22 14.01 9.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.009 . . . . 10.0 111.243 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m80 45.73 43.24 9.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.46 1.104 . . . . 10.0 110.612 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.3 38.27 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.64 -37.82 59.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.011 1.906 . . . . 10.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.99 34.02 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.406 1.003 . . . . 10.0 114.925 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.77 155.37 45.61 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 119.162 1.481 . . . . 10.0 110.367 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.6 m -134.19 155.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 125.136 1.374 . . . . 10.0 108.676 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.91 148.33 23.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.533 0.733 . . . . 10.0 109.424 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -75.56 49.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.795 0.838 . . . . 10.0 110.623 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.452 -0.336 0 O-C-N 121.077 -1.014 . . . . 10.0 111.021 -177.329 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -134.02 146.12 50.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.627 1.171 . . . . 10.0 108.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.68 144.2 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.466 -0.568 . . . . 10.0 109.466 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.51 91.31 5.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -46.69 -38.9 10.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.415 1.486 . . . . 10.0 111.814 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.5 t -49.59 -43.01 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.392 1.477 . . . . 10.0 111.278 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 20.22 18.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.952 0.501 . . . . 10.0 110.688 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 52.84 38.56 27.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.152 1.381 . . . . 10.0 110.099 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.99 -3.11 47.6 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.411 -1.216 . . . . 10.0 115.167 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -78.0 -74.51 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.144 1.972 . . . . 10.0 111.36 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.9 -18.0 1.09 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.626 1.108 . . . . 10.0 111.847 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.73 140.9 31.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.662 1.731 . . . . 10.0 109.587 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 157.6 2.47 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.008 0.744 . . . . 10.0 113.008 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -41.67 136.72 2.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.643 3.562 . . . . 10.0 115.337 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -60.25 2.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.582 0.611 . . . . 10.0 112.227 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 m -70.91 79.69 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.327 0.584 . . . . 10.0 109.928 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.78 162.95 4.43 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.183 0.993 . . . . 10.0 111.865 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.55 153.54 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.86 1.707 . . . . 10.0 110.215 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -98.49 135.0 40.67 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.797 -0.445 . . . . 10.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -50.82 124.93 12.14 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.058 0.943 . . . . 10.0 110.738 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -68.19 115.85 33.22 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 118.597 0.635 . . . . 10.0 109.445 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.25 -34.75 12.39 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.43 1.42 . . . . 10.0 110.806 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -46.25 -38.26 8.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.624 1.569 . . . . 10.0 113.22 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.23 15.29 13.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.315 1.046 . . . . 10.0 110.718 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 50.0 40.59 21.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.973 0.909 . . . . 10.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.06 10.34 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.851 0.739 . . . . 10.0 114.654 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.4 m -64.29 -28.29 69.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.918 1.359 . . . . 10.0 113.339 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 -16.79 57.56 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.483 1.04 . . . . 10.0 114.776 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 146.75 52.47 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.946 1.373 . . . . 10.0 110.455 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.23 155.14 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.271 1.428 . . . . 10.0 107.146 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -126.54 114.71 18.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.2 mtp -76.53 73.17 3.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.87 60.69 0.17 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.144 1.378 . . . . 10.0 112.408 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 48.29 0.63 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.504 1.122 . . . . 10.0 110.797 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.2 -61.78 2.22 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.344 -0.847 . . . . 10.0 112.432 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -102.35 -72.66 0.68 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.981 0.89 . . . . 10.0 113.359 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -73.64 68.99 1.25 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.568 -0.708 . . . . 10.0 111.553 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 59.74 0.63 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.424 1.09 . . . . 10.0 111.35 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.0 m -78.6 151.96 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 C-N-CA 123.138 0.575 . . . . 10.0 111.295 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.1 150.88 24.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.414 1.086 . . . . 10.0 111.921 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -145.13 151.11 37.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -60.5 135.93 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.51 116.38 48.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.001 0.819 . . . . 10.0 109.29 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.02 -38.38 7.3 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.156 1.904 . . . . 10.0 111.33 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -45.3 -42.52 9.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.961 1.704 . . . . 10.0 112.258 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -115.21 20.79 14.69 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.195 0.998 . . . . 10.0 112.077 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 46.92 41.9 11.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.53 1.132 . . . . 10.0 111.354 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.22 -7.04 6.42 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.409 0.923 . . . . 10.0 115.409 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.34 -9.33 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.61 1.705 . . . . 10.0 113.443 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.02 3.33 10.63 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.568 -0.707 . . . . 10.0 112.941 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.78 133.11 47.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.078 1.751 . . . . 10.0 109.933 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.04 122.68 43.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.207 1.403 . . . . 10.0 109.905 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.5 mm -81.02 67.14 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.637 1.575 . . . . 10.0 107.092 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -57.56 -38.03 74.11 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.562 0.579 . . . . 10.0 112.562 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -125.98 84.25 61.56 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.283 1.433 . . . . 10.0 110.44 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.53 132.34 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.959 3.773 . . . . 10.0 115.914 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.1 t -74.62 95.15 2.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -37.4 -50.05 1.04 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.76 1.624 . . . . 10.0 113.009 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -45.13 -36.15 3.54 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.397 1.079 . . . . 10.0 113.508 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -122.59 15.55 10.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.477 0.711 . . . . 10.0 110.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 43.98 45.33 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.939 1.295 . . . . 10.0 111.15 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.78 -3.1 13.51 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 116.291 1.277 . . . . 10.0 116.291 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -66.84 -36.88 83.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.14 1.97 . . . . 10.0 111.132 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.48 56.17 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 123.99 0.805 . . . . 10.0 113.333 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -135.93 160.93 37.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.453 1.126 . . . . 10.0 110.14 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.71 157.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.344 1.457 . . . . 10.0 107.895 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.29 126.97 50.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.861 0.864 . . . . 10.0 109.096 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -77.09 62.93 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.454 -0.249 0 O-C-N 121.463 -0.773 . . . . 10.0 110.919 -177.317 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -109.0 128.36 54.89 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.226 1.811 . . . . 10.0 107.656 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 128.89 39.06 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.573 0.749 . . . . 10.0 109.84 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 t -79.48 88.99 5.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.032 -0.729 . . . . 10.0 109.032 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -49.3 -36.01 19.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.064 1.346 . . . . 10.0 111.418 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -49.47 -48.29 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.796 1.238 . . . . 10.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.1 p -103.21 23.45 12.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.411 0.624 . . . . 10.0 111.001 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 53.33 37.14 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.259 1.424 . . . . 10.0 110.604 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.45 47.37 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.592 -1.115 . . . . 10.0 115.109 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -84.52 -69.57 0.64 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.751 1.775 . . . . 10.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.58 -24.89 1.51 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.205 1.859 . . . . 10.0 109.994 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.99 131.86 40.95 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.804 0.802 . . . . 10.0 111.063 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.7 143.34 6.01 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.849 -0.596 . . . . 10.0 111.741 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -22.27 126.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 1 C-N-CA 127.321 5.347 . . . . 10.0 117.163 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.1 -48.25 2.39 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.848 0.737 . . . . 10.0 112.831 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.89 128.74 38.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.246 1.418 . . . . 10.0 109.772 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.56 152.47 63.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 122.032 -0.418 . . . . 10.0 111.481 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 179.28 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.072 1.848 . . . . 10.0 108.941 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -121.5 131.72 54.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -50.49 125.32 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.056 0.942 . . . . 10.0 112.088 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.36 116.08 45.6 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.5 -38.79 7.86 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.353 1.368 . . . . 10.0 110.589 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -45.2 -39.42 6.25 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.314 1.846 . . . . 10.0 113.06 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.37 30.68 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.744 0.818 . . . . 10.0 110.641 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 39.78 47.96 1.89 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.305 1.442 . . . . 10.0 113.261 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 -4.17 39.61 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 116.279 1.272 . . . . 10.0 116.279 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 p -84.14 -68.99 0.67 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.127 1.964 . . . . 10.0 111.939 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.19 -5.28 0.65 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.261 -1.299 . . . . 10.0 116.277 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 143.55 47.32 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.46 2.13 . . . . 10.0 112.459 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -99.4 130.38 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.611 1.564 . . . . 10.0 108.153 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -103.21 106.31 16.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.045 0.538 . . . . 10.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.3 tpp -77.44 72.76 4.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.4 65.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.38 2.272 . . . . 10.0 112.98 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -79.25 70.07 5.58 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -136.96 27.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.945 -1.262 . . . . 10.0 109.945 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -55.1 -34.93 64.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.074 0.95 . . . . 10.0 112.128 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -74.29 72.13 1.76 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.743 0.817 . . . . 10.0 110.164 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 58.5 0.51 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.544 1.138 . . . . 10.0 111.544 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 m -81.47 157.35 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.538 0.735 . . . . 10.0 109.791 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.25 164.97 29.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.227 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -143.69 153.38 42.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.043 1.337 . . . . 10.0 108.021 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.7 m -60.44 136.4 58.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.74 116.77 51.39 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.42 -39.21 7.44 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.08 1.853 . . . . 10.0 112.116 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.42 -36.88 45.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.1 p -112.82 16.69 19.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.077 0.951 . . . . 10.0 111.28 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 47.77 42.9 16.43 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.987 1.315 . . . . 10.0 110.813 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.78 1.07 53.5 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -87.8 5.65 39.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.623 1.711 . . . . 10.0 113.583 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.42 -3.88 0.75 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.091 0.853 . . . . 10.0 115.009 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -121.81 125.96 47.7 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.417 1.487 . . . . 10.0 111.255 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.68 152.59 23.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.89 85.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -66.89 -23.05 65.96 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -111.62 68.3 0.75 Allowed Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 128.294 2.638 . . . . 10.0 109.973 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.31 133.74 27.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.269 2.646 . . . . 10.0 115.491 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.0 t -70.24 93.16 0.82 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.336 -1.357 . . . . 10.0 107.336 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -40.62 -45.4 2.33 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.693 1.597 . . . . 10.0 112.582 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -42.35 -40.01 2.35 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.348 1.459 . . . . 10.0 112.464 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -124.83 23.08 8.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.906 0.883 . . . . 10.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 46.22 40.96 8.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.987 1.315 . . . . 10.0 111.069 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.04 14.89 48.09 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 118.814 -0.992 . . . . 10.0 115.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.02 -23.57 44.24 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.726 1.763 . . . . 10.0 110.578 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.97 3.18 80.09 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.649 1.595 . . . . 10.0 114.38 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 153.1 31.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.304 1.052 . . . . 10.0 109.288 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.09 140.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 107.752 -1.203 . . . . 10.0 107.752 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -66.16 134.2 52.26 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.727 -0.608 . . . . 10.0 110.646 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -77.47 65.21 2.96 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.674 -0.862 . . . . 10.0 108.674 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.342 1.057 . . . . 10.0 109.045 -179.224 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 77' ' ' GLU . 62.3 mt . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -132.23 124.58 29.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.034 1.733 . . . . 10.0 108.15 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -62.43 135.05 57.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.291 0.636 . . . . 10.0 110.02 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 51.4 t -69.75 114.56 8.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -54.77 -42.78 72.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.228 0.611 . . . . 10.0 111.018 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -54.08 -49.59 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.346 1.058 . . . . 10.0 112.447 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 26.6 p -95.65 -0.44 51.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.609 0.64 . . . . 10.0 112.061 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 66.74 40.52 3.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.766 1.227 . . . . 10.0 109.437 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.39 -3.51 39.98 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.151 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.5 p -75.68 -69.22 0.5 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.073 1.937 . . . . 10.0 110.362 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.26 -8.47 4.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.08 2.752 . . . . 10.0 109.443 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.7 133.93 39.37 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.141 0.971 . . . . 10.0 110.728 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -44.91 142.6 2.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.258 1.423 . . . . 10.0 110.69 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.92 141.68 45.41 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.659 2.239 . . . . 10.0 110.906 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.75 21.04 34.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.642 0.639 . . . . 10.0 113.144 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -134.03 160.56 37.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -121.7 148.7 51.34 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.197 0.999 . . . . 10.0 111.825 -175.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.09 -179.05 5.09 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.15 2.566 . . . . 10.0 108.395 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -117.23 129.71 56.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -49.02 123.53 7.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.745 1.218 . . . . 10.0 110.845 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.2 t -65.68 115.83 26.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.85 -35.69 11.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.646 1.564 . . . . 10.0 111.092 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.71 -38.24 9.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.767 1.627 . . . . 10.0 112.997 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -117.45 15.59 14.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 111.333 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.7 40.91 21.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.18 0.992 . . . . 10.0 110.376 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.18 -11.79 7.88 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.628 0.632 . . . . 10.0 114.535 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -66.98 -11.85 58.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.997 1.398 . . . . 10.0 114.302 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.66 41.23 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.795 -0.566 . . . . 10.0 113.384 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 125.56 33.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.536 1.134 . . . . 10.0 109.163 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.32 131.3 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.72 111.5 21.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.0 mmm -74.24 72.35 1.75 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.003 1.321 . . . . 10.0 108.274 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -66.21 62.48 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.519 1.928 . . . . 10.0 112.704 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 51.86 1.01 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.648 1.179 . . . . 10.0 110.435 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.06 -67.28 0.48 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.27 0.938 . . . . 10.0 113.291 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -98.23 -72.51 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.76 1.224 . . . . 10.0 112.655 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -77.35 69.72 3.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.179 0.899 . . . . 10.0 110.881 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.8 59.68 0.9 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.805 0.842 . . . . 10.0 111.546 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.22 163.59 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.14 0.576 . . . . 10.0 110.246 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -125.04 171.17 10.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.23 154.04 45.58 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -62.21 133.52 55.31 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.37 117.16 56.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.849 0.75 . . . . 10.0 109.62 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.16 -36.38 5.76 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.166 1.911 . . . . 10.0 111.286 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -39.57 24.09 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.529 1.132 . . . . 10.0 112.543 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.7 p -117.62 20.12 13.61 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.249 1.019 . . . . 10.0 110.806 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 42.92 45.49 4.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.437 1.495 . . . . 10.0 112.177 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -9.2 5.36 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.237 0.855 . . . . 10.0 115.237 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -73.57 -8.44 55.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.257 1.529 . . . . 10.0 112.363 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 -13.06 0.55 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.533 1.063 . . . . 10.0 115.167 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.79 133.52 55.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.833 1.653 . . . . 10.0 110.904 -174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.0 116.91 28.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.17 66.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.633 1.573 . . . . 10.0 108.438 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -62.61 -34.08 76.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.255 0.55 . . . . 10.0 109.713 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -107.98 79.91 0.96 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.145 2.578 . . . . 10.0 109.69 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 125.79 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.477 2.118 . . . . 10.0 114.998 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.32 87.13 0.43 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -38.64 -44.7 1.01 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.218 1.807 . . . . 10.0 112.83 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -44.7 -41.42 6.76 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.801 1.24 . . . . 10.0 112.362 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.99 27.4 8.09 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.668 0.787 . . . . 10.0 109.963 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 45.62 37.72 3.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.937 1.695 . . . . 10.0 111.827 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.91 9.46 46.7 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 114.98 0.752 . . . . 10.0 114.98 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.66 -32.16 69.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.299 1.55 . . . . 10.0 109.563 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.44 -23.71 32.49 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.19 1.376 . . . . 10.0 113.525 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.32 151.5 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.267 1.034 . . . . 10.0 109.736 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.26 154.67 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.965 1.306 . . . . 10.0 107.662 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.487 ' HA ' HD23 ' A' ' 11' ' ' LEU . 35.0 tt0 -69.42 142.89 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.577 -0.702 . . . . 10.0 110.216 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -69.42 70.84 0.28 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.734 1.214 . . . . 10.0 109.515 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 125.771 1.628 . . . . 10.0 110.653 -176.211 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 77' ' ' GLU . 81.5 mt . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 111.555 0.206 . . . . 10.0 111.555 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -119.22 144.35 46.78 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.463 1.505 . . . . 10.0 109.929 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.78 135.74 56.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -77.98 87.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -46.46 -38.53 9.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.55 1.54 . . . . 10.0 111.312 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.69 -43.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.897 1.279 . . . . 10.0 111.029 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.64 13.99 29.06 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.845 0.458 . . . . 10.0 111.802 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 53.79 33.15 16.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 10.0 110.496 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.23 3.8 33.14 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.777 -1.013 . . . . 10.0 114.861 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 p -83.93 -24.55 30.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.602 1.701 . . . . 10.0 112.208 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.74 -9.99 74.73 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 119.029 -0.873 . . . . 10.0 110.927 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.6 139.11 33.98 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.862 1.331 . . . . 10.0 111.267 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -50.5 155.46 1.82 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.277 0.631 . . . . 10.0 111.56 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -28.53 121.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 125.308 4.005 . . . . 10.0 116.292 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.86 16.39 1.18 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.165 1.841 . . . . 10.0 116.021 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -93.08 119.51 32.39 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.193 1.496 . . . . 10.0 108.615 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.09 128.28 84.93 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.516 -0.754 . . . . 10.0 111.085 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 19.5 Cg_exo -68.31 -175.97 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.522 2.148 . . . . 10.0 111.618 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -122.33 120.64 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.774 1.63 . . . . 10.0 107.295 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -48.97 124.77 9.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.621 1.168 . . . . 10.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.2 117.32 48.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.62 -38.5 8.02 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.432 1.421 . . . . 10.0 110.898 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -40.1 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.962 1.705 . . . . 10.0 113.221 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.2 21.84 12.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.822 0.849 . . . . 10.0 111.174 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 45.52 43.63 9.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.354 1.062 . . . . 10.0 111.676 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.91 -4.03 25.13 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.422 -1.21 . . . . 10.0 115.987 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -68.53 -58.05 4.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.197 1.998 . . . . 10.0 111.609 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.77 3.31 7.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.233 1.873 . . . . 10.0 110.85 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 131.06 33.03 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.803 1.301 . . . . 10.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -87.09 157.92 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.684 1.193 . . . . 10.0 108.558 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -123.81 112.7 17.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.683 1.193 . . . . 10.0 108.132 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.28 73.08 3.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -68.68 64.41 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.04 1.336 . . . . 10.0 111.885 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.99 59.03 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.437 1.095 . . . . 10.0 110.439 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.69 -66.3 1.08 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.253 0.93 . . . . 10.0 113.028 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -109.68 -65.94 1.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.86 0.864 . . . . 10.0 112.743 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.77 68.49 1.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.911 -0.493 . . . . 10.0 111.324 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.26 63.96 1.06 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.605 1.162 . . . . 10.0 112.077 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.1 m -75.08 160.28 5.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 123.12 0.568 . . . . 10.0 111.707 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -117.91 152.46 35.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.935 0.894 . . . . 10.0 112.907 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -147.1 154.98 41.78 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.366 1.067 . . . . 10.0 108.564 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -60.7 139.38 57.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.37 116.72 57.27 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.54 -37.73 5.19 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.913 1.742 . . . . 10.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.53 -38.93 32.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.958 1.303 . . . . 10.0 113.37 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.4 p -115.7 23.21 12.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.507 1.123 . . . . 10.0 110.988 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 41.25 49.22 3.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.485 1.514 . . . . 10.0 111.987 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.45 -3.55 11.22 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.449 1.34 . . . . 10.0 116.449 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -73.81 -31.34 63.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.173 1.986 . . . . 10.0 112.318 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -6.86 83.16 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.572 -0.611 . . . . 10.0 111.572 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.6 p -116.65 122.87 45.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.708 1.203 . . . . 10.0 111.628 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.4 mt -91.23 171.61 9.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.695 -1.594 . . . . 10.0 106.695 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.53 126.59 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -67.52 -37.63 83.06 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.293 -1.003 . . . . 10.0 108.293 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -109.62 76.79 0.93 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.689 2.396 . . . . 10.0 108.855 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.75 157.06 61.71 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.894 2.396 . . . . 10.0 113.614 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.23 85.71 0.57 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.982 0.913 . . . . 10.0 109.307 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -36.94 -47.38 0.7 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.357 1.863 . . . . 10.0 112.606 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -40.9 -39.53 1.17 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.946 1.698 . . . . 10.0 112.597 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.2 p -127.21 25.1 6.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.823 0.849 . . . . 10.0 110.927 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 49.39 35.96 8.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.613 0.765 . . . . 10.0 110.237 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.6 21.85 29.98 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.78 -1.011 . . . . 10.0 114.64 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -27.52 60.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.397 1.599 . . . . 10.0 111.29 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.99 -8.79 65.44 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.63 1.11 . . . . 10.0 111.976 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -139.46 153.66 47.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.094 0.947 . . . . 10.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.36 173.71 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 127.027 2.131 . . . . 10.0 106.914 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 11' ' ' LEU . 34.5 tt0 -77.75 139.9 39.43 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.525 -0.734 . . . . 10.0 111.434 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -71.19 67.79 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.944 2.098 . . . . 10.0 108.109 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.942 1.697 . . . . 10.0 110.703 -175.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -139.53 150.77 45.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.397 1.479 . . . . 10.0 107.463 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -79.58 137.37 37.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.014 0.526 . . . . 10.0 109.587 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.36 89.22 3.18 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.474 -0.936 . . . . 10.0 108.474 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -44.18 -39.78 4.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.912 1.685 . . . . 10.0 112.153 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -49.25 -42.35 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.457 1.503 . . . . 10.0 111.83 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.1 p -108.32 18.72 20.73 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.828 0.851 . . . . 10.0 110.386 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 52.57 36.49 20.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.209 1.404 . . . . 10.0 110.086 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.95 -0.87 35.21 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.393 -1.226 . . . . 10.0 114.982 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -73.27 -67.22 0.6 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.066 1.933 . . . . 10.0 111.194 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.66 -17.36 3.27 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.267 1.889 . . . . 10.0 110.031 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.98 154.12 38.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.509 1.155 . . . . 10.0 108.92 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -54.99 167.9 0.58 Allowed Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 119.871 1.214 . . . . 10.0 113.38 -174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -39.99 122.98 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.899 3.066 . . . . 10.0 114.325 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.61 26.22 7.39 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.806 1.193 . . . . 10.0 114.461 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.0 m -113.92 145.94 40.78 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.269 -1.382 . . . . 10.0 107.269 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -92.26 151.05 41.23 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 117.947 0.339 . . . . 10.0 110.744 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.59 -179.37 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.235 1.957 . . . . 10.0 108.067 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -110.11 125.5 53.05 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -49.42 124.73 9.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.142 0.977 . . . . 10.0 110.343 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.47 116.72 39.98 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 -37.78 6.95 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.844 1.696 . . . . 10.0 110.915 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.58 -40.82 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.1 1.76 . . . . 10.0 112.957 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.8 16.64 18.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.034 0.934 . . . . 10.0 111.534 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.26 42.3 13.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.301 1.041 . . . . 10.0 110.594 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.18 -4.95 5.49 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.475 -1.181 . . . . 10.0 115.775 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.6 p -67.53 -36.32 80.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.452 2.126 . . . . 10.0 111.972 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.36 50.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.506 1.05 . . . . 10.0 112.651 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -134.02 150.17 51.22 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.993 1.397 . . . . 10.0 111.0 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.4 130.07 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -115.67 110.47 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.522 0.677 . . . . 10.0 109.796 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 62.3 mmm -73.25 79.96 1.32 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.106 1.362 . . . . 10.0 107.328 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.73 67.72 0.81 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.008 0.923 . . . . 10.0 110.012 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.37 70.3 0.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.725 1.21 . . . . 10.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 -63.63 2.07 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.421 1.01 . . . . 10.0 111.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.72 -35.84 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.364 0.666 . . . . 10.0 112.707 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -75.46 59.59 1.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.538 1.063 . . . . 10.0 109.991 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 128.58 36.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.741 0.816 . . . . 10.0 111.275 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.52 155.88 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 106.868 -1.53 . . . . 10.0 106.868 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.81 161.48 37.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.775 0.657 . . . . 10.0 112.775 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.63 163.86 31.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.631 1.172 . . . . 10.0 108.57 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -61.78 137.51 58.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -69.98 117.29 52.49 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.861 0.755 . . . . 10.0 109.148 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 -40.31 5.18 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.124 1.882 . . . . 10.0 111.479 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.09 -39.58 20.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.798 1.239 . . . . 10.0 113.284 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.4 p -116.08 21.73 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.102 0.961 . . . . 10.0 111.48 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 44.1 44.97 6.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.561 1.145 . . . . 10.0 111.517 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 -6.14 8.26 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.214 1.246 . . . . 10.0 116.214 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -76.69 -8.72 57.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.361 2.08 . . . . 10.0 112.672 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.08 6.12 23.87 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.496 -0.752 . . . . 10.0 112.449 -174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.87 131.28 38.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.748 1.219 . . . . 10.0 111.574 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.87 122.26 32.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.532 1.533 . . . . 10.0 107.699 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 mm -75.74 77.33 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 124.694 1.198 . . . . 10.0 108.815 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -37.2 -51.51 1.02 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.805 2.042 . . . . 10.0 111.792 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 119.01 10.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.854 1.662 . . . . 10.0 106.673 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 126.46 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.34 2.027 . . . . 10.0 113.782 -174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.65 94.63 0.8 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.597 1.159 . . . . 10.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -38.25 -48.98 1.35 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.346 1.458 . . . . 10.0 112.727 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -43.93 -38.23 3.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.7 p -122.2 11.7 10.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.438 0.695 . . . . 10.0 110.882 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 m80 45.83 45.79 11.71 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.791 1.236 . . . . 10.0 111.495 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.86 28.58 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.06 -0.855 . . . . 10.0 114.838 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -11.53 60.48 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.349 1.574 . . . . 10.0 110.567 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 -49.11 3.56 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.564 0.602 . . . . 10.0 112.333 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.59 168.2 9.64 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.158 0.983 . . . . 10.0 110.797 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.51 157.94 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.559 1.944 . . . . 10.0 106.383 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -99.3 132.78 44.38 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.077 -1.082 . . . . 10.0 108.077 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -68.98 76.13 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.149 1.379 . . . . 10.0 110.569 -174.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 111.587 0.217 . . . . 10.0 111.587 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -106.12 131.19 53.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.86 124.89 20.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.728 1.211 . . . . 10.0 109.699 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -78.99 87.23 4.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.23 -36.28 13.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.563 1.545 . . . . 10.0 111.549 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -49.75 -49.46 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.725 1.21 . . . . 10.0 110.303 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -99.86 19.2 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.116 0.484 . . . . 10.0 110.945 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 56.39 34.4 24.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.651 1.181 . . . . 10.0 109.687 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 -1.98 34.66 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.791 -1.005 . . . . 10.0 115.086 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -76.04 -67.4 0.68 Allowed 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.671 1.735 . . . . 10.0 110.67 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.37 -22.51 2.05 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.869 1.223 . . . . 10.0 111.804 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.85 147.75 23.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.963 1.382 . . . . 10.0 109.991 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 154.01 1.62 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -34.35 128.43 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 125.503 4.136 . . . . 10.0 115.902 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.49 -49.4 1.97 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.867 0.746 . . . . 10.0 113.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -75.31 69.25 2.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.471 1.109 . . . . 10.0 109.355 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.04 156.67 18.92 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.105 1.762 . . . . 10.0 110.328 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.63 176.64 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.283 1.988 . . . . 10.0 111.168 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -112.87 136.87 52.04 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -54.0 123.55 12.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.539 0.735 . . . . 10.0 111.176 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.62 119.32 70.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.982 -1.118 . . . . 10.0 107.982 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.67 -37.47 9.33 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.608 1.539 . . . . 10.0 111.399 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.55 -49.14 27.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.305 1.442 . . . . 10.0 112.61 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.08 11.85 37.8 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.618 0.767 . . . . 10.0 111.611 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 51.38 46.73 26.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.528 0.731 . . . . 10.0 109.306 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.47 -2.33 1.21 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.38 0.991 . . . . 10.0 114.703 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -90.46 11.72 20.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.736 1.268 . . . . 10.0 113.426 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -26.54 0.61 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 116.417 1.327 . . . . 10.0 116.417 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.75 136.1 53.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.657 1.229 . . . . 10.0 110.908 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 m -87.67 158.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -135.17 114.59 12.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 75.83 3.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -68.33 63.19 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.504 1.521 . . . . 10.0 113.426 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 52.79 0.99 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.586 0.754 . . . . 10.0 110.345 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.14 -68.44 0.34 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.353 0.978 . . . . 10.0 113.417 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -96.39 -71.47 0.67 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.909 1.283 . . . . 10.0 112.4 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -77.04 68.9 3.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.237 0.926 . . . . 10.0 110.94 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.8 0.96 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.211 1.004 . . . . 10.0 110.633 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.8 m -75.48 140.32 17.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.757 0.789 . . . . 10.0 112.691 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -91.77 154.44 18.93 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.504 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.27 152.04 42.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 m -65.5 131.88 47.52 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.52 117.43 55.14 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 119.087 0.858 . . . . 10.0 109.616 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.15 -38.44 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.754 1.636 . . . . 10.0 111.051 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.86 -37.54 2.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.408 1.483 . . . . 10.0 113.259 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 p -127.41 25.75 6.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.192 0.997 . . . . 10.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 41.94 48.5 3.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.813 1.245 . . . . 10.0 112.196 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.98 -8.77 7.44 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 115.564 0.985 . . . . 10.0 115.564 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -75.29 -8.87 57.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.792 1.796 . . . . 10.0 113.406 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.14 0.29 4.23 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.873 0.749 . . . . 10.0 114.588 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.48 129.46 51.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.144 1.377 . . . . 10.0 110.58 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.52 107.16 16.61 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.86 -1.904 . . . . 10.0 105.86 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.67 74.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.788 1.235 . . . . 10.0 108.68 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -40.42 -50.76 2.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.357 1.863 . . . . 10.0 112.501 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -142.87 99.99 5.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.875 1.67 . . . . 10.0 107.585 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.04 141.4 57.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.387 2.725 . . . . 10.0 116.113 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.9 t -77.76 93.81 4.37 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.357 1.463 . . . . 10.0 107.679 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -41.25 -45.59 2.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.956 1.703 . . . . 10.0 112.544 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -43.35 -38.8 2.84 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.171 1.788 . . . . 10.0 112.685 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.2 p -123.22 23.37 9.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.067 0.947 . . . . 10.0 110.653 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.0 39.01 5.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.312 1.445 . . . . 10.0 111.388 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.68 -2.59 39.22 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.578 -1.124 . . . . 10.0 115.75 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.32 -29.97 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 120.283 2.041 . . . . 10.0 111.906 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.95 7.84 60.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.829 1.204 . . . . 10.0 114.027 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.15 150.51 29.95 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.147 0.974 . . . . 10.0 109.331 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.05 132.13 60.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.31 101.57 12.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.393 0.677 . . . . 10.0 109.18 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -79.84 60.86 3.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.149 -0.685 . . . . 10.0 109.149 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.457 -0.105 0 C-N-CA 124.894 1.278 . . . . 10.0 108.613 -179.831 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.231 0.092 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.25 139.91 49.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.713 1.605 . . . . 10.0 107.922 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.46 140.32 48.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.26 93.95 4.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.065 -1.087 . . . . 10.0 108.065 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.56 -37.26 17.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.43 1.492 . . . . 10.0 111.628 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.08 -40.94 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.269 1.028 . . . . 10.0 110.9 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.5 p -106.05 20.31 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.573 0.624 . . . . 10.0 110.748 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.81 35.19 23.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.847 1.259 . . . . 10.0 110.197 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 7.86 67.44 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.206 -1.33 . . . . 10.0 114.848 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.1 p -85.5 -74.06 0.42 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.943 1.872 . . . . 10.0 110.401 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -20.15 1.04 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.982 1.753 . . . . 10.0 112.242 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.98 154.18 20.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.241 1.521 . . . . 10.0 110.584 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -49.63 148.51 5.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 118.41 0.55 . . . . 10.0 112.458 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.1 135.76 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 125.129 3.886 . . . . 10.0 114.692 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.73 -52.91 2.02 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.233 0.921 . . . . 10.0 112.653 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 m -73.6 79.77 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.881 0.872 . . . . 10.0 109.203 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.11 156.48 13.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.904 0.882 . . . . 10.0 111.369 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.89 168.39 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.78 2.32 . . . . 10.0 113.231 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -90.26 121.8 32.6 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -52.44 124.62 13.92 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.911 0.884 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.65 118.49 54.81 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 -37.61 9.95 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.567 1.512 . . . . 10.0 111.505 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -46.57 -47.59 19.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.084 1.354 . . . . 10.0 113.161 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.0 p -100.73 6.41 43.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.75 0.82 . . . . 10.0 111.139 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 54.31 39.56 30.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.702 -0.851 . . . . 10.0 108.702 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.66 13.57 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.731 0.681 . . . . 10.0 113.943 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -72.0 4.86 3.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.602 1.704 . . . . 10.0 115.602 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.05 -28.93 0.95 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 115.821 1.089 . . . . 10.0 115.821 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.65 154.46 46.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.22 1.01 . . . . 10.0 109.61 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.29 147.32 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.46 109.34 18.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.1 tpp -102.41 139.72 37.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.428 1.491 . . . . 10.0 109.331 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -90.65 107.77 19.38 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 58.88 1.36 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.294 0.569 . . . . 10.0 111.503 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.43 -44.19 2.18 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.124 -0.985 . . . . 10.0 111.624 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -114.02 -72.54 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.884 1.274 . . . . 10.0 111.672 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -102.54 163.06 12.44 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 124.845 1.258 . . . . 10.0 112.9 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.75 128.9 34.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.799 1.24 . . . . 10.0 109.924 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.57 148.63 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.68 1.192 . . . . 10.0 108.553 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.84 145.25 28.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.525 0.73 . . . . 10.0 111.778 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -137.28 142.48 41.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 m -57.63 135.21 56.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.397 0.544 . . . . 10.0 110.013 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.2 t -75.97 117.9 67.23 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.885 -0.783 . . . . 10.0 108.885 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 -37.85 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.25 1.967 . . . . 10.0 112.062 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -38.82 22.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.796 1.239 . . . . 10.0 113.143 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.3 p -115.43 21.42 14.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.849 1.26 . . . . 10.0 111.189 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 44.01 45.4 6.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.922 1.289 . . . . 10.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.49 -9.71 7.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.52 -1.156 . . . . 10.0 115.986 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -67.21 -45.41 76.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.32 2.06 . . . . 10.0 111.285 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.13 46.66 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.897 1.237 . . . . 10.0 110.523 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 p -114.05 131.37 56.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.97 1.708 . . . . 10.0 111.709 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.03 113.5 25.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.48 69.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 108.068 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -59.35 -44.08 92.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.034 0.445 . . . . 10.0 110.64 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -120.73 82.86 34.95 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 127.318 2.247 . . . . 10.0 109.421 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.12 139.95 69.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.855 3.036 . . . . 10.0 116.617 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.6 t -74.0 89.94 1.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -41.72 -43.33 2.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.138 1.375 . . . . 10.0 112.915 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -46.32 -43.85 16.26 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 10.0 112.31 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.6 p -112.86 24.49 12.35 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.308 0.643 . . . . 10.0 110.208 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.59 43.02 12.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.083 1.353 . . . . 10.0 111.047 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.63 7.39 27.62 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.777 -1.013 . . . . 10.0 115.349 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -59.4 3.22 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.597 1.698 . . . . 10.0 108.872 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.75 11.83 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.956 1.265 . . . . 10.0 114.056 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.47 153.06 40.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.9 -1.519 . . . . 10.0 106.9 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.35 161.58 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.204 1.001 . . . . 10.0 109.524 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.04 149.79 32.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.258 -0.645 . . . . 10.0 109.258 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ttp-105 -75.86 52.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.034 1.334 . . . . 10.0 108.448 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.452 -0.356 0 O-C-N 121.143 -0.973 . . . . 10.0 111.079 -176.741 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.49 -0.559 . . . . 10.0 109.49 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.97 150.32 42.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.938 2.095 . . . . 10.0 106.808 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.81 143.06 51.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.05 91.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.62 -37.29 12.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.49 1.516 . . . . 10.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.06 -48.73 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.572 1.149 . . . . 10.0 110.205 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.61 22.0 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.159 0.504 . . . . 10.0 111.006 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.31 35.37 22.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.9 1.28 . . . . 10.0 110.436 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.37 -0.76 46.64 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.628 -1.096 . . . . 10.0 114.84 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -77.7 -71.02 0.44 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.773 1.787 . . . . 10.0 110.571 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.77 -17.06 2.2 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.065 1.793 . . . . 10.0 110.766 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.28 135.83 33.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.799 1.299 . . . . 10.0 109.862 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -50.26 147.06 7.87 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 -175.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -22.54 126.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 1 C-N-CA 127.513 5.475 . . . . 10.0 117.913 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.48 -42.67 0.85 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.556 1.074 . . . . 10.0 113.801 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -72.44 82.82 1.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.693 1.197 . . . . 10.0 108.195 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.03 155.1 16.82 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 122.789 0.436 . . . . 10.0 111.711 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.88 152.63 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 107.804 -1.652 . . . . 10.0 107.804 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -89.52 118.89 29.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.136 -1.431 . . . . 10.0 107.136 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -50.51 123.16 8.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.806 0.842 . . . . 10.0 109.105 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.65 115.49 15.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.24 -35.59 8.36 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.572 1.515 . . . . 10.0 110.348 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.67 -39.46 11.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.565 1.546 . . . . 10.0 112.806 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.5 p -115.18 16.8 16.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.341 0.656 . . . . 10.0 111.632 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.13 48.39 15.82 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.44 1.096 . . . . 10.0 110.384 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.89 -47.91 2.27 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.207 -0.774 . . . . 10.0 113.239 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.6 -45.4 0.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.756 2.422 . . . . 10.0 115.971 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.13 5.28 43.86 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.425 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.83 152.1 50.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.683 1.741 . . . . 10.0 112.235 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.12 158.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.769 1.627 . . . . 10.0 107.72 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -113.83 105.41 13.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.893 0.877 . . . . 10.0 110.027 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 tpt -72.28 93.3 1.47 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.079 -1.823 . . . . 10.0 106.079 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -92.64 121.22 33.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.196 2.598 . . . . 10.0 109.588 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.37 55.25 0.74 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.83 -77.61 0.21 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.792 1.187 . . . . 10.0 112.301 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -81.52 -65.95 0.95 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.774 0.829 . . . . 10.0 109.932 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -83.9 162.96 20.33 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.65 154.16 20.07 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.18 165.99 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 107.84 -1.171 . . . . 10.0 107.84 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -123.71 137.66 54.66 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.617 0.767 . . . . 10.0 110.521 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 162.03 37.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.706 0.629 . . . . 10.0 109.513 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 m -55.49 137.18 49.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 10.0 110.84 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.21 116.28 45.27 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.8 -0.619 . . . . 10.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.35 -39.38 7.38 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.843 1.695 . . . . 10.0 111.159 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -35.63 5.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.832 1.253 . . . . 10.0 113.204 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.1 p -125.16 25.87 7.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.089 0.956 . . . . 10.0 111.058 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 41.49 45.35 2.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.184 1.394 . . . . 10.0 112.316 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.91 -7.04 3.29 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.625 1.01 . . . . 10.0 115.625 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -69.49 -28.44 66.06 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.508 1.654 . . . . 10.0 110.952 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -9.59 76.54 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.799 0.714 . . . . 10.0 112.315 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 p -116.06 131.81 56.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.954 1.701 . . . . 10.0 113.455 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.14 100.59 12.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.0 mt -82.93 71.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.87 -24.64 67.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.959 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -124.44 75.52 62.11 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.894 2.078 . . . . 10.0 110.999 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.92 133.5 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.223 3.282 . . . . 10.0 116.295 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.48 88.81 2.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.653 -1.24 . . . . 10.0 107.653 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -36.96 -47.84 0.73 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.156 1.782 . . . . 10.0 112.98 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.37 -43.71 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.518 1.527 . . . . 10.0 112.415 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.6 p -116.99 22.26 12.7 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.725 0.81 . . . . 10.0 110.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 47.0 40.95 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.867 1.267 . . . . 10.0 110.241 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.81 10.57 13.8 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.882 1.113 . . . . 10.0 115.882 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.3 82.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.784 1.792 . . . . 10.0 109.319 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.17 59.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.563 2.03 . . . . 10.0 113.544 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.91 155.39 41.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.036 0.934 . . . . 10.0 108.668 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.87 152.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 125.296 1.438 . . . . 10.0 108.402 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.73 138.33 58.44 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.849 0.46 . . . . 10.0 110.152 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -78.83 61.31 3.04 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.532 0.263 0 O-C-N 121.522 -0.736 . . . . 10.0 110.582 -178.144 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.379 -0.23 . . . . 10.0 110.379 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.33 145.49 47.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.217 1.407 . . . . 10.0 108.194 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -72.47 131.6 42.77 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.298 0.639 . . . . 10.0 110.145 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.94 86.21 4.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.591 0.71 . . . . 10.0 109.14 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -48.1 -35.82 12.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.307 1.443 . . . . 10.0 111.38 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.44 -45.43 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.009 1.324 . . . . 10.0 110.835 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -102.29 17.2 24.04 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.269 0.486 . . . . 10.0 111.087 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.47 34.43 23.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.365 1.066 . . . . 10.0 109.17 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 -4.21 20.94 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.552 -1.138 . . . . 10.0 115.583 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -71.77 -61.17 1.88 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.293 2.046 . . . . 10.0 110.589 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.34 -12.31 6.36 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.65 2.072 . . . . 10.0 109.215 -173.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 141.71 33.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.63 1.215 . . . . 10.0 109.247 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -51.26 152.28 4.36 Favored Pre-proline 0 CA--C 1.551 1.003 0 CA-C-N 119.031 0.832 . . . . 10.0 112.415 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.26 129.7 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.076 3.85 . . . . 10.0 116.205 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.46 12.73 3.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.105 1.336 . . . . 10.0 115.248 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.9 m -110.58 125.45 53.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.893 1.346 . . . . 10.0 107.59 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.52 144.36 98.61 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 122.935 0.494 . . . . 10.0 111.302 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.34 164.68 34.53 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 N-CA-C 106.829 -2.027 . . . . 10.0 106.829 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.54 115.62 27.73 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.609 -0.682 . . . . 10.0 109.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -48.42 124.14 7.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.413 1.085 . . . . 10.0 110.452 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -65.6 115.82 25.83 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -35.55 8.0 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.319 1.346 . . . . 10.0 110.1 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -39.27 7.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.613 1.565 . . . . 10.0 113.181 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.77 17.09 13.55 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.435 0.694 . . . . 10.0 111.22 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 47.95 48.85 17.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.036 0.934 . . . . 10.0 110.201 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.68 -46.71 2.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.408 -0.808 . . . . 10.0 113.271 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -29.94 -40.59 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.976 2.91 . . . . 10.0 116.5 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.68 0.16 52.69 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.65 1.119 . . . . 10.0 115.811 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.28 151.65 40.78 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.815 1.307 . . . . 10.0 109.609 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -113.75 133.56 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.889 1.676 . . . . 10.0 108.178 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -107.92 91.08 3.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.435 1.094 . . . . 10.0 109.065 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.0 mmm -81.82 57.7 3.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.994 0.739 . . . . 10.0 112.994 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 176.12 165.15 0.41 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.083 2.153 . . . . 10.0 108.864 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.9 147.15 9.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.259 1.024 . . . . 10.0 108.77 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.96 40.22 6.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.168 0.89 . . . . 10.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -174.24 -149.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.444 -2.428 . . . . 10.0 104.444 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.36 73.45 2.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.526 1.057 . . . . 10.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.6 68.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.834 1.654 . . . . 10.0 112.124 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.99 160.35 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 124.134 0.974 . . . . 10.0 109.785 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -146.34 160.83 41.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 123.438 0.461 . . . . 10.0 111.367 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 163.14 34.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.088 0.955 . . . . 10.0 108.621 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.6 m -55.8 137.95 48.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.042 0.937 . . . . 10.0 109.471 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.69 118.69 68.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 118.569 0.622 . . . . 10.0 109.471 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.99 -38.6 7.09 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.186 1.924 . . . . 10.0 111.387 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -47.52 -42.29 22.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.586 1.554 . . . . 10.0 112.838 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.7 p -112.82 20.89 16.05 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.314 1.046 . . . . 10.0 111.585 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 44.18 44.45 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.799 1.24 . . . . 10.0 111.176 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.26 -7.02 5.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.486 -1.174 . . . . 10.0 115.976 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -68.42 -39.32 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 120.288 2.044 . . . . 10.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.27 -19.21 46.52 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.326 0.965 . . . . 10.0 110.711 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 132.4 54.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.524 1.93 . . . . 10.0 111.712 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -92.45 120.05 32.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.869 1.268 . . . . 10.0 108.11 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.86 63.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.95 -35.23 79.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.141 0.576 . . . . 10.0 111.212 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -111.45 74.49 1.17 Allowed Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.268 2.227 . . . . 10.0 109.083 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.67 133.92 38.7 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.657 2.904 . . . . 10.0 116.632 -172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.2 90.66 2.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.494 1.518 . . . . 10.0 107.212 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -39.51 -46.88 1.79 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.433 1.493 . . . . 10.0 112.489 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.17 -44.68 5.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.588 1.155 . . . . 10.0 112.643 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -113.89 14.2 18.5 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.204 0.602 . . . . 10.0 111.072 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.92 36.02 20.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.757 0.823 . . . . 10.0 109.919 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.09 15.19 49.51 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.127 -0.818 . . . . 10.0 114.393 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -2.02 40.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.326 1.563 . . . . 10.0 111.895 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.09 -43.77 2.28 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.384 -0.823 . . . . 10.0 113.091 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 168.84 9.44 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.283 1.433 . . . . 10.0 110.851 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.15 144.16 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 125.721 1.608 . . . . 10.0 107.722 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -87.84 105.54 17.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -71.94 81.73 0.92 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 126.455 1.902 . . . . 10.0 109.837 -178.282 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -120.34 145.5 47.06 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.108 1.363 . . . . 10.0 110.041 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -54.09 134.79 43.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.187 0.995 . . . . 10.0 111.642 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -77.43 103.93 7.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -46.84 -42.85 17.95 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.212 1.405 . . . . 10.0 111.126 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.11 -38.62 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.524 1.13 . . . . 10.0 111.928 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -106.75 4.2 27.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.085 0.857 . . . . 10.0 111.812 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.93 33.54 12.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.733 0.813 . . . . 10.0 108.935 174.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.78 -11.82 44.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.326 -1.263 . . . . 10.0 114.628 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.4 p -71.5 -71.59 0.26 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.066 1.933 . . . . 10.0 111.213 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.31 -24.66 2.2 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.814 2.15 . . . . 10.0 109.458 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 150.27 43.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.747 0.774 . . . . 10.0 110.017 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.21 165.1 2.98 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 122.086 -0.384 . . . . 10.0 111.133 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -40.48 127.68 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.908 3.072 . . . . 10.0 114.956 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.7 19.86 5.26 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.938 1.256 . . . . 10.0 114.786 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -108.12 135.16 49.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.606 -1.628 . . . . 10.0 106.606 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -79.94 147.55 66.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 118.466 0.576 . . . . 10.0 111.161 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.63 -173.32 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.152 -1.903 . . . . 10.0 107.152 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -126.05 123.17 37.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -45.54 124.85 5.3 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.813 1.245 . . . . 10.0 111.922 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -68.89 117.53 52.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.32 -36.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.796 1.664 . . . . 10.0 110.756 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.54 -46.49 19.35 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.664 1.585 . . . . 10.0 112.363 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -105.44 14.93 27.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.796 0.839 . . . . 10.0 111.634 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 49.22 40.39 17.84 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.961 0.904 . . . . 10.0 110.68 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -5.37 7.07 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.854 -0.97 . . . . 10.0 115.412 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.0 p -69.48 -26.61 64.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 120.096 1.948 . . . . 10.0 112.804 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.43 71.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 133.2 35.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.463 1.131 . . . . 10.0 110.482 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.47 157.55 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.282 1.433 . . . . 10.0 107.99 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -108.38 117.78 35.05 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.951 -1.499 . . . . 10.0 106.951 172.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.36 92.21 2.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.699 -2.704 . . . . 10.0 103.699 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -65.73 40.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.574 1.694 . . . . 10.0 115.574 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -78.61 55.66 1.69 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.299 -1.501 . . . . 10.0 111.043 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 26.15 -92.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 128.046 2.736 . . . . 10.0 114.064 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -36.74 -44.96 0.5 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.603 1.961 . . . . 10.0 112.678 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -129.68 56.6 1.71 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.07 69.1 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.187 0.995 . . . . 10.0 111.376 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 169.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.602 1.161 . . . . 10.0 112.491 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -109.2 149.8 28.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.487 1.115 . . . . 10.0 111.415 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -141.58 151.51 43.24 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.568 1.547 . . . . 10.0 108.037 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 m -58.25 138.09 56.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.863 0.756 . . . . 10.0 109.957 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.76 117.75 63.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.874 0.761 . . . . 10.0 108.998 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.99 -41.66 3.8 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.795 1.664 . . . . 10.0 111.16 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -47.66 -42.03 23.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.864 1.265 . . . . 10.0 113.547 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.21 21.66 15.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.66 0.784 . . . . 10.0 111.456 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 45.96 46.74 12.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.619 1.167 . . . . 10.0 111.369 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.31 -6.81 9.61 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.652 1.021 . . . . 10.0 115.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -68.18 -25.57 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.866 1.833 . . . . 10.0 112.652 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 1.51 87.07 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.38 0.514 . . . . 10.0 112.601 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.5 p -118.12 125.7 50.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.463 1.505 . . . . 10.0 111.304 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.65 151.67 22.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.26 90.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -64.88 -27.46 68.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -106.77 69.57 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.946 2.498 . . . . 10.0 109.856 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.26 128.74 22.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.195 1.93 . . . . 10.0 113.457 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.3 91.73 0.17 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -33.3 -51.54 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.011 2.124 . . . . 10.0 113.894 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -44.54 -45.63 9.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.187 1.395 . . . . 10.0 112.624 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.9 p -111.45 15.79 21.08 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.112 0.565 . . . . 10.0 110.45 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 54.14 34.08 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.222 1.009 . . . . 10.0 110.382 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.21 15.21 60.59 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 119.39 -0.672 . . . . 10.0 113.938 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -77.35 -4.41 44.98 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.036 1.418 . . . . 10.0 111.765 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.51 -43.5 2.1 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.028 -1.045 . . . . 10.0 114.242 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -134.5 155.52 50.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.162 0.985 . . . . 10.0 110.235 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.66 158.41 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 C-N-CA 124.748 1.219 . . . . 10.0 109.922 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -69.6 139.51 53.65 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -74.0 55.97 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.533 1.533 . . . . 10.0 110.634 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.453 -0.32 0 O-C-N 121.273 -0.892 . . . . 10.0 110.929 -178.384 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.076 0.398 . . . . 10.0 112.076 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -128.67 150.54 50.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.779 1.232 . . . . 10.0 108.399 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.13 135.14 56.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.794 0.838 . . . . 10.0 111.2 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -80.02 87.49 5.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 10.0 108.167 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -48.67 -37.01 17.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 10.0 111.528 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -49.98 -53.52 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.657 1.183 . . . . 10.0 110.157 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -93.38 18.6 9.45 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.264 0.484 . . . . 10.0 111.255 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 54.24 35.92 23.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.986 0.914 . . . . 10.0 109.898 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.54 4.63 61.55 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.282 -1.288 . . . . 10.0 115.452 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -87.0 -81.34 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.811 1.805 . . . . 10.0 111.382 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.7 -8.39 0.07 OUTLIER Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.616 -1.102 . . . . 10.0 114.61 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.44 157.77 20.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.702 1.751 . . . . 10.0 109.961 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -49.95 163.65 0.4 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.89 1.07 . . . . 10.0 113.89 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.23 135.99 24.87 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.107 2.538 . . . . 10.0 112.733 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 -57.7 2.65 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.992 -0.338 . . . . 10.0 112.417 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.1 m -72.68 64.67 0.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.804 1.242 . . . . 10.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 159.57 27.31 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.759 0.823 . . . . 10.0 112.331 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.57 176.06 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 10.0 110.946 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -117.74 124.76 49.24 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -44.3 124.0 3.78 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 10.0 111.807 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.67 116.71 40.44 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -38.06 7.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.63 1.554 . . . . 10.0 110.952 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -42.65 12.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.776 1.63 . . . . 10.0 112.861 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.0 p -112.18 18.17 18.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.813 0.845 . . . . 10.0 111.454 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.67 41.56 13.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.949 0.9 . . . . 10.0 111.172 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.17 0.08 55.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.283 -1.287 . . . . 10.0 115.801 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.7 p -69.56 -61.08 1.93 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 120.461 2.13 . . . . 10.0 111.321 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.31 10.34 7.37 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.115 2.293 . . . . 10.0 110.86 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 151.18 47.95 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.127 1.464 . . . . 10.0 110.48 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.44 144.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.342 1.457 . . . . 10.0 108.042 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -106.34 110.09 22.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.632 -0.877 . . . . 10.0 108.632 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.8 ttm -77.65 90.34 3.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.111 -1.07 . . . . 10.0 108.111 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -73.37 69.22 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.327 0.651 . . . . 10.0 110.517 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 45.44 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.45 -73.0 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.069 1.318 . . . . 10.0 115.059 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.74 -42.64 73.66 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.777 0.831 . . . . 10.0 110.438 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -120.48 170.64 9.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.705 1.202 . . . . 10.0 107.886 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 63.98 1.11 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.113 0.565 . . . . 10.0 109.694 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.65 176.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 110.465 -0.198 . . . . 10.0 110.465 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.44 159.27 41.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.526 0.33 . . . . 10.0 111.363 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.84 164.85 28.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.678 1.191 . . . . 10.0 108.429 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 m -63.87 140.76 58.9 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.64 116.0 45.4 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 118.849 0.75 . . . . 10.0 109.587 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.42 -38.81 7.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.043 1.829 . . . . 10.0 111.274 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.14 -34.22 5.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.245 . . . . 10.0 113.287 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.9 p -123.86 21.83 9.02 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.006 0.922 . . . . 10.0 111.189 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 45.5 42.21 7.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 10.0 111.928 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.38 -1.57 19.36 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.263 0.865 . . . . 10.0 115.263 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -79.32 -4.48 51.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.277 1.538 . . . . 10.0 111.744 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.59 -12.57 0.71 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.426 1.013 . . . . 10.0 113.978 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -122.03 132.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 10.0 111.094 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.13 106.03 7.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.895 -2.261 . . . . 10.0 104.895 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.14 77.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.259 1.423 . . . . 10.0 108.054 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -43.06 2.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.579 1.952 . . . . 10.0 111.022 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -145.2 144.99 25.15 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 104.441 -2.429 . . . . 10.0 104.441 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.0 125.39 3.11 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.187 1.925 . . . . 10.0 112.15 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -71.03 85.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -39.88 -46.03 1.92 Allowed 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 125.899 1.68 . . . . 10.0 113.172 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -42.61 -40.2 2.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.525 1.13 . . . . 10.0 112.683 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.16 18.73 12.31 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.539 0.736 . . . . 10.0 111.256 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 45.74 42.53 8.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.487 1.115 . . . . 10.0 109.537 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 51.96 25.41 16.62 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.528 1.537 . . . . 10.0 116.328 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -79.04 -38.88 35.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.588 1.694 . . . . 10.0 108.754 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.27 -0.91 55.96 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.095 1.807 . . . . 10.0 113.791 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 151.4 44.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.83 142.65 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.045 0.938 . . . . 10.0 110.47 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -77.53 78.29 4.05 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -76.19 60.27 1.46 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.452 1.101 . . . . 10.0 111.537 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 10.0 108.657 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.804 0.811 . . . . 10.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.81 127.62 33.41 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.437 1.895 . . . . 10.0 110.422 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.56 126.65 28.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.601 0.76 . . . . 10.0 110.593 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.19 89.84 3.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.28 -38.54 19.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.302 1.441 . . . . 10.0 111.319 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -50.27 -41.81 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.776 1.23 . . . . 10.0 111.618 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.4 p -107.56 19.28 20.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.916 0.486 . . . . 10.0 110.662 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.38 38.74 18.76 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.059 1.344 . . . . 10.0 110.163 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.63 24.16 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.445 -1.197 . . . . 10.0 115.561 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -72.7 -66.24 0.69 Allowed 'General case' 0 C--N 1.341 0.207 0 CA-C-N 120.098 1.949 . . . . 10.0 111.057 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.15 -8.13 4.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.226 2.346 . . . . 10.0 110.183 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.39 138.87 40.67 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.902 1.351 . . . . 10.0 111.031 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -51.76 144.45 18.92 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.817 0.735 . . . . 10.0 110.695 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -49.26 -37.0 38.97 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.298 2.665 . . . . 10.0 113.792 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.41 12.23 68.84 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.017 -1.435 . . . . 10.0 115.113 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -155.66 147.1 22.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.126 2.463 . . . . 10.0 110.938 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.77 157.73 66.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.823 -0.608 . . . . 10.0 109.495 176.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.62 169.64 19.45 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.281 1.987 . . . . 10.0 108.057 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -101.41 115.78 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 119.127 -0.463 . . . . 10.0 110.207 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -42.92 122.23 2.34 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.561 1.144 . . . . 10.0 111.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -65.61 115.57 23.49 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.66 -36.09 6.94 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.823 1.682 . . . . 10.0 110.709 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.38 -39.83 7.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.681 1.593 . . . . 10.0 112.883 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.3 p -114.86 12.48 16.92 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.094 0.958 . . . . 10.0 111.751 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.77 42.46 23.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.013 0.925 . . . . 10.0 109.995 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.08 -8.44 8.36 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 114.805 0.682 . . . . 10.0 114.805 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -68.27 -8.61 40.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.425 1.612 . . . . 10.0 114.045 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 14.66 55.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.602 1.096 . . . . 10.0 113.769 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -145.04 142.29 29.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.145 0.972 . . . . 10.0 110.088 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.11 133.15 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.625 1.57 . . . . 10.0 106.93 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.54 109.61 22.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.03 0.532 . . . . 10.0 110.428 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.99 88.5 0.4 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.331 1.052 . . . . 10.0 108.59 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -73.89 62.3 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.67 0.788 . . . . 10.0 110.238 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 43.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.632 1.173 . . . . 10.0 112.729 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.17 -64.45 1.3 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.684 -0.635 . . . . 10.0 112.391 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.99 -78.23 0.37 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.122 0.969 . . . . 10.0 113.09 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -84.11 98.15 9.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.536 0.734 . . . . 10.0 111.455 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 58.84 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.375 0.67 . . . . 10.0 111.266 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.02 162.36 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 O-C-N 121.878 -0.514 . . . . 10.0 110.05 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.39 171.97 7.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.812 1.041 . . . . 10.0 113.812 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 153.13 47.37 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.645 -1.983 . . . . 10.0 105.645 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 m -58.86 135.76 57.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.85 116.99 49.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.908 0.776 . . . . 10.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.15 -38.05 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.027 1.818 . . . . 10.0 111.367 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.41 -39.49 22.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.599 1.16 . . . . 10.0 113.174 -177.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.49 18.66 15.85 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.094 . . . . 10.0 111.47 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 47.01 43.51 13.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.341 1.056 . . . . 10.0 111.113 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.34 6.43 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.44 0.936 . . . . 10.0 115.44 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -74.54 -7.38 52.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.918 1.859 . . . . 10.0 112.737 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.39 1.21 7.26 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.403 -0.811 . . . . 10.0 113.216 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -133.18 132.91 42.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.17 1.388 . . . . 10.0 109.783 -174.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.74 118.58 27.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.875 1.27 . . . . 10.0 108.323 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -78.4 61.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.976 1.31 . . . . 10.0 108.435 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.74 -34.4 77.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.588 0.709 . . . . 10.0 109.752 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.79 78.14 1.18 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.011 2.924 . . . . 10.0 109.108 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.07 136.65 35.39 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.296 2.664 . . . . 10.0 116.342 -173.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.8 t -74.15 87.95 1.94 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.466 -1.679 . . . . 10.0 106.466 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.96 -40.79 4.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.97 1.308 . . . . 10.0 111.859 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -46.45 -38.66 9.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.932 0.893 . . . . 10.0 112.123 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.6 p -122.26 22.93 9.99 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.534 0.734 . . . . 10.0 110.477 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 45.87 39.81 5.88 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 10.0 110.949 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.07 17.7 31.13 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.249 0.86 . . . . 10.0 115.249 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -36.73 64.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.151 1.475 . . . . 10.0 110.328 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.04 -23.85 17.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.557 1.075 . . . . 10.0 112.031 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.73 159.17 44.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.141 0.97 . . . . 10.0 110.321 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.48 145.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 124.952 1.301 . . . . 10.0 109.865 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -69.77 139.45 53.27 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.905 -0.497 . . . . 10.0 109.876 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -64.61 71.37 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.093 1.757 . . . . 10.0 109.862 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 125.576 1.55 . . . . 10.0 110.633 -176.917 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -120.16 156.4 31.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.873 1.669 . . . . 10.0 110.383 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.66 129.13 19.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 112.081 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -77.24 89.59 3.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -49.09 -38.02 23.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.784 1.233 . . . . 10.0 111.313 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.8 -31.43 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.249 1.42 . . . . 10.0 112.221 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -123.24 22.52 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 10.0 110.13 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 45.01 41.71 5.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.589 1.556 . . . . 10.0 111.238 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.53 -4.44 27.65 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.803 1.081 . . . . 10.0 115.803 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -73.17 -68.95 0.45 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.742 1.771 . . . . 10.0 109.164 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.13 -6.52 4.35 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.58 2.038 . . . . 10.0 109.105 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 128.12 34.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.924 1.362 . . . . 10.0 109.673 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 156.42 2.6 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -38.76 133.59 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.408 3.406 . . . . 10.0 114.794 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.58 19.52 9.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.968 1.27 . . . . 10.0 114.498 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -126.11 140.9 52.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.68 153.44 42.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 122.809 0.444 . . . . 10.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.97 168.67 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 107.768 -1.666 . . . . 10.0 107.768 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.98 119.29 33.24 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -51.15 124.37 11.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.893 0.877 . . . . 10.0 109.362 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -64.23 115.18 17.52 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 118.702 0.683 . . . . 10.0 109.397 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.0 -35.85 8.4 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.632 1.555 . . . . 10.0 110.587 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -45.37 -38.34 5.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 10.0 113.056 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.35 13.95 13.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.241 1.016 . . . . 10.0 111.471 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.3 41.89 21.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.886 0.874 . . . . 10.0 110.195 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.8 -8.08 8.27 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 119.233 -0.76 . . . . 10.0 114.979 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -65.39 -15.7 62.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.563 1.682 . . . . 10.0 113.955 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 4.61 68.47 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.864 0.745 . . . . 10.0 113.651 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.97 156.74 44.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.94 1.37 . . . . 10.0 110.611 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.99 141.64 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 126.451 1.9 . . . . 10.0 107.391 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -124.55 115.47 20.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.16 165.43 24.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.427 1.091 . . . . 10.0 108.399 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -131.33 46.06 2.72 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.274 0.63 . . . . 10.0 112.434 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -78.74 64.0 3.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.874 0.845 . . . . 10.0 109.399 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 37.03 -104.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.439 2.447 . . . . 10.0 113.18 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -47.82 -35.19 9.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.251 1.42 . . . . 10.0 113.591 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -124.43 57.87 1.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.025 0.375 . . . . 10.0 111.227 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.99 66.48 0.38 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.443 1.097 . . . . 10.0 110.589 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.74 167.01 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.49 1.116 . . . . 10.0 112.885 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -126.44 156.86 39.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.063 0.945 . . . . 10.0 111.474 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.18 162.39 35.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.502 1.121 . . . . 10.0 108.94 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 m -62.4 140.99 58.56 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.777 0.831 . . . . 10.0 108.968 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.9 117.48 61.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 118.752 0.706 . . . . 10.0 109.605 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.31 -40.49 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.079 1.853 . . . . 10.0 111.46 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -44.73 -40.11 5.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.992 1.317 . . . . 10.0 112.625 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.59 22.54 11.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 10.0 112.05 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 44.39 43.11 5.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.535 1.134 . . . . 10.0 111.641 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.56 -6.16 6.42 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.757 1.063 . . . . 10.0 115.757 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -78.8 -2.73 40.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.674 1.737 . . . . 10.0 112.775 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.8 -8.97 0.73 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.205 0.907 . . . . 10.0 114.671 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -125.1 135.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.684 1.593 . . . . 10.0 110.655 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.6 mt -97.77 120.58 38.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.883 1.273 . . . . 10.0 108.073 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.5 mm -78.13 63.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.536 1.135 . . . . 10.0 108.23 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -69.36 -26.23 64.57 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.663 -0.648 . . . . 10.0 110.69 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -111.28 72.85 0.93 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 127.253 2.221 . . . . 10.0 109.46 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -62.99 129.42 25.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.019 2.479 . . . . 10.0 115.536 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.2 92.38 0.76 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.989 1.716 . . . . 10.0 106.543 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -37.23 -49.01 0.91 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.272 1.829 . . . . 10.0 112.613 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.73 -38.12 4.21 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.11 1.364 . . . . 10.0 112.812 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.0 p -121.85 16.29 10.97 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.893 0.877 . . . . 10.0 111.069 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 48.23 37.84 9.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.382 1.073 . . . . 10.0 110.836 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.52 6.76 43.51 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 118.955 -0.914 . . . . 10.0 115.058 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -44.0 87.01 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.78 1.79 . . . . 10.0 110.643 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.81 30.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.816 1.198 . . . . 10.0 113.405 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -146.25 154.61 41.92 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.481 1.64 . . . . 10.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 155.77 33.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 125.771 1.629 . . . . 10.0 109.298 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.53 141.56 51.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.286 -0.635 . . . . 10.0 109.286 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.97 67.28 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.756 2.022 . . . . 10.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.457 -0.096 0 C-N-CA 125.906 1.682 . . . . 10.0 108.288 176.368 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -112.84 124.5 52.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.487 1.115 . . . . 10.0 108.959 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.63 125.21 15.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.233 1.013 . . . . 10.0 110.584 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -81.1 89.04 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 109.688 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -49.5 -38.04 28.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.516 1.126 . . . . 10.0 111.016 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.07 -36.42 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.46 1.504 . . . . 10.0 111.655 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 p -117.52 23.92 11.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.078 0.551 . . . . 10.0 110.791 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.5 p80 46.03 42.35 9.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.64 1.576 . . . . 10.0 111.486 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.0 -3.72 27.46 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -77.84 -67.82 0.69 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 120.099 1.95 . . . . 10.0 110.196 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.65 -3.54 3.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.184 1.849 . . . . 10.0 110.496 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.49 140.23 30.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.008 1.904 . . . . 10.0 111.196 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -48.42 140.72 9.78 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.067 0.947 . . . . 10.0 111.625 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -36.28 133.41 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 125.165 3.91 . . . . 10.0 113.942 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.77 -45.72 1.64 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.236 0.922 . . . . 10.0 112.456 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 68.97 0.64 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.542 2.337 . . . . 10.0 108.503 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.55 151.76 28.42 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.178 0.991 . . . . 10.0 112.419 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.09 146.93 53.29 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.294 1.329 . . . . 10.0 108.786 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -83.06 140.38 32.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -57.71 123.26 15.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.547 0.739 . . . . 10.0 109.734 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -67.61 116.3 36.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.264 0.938 . . . . 10.0 108.981 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.64 -38.35 10.85 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 120.557 1.235 . . . . 10.0 110.777 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.22 -40.31 11.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.388 1.875 . . . . 10.0 113.134 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 p -121.3 27.68 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.821 0.849 . . . . 10.0 110.598 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 45.39 42.12 7.2 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.724 1.21 . . . . 10.0 112.788 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.46 58.29 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.328 -1.262 . . . . 10.0 116.196 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.6 p -81.31 -66.27 0.91 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.991 1.895 . . . . 10.0 112.02 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.43 -6.31 0.78 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.556 -1.135 . . . . 10.0 115.761 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.06 132.93 43.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.095 1.947 . . . . 10.0 111.67 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -75.99 138.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.1 114.69 23.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.7 mtp -77.49 73.72 4.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -68.71 62.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.292 1.437 . . . . 10.0 112.299 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.12 51.4 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.385 1.474 . . . . 10.0 110.489 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.23 -65.98 0.73 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.386 0.993 . . . . 10.0 113.332 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -100.91 -69.68 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.835 1.254 . . . . 10.0 112.122 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -74.52 68.69 1.63 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.573 -0.704 . . . . 10.0 111.213 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.24 59.24 0.75 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.21 1.004 . . . . 10.0 112.16 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.35 169.93 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 124.614 1.166 . . . . 10.0 110.7 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -146.84 159.52 43.41 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.621 0.6 . . . . 10.0 112.621 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.59 158.69 43.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.832 1.253 . . . . 10.0 108.572 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -53.55 134.44 40.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.062 0.545 . . . . 10.0 110.209 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.7 t -75.93 116.97 60.42 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.865 -0.588 . . . . 10.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.67 -39.01 7.2 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.169 1.913 . . . . 10.0 111.336 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -44.84 -43.41 8.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.997 1.719 . . . . 10.0 112.552 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.06 23.0 12.53 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.083 0.953 . . . . 10.0 111.699 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 44.21 44.68 6.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.781 1.232 . . . . 10.0 111.713 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -5.09 17.48 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -81.26 -8.32 59.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.308 2.054 . . . . 10.0 113.43 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.04 -7.63 3.05 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 121.459 -0.775 . . . . 10.0 113.192 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 133.61 55.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.747 2.019 . . . . 10.0 111.874 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.63 119.56 33.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.216 1.406 . . . . 10.0 108.854 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.31 81.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.79 1.636 . . . . 10.0 108.856 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -42.44 -49.95 5.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.415 1.486 . . . . 10.0 111.294 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -149.03 128.45 6.34 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.17 136.35 31.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.769 2.313 . . . . 10.0 114.848 -171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.5 t -73.68 90.82 1.84 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.673 1.589 . . . . 10.0 106.831 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -39.41 -45.39 1.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.73 1.612 . . . . 10.0 112.685 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.12 -39.32 2.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.827 1.251 . . . . 10.0 112.731 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.8 24.63 8.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.886 0.875 . . . . 10.0 110.631 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 47.99 35.59 5.23 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.296 1.038 . . . . 10.0 110.849 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.52 21.0 53.5 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.973 0.749 . . . . 10.0 114.973 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.42 -40.46 57.7 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.881 1.34 . . . . 10.0 110.367 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.72 -13.73 14.87 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.471 1.51 . . . . 10.0 112.073 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.62 145.5 29.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.155 0.978 . . . . 10.0 109.686 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.49 138.14 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.98 124.28 33.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -68.76 73.27 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.076 1.35 . . . . 10.0 108.406 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.631 1.973 . . . . 10.0 109.662 -176.643 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.69 132.78 54.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.229 1.812 . . . . 10.0 107.448 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.21 129.79 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -75.54 88.43 2.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -48.06 -39.48 20.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.831 1.252 . . . . 10.0 111.292 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -49.83 -33.44 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.143 1.377 . . . . 10.0 112.224 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.66 27.19 8.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.62 0.645 . . . . 10.0 110.656 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 44.69 41.97 5.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.47 1.508 . . . . 10.0 111.499 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 -3.52 30.95 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.131 -1.372 . . . . 10.0 116.044 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -80.9 -71.63 0.46 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 120.024 1.912 . . . . 10.0 110.661 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.43 -10.44 1.72 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.934 1.255 . . . . 10.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.63 137.81 33.64 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.222 2.011 . . . . 10.0 109.225 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 152.33 4.59 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 118.882 0.764 . . . . 10.0 112.071 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -46.82 141.77 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.122 3.214 . . . . 10.0 114.322 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.6 -58.32 3.78 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.783 0.706 . . . . 10.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 81.82 1.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.588 0.709 . . . . 10.0 109.852 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -56.49 157.32 9.91 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.636 1.174 . . . . 10.0 112.475 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.95 -174.72 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.328 2.019 . . . . 10.0 109.397 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -119.24 156.52 29.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -65.66 131.29 45.98 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.525 -1.359 . . . . 10.0 110.493 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -75.03 114.9 39.63 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.312 0.96 . . . . 10.0 109.389 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.1 -37.55 8.22 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.607 1.538 . . . . 10.0 110.558 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.96 -38.63 7.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.818 1.647 . . . . 10.0 112.964 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.3 p -119.06 20.45 12.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.797 0.839 . . . . 10.0 111.334 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 46.0 44.08 11.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.478 1.111 . . . . 10.0 111.483 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.13 -1.19 34.72 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.315 -1.269 . . . . 10.0 115.737 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.8 p -70.33 -63.2 1.13 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 120.336 2.068 . . . . 10.0 111.256 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.71 7.11 4.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.474 1.988 . . . . 10.0 111.529 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -134.7 146.93 49.93 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.426 1.613 . . . . 10.0 111.759 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 m -111.93 145.61 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.546 1.538 . . . . 10.0 108.336 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -107.91 113.33 26.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.072 -1.085 . . . . 10.0 108.072 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.7 tpp -75.15 73.95 2.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -70.76 60.98 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.655 1.582 . . . . 10.0 112.023 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -76.99 56.59 1.24 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.258 1.423 . . . . 10.0 110.861 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.68 -71.3 0.38 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.503 1.049 . . . . 10.0 112.847 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -98.63 -63.76 1.1 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.058 0.943 . . . . 10.0 112.025 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -77.49 60.73 2.14 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.895 0.878 . . . . 10.0 111.059 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.14 60.38 0.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.736 1.214 . . . . 10.0 113.096 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.29 -179.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.806 0.842 . . . . 10.0 110.013 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.6 160.08 40.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.46 166.6 24.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.513 1.125 . . . . 10.0 108.722 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 m -63.98 141.13 58.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.3 t -75.62 115.34 44.94 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 118.613 0.642 . . . . 10.0 109.707 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.45 -37.83 9.35 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.263 1.975 . . . . 10.0 111.052 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -45.38 -33.42 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.831 1.652 . . . . 10.0 112.538 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.07 21.79 6.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.9 0.88 . . . . 10.0 111.746 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.83 40.42 8.94 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.134 0.974 . . . . 10.0 112.263 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.29 53.62 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.114 0.805 . . . . 10.0 115.114 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -82.69 -7.77 59.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.966 1.383 . . . . 10.0 112.405 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.03 -6.49 2.97 Favored Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.465 -0.772 . . . . 10.0 113.041 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.56 127.04 52.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.184 1.793 . . . . 10.0 112.172 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.57 116.89 10.5 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.699 1.6 . . . . 10.0 107.482 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 mm -72.07 74.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 126.121 1.768 . . . . 10.0 109.291 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -42.47 -47.75 5.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.17 1.788 . . . . 10.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.22 94.96 5.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.87 1.268 . . . . 10.0 109.263 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.61 123.22 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 1 C-N-CA 125.573 4.182 . . . . 10.0 117.553 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.97 91.41 2.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.187 1.795 . . . . 10.0 107.142 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -36.98 -48.27 0.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.198 1.799 . . . . 10.0 112.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -43.37 -42.68 4.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.678 1.591 . . . . 10.0 112.639 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.28 16.87 14.81 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 123.756 0.823 . . . . 10.0 110.795 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 51.25 35.02 12.54 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.54 1.136 . . . . 10.0 110.27 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.64 14.25 57.45 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.688 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -75.05 -27.28 59.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.184 1.492 . . . . 10.0 111.627 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.56 -34.26 4.84 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.578 1.085 . . . . 10.0 113.718 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 144.37 50.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.123 0.969 . . . . 10.0 108.72 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.37 145.39 34.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.154 0.982 . . . . 10.0 109.412 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -80.47 138.69 36.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -67.79 72.09 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.034 1.334 . . . . 10.0 109.291 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 125.48 1.512 . . . . 10.0 110.625 -176.055 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -129.56 150.39 50.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.16 0.984 . . . . 10.0 109.531 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 131.44 43.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.808 1.643 . . . . 10.0 112.412 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.3 t -76.99 101.13 5.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.195 -1.78 . . . . 10.0 106.195 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -48.8 -41.97 34.44 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.288 1.435 . . . . 10.0 111.518 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.5 t -52.23 -33.38 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.103 1.361 . . . . 10.0 111.89 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.76 19.54 14.43 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.404 0.547 . . . . 10.0 110.925 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.08 38.31 16.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.019 1.327 . . . . 10.0 111.242 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.34 60.19 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.593 -1.115 . . . . 10.0 115.382 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.6 p -79.28 -67.88 0.71 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.89 1.845 . . . . 10.0 110.909 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.11 -9.47 3.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.981 2.705 . . . . 10.0 110.028 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 126.63 30.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.209 1.003 . . . . 10.0 111.739 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -44.76 141.49 2.92 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.916 1.687 . . . . 10.0 111.258 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.13 145.35 65.2 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.641 2.227 . . . . 10.0 110.185 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.05 39.06 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.44 0.543 . . . . 10.0 113.118 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -137.87 169.77 17.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 150.68 75.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 118.933 0.788 . . . . 10.0 111.047 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.86 168.05 10.98 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.236 2.624 . . . . 10.0 108.506 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -105.37 126.09 51.72 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 122.191 -0.318 . . . . 10.0 110.647 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -50.13 121.92 6.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 10.0 110.573 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.85 115.8 26.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -70.21 -36.27 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.642 1.561 . . . . 10.0 110.754 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.14 -40.26 10.8 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.679 1.592 . . . . 10.0 112.907 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 p -115.73 18.14 15.86 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 10.0 111.32 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 47.79 42.0 15.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.249 1.02 . . . . 10.0 110.722 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.37 -2.95 8.81 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.385 -1.231 . . . . 10.0 115.518 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -45.41 82.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.324 2.062 . . . . 10.0 111.322 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.06 3.24 28.06 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.365 1.459 . . . . 10.0 111.262 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -135.12 143.11 46.39 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.074 1.437 . . . . 10.0 112.079 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 m -99.46 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 126.096 1.758 . . . . 10.0 107.679 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -126.68 118.7 25.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.01 -1.478 . . . . 10.0 107.01 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -107.77 135.62 48.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.698 1.199 . . . . 10.0 108.843 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -99.05 115.26 28.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.767 1.227 . . . . 10.0 108.234 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 58.05 3.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.585 -0.895 . . . . 10.0 108.585 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 -66.7 2.07 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -101.23 -76.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.841 1.256 . . . . 10.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.46 172.84 6.61 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.475 0.579 . . . . 10.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.34 152.24 40.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.784 -0.573 . . . . 10.0 109.718 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.43 156.87 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.419 1.088 . . . . 10.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 158.85 23.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.595 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -147.03 155.13 41.97 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.231 -1.396 . . . . 10.0 107.231 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -63.76 133.99 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.34 117.35 56.07 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 119.178 0.899 . . . . 10.0 109.087 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.26 -37.04 8.47 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.95 1.767 . . . . 10.0 111.422 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -39.25 25.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.779 1.231 . . . . 10.0 113.566 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -116.26 19.63 14.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.892 1.277 . . . . 10.0 110.892 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 46.59 44.59 13.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.631 1.172 . . . . 10.0 111.319 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.84 -8.18 6.39 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.451 0.94 . . . . 10.0 115.451 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -74.94 -17.65 60.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.775 1.787 . . . . 10.0 112.714 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.2 12.64 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.843 -0.536 . . . . 10.0 112.385 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -106.54 130.49 54.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.703 1.601 . . . . 10.0 112.069 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.6 mt -81.63 115.82 21.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -75.68 67.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.321 1.048 . . . . 10.0 108.192 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.91 -24.59 67.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.078 0.551 . . . . 10.0 109.575 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -118.35 80.18 15.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 128.396 2.678 . . . . 10.0 110.655 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.6 122.17 11.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.962 2.442 . . . . 10.0 115.191 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.43 89.42 0.69 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.367 -1.345 . . . . 10.0 107.367 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -39.26 -46.31 1.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.283 1.833 . . . . 10.0 112.848 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -45.59 -36.79 4.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.274 1.03 . . . . 10.0 112.555 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.1 26.07 6.58 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.822 0.849 . . . . 10.0 110.182 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 43.44 40.13 2.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.549 1.54 . . . . 10.0 112.117 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.97 37.32 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.198 -0.939 . . . . 10.0 115.245 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.42 -39.27 88.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.727 1.763 . . . . 10.0 109.547 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.26 -9.08 67.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.213 1.863 . . . . 10.0 114.333 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.74 44.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.865 1.332 . . . . 10.0 109.271 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.72 147.9 30.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.558 1.143 . . . . 10.0 110.419 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 79.88 1.99 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.351 1.06 . . . . 10.0 108.439 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -79.48 50.28 1.1 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.396 1.079 . . . . 10.0 110.764 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.455 -0.218 0 O-C-N 121.513 -0.742 . . . . 10.0 109.888 -179.418 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -110.78 127.01 55.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.766 1.626 . . . . 10.0 107.566 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.4 127.11 30.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.795 1.238 . . . . 10.0 109.798 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.1 85.23 4.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.289 0.566 . . . . 10.0 110.041 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -46.77 -38.7 10.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.258 1.423 . . . . 10.0 111.708 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -49.16 -38.48 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.798 1.639 . . . . 10.0 111.712 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.14 19.52 17.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.147 0.579 . . . . 10.0 110.585 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 51.89 36.27 17.82 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.218 1.407 . . . . 10.0 109.772 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 3.66 42.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.43 1.014 . . . . 10.0 115.546 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -75.34 -66.3 0.78 Allowed 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.61 1.705 . . . . 10.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.89 -9.91 3.64 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.978 2.228 . . . . 10.0 109.82 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.18 139.65 46.46 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.355 1.578 . . . . 10.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -56.13 146.4 50.84 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.438 -0.791 . . . . 10.0 109.407 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -32.81 -66.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 1 C-N-CA 125.349 4.033 . . . . 10.0 115.68 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.29 44.5 3.06 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.583 -0.698 . . . . 10.0 113.074 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -158.13 158.65 35.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.673 1.236 . . . . 10.0 107.975 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 147.25 36.73 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.105 1.362 . . . . 10.0 108.662 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.401 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 29.8 Cg_endo -74.21 160.15 42.84 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.413 2.075 . . . . 10.0 107.247 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -105.32 126.18 51.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -36.75 116.92 0.46 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.949 1.3 . . . . 10.0 113.073 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.6 115.52 44.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.14 -31.75 18.26 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.649 1.566 . . . . 10.0 110.589 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -43.56 29.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.151 1.38 . . . . 10.0 112.062 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -108.04 11.55 27.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.081 0.953 . . . . 10.0 111.28 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 52.15 37.93 23.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.272 1.029 . . . . 10.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 -8.35 19.18 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.799 -0.563 . . . . 10.0 113.993 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 m -71.38 -8.7 55.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.989 1.394 . . . . 10.0 114.438 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.92 -18.78 11.35 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.064 0.847 . . . . 10.0 113.729 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -133.61 131.62 39.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.246 1.023 . . . . 10.0 109.566 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 m -73.8 150.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.337 1.455 . . . . 10.0 107.291 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.51 107.22 14.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.341 0.657 . . . . 10.0 109.889 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.32 114.87 22.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -97.95 133.12 42.87 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.578 1.151 . . . . 10.0 109.984 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.07 80.94 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.902 1.681 . . . . 10.0 107.606 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.37 -64.2 2.5 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.996 0.807 . . . . 10.0 111.704 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.71 -66.69 0.82 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.258 1.023 . . . . 10.0 109.416 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -59.92 155.33 16.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.981 0.512 . . . . 10.0 109.715 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.01 157.21 43.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.418 0.287 . . . . 10.0 110.83 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.92 148.57 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.429 1.092 . . . . 10.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.83 144.76 30.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.883 0.873 . . . . 10.0 112.177 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -140.15 143.81 36.36 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.302 1.441 . . . . 10.0 107.843 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -53.09 135.39 37.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.253 0.933 . . . . 10.0 111.489 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.2 t -79.53 116.89 64.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.97 -41.94 3.59 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.133 1.889 . . . . 10.0 111.259 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.2 -29.83 2.59 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.95 1.092 . . . . 10.0 113.95 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.2 p -127.46 29.95 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.759 0.824 . . . . 10.0 111.594 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 38.78 49.83 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.239 1.416 . . . . 10.0 111.945 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.54 -11.03 3.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.203 1.241 . . . . 10.0 116.203 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -74.08 -13.82 60.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.106 1.953 . . . . 10.0 113.574 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.35 7.2 86.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.559 -0.578 . . . . 10.0 114.339 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' PRO . 77.3 p -132.03 119.05 20.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.444 1.122 . . . . 10.0 110.565 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.03 150.19 43.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.002 1.321 . . . . 10.0 110.209 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -112.72 73.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 125.557 1.543 . . . . 10.0 109.961 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -68.45 -24.67 64.74 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.275 -0.891 . . . . 10.0 109.613 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -107.4 79.14 0.73 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.942 2.497 . . . . 10.0 110.323 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 118.09 5.06 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.296 2.664 . . . . 10.0 115.801 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.6 t -65.6 95.49 0.23 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.481 -1.674 . . . . 10.0 106.481 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -38.79 -48.81 1.56 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.869 1.668 . . . . 10.0 112.776 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -42.93 -39.89 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.725 1.21 . . . . 10.0 112.752 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.01 19.5 10.03 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.594 0.757 . . . . 10.0 111.047 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 46.38 41.93 9.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.653 1.181 . . . . 10.0 110.776 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.13 15.46 44.04 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.409 0.924 . . . . 10.0 115.409 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.83 -44.63 31.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.625 1.712 . . . . 10.0 109.009 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.75 -7.43 13.41 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.906 1.717 . . . . 10.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.62 152.85 32.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.881 -1.364 . . . . 10.0 109.688 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.08 146.45 13.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -98.59 137.69 36.86 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.344 -0.613 . . . . 10.0 109.344 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -78.26 59.98 2.41 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.064 -1.087 . . . . 10.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.31 1.044 . . . . 10.0 110.86 -178.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.457 0 N-CA-C 108.519 -1.833 . . . . 10.0 108.519 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.78 -23.68 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.504 1.122 . . . . 10.0 111.825 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -65.81 -35.9 81.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.906 2.082 . . . . 10.0 110.974 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -93.91 -49.61 5.73 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.378 1.071 . . . . 10.0 108.496 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.29 65.71 1.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.564 1.546 . . . . 10.0 108.292 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.5 pt -70.02 73.09 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.182 0.993 . . . . 10.0 112.142 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 55.36 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.08 2.152 . . . . 10.0 113.484 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.58 86.77 52.0 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.713 -1.588 . . . . 10.0 106.713 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -42.62 138.56 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.355 3.37 . . . . 10.0 115.297 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.57 146.27 14.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.358 -1.719 . . . . 10.0 106.358 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.59 147.7 23.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.907 0.483 . . . . 10.0 109.905 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -138.16 144.22 40.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.844 1.257 . . . . 10.0 108.059 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.95 142.95 45.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.0 t -76.58 87.26 3.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -41.67 -41.86 2.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.567 1.947 . . . . 10.0 111.751 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -51.67 -45.69 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 10.0 111.443 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.79 18.49 18.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.768 0.713 . . . . 10.0 110.599 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.83 35.95 25.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.26 1.424 . . . . 10.0 110.166 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.86 3.06 58.77 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.144 -1.364 . . . . 10.0 115.02 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -80.05 -75.22 0.27 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.012 1.906 . . . . 10.0 110.388 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.89 -19.25 0.76 Allowed Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.628 1.585 . . . . 10.0 112.308 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.71 151.53 26.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.596 1.698 . . . . 10.0 111.087 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -52.82 151.59 8.13 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.182 0.901 . . . . 10.0 111.92 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -50.51 137.23 40.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.54 2.827 . . . . 10.0 112.06 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.82 -51.8 2.75 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.598 1.094 . . . . 10.0 111.1 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -68.56 70.42 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.235 2.614 . . . . 10.0 108.904 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -56.76 158.43 8.68 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.383 0.673 . . . . 10.0 112.656 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.59 145.21 60.08 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.69 1.593 . . . . 10.0 109.287 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -84.6 123.01 29.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -50.78 121.35 5.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.914 0.886 . . . . 10.0 109.624 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.92 116.9 33.7 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.898 -0.778 . . . . 10.0 108.898 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.27 -38.46 6.66 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.582 1.521 . . . . 10.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.58 -39.71 7.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.289 1.836 . . . . 10.0 113.272 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -115.4 17.0 16.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.926 0.89 . . . . 10.0 111.568 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 47.1 49.71 14.77 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.0 0.92 . . . . 10.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.67 2.92 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.779 1.18 . . . . 10.0 115.247 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -90.12 2.84 54.86 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.843 1.321 . . . . 10.0 113.107 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.99 -8.82 5.83 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.776 1.07 . . . . 10.0 115.776 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.98 130.75 52.99 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.068 1.434 . . . . 10.0 110.031 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 m -87.95 143.85 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.658 -1.608 . . . . 10.0 106.658 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -98.33 110.67 23.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.93 -1.137 . . . . 10.0 107.93 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.6 tpt -75.79 73.29 2.73 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -69.44 55.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.064 2.146 . . . . 10.0 112.981 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.27 64.29 4.13 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.764 1.226 . . . . 10.0 108.414 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 -126.91 31.88 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -53.59 -47.83 69.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.306 1.042 . . . . 10.0 113.284 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -79.67 58.17 2.69 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.983 0.513 . . . . 10.0 111.143 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 59.0 2.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.261 0.625 . . . . 10.0 112.527 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.65 175.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -115.42 171.12 7.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -141.63 154.64 45.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.827 -1.916 . . . . 10.0 105.827 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -65.65 136.08 55.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 39.1 t -71.04 116.57 47.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.848 0.749 . . . . 10.0 109.649 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -38.99 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.874 1.716 . . . . 10.0 111.251 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -47.21 -41.14 17.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.004 1.322 . . . . 10.0 113.101 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.3 p -116.02 20.63 14.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.139 0.976 . . . . 10.0 111.299 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 46.8 42.92 12.58 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.374 1.07 . . . . 10.0 111.6 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.95 -4.09 11.18 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.433 0.933 . . . . 10.0 115.433 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -78.86 -5.5 53.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.644 1.722 . . . . 10.0 113.041 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.94 5.64 5.77 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.39 0.995 . . . . 10.0 114.642 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 p -129.14 132.41 47.34 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.773 1.229 . . . . 10.0 111.322 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -104.56 120.26 40.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.391 1.077 . . . . 10.0 110.111 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -78.01 65.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.356 1.462 . . . . 10.0 107.429 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -56.83 -45.43 82.34 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.296 0.57 . . . . 10.0 109.479 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -114.02 100.03 51.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.981 1.712 . . . . 10.0 108.475 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.72 131.04 19.13 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.925 1.75 . . . . 10.0 112.34 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.47 100.21 0.48 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -40.73 -50.37 3.1 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.63 1.572 . . . . 10.0 112.805 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -45.21 -40.0 6.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.861 1.265 . . . . 10.0 112.973 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -118.45 19.78 13.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.286 0.634 . . . . 10.0 111.004 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 46.5 42.92 11.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.647 1.179 . . . . 10.0 110.827 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.73 29.3 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.236 -1.313 . . . . 10.0 116.279 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -65.99 -55.95 14.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.278 2.039 . . . . 10.0 110.293 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.69 -9.62 16.51 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.718 1.151 . . . . 10.0 114.415 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.73 156.36 41.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.34 -1.356 . . . . 10.0 107.34 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.14 166.51 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.155 0.582 . . . . 10.0 109.69 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.57 136.59 36.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.817 -1.92 . . . . 10.0 105.817 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -51.11 116.19 1.89 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.414 -0.588 . . . . 10.0 109.414 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 124.334 1.054 . . . . 10.0 108.247 -177.748 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.788 0 N-CA-C 111.011 -0.836 . . . . 10.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.72 -42.69 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.607 0.763 . . . . 10.0 109.955 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -166.83 -166.64 0.85 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -167.92 -159.16 0.28 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.418 1.887 . . . . 10.0 107.074 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -75.67 65.92 1.92 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.555 -0.716 . . . . 10.0 109.936 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 62.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.942 0.897 . . . . 10.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 62.03 2.79 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.077 -1.014 . . . . 10.0 108.516 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mm -78.72 135.94 59.45 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 105.722 -1.955 . . . . 10.0 105.722 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.11 91.08 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.544 2.163 . . . . 10.0 108.609 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 62.51 0.25 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.558 1.943 . . . . 10.0 112.469 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.9 mt -68.28 109.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.998 -0.438 . . . . 10.0 109.845 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -118.05 147.09 43.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.79 138.34 58.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.406 0.441 . . . . 10.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.03 100.09 4.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.057 -1.461 . . . . 10.0 107.057 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.16 -43.38 20.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.563 . . . . 10.0 111.577 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.7 -29.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.277 1.431 . . . . 10.0 112.445 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.31 19.84 8.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.816 0.846 . . . . 10.0 110.808 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 44.93 42.44 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.344 1.458 . . . . 10.0 111.314 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.29 -11.26 38.34 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.165 1.226 . . . . 10.0 116.165 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.8 p -70.32 -68.72 0.4 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 120.036 1.918 . . . . 10.0 110.816 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.74 -5.5 5.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.863 2.173 . . . . 10.0 109.205 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.54 131.32 35.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.519 1.16 . . . . 10.0 109.159 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -54.69 159.41 3.53 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -42.5 137.35 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.983 3.122 . . . . 10.0 114.68 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.41 10.92 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.789 1.185 . . . . 10.0 114.157 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 m -127.36 136.07 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -90.86 146.12 33.26 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 124.12 0.968 . . . . 10.0 110.319 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -68.75 158.21 58.75 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 106.839 -2.023 . . . . 10.0 106.839 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -89.96 114.22 26.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -48.07 124.13 7.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.381 1.072 . . . . 10.0 109.866 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.53 115.39 17.96 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.74 -36.94 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.815 1.676 . . . . 10.0 110.725 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.61 -39.93 8.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.682 1.593 . . . . 10.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 p -114.6 12.65 17.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.788 . . . . 10.0 111.667 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.89 41.93 23.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.024 0.93 . . . . 10.0 109.895 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.53 -7.81 8.18 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.246 -0.752 . . . . 10.0 114.846 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -68.14 -9.06 43.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.499 1.65 . . . . 10.0 113.898 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.25 54.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.356 0.979 . . . . 10.0 113.68 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.4 143.55 30.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.509 1.154 . . . . 10.0 110.404 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.34 152.03 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.1 1.76 . . . . 10.0 107.534 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -125.66 118.94 26.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 89.6 mtp -104.02 121.48 43.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.873 1.269 . . . . 10.0 108.505 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -95.28 112.18 23.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.568 1.147 . . . . 10.0 108.914 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.82 53.73 2.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.43 -71.25 0.35 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.341 0.972 . . . . 10.0 112.427 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -80.56 -68.49 0.68 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 10.0 110.099 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.94 174.31 7.23 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.269 0.628 . . . . 10.0 110.058 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.14 43.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.703 0.801 . . . . 10.0 109.443 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 164.58 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 124.644 1.177 . . . . 10.0 108.576 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.56 152.63 43.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.113 0.965 . . . . 10.0 111.621 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.1 160.04 41.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -59.75 136.74 58.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.4 t -72.05 117.14 55.58 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.812 0.733 . . . . 10.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.09 -40.44 6.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.086 1.857 . . . . 10.0 111.357 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -45.85 -36.87 5.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.651 1.18 . . . . 10.0 113.013 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.4 p -121.43 21.49 10.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.877 0.871 . . . . 10.0 111.595 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 44.86 42.99 6.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.407 1.083 . . . . 10.0 111.705 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -4.76 9.13 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.699 1.04 . . . . 10.0 115.699 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -77.62 -7.8 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.425 1.612 . . . . 10.0 112.932 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.82 -2.21 2.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.105 0.86 . . . . 10.0 114.14 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 135.28 49.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.657 1.583 . . . . 10.0 109.876 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -101.88 119.79 39.35 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.773 1.229 . . . . 10.0 108.252 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.0 66.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 10.0 108.351 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -63.43 -35.51 80.68 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.786 -0.571 . . . . 10.0 110.22 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -109.64 77.05 0.96 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 127.795 2.438 . . . . 10.0 110.086 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.81 124.52 13.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.222 2.614 . . . . 10.0 115.591 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.99 94.89 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.495 1.518 . . . . 10.0 107.989 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -39.54 -47.83 1.95 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.476 1.51 . . . . 10.0 113.273 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -45.97 -43.29 13.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.972 0.909 . . . . 10.0 112.7 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.43 19.69 16.72 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 122.923 0.489 . . . . 10.0 110.461 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.08 40.85 18.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.436 1.094 . . . . 10.0 110.314 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.44 20.56 45.61 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.388 -0.673 . . . . 10.0 114.325 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -67.69 0.65 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.145 1.473 . . . . 10.0 107.371 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.92 -45.04 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.475 -0.65 . . . . 10.0 111.475 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.29 161.36 26.0 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.167 0.987 . . . . 10.0 110.237 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.7 149.78 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.226 1.011 . . . . 10.0 110.107 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.2 71.55 2.23 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.321 1.048 . . . . 10.0 109.371 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 67.14 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.906 2.083 . . . . 10.0 109.044 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.451 -0.422 0 C-N-CA 125.875 1.67 . . . . 10.0 111.724 -175.552 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 108.93 -1.668 . . . . 10.0 108.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.25 -49.78 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.6 p -78.35 68.35 4.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -49.7 -37.37 28.71 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.922 1.289 . . . . 10.0 111.856 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -73.23 63.7 0.74 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.951 1.3 . . . . 10.0 110.279 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.0 pt -73.53 53.93 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.56 1.144 . . . . 10.0 111.986 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -98.36 36.56 1.59 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.586 1.154 . . . . 10.0 108.747 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -157.15 155.65 28.29 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 128.627 2.771 . . . . 10.0 104.591 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.38 74.76 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.977 3.118 . . . . 10.0 111.072 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -78.23 67.32 4.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.177 1.391 . . . . 10.0 108.391 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 mt -101.72 142.3 33.26 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.938 1.295 . . . . 10.0 110.903 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -129.82 156.26 44.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.731 1.612 . . . . 10.0 108.243 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.18 137.08 58.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.197 0.599 . . . . 10.0 109.783 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 t -76.6 81.63 3.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -46.18 -38.19 8.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.419 1.487 . . . . 10.0 111.502 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.04 -42.5 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.359 1.464 . . . . 10.0 111.776 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.8 p -110.36 20.19 18.03 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.511 0.724 . . . . 10.0 110.34 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 49.93 38.01 15.17 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.418 1.487 . . . . 10.0 110.27 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.84 0.54 14.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.544 -1.142 . . . . 10.0 115.384 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -73.77 -57.88 3.68 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 120.123 1.961 . . . . 10.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.85 5.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.433 1.968 . . . . 10.0 109.829 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 129.57 40.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.215 1.008 . . . . 10.0 112.172 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -42.2 145.59 0.76 Allowed Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.556 1.943 . . . . 10.0 111.729 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -39.13 132.08 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.725 2.95 . . . . 10.0 113.139 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.46 15.27 23.85 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.13 -0.817 . . . . 10.0 114.307 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -119.21 157.51 27.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.783 1.233 . . . . 10.0 107.717 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.99 152.63 43.77 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.1 1.36 . . . . 10.0 109.019 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.83 -177.9 4.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.149 1.899 . . . . 10.0 108.996 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -117.64 125.93 51.61 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -47.01 122.33 4.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.305 1.042 . . . . 10.0 110.897 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.61 115.79 27.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 -36.76 9.04 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.603 1.535 . . . . 10.0 110.887 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -46.32 -38.88 9.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.951 1.7 . . . . 10.0 112.985 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.21 19.99 13.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.089 0.956 . . . . 10.0 111.261 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 46.65 42.68 11.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.357 1.063 . . . . 10.0 111.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.41 -6.31 11.87 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.691 -1.061 . . . . 10.0 115.615 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.3 p -68.12 -44.48 76.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.073 1.936 . . . . 10.0 112.069 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.59 2.51 34.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.264 1.411 . . . . 10.0 111.136 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -128.82 130.07 46.46 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.714 1.257 . . . . 10.0 110.19 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.51 132.73 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -116.92 116.53 27.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.9 mmt -68.98 158.48 34.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -144.28 41.34 1.37 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.769 0.828 . . . . 10.0 109.854 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -163.69 0.59 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.015 1.726 . . . . 10.0 107.754 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.25 3.24 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.975 -0.85 . . . . 10.0 110.975 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -158.07 -60.74 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.295 0.547 . . . . 10.0 110.915 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -135.77 156.15 49.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.211 1.404 . . . . 10.0 107.404 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.7 63.03 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -78.34 172.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 123.412 0.685 . . . . 10.0 111.005 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.1 164.24 30.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.421 0.526 . . . . 10.0 112.421 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -144.6 161.69 38.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.718 1.207 . . . . 10.0 108.272 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -62.41 134.17 56.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.52 117.1 40.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 119.031 0.832 . . . . 10.0 109.748 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.88 -39.8 5.86 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.819 1.679 . . . . 10.0 111.241 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.88 -39.88 27.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.501 1.12 . . . . 10.0 113.635 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.8 p -113.12 16.23 19.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.196 0.998 . . . . 10.0 111.384 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 48.07 44.57 19.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 10.0 110.608 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.57 -2.36 16.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -78.63 -2.67 40.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.028 1.914 . . . . 10.0 113.343 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.54 -0.28 2.22 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.176 0.893 . . . . 10.0 114.279 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -125.71 128.59 48.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.628 1.571 . . . . 10.0 109.971 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.41 144.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.588 -1.264 . . . . 10.0 107.588 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mm -108.62 73.74 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.515 1.126 . . . . 10.0 109.334 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -66.14 -27.82 68.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.968 . . . . 10.0 108.719 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 80.23 0.42 Allowed Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 127.392 2.277 . . . . 10.0 110.061 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.36 121.69 9.01 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.292 2.661 . . . . 10.0 114.716 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.0 t -68.55 91.65 0.43 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.339 -1.726 . . . . 10.0 106.339 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -40.87 -44.19 2.23 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 125.347 1.459 . . . . 10.0 112.596 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -44.16 -37.22 3.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.08 0.952 . . . . 10.0 112.599 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -124.22 14.01 9.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.009 . . . . 10.0 111.243 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m80 45.73 43.24 9.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.46 1.104 . . . . 10.0 110.612 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.3 38.27 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.64 -37.82 59.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.011 1.906 . . . . 10.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.99 34.02 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.406 1.003 . . . . 10.0 114.925 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.77 155.37 45.61 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 119.162 1.481 . . . . 10.0 110.367 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.6 m -134.19 155.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 125.136 1.374 . . . . 10.0 108.676 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.91 148.33 23.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.533 0.733 . . . . 10.0 109.424 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -75.56 49.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.795 0.838 . . . . 10.0 110.623 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.452 -0.336 0 O-C-N 121.077 -1.014 . . . . 10.0 111.021 -177.329 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 109.143 -1.583 . . . . 10.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -54.42 -34.82 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -63.08 -33.09 74.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.816 2.046 . . . . 10.0 112.302 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -85.25 -41.28 15.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.353 1.061 . . . . 10.0 109.44 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -56.8 145.69 28.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.02 0.928 . . . . 10.0 109.495 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt -71.22 66.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.782 0.833 . . . . 10.0 113.018 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -79.11 56.86 2.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.139 0.975 . . . . 10.0 109.644 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 pt -70.7 132.3 87.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.397 -0.811 . . . . 10.0 108.908 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.85 103.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.118 3.212 . . . . 10.0 112.965 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 m -134.05 129.21 35.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.4 mt -76.28 136.32 39.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.305 0.502 . . . . 10.0 109.667 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -134.02 146.12 50.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.627 1.171 . . . . 10.0 108.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.68 144.2 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.466 -0.568 . . . . 10.0 109.466 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.51 91.31 5.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -46.69 -38.9 10.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.415 1.486 . . . . 10.0 111.814 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.5 t -49.59 -43.01 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.392 1.477 . . . . 10.0 111.278 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 20.22 18.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.952 0.501 . . . . 10.0 110.688 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 52.84 38.56 27.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.152 1.381 . . . . 10.0 110.099 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.99 -3.11 47.6 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.411 -1.216 . . . . 10.0 115.167 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -78.0 -74.51 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.144 1.972 . . . . 10.0 111.36 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.9 -18.0 1.09 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.626 1.108 . . . . 10.0 111.847 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.73 140.9 31.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.662 1.731 . . . . 10.0 109.587 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 157.6 2.47 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.008 0.744 . . . . 10.0 113.008 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -41.67 136.72 2.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.643 3.562 . . . . 10.0 115.337 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -60.25 2.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.582 0.611 . . . . 10.0 112.227 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 m -70.91 79.69 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.327 0.584 . . . . 10.0 109.928 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.78 162.95 4.43 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.183 0.993 . . . . 10.0 111.865 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.55 153.54 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.86 1.707 . . . . 10.0 110.215 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -98.49 135.0 40.67 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.797 -0.445 . . . . 10.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -50.82 124.93 12.14 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.058 0.943 . . . . 10.0 110.738 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -68.19 115.85 33.22 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 118.597 0.635 . . . . 10.0 109.445 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.25 -34.75 12.39 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.43 1.42 . . . . 10.0 110.806 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -46.25 -38.26 8.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.624 1.569 . . . . 10.0 113.22 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.23 15.29 13.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.315 1.046 . . . . 10.0 110.718 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 50.0 40.59 21.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.973 0.909 . . . . 10.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.06 10.34 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.851 0.739 . . . . 10.0 114.654 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.4 m -64.29 -28.29 69.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.918 1.359 . . . . 10.0 113.339 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 -16.79 57.56 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.483 1.04 . . . . 10.0 114.776 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 146.75 52.47 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.946 1.373 . . . . 10.0 110.455 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.23 155.14 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.271 1.428 . . . . 10.0 107.146 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -126.54 114.71 18.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.2 mtp -76.53 73.17 3.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.87 60.69 0.17 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.144 1.378 . . . . 10.0 112.408 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 48.29 0.63 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.504 1.122 . . . . 10.0 110.797 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.2 -61.78 2.22 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.344 -0.847 . . . . 10.0 112.432 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -102.35 -72.66 0.68 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.981 0.89 . . . . 10.0 113.359 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -73.64 68.99 1.25 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.568 -0.708 . . . . 10.0 111.553 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 59.74 0.63 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.424 1.09 . . . . 10.0 111.35 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.0 m -78.6 151.96 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 C-N-CA 123.138 0.575 . . . . 10.0 111.295 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.1 150.88 24.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.414 1.086 . . . . 10.0 111.921 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -145.13 151.11 37.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -60.5 135.93 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.51 116.38 48.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.001 0.819 . . . . 10.0 109.29 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.02 -38.38 7.3 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.156 1.904 . . . . 10.0 111.33 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -45.3 -42.52 9.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.961 1.704 . . . . 10.0 112.258 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -115.21 20.79 14.69 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.195 0.998 . . . . 10.0 112.077 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 46.92 41.9 11.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.53 1.132 . . . . 10.0 111.354 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.22 -7.04 6.42 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.409 0.923 . . . . 10.0 115.409 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.34 -9.33 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.61 1.705 . . . . 10.0 113.443 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.02 3.33 10.63 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.568 -0.707 . . . . 10.0 112.941 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.78 133.11 47.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.078 1.751 . . . . 10.0 109.933 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.04 122.68 43.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.207 1.403 . . . . 10.0 109.905 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.5 mm -81.02 67.14 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.637 1.575 . . . . 10.0 107.092 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -57.56 -38.03 74.11 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.562 0.579 . . . . 10.0 112.562 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -125.98 84.25 61.56 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.283 1.433 . . . . 10.0 110.44 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.53 132.34 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.959 3.773 . . . . 10.0 115.914 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.1 t -74.62 95.15 2.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -37.4 -50.05 1.04 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.76 1.624 . . . . 10.0 113.009 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -45.13 -36.15 3.54 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.397 1.079 . . . . 10.0 113.508 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -122.59 15.55 10.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.477 0.711 . . . . 10.0 110.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 43.98 45.33 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.939 1.295 . . . . 10.0 111.15 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.78 -3.1 13.51 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 116.291 1.277 . . . . 10.0 116.291 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -66.84 -36.88 83.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.14 1.97 . . . . 10.0 111.132 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.48 56.17 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 123.99 0.805 . . . . 10.0 113.333 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -135.93 160.93 37.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.453 1.126 . . . . 10.0 110.14 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.71 157.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.344 1.457 . . . . 10.0 107.895 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.29 126.97 50.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.861 0.864 . . . . 10.0 109.096 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -77.09 62.93 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.454 -0.249 0 O-C-N 121.463 -0.773 . . . . 10.0 110.919 -177.317 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 109.192 -1.563 . . . . 10.0 109.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.46 152.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 117.193 0.497 . . . . 10.0 109.921 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t -64.85 154.32 37.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.029 0.442 . . . . 10.0 110.069 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.49 -28.26 69.07 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.08 57.76 2.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.801 -0.562 . . . . 10.0 111.476 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 pt -66.11 -15.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.892 0.377 . . . . 10.0 111.351 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -76.56 51.76 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.342 1.857 . . . . 10.0 108.851 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -55.48 138.11 68.81 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.078 0.551 . . . . 10.0 110.222 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.59 51.79 3.09 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.301 2.668 . . . . 10.0 112.88 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -81.11 55.82 2.63 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.1 mt -140.02 137.13 34.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.361 1.464 . . . . 10.0 108.687 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -109.0 128.36 54.89 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.226 1.811 . . . . 10.0 107.656 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 128.89 39.06 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.573 0.749 . . . . 10.0 109.84 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 t -79.48 88.99 5.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.032 -0.729 . . . . 10.0 109.032 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -49.3 -36.01 19.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.064 1.346 . . . . 10.0 111.418 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -49.47 -48.29 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.796 1.238 . . . . 10.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.1 p -103.21 23.45 12.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.411 0.624 . . . . 10.0 111.001 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 53.33 37.14 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.259 1.424 . . . . 10.0 110.604 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.45 47.37 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.592 -1.115 . . . . 10.0 115.109 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -84.52 -69.57 0.64 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.751 1.775 . . . . 10.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.58 -24.89 1.51 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.205 1.859 . . . . 10.0 109.994 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.99 131.86 40.95 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.804 0.802 . . . . 10.0 111.063 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.7 143.34 6.01 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.849 -0.596 . . . . 10.0 111.741 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -22.27 126.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 1 C-N-CA 127.321 5.347 . . . . 10.0 117.163 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.1 -48.25 2.39 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.848 0.737 . . . . 10.0 112.831 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.89 128.74 38.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.246 1.418 . . . . 10.0 109.772 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.56 152.47 63.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 122.032 -0.418 . . . . 10.0 111.481 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 179.28 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.072 1.848 . . . . 10.0 108.941 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -121.5 131.72 54.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -50.49 125.32 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.056 0.942 . . . . 10.0 112.088 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.36 116.08 45.6 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.5 -38.79 7.86 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.353 1.368 . . . . 10.0 110.589 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -45.2 -39.42 6.25 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.314 1.846 . . . . 10.0 113.06 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.37 30.68 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.744 0.818 . . . . 10.0 110.641 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 39.78 47.96 1.89 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.305 1.442 . . . . 10.0 113.261 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 -4.17 39.61 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 116.279 1.272 . . . . 10.0 116.279 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 p -84.14 -68.99 0.67 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.127 1.964 . . . . 10.0 111.939 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.19 -5.28 0.65 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.261 -1.299 . . . . 10.0 116.277 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 143.55 47.32 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.46 2.13 . . . . 10.0 112.459 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -99.4 130.38 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.611 1.564 . . . . 10.0 108.153 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -103.21 106.31 16.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.045 0.538 . . . . 10.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.3 tpp -77.44 72.76 4.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.4 65.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.38 2.272 . . . . 10.0 112.98 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -79.25 70.07 5.58 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -136.96 27.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.945 -1.262 . . . . 10.0 109.945 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -55.1 -34.93 64.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.074 0.95 . . . . 10.0 112.128 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -74.29 72.13 1.76 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.743 0.817 . . . . 10.0 110.164 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 58.5 0.51 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.544 1.138 . . . . 10.0 111.544 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 m -81.47 157.35 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.538 0.735 . . . . 10.0 109.791 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.25 164.97 29.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.227 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -143.69 153.38 42.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.043 1.337 . . . . 10.0 108.021 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.7 m -60.44 136.4 58.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.74 116.77 51.39 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.42 -39.21 7.44 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.08 1.853 . . . . 10.0 112.116 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.42 -36.88 45.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.1 p -112.82 16.69 19.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.077 0.951 . . . . 10.0 111.28 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 47.77 42.9 16.43 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.987 1.315 . . . . 10.0 110.813 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.78 1.07 53.5 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -87.8 5.65 39.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.623 1.711 . . . . 10.0 113.583 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.42 -3.88 0.75 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.091 0.853 . . . . 10.0 115.009 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -121.81 125.96 47.7 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.417 1.487 . . . . 10.0 111.255 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.68 152.59 23.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.89 85.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -66.89 -23.05 65.96 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -111.62 68.3 0.75 Allowed Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 128.294 2.638 . . . . 10.0 109.973 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.31 133.74 27.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.269 2.646 . . . . 10.0 115.491 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.0 t -70.24 93.16 0.82 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.336 -1.357 . . . . 10.0 107.336 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -40.62 -45.4 2.33 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.693 1.597 . . . . 10.0 112.582 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -42.35 -40.01 2.35 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.348 1.459 . . . . 10.0 112.464 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -124.83 23.08 8.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.906 0.883 . . . . 10.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 46.22 40.96 8.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.987 1.315 . . . . 10.0 111.069 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.04 14.89 48.09 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 118.814 -0.992 . . . . 10.0 115.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.02 -23.57 44.24 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.726 1.763 . . . . 10.0 110.578 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.97 3.18 80.09 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.649 1.595 . . . . 10.0 114.38 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 153.1 31.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.304 1.052 . . . . 10.0 109.288 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.09 140.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 107.752 -1.203 . . . . 10.0 107.752 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -66.16 134.2 52.26 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.727 -0.608 . . . . 10.0 110.646 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -77.47 65.21 2.96 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.674 -0.862 . . . . 10.0 108.674 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.342 1.057 . . . . 10.0 109.045 -179.224 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.856 0 N-CA-C 110.114 -1.194 . . . . 10.0 110.114 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.15 174.57 7.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.32 1.448 . . . . 10.0 107.952 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.9 p -74.6 61.12 0.94 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.26 1.024 . . . . 10.0 111.433 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -94.37 -44.32 7.97 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.625 1.17 . . . . 10.0 108.124 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.08 51.02 0.94 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.305 0.642 . . . . 10.0 111.475 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.37 61.62 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.764 0.792 . . . . 10.0 109.871 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -79.73 71.98 6.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.4 mt -42.56 135.19 2.66 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.455 1.502 . . . . 10.0 108.669 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.1 62.19 1.95 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.831 3.02 . . . . 10.0 113.878 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m -142.41 54.62 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.038 -2.208 . . . . 10.0 105.038 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 77' ' ' GLU . 62.3 mt -141.43 155.43 45.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.815 1.646 . . . . 10.0 108.11 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -132.23 124.58 29.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.034 1.733 . . . . 10.0 108.15 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -62.43 135.05 57.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.291 0.636 . . . . 10.0 110.02 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 51.4 t -69.75 114.56 8.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -54.77 -42.78 72.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.228 0.611 . . . . 10.0 111.018 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -54.08 -49.59 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.346 1.058 . . . . 10.0 112.447 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 26.6 p -95.65 -0.44 51.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.609 0.64 . . . . 10.0 112.061 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 66.74 40.52 3.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.766 1.227 . . . . 10.0 109.437 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.39 -3.51 39.98 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.151 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.5 p -75.68 -69.22 0.5 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.073 1.937 . . . . 10.0 110.362 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.26 -8.47 4.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.08 2.752 . . . . 10.0 109.443 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.7 133.93 39.37 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.141 0.971 . . . . 10.0 110.728 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -44.91 142.6 2.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.258 1.423 . . . . 10.0 110.69 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.92 141.68 45.41 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.659 2.239 . . . . 10.0 110.906 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.75 21.04 34.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.642 0.639 . . . . 10.0 113.144 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -134.03 160.56 37.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -121.7 148.7 51.34 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.197 0.999 . . . . 10.0 111.825 -175.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.09 -179.05 5.09 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.15 2.566 . . . . 10.0 108.395 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -117.23 129.71 56.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -49.02 123.53 7.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.745 1.218 . . . . 10.0 110.845 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.2 t -65.68 115.83 26.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.85 -35.69 11.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.646 1.564 . . . . 10.0 111.092 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.71 -38.24 9.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.767 1.627 . . . . 10.0 112.997 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -117.45 15.59 14.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 111.333 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.7 40.91 21.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.18 0.992 . . . . 10.0 110.376 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.18 -11.79 7.88 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.628 0.632 . . . . 10.0 114.535 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -66.98 -11.85 58.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.997 1.398 . . . . 10.0 114.302 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.66 41.23 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.795 -0.566 . . . . 10.0 113.384 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 125.56 33.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.536 1.134 . . . . 10.0 109.163 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.32 131.3 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.72 111.5 21.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.0 mmm -74.24 72.35 1.75 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.003 1.321 . . . . 10.0 108.274 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -66.21 62.48 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.519 1.928 . . . . 10.0 112.704 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 51.86 1.01 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.648 1.179 . . . . 10.0 110.435 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.06 -67.28 0.48 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.27 0.938 . . . . 10.0 113.291 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -98.23 -72.51 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.76 1.224 . . . . 10.0 112.655 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -77.35 69.72 3.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.179 0.899 . . . . 10.0 110.881 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.8 59.68 0.9 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.805 0.842 . . . . 10.0 111.546 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.22 163.59 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.14 0.576 . . . . 10.0 110.246 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -125.04 171.17 10.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.23 154.04 45.58 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -62.21 133.52 55.31 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.37 117.16 56.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.849 0.75 . . . . 10.0 109.62 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.16 -36.38 5.76 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.166 1.911 . . . . 10.0 111.286 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -39.57 24.09 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.529 1.132 . . . . 10.0 112.543 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.7 p -117.62 20.12 13.61 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.249 1.019 . . . . 10.0 110.806 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 42.92 45.49 4.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.437 1.495 . . . . 10.0 112.177 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -9.2 5.36 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.237 0.855 . . . . 10.0 115.237 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -73.57 -8.44 55.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.257 1.529 . . . . 10.0 112.363 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 -13.06 0.55 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.533 1.063 . . . . 10.0 115.167 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.79 133.52 55.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.833 1.653 . . . . 10.0 110.904 -174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.0 116.91 28.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.17 66.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.633 1.573 . . . . 10.0 108.438 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -62.61 -34.08 76.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.255 0.55 . . . . 10.0 109.713 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -107.98 79.91 0.96 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.145 2.578 . . . . 10.0 109.69 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 125.79 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.477 2.118 . . . . 10.0 114.998 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.32 87.13 0.43 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -38.64 -44.7 1.01 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.218 1.807 . . . . 10.0 112.83 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -44.7 -41.42 6.76 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.801 1.24 . . . . 10.0 112.362 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.99 27.4 8.09 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.668 0.787 . . . . 10.0 109.963 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 45.62 37.72 3.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.937 1.695 . . . . 10.0 111.827 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.91 9.46 46.7 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 114.98 0.752 . . . . 10.0 114.98 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.66 -32.16 69.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.299 1.55 . . . . 10.0 109.563 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.44 -23.71 32.49 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.19 1.376 . . . . 10.0 113.525 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.32 151.5 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.267 1.034 . . . . 10.0 109.736 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.26 154.67 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.965 1.306 . . . . 10.0 107.662 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.487 ' HA ' HD23 ' A' ' 11' ' ' LEU . 35.0 tt0 -69.42 142.89 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.577 -0.702 . . . . 10.0 110.216 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -69.42 70.84 0.28 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.734 1.214 . . . . 10.0 109.515 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 125.771 1.628 . . . . 10.0 110.653 -176.211 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 110.501 -1.04 . . . . 10.0 110.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -54.52 71.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.312 2.245 . . . . 10.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -145.55 -78.57 0.18 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.497 1.919 . . . . 10.0 107.312 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -141.22 -56.36 0.49 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.73 2.412 . . . . 10.0 106.126 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.88 72.55 2.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.12 63.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.785 1.634 . . . . 10.0 111.639 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.8 mtm105 -76.55 59.18 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.991 1.316 . . . . 10.0 111.811 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' N ' ' CD ' ' A' ' 9' ' ' PRO 0.278 9.3 mm -60.33 -49.4 90.66 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.106 -0.237 . . . . 10.0 110.77 174.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 8' ' ' ILE . 18.3 Cg_exo -67.88 175.24 6.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.471 3.448 . . . . 10.0 109.761 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -59.73 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.386 2.674 . . . . 10.0 114.346 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 77' ' ' GLU . 81.5 mt -132.54 145.75 51.38 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.655 1.182 . . . . 10.0 111.555 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -119.22 144.35 46.78 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.463 1.505 . . . . 10.0 109.929 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.78 135.74 56.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -77.98 87.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -46.46 -38.53 9.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.55 1.54 . . . . 10.0 111.312 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.69 -43.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.897 1.279 . . . . 10.0 111.029 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.64 13.99 29.06 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.845 0.458 . . . . 10.0 111.802 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 53.79 33.15 16.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 10.0 110.496 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.23 3.8 33.14 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.777 -1.013 . . . . 10.0 114.861 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 p -83.93 -24.55 30.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.602 1.701 . . . . 10.0 112.208 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.74 -9.99 74.73 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 119.029 -0.873 . . . . 10.0 110.927 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.6 139.11 33.98 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.862 1.331 . . . . 10.0 111.267 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -50.5 155.46 1.82 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.277 0.631 . . . . 10.0 111.56 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -28.53 121.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 125.308 4.005 . . . . 10.0 116.292 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.86 16.39 1.18 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.165 1.841 . . . . 10.0 116.021 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -93.08 119.51 32.39 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.193 1.496 . . . . 10.0 108.615 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.09 128.28 84.93 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.516 -0.754 . . . . 10.0 111.085 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 19.5 Cg_exo -68.31 -175.97 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.522 2.148 . . . . 10.0 111.618 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -122.33 120.64 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.774 1.63 . . . . 10.0 107.295 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -48.97 124.77 9.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.621 1.168 . . . . 10.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.2 117.32 48.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.62 -38.5 8.02 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.432 1.421 . . . . 10.0 110.898 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -40.1 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.962 1.705 . . . . 10.0 113.221 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.2 21.84 12.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.822 0.849 . . . . 10.0 111.174 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 45.52 43.63 9.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.354 1.062 . . . . 10.0 111.676 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.91 -4.03 25.13 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.422 -1.21 . . . . 10.0 115.987 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -68.53 -58.05 4.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.197 1.998 . . . . 10.0 111.609 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.77 3.31 7.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.233 1.873 . . . . 10.0 110.85 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 131.06 33.03 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.803 1.301 . . . . 10.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -87.09 157.92 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.684 1.193 . . . . 10.0 108.558 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -123.81 112.7 17.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.683 1.193 . . . . 10.0 108.132 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.28 73.08 3.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -68.68 64.41 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.04 1.336 . . . . 10.0 111.885 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.99 59.03 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.437 1.095 . . . . 10.0 110.439 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.69 -66.3 1.08 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.253 0.93 . . . . 10.0 113.028 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -109.68 -65.94 1.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.86 0.864 . . . . 10.0 112.743 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.77 68.49 1.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.911 -0.493 . . . . 10.0 111.324 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.26 63.96 1.06 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.605 1.162 . . . . 10.0 112.077 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.1 m -75.08 160.28 5.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 123.12 0.568 . . . . 10.0 111.707 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -117.91 152.46 35.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.935 0.894 . . . . 10.0 112.907 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -147.1 154.98 41.78 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.366 1.067 . . . . 10.0 108.564 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -60.7 139.38 57.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.37 116.72 57.27 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.54 -37.73 5.19 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.913 1.742 . . . . 10.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.53 -38.93 32.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.958 1.303 . . . . 10.0 113.37 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.4 p -115.7 23.21 12.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.507 1.123 . . . . 10.0 110.988 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 41.25 49.22 3.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.485 1.514 . . . . 10.0 111.987 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.45 -3.55 11.22 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.449 1.34 . . . . 10.0 116.449 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -73.81 -31.34 63.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.173 1.986 . . . . 10.0 112.318 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -6.86 83.16 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.572 -0.611 . . . . 10.0 111.572 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.6 p -116.65 122.87 45.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.708 1.203 . . . . 10.0 111.628 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.4 mt -91.23 171.61 9.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.695 -1.594 . . . . 10.0 106.695 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.53 126.59 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -67.52 -37.63 83.06 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.293 -1.003 . . . . 10.0 108.293 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -109.62 76.79 0.93 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.689 2.396 . . . . 10.0 108.855 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.75 157.06 61.71 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.894 2.396 . . . . 10.0 113.614 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.23 85.71 0.57 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.982 0.913 . . . . 10.0 109.307 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -36.94 -47.38 0.7 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.357 1.863 . . . . 10.0 112.606 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -40.9 -39.53 1.17 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.946 1.698 . . . . 10.0 112.597 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.2 p -127.21 25.1 6.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.823 0.849 . . . . 10.0 110.927 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 49.39 35.96 8.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.613 0.765 . . . . 10.0 110.237 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.6 21.85 29.98 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.78 -1.011 . . . . 10.0 114.64 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -27.52 60.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.397 1.599 . . . . 10.0 111.29 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.99 -8.79 65.44 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.63 1.11 . . . . 10.0 111.976 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -139.46 153.66 47.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.094 0.947 . . . . 10.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.36 173.71 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 127.027 2.131 . . . . 10.0 106.914 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 11' ' ' LEU . 34.5 tt0 -77.75 139.9 39.43 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.525 -0.734 . . . . 10.0 111.434 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -71.19 67.79 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.944 2.098 . . . . 10.0 108.109 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.942 1.697 . . . . 10.0 110.703 -175.974 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 108.668 -1.773 . . . . 10.0 108.668 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -56.17 -29.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.407 0.683 . . . . 10.0 110.365 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 p -55.24 -35.62 65.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.817 1.647 . . . . 10.0 110.922 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.83 -51.09 5.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.81 60.23 1.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.95 0.9 . . . . 10.0 111.061 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 pt -78.71 64.08 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -75.55 61.12 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.523 1.129 . . . . 10.0 110.632 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -138.21 154.51 74.01 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.679 1.992 . . . . 10.0 107.187 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.32 73.26 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.533 3.489 . . . . 10.0 109.803 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 m -71.0 112.06 6.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.597 1.159 . . . . 10.0 109.853 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.61 149.31 34.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -139.53 150.77 45.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.397 1.479 . . . . 10.0 107.463 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -79.58 137.37 37.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.014 0.526 . . . . 10.0 109.587 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.36 89.22 3.18 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.474 -0.936 . . . . 10.0 108.474 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -44.18 -39.78 4.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.912 1.685 . . . . 10.0 112.153 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -49.25 -42.35 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.457 1.503 . . . . 10.0 111.83 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.1 p -108.32 18.72 20.73 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.828 0.851 . . . . 10.0 110.386 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 52.57 36.49 20.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.209 1.404 . . . . 10.0 110.086 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.95 -0.87 35.21 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.393 -1.226 . . . . 10.0 114.982 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -73.27 -67.22 0.6 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.066 1.933 . . . . 10.0 111.194 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.66 -17.36 3.27 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.267 1.889 . . . . 10.0 110.031 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.98 154.12 38.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.509 1.155 . . . . 10.0 108.92 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -54.99 167.9 0.58 Allowed Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 119.871 1.214 . . . . 10.0 113.38 -174.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -39.99 122.98 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.899 3.066 . . . . 10.0 114.325 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.61 26.22 7.39 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.806 1.193 . . . . 10.0 114.461 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.0 m -113.92 145.94 40.78 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.269 -1.382 . . . . 10.0 107.269 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -92.26 151.05 41.23 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 117.947 0.339 . . . . 10.0 110.744 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.59 -179.37 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.235 1.957 . . . . 10.0 108.067 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -110.11 125.5 53.05 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -49.42 124.73 9.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.142 0.977 . . . . 10.0 110.343 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.47 116.72 39.98 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 -37.78 6.95 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.844 1.696 . . . . 10.0 110.915 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.58 -40.82 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.1 1.76 . . . . 10.0 112.957 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.8 16.64 18.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.034 0.934 . . . . 10.0 111.534 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.26 42.3 13.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.301 1.041 . . . . 10.0 110.594 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.18 -4.95 5.49 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.475 -1.181 . . . . 10.0 115.775 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.6 p -67.53 -36.32 80.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.452 2.126 . . . . 10.0 111.972 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.36 50.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.506 1.05 . . . . 10.0 112.651 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -134.02 150.17 51.22 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.993 1.397 . . . . 10.0 111.0 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.4 130.07 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -115.67 110.47 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.522 0.677 . . . . 10.0 109.796 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 62.3 mmm -73.25 79.96 1.32 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.106 1.362 . . . . 10.0 107.328 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.73 67.72 0.81 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.008 0.923 . . . . 10.0 110.012 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.37 70.3 0.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.725 1.21 . . . . 10.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 -63.63 2.07 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.421 1.01 . . . . 10.0 111.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.72 -35.84 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.364 0.666 . . . . 10.0 112.707 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -75.46 59.59 1.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.538 1.063 . . . . 10.0 109.991 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 128.58 36.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.741 0.816 . . . . 10.0 111.275 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.52 155.88 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 106.868 -1.53 . . . . 10.0 106.868 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.81 161.48 37.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.775 0.657 . . . . 10.0 112.775 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.63 163.86 31.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.631 1.172 . . . . 10.0 108.57 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -61.78 137.51 58.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -69.98 117.29 52.49 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.861 0.755 . . . . 10.0 109.148 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 -40.31 5.18 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.124 1.882 . . . . 10.0 111.479 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.09 -39.58 20.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.798 1.239 . . . . 10.0 113.284 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.4 p -116.08 21.73 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.102 0.961 . . . . 10.0 111.48 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 44.1 44.97 6.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.561 1.145 . . . . 10.0 111.517 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 -6.14 8.26 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.214 1.246 . . . . 10.0 116.214 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -76.69 -8.72 57.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.361 2.08 . . . . 10.0 112.672 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.08 6.12 23.87 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.496 -0.752 . . . . 10.0 112.449 -174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.87 131.28 38.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.748 1.219 . . . . 10.0 111.574 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.87 122.26 32.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.532 1.533 . . . . 10.0 107.699 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 mm -75.74 77.33 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 124.694 1.198 . . . . 10.0 108.815 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -37.2 -51.51 1.02 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.805 2.042 . . . . 10.0 111.792 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 119.01 10.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.854 1.662 . . . . 10.0 106.673 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 126.46 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.34 2.027 . . . . 10.0 113.782 -174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.65 94.63 0.8 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.597 1.159 . . . . 10.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -38.25 -48.98 1.35 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.346 1.458 . . . . 10.0 112.727 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -43.93 -38.23 3.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.7 p -122.2 11.7 10.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.438 0.695 . . . . 10.0 110.882 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 m80 45.83 45.79 11.71 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.791 1.236 . . . . 10.0 111.495 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.86 28.58 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.06 -0.855 . . . . 10.0 114.838 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -11.53 60.48 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.349 1.574 . . . . 10.0 110.567 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 -49.11 3.56 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.564 0.602 . . . . 10.0 112.333 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.59 168.2 9.64 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.158 0.983 . . . . 10.0 110.797 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.51 157.94 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.559 1.944 . . . . 10.0 106.383 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -99.3 132.78 44.38 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.077 -1.082 . . . . 10.0 108.077 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -68.98 76.13 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.149 1.379 . . . . 10.0 110.569 -174.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.513 0 N-CA-C 108.856 -1.698 . . . . 10.0 108.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.82 -26.75 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.488 0.715 . . . . 10.0 111.257 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -68.01 -42.43 80.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.681 1.993 . . . . 10.0 110.897 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -79.76 -38.1 33.95 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.535 1.134 . . . . 10.0 110.472 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -72.25 68.85 0.76 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.228 1.011 . . . . 10.0 109.831 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.6 pt -67.49 66.11 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.756 1.622 . . . . 10.0 112.597 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -74.31 60.07 0.81 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.294 1.838 . . . . 10.0 110.604 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.9 mm -56.4 121.23 41.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.168 -0.92 . . . . 10.0 108.544 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.35 74.65 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.598 2.865 . . . . 10.0 110.217 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -79.72 62.8 4.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.45 1.5 . . . . 10.0 108.181 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -79.12 121.08 24.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.473 0.709 . . . . 10.0 111.587 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -106.12 131.19 53.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.86 124.89 20.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.728 1.211 . . . . 10.0 109.699 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -78.99 87.23 4.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.23 -36.28 13.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.563 1.545 . . . . 10.0 111.549 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -49.75 -49.46 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.725 1.21 . . . . 10.0 110.303 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -99.86 19.2 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.116 0.484 . . . . 10.0 110.945 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 56.39 34.4 24.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.651 1.181 . . . . 10.0 109.687 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 -1.98 34.66 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.791 -1.005 . . . . 10.0 115.086 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -76.04 -67.4 0.68 Allowed 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.671 1.735 . . . . 10.0 110.67 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.37 -22.51 2.05 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.869 1.223 . . . . 10.0 111.804 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.85 147.75 23.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.963 1.382 . . . . 10.0 109.991 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 154.01 1.62 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -34.35 128.43 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 125.503 4.136 . . . . 10.0 115.902 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.49 -49.4 1.97 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.867 0.746 . . . . 10.0 113.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -75.31 69.25 2.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.471 1.109 . . . . 10.0 109.355 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.04 156.67 18.92 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.105 1.762 . . . . 10.0 110.328 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.63 176.64 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.283 1.988 . . . . 10.0 111.168 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -112.87 136.87 52.04 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -54.0 123.55 12.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.539 0.735 . . . . 10.0 111.176 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.62 119.32 70.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.982 -1.118 . . . . 10.0 107.982 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.67 -37.47 9.33 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.608 1.539 . . . . 10.0 111.399 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.55 -49.14 27.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.305 1.442 . . . . 10.0 112.61 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.08 11.85 37.8 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.618 0.767 . . . . 10.0 111.611 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 51.38 46.73 26.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.528 0.731 . . . . 10.0 109.306 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.47 -2.33 1.21 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.38 0.991 . . . . 10.0 114.703 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -90.46 11.72 20.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.736 1.268 . . . . 10.0 113.426 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -26.54 0.61 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 116.417 1.327 . . . . 10.0 116.417 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.75 136.1 53.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.657 1.229 . . . . 10.0 110.908 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 m -87.67 158.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -135.17 114.59 12.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 75.83 3.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -68.33 63.19 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.504 1.521 . . . . 10.0 113.426 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 52.79 0.99 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.586 0.754 . . . . 10.0 110.345 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.14 -68.44 0.34 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.353 0.978 . . . . 10.0 113.417 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -96.39 -71.47 0.67 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.909 1.283 . . . . 10.0 112.4 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -77.04 68.9 3.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.237 0.926 . . . . 10.0 110.94 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.8 0.96 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.211 1.004 . . . . 10.0 110.633 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.8 m -75.48 140.32 17.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.757 0.789 . . . . 10.0 112.691 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -91.77 154.44 18.93 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.504 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.27 152.04 42.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 m -65.5 131.88 47.52 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.52 117.43 55.14 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 119.087 0.858 . . . . 10.0 109.616 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.15 -38.44 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.754 1.636 . . . . 10.0 111.051 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.86 -37.54 2.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.408 1.483 . . . . 10.0 113.259 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 p -127.41 25.75 6.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.192 0.997 . . . . 10.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 41.94 48.5 3.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.813 1.245 . . . . 10.0 112.196 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.98 -8.77 7.44 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 115.564 0.985 . . . . 10.0 115.564 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -75.29 -8.87 57.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.792 1.796 . . . . 10.0 113.406 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.14 0.29 4.23 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.873 0.749 . . . . 10.0 114.588 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.48 129.46 51.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.144 1.377 . . . . 10.0 110.58 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.52 107.16 16.61 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.86 -1.904 . . . . 10.0 105.86 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.67 74.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.788 1.235 . . . . 10.0 108.68 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -40.42 -50.76 2.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.357 1.863 . . . . 10.0 112.501 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -142.87 99.99 5.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.875 1.67 . . . . 10.0 107.585 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.04 141.4 57.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.387 2.725 . . . . 10.0 116.113 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.9 t -77.76 93.81 4.37 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.357 1.463 . . . . 10.0 107.679 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -41.25 -45.59 2.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.956 1.703 . . . . 10.0 112.544 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -43.35 -38.8 2.84 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.171 1.788 . . . . 10.0 112.685 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.2 p -123.22 23.37 9.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.067 0.947 . . . . 10.0 110.653 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.0 39.01 5.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.312 1.445 . . . . 10.0 111.388 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.68 -2.59 39.22 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.578 -1.124 . . . . 10.0 115.75 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.32 -29.97 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 120.283 2.041 . . . . 10.0 111.906 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.95 7.84 60.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.829 1.204 . . . . 10.0 114.027 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.15 150.51 29.95 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.147 0.974 . . . . 10.0 109.331 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.05 132.13 60.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.31 101.57 12.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.393 0.677 . . . . 10.0 109.18 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -79.84 60.86 3.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.149 -0.685 . . . . 10.0 109.149 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.457 -0.105 0 C-N-CA 124.894 1.278 . . . . 10.0 108.613 -179.831 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.595 -1.002 . . . . 10.0 110.595 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -50.2 -33.19 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.838 1.255 . . . . 10.0 111.326 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -50.05 -32.72 16.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 10.0 112.078 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -66.2 -29.01 69.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.764 -0.585 . . . . 10.0 111.344 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -78.17 56.13 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.474 0.709 . . . . 10.0 111.424 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.21 -17.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.941 0.897 . . . . 10.0 112.282 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -56.11 -30.32 61.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.008 1.323 . . . . 10.0 110.781 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.2 tt -125.13 85.01 58.6 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 105.876 -1.898 . . . . 10.0 105.876 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.04 179.38 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.332 2.021 . . . . 10.0 112.239 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -163.53 160.24 22.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.503 -2.036 . . . . 10.0 105.503 175.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.5 mt -109.51 144.44 37.78 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.25 139.91 49.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.713 1.605 . . . . 10.0 107.922 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.46 140.32 48.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.26 93.95 4.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.065 -1.087 . . . . 10.0 108.065 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.56 -37.26 17.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.43 1.492 . . . . 10.0 111.628 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.08 -40.94 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.269 1.028 . . . . 10.0 110.9 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.5 p -106.05 20.31 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.573 0.624 . . . . 10.0 110.748 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.81 35.19 23.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.847 1.259 . . . . 10.0 110.197 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 7.86 67.44 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.206 -1.33 . . . . 10.0 114.848 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.1 p -85.5 -74.06 0.42 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.943 1.872 . . . . 10.0 110.401 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -20.15 1.04 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.982 1.753 . . . . 10.0 112.242 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.98 154.18 20.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.241 1.521 . . . . 10.0 110.584 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -49.63 148.51 5.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 118.41 0.55 . . . . 10.0 112.458 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.1 135.76 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 125.129 3.886 . . . . 10.0 114.692 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.73 -52.91 2.02 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.233 0.921 . . . . 10.0 112.653 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 m -73.6 79.77 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.881 0.872 . . . . 10.0 109.203 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.11 156.48 13.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.904 0.882 . . . . 10.0 111.369 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.89 168.39 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.78 2.32 . . . . 10.0 113.231 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -90.26 121.8 32.6 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -52.44 124.62 13.92 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.911 0.884 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.65 118.49 54.81 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 -37.61 9.95 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.567 1.512 . . . . 10.0 111.505 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -46.57 -47.59 19.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.084 1.354 . . . . 10.0 113.161 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.0 p -100.73 6.41 43.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.75 0.82 . . . . 10.0 111.139 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 54.31 39.56 30.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.702 -0.851 . . . . 10.0 108.702 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.66 13.57 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.731 0.681 . . . . 10.0 113.943 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -72.0 4.86 3.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.602 1.704 . . . . 10.0 115.602 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.05 -28.93 0.95 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 115.821 1.089 . . . . 10.0 115.821 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.65 154.46 46.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.22 1.01 . . . . 10.0 109.61 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.29 147.32 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.46 109.34 18.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.1 tpp -102.41 139.72 37.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.428 1.491 . . . . 10.0 109.331 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -90.65 107.77 19.38 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 58.88 1.36 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.294 0.569 . . . . 10.0 111.503 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.43 -44.19 2.18 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.124 -0.985 . . . . 10.0 111.624 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -114.02 -72.54 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.884 1.274 . . . . 10.0 111.672 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -102.54 163.06 12.44 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 124.845 1.258 . . . . 10.0 112.9 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.75 128.9 34.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.799 1.24 . . . . 10.0 109.924 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.57 148.63 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.68 1.192 . . . . 10.0 108.553 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.84 145.25 28.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.525 0.73 . . . . 10.0 111.778 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -137.28 142.48 41.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 m -57.63 135.21 56.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.397 0.544 . . . . 10.0 110.013 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.2 t -75.97 117.9 67.23 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.885 -0.783 . . . . 10.0 108.885 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 -37.85 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.25 1.967 . . . . 10.0 112.062 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -38.82 22.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.796 1.239 . . . . 10.0 113.143 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.3 p -115.43 21.42 14.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.849 1.26 . . . . 10.0 111.189 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 44.01 45.4 6.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.922 1.289 . . . . 10.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.49 -9.71 7.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.52 -1.156 . . . . 10.0 115.986 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -67.21 -45.41 76.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.32 2.06 . . . . 10.0 111.285 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.13 46.66 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.897 1.237 . . . . 10.0 110.523 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 p -114.05 131.37 56.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.97 1.708 . . . . 10.0 111.709 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.03 113.5 25.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.48 69.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 108.068 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -59.35 -44.08 92.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.034 0.445 . . . . 10.0 110.64 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -120.73 82.86 34.95 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 127.318 2.247 . . . . 10.0 109.421 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.12 139.95 69.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.855 3.036 . . . . 10.0 116.617 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.6 t -74.0 89.94 1.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -41.72 -43.33 2.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.138 1.375 . . . . 10.0 112.915 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -46.32 -43.85 16.26 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 10.0 112.31 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.6 p -112.86 24.49 12.35 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.308 0.643 . . . . 10.0 110.208 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.59 43.02 12.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.083 1.353 . . . . 10.0 111.047 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.63 7.39 27.62 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.777 -1.013 . . . . 10.0 115.349 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -59.4 3.22 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.597 1.698 . . . . 10.0 108.872 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.75 11.83 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.956 1.265 . . . . 10.0 114.056 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.47 153.06 40.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.9 -1.519 . . . . 10.0 106.9 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.35 161.58 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.204 1.001 . . . . 10.0 109.524 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.04 149.79 32.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.258 -0.645 . . . . 10.0 109.258 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ttp-105 -75.86 52.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.034 1.334 . . . . 10.0 108.448 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.452 -0.356 0 O-C-N 121.143 -0.973 . . . . 10.0 111.079 -176.741 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 109.657 -1.377 . . . . 10.0 109.657 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.39 -44.55 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.707 1.203 . . . . 10.0 112.209 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -52.18 -36.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.339 1.856 . . . . 10.0 112.581 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -91.06 -34.07 15.24 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.214 1.006 . . . . 10.0 110.028 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.29 -41.8 94.15 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.057 0.456 . . . . 10.0 111.969 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.7 pt -61.4 125.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -76.7 57.98 1.34 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 10.0 111.806 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.61 129.2 24.45 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 104.55 -2.389 . . . . 10.0 104.55 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -42.0 115.94 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.538 2.825 . . . . 10.0 110.948 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -68.99 59.74 0.1 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.595 1.558 . . . . 10.0 114.044 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt -138.43 161.62 36.52 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.741 1.616 . . . . 10.0 109.49 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.97 150.32 42.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.938 2.095 . . . . 10.0 106.808 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.81 143.06 51.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.05 91.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.62 -37.29 12.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.49 1.516 . . . . 10.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.06 -48.73 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.572 1.149 . . . . 10.0 110.205 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.61 22.0 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.159 0.504 . . . . 10.0 111.006 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.31 35.37 22.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.9 1.28 . . . . 10.0 110.436 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.37 -0.76 46.64 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.628 -1.096 . . . . 10.0 114.84 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -77.7 -71.02 0.44 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.773 1.787 . . . . 10.0 110.571 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.77 -17.06 2.2 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.065 1.793 . . . . 10.0 110.766 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.28 135.83 33.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.799 1.299 . . . . 10.0 109.862 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -50.26 147.06 7.87 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 -175.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -22.54 126.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 1 C-N-CA 127.513 5.475 . . . . 10.0 117.913 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.48 -42.67 0.85 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.556 1.074 . . . . 10.0 113.801 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -72.44 82.82 1.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.693 1.197 . . . . 10.0 108.195 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.03 155.1 16.82 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 122.789 0.436 . . . . 10.0 111.711 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.88 152.63 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 107.804 -1.652 . . . . 10.0 107.804 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -89.52 118.89 29.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.136 -1.431 . . . . 10.0 107.136 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -50.51 123.16 8.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.806 0.842 . . . . 10.0 109.105 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.65 115.49 15.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.24 -35.59 8.36 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.572 1.515 . . . . 10.0 110.348 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.67 -39.46 11.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.565 1.546 . . . . 10.0 112.806 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.5 p -115.18 16.8 16.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.341 0.656 . . . . 10.0 111.632 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.13 48.39 15.82 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.44 1.096 . . . . 10.0 110.384 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.89 -47.91 2.27 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.207 -0.774 . . . . 10.0 113.239 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.6 -45.4 0.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.756 2.422 . . . . 10.0 115.971 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.13 5.28 43.86 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.425 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.83 152.1 50.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.683 1.741 . . . . 10.0 112.235 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.12 158.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.769 1.627 . . . . 10.0 107.72 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -113.83 105.41 13.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.893 0.877 . . . . 10.0 110.027 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 tpt -72.28 93.3 1.47 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.079 -1.823 . . . . 10.0 106.079 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -92.64 121.22 33.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.196 2.598 . . . . 10.0 109.588 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.37 55.25 0.74 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.83 -77.61 0.21 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.792 1.187 . . . . 10.0 112.301 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -81.52 -65.95 0.95 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.774 0.829 . . . . 10.0 109.932 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -83.9 162.96 20.33 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.65 154.16 20.07 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.18 165.99 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 107.84 -1.171 . . . . 10.0 107.84 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -123.71 137.66 54.66 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.617 0.767 . . . . 10.0 110.521 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 162.03 37.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.706 0.629 . . . . 10.0 109.513 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 m -55.49 137.18 49.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 10.0 110.84 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.21 116.28 45.27 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.8 -0.619 . . . . 10.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.35 -39.38 7.38 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.843 1.695 . . . . 10.0 111.159 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -35.63 5.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.832 1.253 . . . . 10.0 113.204 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.1 p -125.16 25.87 7.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.089 0.956 . . . . 10.0 111.058 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 41.49 45.35 2.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.184 1.394 . . . . 10.0 112.316 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.91 -7.04 3.29 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.625 1.01 . . . . 10.0 115.625 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -69.49 -28.44 66.06 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.508 1.654 . . . . 10.0 110.952 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -9.59 76.54 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.799 0.714 . . . . 10.0 112.315 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 p -116.06 131.81 56.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.954 1.701 . . . . 10.0 113.455 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.14 100.59 12.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.0 mt -82.93 71.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.87 -24.64 67.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.959 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -124.44 75.52 62.11 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.894 2.078 . . . . 10.0 110.999 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.92 133.5 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.223 3.282 . . . . 10.0 116.295 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.48 88.81 2.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.653 -1.24 . . . . 10.0 107.653 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -36.96 -47.84 0.73 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.156 1.782 . . . . 10.0 112.98 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.37 -43.71 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.518 1.527 . . . . 10.0 112.415 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.6 p -116.99 22.26 12.7 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.725 0.81 . . . . 10.0 110.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 47.0 40.95 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.867 1.267 . . . . 10.0 110.241 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.81 10.57 13.8 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.882 1.113 . . . . 10.0 115.882 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.3 82.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.784 1.792 . . . . 10.0 109.319 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.17 59.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.563 2.03 . . . . 10.0 113.544 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.91 155.39 41.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.036 0.934 . . . . 10.0 108.668 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.87 152.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 125.296 1.438 . . . . 10.0 108.402 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.73 138.33 58.44 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.849 0.46 . . . . 10.0 110.152 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -78.83 61.31 3.04 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.532 0.263 0 O-C-N 121.522 -0.736 . . . . 10.0 110.582 -178.144 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.596 0 N-CA-C 108.639 -1.784 . . . . 10.0 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.1 t -54.87 -31.57 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.094 0.958 . . . . 10.0 109.282 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 p -46.18 -38.09 7.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.069 1.748 . . . . 10.0 111.58 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -67.42 -30.34 70.06 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.94 0.337 . . . . 10.0 111.856 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -85.39 -41.28 15.59 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.315 1.046 . . . . 10.0 112.531 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 pt -75.91 69.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.517 0.675 . . . . 10.0 109.373 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -76.62 58.07 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.572 1.149 . . . . 10.0 111.106 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -77.08 134.57 67.63 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.79 -1.93 . . . . 10.0 105.79 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.68 51.57 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.221 2.614 . . . . 10.0 112.834 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.5 73.71 5.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.174 -1.417 . . . . 10.0 107.174 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.15 123.26 20.64 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.549 -0.719 . . . . 10.0 110.379 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.33 145.49 47.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.217 1.407 . . . . 10.0 108.194 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -72.47 131.6 42.77 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.298 0.639 . . . . 10.0 110.145 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.94 86.21 4.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.591 0.71 . . . . 10.0 109.14 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -48.1 -35.82 12.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.307 1.443 . . . . 10.0 111.38 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.44 -45.43 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.009 1.324 . . . . 10.0 110.835 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -102.29 17.2 24.04 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.269 0.486 . . . . 10.0 111.087 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.47 34.43 23.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.365 1.066 . . . . 10.0 109.17 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 -4.21 20.94 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.552 -1.138 . . . . 10.0 115.583 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -71.77 -61.17 1.88 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.293 2.046 . . . . 10.0 110.589 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.34 -12.31 6.36 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.65 2.072 . . . . 10.0 109.215 -173.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 141.71 33.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.63 1.215 . . . . 10.0 109.247 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -51.26 152.28 4.36 Favored Pre-proline 0 CA--C 1.551 1.003 0 CA-C-N 119.031 0.832 . . . . 10.0 112.415 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.26 129.7 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.076 3.85 . . . . 10.0 116.205 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.46 12.73 3.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.105 1.336 . . . . 10.0 115.248 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.9 m -110.58 125.45 53.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.893 1.346 . . . . 10.0 107.59 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.52 144.36 98.61 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 122.935 0.494 . . . . 10.0 111.302 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.34 164.68 34.53 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 N-CA-C 106.829 -2.027 . . . . 10.0 106.829 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.54 115.62 27.73 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.609 -0.682 . . . . 10.0 109.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -48.42 124.14 7.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.413 1.085 . . . . 10.0 110.452 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -65.6 115.82 25.83 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -35.55 8.0 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.319 1.346 . . . . 10.0 110.1 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -39.27 7.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.613 1.565 . . . . 10.0 113.181 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.77 17.09 13.55 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.435 0.694 . . . . 10.0 111.22 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 47.95 48.85 17.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.036 0.934 . . . . 10.0 110.201 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.68 -46.71 2.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.408 -0.808 . . . . 10.0 113.271 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -29.94 -40.59 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.976 2.91 . . . . 10.0 116.5 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.68 0.16 52.69 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.65 1.119 . . . . 10.0 115.811 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.28 151.65 40.78 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.815 1.307 . . . . 10.0 109.609 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -113.75 133.56 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.889 1.676 . . . . 10.0 108.178 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -107.92 91.08 3.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.435 1.094 . . . . 10.0 109.065 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.0 mmm -81.82 57.7 3.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.994 0.739 . . . . 10.0 112.994 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 176.12 165.15 0.41 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.083 2.153 . . . . 10.0 108.864 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.9 147.15 9.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.259 1.024 . . . . 10.0 108.77 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.96 40.22 6.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.168 0.89 . . . . 10.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -174.24 -149.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.444 -2.428 . . . . 10.0 104.444 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.36 73.45 2.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.526 1.057 . . . . 10.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.6 68.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.834 1.654 . . . . 10.0 112.124 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.99 160.35 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 124.134 0.974 . . . . 10.0 109.785 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -146.34 160.83 41.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 123.438 0.461 . . . . 10.0 111.367 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 163.14 34.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.088 0.955 . . . . 10.0 108.621 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.6 m -55.8 137.95 48.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.042 0.937 . . . . 10.0 109.471 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.69 118.69 68.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 118.569 0.622 . . . . 10.0 109.471 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.99 -38.6 7.09 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.186 1.924 . . . . 10.0 111.387 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -47.52 -42.29 22.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.586 1.554 . . . . 10.0 112.838 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.7 p -112.82 20.89 16.05 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.314 1.046 . . . . 10.0 111.585 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 44.18 44.45 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.799 1.24 . . . . 10.0 111.176 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.26 -7.02 5.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.486 -1.174 . . . . 10.0 115.976 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -68.42 -39.32 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 120.288 2.044 . . . . 10.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.27 -19.21 46.52 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.326 0.965 . . . . 10.0 110.711 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 132.4 54.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.524 1.93 . . . . 10.0 111.712 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -92.45 120.05 32.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.869 1.268 . . . . 10.0 108.11 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.86 63.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.95 -35.23 79.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.141 0.576 . . . . 10.0 111.212 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -111.45 74.49 1.17 Allowed Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.268 2.227 . . . . 10.0 109.083 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.67 133.92 38.7 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.657 2.904 . . . . 10.0 116.632 -172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.2 90.66 2.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.494 1.518 . . . . 10.0 107.212 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -39.51 -46.88 1.79 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.433 1.493 . . . . 10.0 112.489 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.17 -44.68 5.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.588 1.155 . . . . 10.0 112.643 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -113.89 14.2 18.5 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.204 0.602 . . . . 10.0 111.072 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.92 36.02 20.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.757 0.823 . . . . 10.0 109.919 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.09 15.19 49.51 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.127 -0.818 . . . . 10.0 114.393 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -2.02 40.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.326 1.563 . . . . 10.0 111.895 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.09 -43.77 2.28 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.384 -0.823 . . . . 10.0 113.091 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 168.84 9.44 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.283 1.433 . . . . 10.0 110.851 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.15 144.16 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 125.721 1.608 . . . . 10.0 107.722 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -87.84 105.54 17.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -71.94 81.73 0.92 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 126.455 1.902 . . . . 10.0 109.837 -178.282 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 111.987 -0.445 . . . . 10.0 111.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -74.07 144.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 t -53.46 -21.29 5.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.743 1.016 . . . . 10.0 113.743 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -63.78 -27.1 68.96 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 10.0 110.383 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.83 66.16 2.05 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.178 0.991 . . . . 10.0 109.1 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.45 66.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.817 1.247 . . . . 10.0 112.994 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -75.55 62.41 1.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.394 -0.816 . . . . 10.0 109.39 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -130.65 121.81 19.35 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 125.663 1.585 . . . . 10.0 106.771 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.77 72.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.571 3.514 . . . . 10.0 112.394 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -72.95 146.74 45.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.976 1.311 . . . . 10.0 110.691 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -120.34 145.5 47.06 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.108 1.363 . . . . 10.0 110.041 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -54.09 134.79 43.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.187 0.995 . . . . 10.0 111.642 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -77.43 103.93 7.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -46.84 -42.85 17.95 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.212 1.405 . . . . 10.0 111.126 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.11 -38.62 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.524 1.13 . . . . 10.0 111.928 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -106.75 4.2 27.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.085 0.857 . . . . 10.0 111.812 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.93 33.54 12.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.733 0.813 . . . . 10.0 108.935 174.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.78 -11.82 44.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.326 -1.263 . . . . 10.0 114.628 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.4 p -71.5 -71.59 0.26 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.066 1.933 . . . . 10.0 111.213 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.31 -24.66 2.2 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.814 2.15 . . . . 10.0 109.458 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 150.27 43.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.747 0.774 . . . . 10.0 110.017 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.21 165.1 2.98 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 122.086 -0.384 . . . . 10.0 111.133 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -40.48 127.68 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.908 3.072 . . . . 10.0 114.956 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.7 19.86 5.26 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.938 1.256 . . . . 10.0 114.786 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -108.12 135.16 49.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.606 -1.628 . . . . 10.0 106.606 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -79.94 147.55 66.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 118.466 0.576 . . . . 10.0 111.161 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.63 -173.32 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.152 -1.903 . . . . 10.0 107.152 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -126.05 123.17 37.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -45.54 124.85 5.3 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.813 1.245 . . . . 10.0 111.922 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -68.89 117.53 52.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.32 -36.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.796 1.664 . . . . 10.0 110.756 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.54 -46.49 19.35 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.664 1.585 . . . . 10.0 112.363 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -105.44 14.93 27.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.796 0.839 . . . . 10.0 111.634 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 49.22 40.39 17.84 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.961 0.904 . . . . 10.0 110.68 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -5.37 7.07 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.854 -0.97 . . . . 10.0 115.412 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.0 p -69.48 -26.61 64.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 120.096 1.948 . . . . 10.0 112.804 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.43 71.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 133.2 35.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.463 1.131 . . . . 10.0 110.482 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.47 157.55 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.282 1.433 . . . . 10.0 107.99 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -108.38 117.78 35.05 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.951 -1.499 . . . . 10.0 106.951 172.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.36 92.21 2.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.699 -2.704 . . . . 10.0 103.699 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -65.73 40.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.574 1.694 . . . . 10.0 115.574 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -78.61 55.66 1.69 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.299 -1.501 . . . . 10.0 111.043 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 26.15 -92.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 128.046 2.736 . . . . 10.0 114.064 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -36.74 -44.96 0.5 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.603 1.961 . . . . 10.0 112.678 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -129.68 56.6 1.71 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.07 69.1 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.187 0.995 . . . . 10.0 111.376 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 169.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.602 1.161 . . . . 10.0 112.491 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -109.2 149.8 28.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.487 1.115 . . . . 10.0 111.415 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -141.58 151.51 43.24 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.568 1.547 . . . . 10.0 108.037 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 m -58.25 138.09 56.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.863 0.756 . . . . 10.0 109.957 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.76 117.75 63.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.874 0.761 . . . . 10.0 108.998 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.99 -41.66 3.8 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.795 1.664 . . . . 10.0 111.16 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -47.66 -42.03 23.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.864 1.265 . . . . 10.0 113.547 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.21 21.66 15.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.66 0.784 . . . . 10.0 111.456 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 45.96 46.74 12.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.619 1.167 . . . . 10.0 111.369 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.31 -6.81 9.61 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.652 1.021 . . . . 10.0 115.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -68.18 -25.57 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.866 1.833 . . . . 10.0 112.652 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 1.51 87.07 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.38 0.514 . . . . 10.0 112.601 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.5 p -118.12 125.7 50.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.463 1.505 . . . . 10.0 111.304 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.65 151.67 22.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.26 90.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -64.88 -27.46 68.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -106.77 69.57 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.946 2.498 . . . . 10.0 109.856 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.26 128.74 22.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.195 1.93 . . . . 10.0 113.457 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.3 91.73 0.17 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -33.3 -51.54 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.011 2.124 . . . . 10.0 113.894 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -44.54 -45.63 9.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.187 1.395 . . . . 10.0 112.624 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.9 p -111.45 15.79 21.08 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.112 0.565 . . . . 10.0 110.45 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 54.14 34.08 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.222 1.009 . . . . 10.0 110.382 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.21 15.21 60.59 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 119.39 -0.672 . . . . 10.0 113.938 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -77.35 -4.41 44.98 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.036 1.418 . . . . 10.0 111.765 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.51 -43.5 2.1 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.028 -1.045 . . . . 10.0 114.242 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -134.5 155.52 50.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.162 0.985 . . . . 10.0 110.235 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.66 158.41 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 C-N-CA 124.748 1.219 . . . . 10.0 109.922 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -69.6 139.51 53.65 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -74.0 55.97 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.533 1.533 . . . . 10.0 110.634 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.453 -0.32 0 O-C-N 121.273 -0.892 . . . . 10.0 110.929 -178.384 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.58 0 N-CA-C 109.603 -1.399 . . . . 10.0 109.603 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.31 -31.7 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -159.86 -176.35 5.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 176.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -84.85 -34.22 22.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -75.05 47.91 0.37 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.28 55.51 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.1 mmt-85 4.63 39.9 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.588 1 C-N-CA 132.389 4.276 . . . . 10.0 118.603 -171.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.6 mt -95.19 130.26 32.98 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -44.98 97.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.646 3.564 . . . . 10.0 114.763 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -154.02 59.6 0.72 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 106.148 -1.797 . . . . 10.0 106.148 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.46 119.49 13.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.201 -0.909 . . . . 10.0 112.076 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -128.67 150.54 50.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.779 1.232 . . . . 10.0 108.399 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.13 135.14 56.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.794 0.838 . . . . 10.0 111.2 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -80.02 87.49 5.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 10.0 108.167 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -48.67 -37.01 17.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 10.0 111.528 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -49.98 -53.52 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.657 1.183 . . . . 10.0 110.157 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -93.38 18.6 9.45 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.264 0.484 . . . . 10.0 111.255 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 54.24 35.92 23.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.986 0.914 . . . . 10.0 109.898 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.54 4.63 61.55 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.282 -1.288 . . . . 10.0 115.452 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -87.0 -81.34 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.811 1.805 . . . . 10.0 111.382 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.7 -8.39 0.07 OUTLIER Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.616 -1.102 . . . . 10.0 114.61 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.44 157.77 20.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.702 1.751 . . . . 10.0 109.961 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -49.95 163.65 0.4 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.89 1.07 . . . . 10.0 113.89 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.23 135.99 24.87 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.107 2.538 . . . . 10.0 112.733 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 -57.7 2.65 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.992 -0.338 . . . . 10.0 112.417 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.1 m -72.68 64.67 0.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.804 1.242 . . . . 10.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 159.57 27.31 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.759 0.823 . . . . 10.0 112.331 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.57 176.06 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 10.0 110.946 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -117.74 124.76 49.24 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -44.3 124.0 3.78 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 10.0 111.807 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.67 116.71 40.44 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -38.06 7.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.63 1.554 . . . . 10.0 110.952 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -42.65 12.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.776 1.63 . . . . 10.0 112.861 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.0 p -112.18 18.17 18.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.813 0.845 . . . . 10.0 111.454 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.67 41.56 13.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.949 0.9 . . . . 10.0 111.172 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.17 0.08 55.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.283 -1.287 . . . . 10.0 115.801 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.7 p -69.56 -61.08 1.93 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 120.461 2.13 . . . . 10.0 111.321 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.31 10.34 7.37 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.115 2.293 . . . . 10.0 110.86 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 151.18 47.95 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.127 1.464 . . . . 10.0 110.48 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.44 144.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.342 1.457 . . . . 10.0 108.042 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -106.34 110.09 22.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.632 -0.877 . . . . 10.0 108.632 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.8 ttm -77.65 90.34 3.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.111 -1.07 . . . . 10.0 108.111 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -73.37 69.22 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.327 0.651 . . . . 10.0 110.517 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 45.44 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.45 -73.0 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.069 1.318 . . . . 10.0 115.059 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.74 -42.64 73.66 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.777 0.831 . . . . 10.0 110.438 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -120.48 170.64 9.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.705 1.202 . . . . 10.0 107.886 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 63.98 1.11 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.113 0.565 . . . . 10.0 109.694 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.65 176.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 110.465 -0.198 . . . . 10.0 110.465 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.44 159.27 41.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.526 0.33 . . . . 10.0 111.363 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.84 164.85 28.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.678 1.191 . . . . 10.0 108.429 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 m -63.87 140.76 58.9 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.64 116.0 45.4 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 118.849 0.75 . . . . 10.0 109.587 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.42 -38.81 7.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.043 1.829 . . . . 10.0 111.274 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.14 -34.22 5.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.245 . . . . 10.0 113.287 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.9 p -123.86 21.83 9.02 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.006 0.922 . . . . 10.0 111.189 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 45.5 42.21 7.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 10.0 111.928 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.38 -1.57 19.36 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.263 0.865 . . . . 10.0 115.263 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -79.32 -4.48 51.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.277 1.538 . . . . 10.0 111.744 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.59 -12.57 0.71 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.426 1.013 . . . . 10.0 113.978 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -122.03 132.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 10.0 111.094 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.13 106.03 7.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.895 -2.261 . . . . 10.0 104.895 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.14 77.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.259 1.423 . . . . 10.0 108.054 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -43.06 2.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.579 1.952 . . . . 10.0 111.022 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -145.2 144.99 25.15 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 104.441 -2.429 . . . . 10.0 104.441 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.0 125.39 3.11 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.187 1.925 . . . . 10.0 112.15 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -71.03 85.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -39.88 -46.03 1.92 Allowed 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 125.899 1.68 . . . . 10.0 113.172 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -42.61 -40.2 2.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.525 1.13 . . . . 10.0 112.683 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.16 18.73 12.31 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.539 0.736 . . . . 10.0 111.256 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 45.74 42.53 8.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.487 1.115 . . . . 10.0 109.537 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 51.96 25.41 16.62 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.528 1.537 . . . . 10.0 116.328 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -79.04 -38.88 35.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.588 1.694 . . . . 10.0 108.754 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.27 -0.91 55.96 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.095 1.807 . . . . 10.0 113.791 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 151.4 44.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.83 142.65 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.045 0.938 . . . . 10.0 110.47 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -77.53 78.29 4.05 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -76.19 60.27 1.46 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.452 1.101 . . . . 10.0 111.537 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 10.0 108.657 177.766 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.0 m -40.95 -48.02 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.987 1.315 . . . . 10.0 112.615 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -52.03 -43.69 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.599 1.56 . . . . 10.0 111.821 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -55.32 -41.25 72.15 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 pt -74.09 56.34 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.7 0.762 . . . . 10.0 111.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -56.47 -38.35 71.57 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.13 -0.981 . . . . 10.0 112.229 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' H ' ' CD ' ' A' ' 9' ' ' PRO 0.255 0.2 OUTLIER -117.96 -48.45 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.637 1.975 . . . . 10.0 116.168 -178.514 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.51 ' CD ' ' H ' ' A' ' 8' ' ' ILE . 87.3 Cg_exo -54.38 74.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 1 C-N-CA 126.712 4.941 . . . . 10.0 117.209 -175.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 m -152.5 114.84 4.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.45 99.84 12.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.804 0.811 . . . . 10.0 111.185 -175.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.81 127.62 33.41 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.437 1.895 . . . . 10.0 110.422 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.56 126.65 28.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.601 0.76 . . . . 10.0 110.593 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.19 89.84 3.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.28 -38.54 19.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.302 1.441 . . . . 10.0 111.319 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -50.27 -41.81 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.776 1.23 . . . . 10.0 111.618 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.4 p -107.56 19.28 20.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.916 0.486 . . . . 10.0 110.662 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.38 38.74 18.76 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.059 1.344 . . . . 10.0 110.163 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.63 24.16 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.445 -1.197 . . . . 10.0 115.561 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -72.7 -66.24 0.69 Allowed 'General case' 0 C--N 1.341 0.207 0 CA-C-N 120.098 1.949 . . . . 10.0 111.057 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.15 -8.13 4.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.226 2.346 . . . . 10.0 110.183 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.39 138.87 40.67 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.902 1.351 . . . . 10.0 111.031 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -51.76 144.45 18.92 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.817 0.735 . . . . 10.0 110.695 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -49.26 -37.0 38.97 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.298 2.665 . . . . 10.0 113.792 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.41 12.23 68.84 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.017 -1.435 . . . . 10.0 115.113 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -155.66 147.1 22.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.126 2.463 . . . . 10.0 110.938 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.77 157.73 66.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.823 -0.608 . . . . 10.0 109.495 176.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.62 169.64 19.45 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.281 1.987 . . . . 10.0 108.057 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -101.41 115.78 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 119.127 -0.463 . . . . 10.0 110.207 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -42.92 122.23 2.34 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.561 1.144 . . . . 10.0 111.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -65.61 115.57 23.49 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.66 -36.09 6.94 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.823 1.682 . . . . 10.0 110.709 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.38 -39.83 7.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.681 1.593 . . . . 10.0 112.883 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.3 p -114.86 12.48 16.92 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.094 0.958 . . . . 10.0 111.751 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.77 42.46 23.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.013 0.925 . . . . 10.0 109.995 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.08 -8.44 8.36 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 114.805 0.682 . . . . 10.0 114.805 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -68.27 -8.61 40.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.425 1.612 . . . . 10.0 114.045 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 14.66 55.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.602 1.096 . . . . 10.0 113.769 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -145.04 142.29 29.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.145 0.972 . . . . 10.0 110.088 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.11 133.15 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.625 1.57 . . . . 10.0 106.93 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.54 109.61 22.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.03 0.532 . . . . 10.0 110.428 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.99 88.5 0.4 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.331 1.052 . . . . 10.0 108.59 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -73.89 62.3 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.67 0.788 . . . . 10.0 110.238 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 43.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.632 1.173 . . . . 10.0 112.729 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.17 -64.45 1.3 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.684 -0.635 . . . . 10.0 112.391 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.99 -78.23 0.37 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.122 0.969 . . . . 10.0 113.09 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -84.11 98.15 9.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.536 0.734 . . . . 10.0 111.455 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 58.84 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.375 0.67 . . . . 10.0 111.266 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.02 162.36 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 O-C-N 121.878 -0.514 . . . . 10.0 110.05 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.39 171.97 7.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.812 1.041 . . . . 10.0 113.812 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 153.13 47.37 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.645 -1.983 . . . . 10.0 105.645 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 m -58.86 135.76 57.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.85 116.99 49.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.908 0.776 . . . . 10.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.15 -38.05 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.027 1.818 . . . . 10.0 111.367 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.41 -39.49 22.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.599 1.16 . . . . 10.0 113.174 -177.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.49 18.66 15.85 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.094 . . . . 10.0 111.47 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 47.01 43.51 13.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.341 1.056 . . . . 10.0 111.113 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.34 6.43 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.44 0.936 . . . . 10.0 115.44 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -74.54 -7.38 52.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.918 1.859 . . . . 10.0 112.737 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.39 1.21 7.26 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.403 -0.811 . . . . 10.0 113.216 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -133.18 132.91 42.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.17 1.388 . . . . 10.0 109.783 -174.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.74 118.58 27.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.875 1.27 . . . . 10.0 108.323 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -78.4 61.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.976 1.31 . . . . 10.0 108.435 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.74 -34.4 77.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.588 0.709 . . . . 10.0 109.752 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.79 78.14 1.18 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.011 2.924 . . . . 10.0 109.108 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.07 136.65 35.39 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.296 2.664 . . . . 10.0 116.342 -173.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.8 t -74.15 87.95 1.94 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.466 -1.679 . . . . 10.0 106.466 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.96 -40.79 4.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.97 1.308 . . . . 10.0 111.859 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -46.45 -38.66 9.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.932 0.893 . . . . 10.0 112.123 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.6 p -122.26 22.93 9.99 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.534 0.734 . . . . 10.0 110.477 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 45.87 39.81 5.88 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 10.0 110.949 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.07 17.7 31.13 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.249 0.86 . . . . 10.0 115.249 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -36.73 64.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.151 1.475 . . . . 10.0 110.328 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.04 -23.85 17.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.557 1.075 . . . . 10.0 112.031 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.73 159.17 44.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.141 0.97 . . . . 10.0 110.321 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.48 145.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 124.952 1.301 . . . . 10.0 109.865 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -69.77 139.45 53.27 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.905 -0.497 . . . . 10.0 109.876 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -64.61 71.37 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.093 1.757 . . . . 10.0 109.862 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 125.576 1.55 . . . . 10.0 110.633 -176.917 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 108.546 -1.822 . . . . 10.0 108.546 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.95 -31.93 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.026 0.53 . . . . 10.0 110.198 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p -48.82 -33.67 10.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.763 2.025 . . . . 10.0 111.737 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -67.17 -30.87 70.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.862 0.465 . . . . 10.0 111.027 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -89.56 -56.58 3.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.389 1.09 . . . . 10.0 111.374 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 pt -76.47 71.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.542 -1.208 . . . . 10.0 110.379 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -72.68 58.47 0.44 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 10.0 111.578 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.91 138.64 61.5 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.05 76.32 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.691 2.927 . . . . 10.0 109.685 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m -87.41 101.85 13.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.062 1.745 . . . . 10.0 108.982 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.25 120.1 23.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -120.16 156.4 31.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.873 1.669 . . . . 10.0 110.383 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.66 129.13 19.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 112.081 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -77.24 89.59 3.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -49.09 -38.02 23.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.784 1.233 . . . . 10.0 111.313 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.8 -31.43 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.249 1.42 . . . . 10.0 112.221 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -123.24 22.52 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 10.0 110.13 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 45.01 41.71 5.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.589 1.556 . . . . 10.0 111.238 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.53 -4.44 27.65 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.803 1.081 . . . . 10.0 115.803 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -73.17 -68.95 0.45 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.742 1.771 . . . . 10.0 109.164 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.13 -6.52 4.35 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.58 2.038 . . . . 10.0 109.105 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 128.12 34.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.924 1.362 . . . . 10.0 109.673 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 156.42 2.6 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -38.76 133.59 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.408 3.406 . . . . 10.0 114.794 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.58 19.52 9.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.968 1.27 . . . . 10.0 114.498 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -126.11 140.9 52.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.68 153.44 42.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 122.809 0.444 . . . . 10.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.97 168.67 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 107.768 -1.666 . . . . 10.0 107.768 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.98 119.29 33.24 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -51.15 124.37 11.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.893 0.877 . . . . 10.0 109.362 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -64.23 115.18 17.52 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 118.702 0.683 . . . . 10.0 109.397 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.0 -35.85 8.4 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.632 1.555 . . . . 10.0 110.587 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -45.37 -38.34 5.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 10.0 113.056 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.35 13.95 13.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.241 1.016 . . . . 10.0 111.471 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.3 41.89 21.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.886 0.874 . . . . 10.0 110.195 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.8 -8.08 8.27 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 119.233 -0.76 . . . . 10.0 114.979 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -65.39 -15.7 62.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.563 1.682 . . . . 10.0 113.955 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 4.61 68.47 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.864 0.745 . . . . 10.0 113.651 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.97 156.74 44.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.94 1.37 . . . . 10.0 110.611 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.99 141.64 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 126.451 1.9 . . . . 10.0 107.391 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -124.55 115.47 20.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.16 165.43 24.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.427 1.091 . . . . 10.0 108.399 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -131.33 46.06 2.72 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.274 0.63 . . . . 10.0 112.434 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -78.74 64.0 3.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.874 0.845 . . . . 10.0 109.399 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 37.03 -104.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.439 2.447 . . . . 10.0 113.18 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -47.82 -35.19 9.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.251 1.42 . . . . 10.0 113.591 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -124.43 57.87 1.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.025 0.375 . . . . 10.0 111.227 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.99 66.48 0.38 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.443 1.097 . . . . 10.0 110.589 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.74 167.01 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.49 1.116 . . . . 10.0 112.885 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -126.44 156.86 39.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.063 0.945 . . . . 10.0 111.474 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.18 162.39 35.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.502 1.121 . . . . 10.0 108.94 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 m -62.4 140.99 58.56 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.777 0.831 . . . . 10.0 108.968 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.9 117.48 61.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 118.752 0.706 . . . . 10.0 109.605 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.31 -40.49 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.079 1.853 . . . . 10.0 111.46 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -44.73 -40.11 5.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.992 1.317 . . . . 10.0 112.625 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.59 22.54 11.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 10.0 112.05 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 44.39 43.11 5.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.535 1.134 . . . . 10.0 111.641 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.56 -6.16 6.42 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.757 1.063 . . . . 10.0 115.757 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -78.8 -2.73 40.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.674 1.737 . . . . 10.0 112.775 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.8 -8.97 0.73 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.205 0.907 . . . . 10.0 114.671 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -125.1 135.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.684 1.593 . . . . 10.0 110.655 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.6 mt -97.77 120.58 38.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.883 1.273 . . . . 10.0 108.073 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.5 mm -78.13 63.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.536 1.135 . . . . 10.0 108.23 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -69.36 -26.23 64.57 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.663 -0.648 . . . . 10.0 110.69 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -111.28 72.85 0.93 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 127.253 2.221 . . . . 10.0 109.46 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -62.99 129.42 25.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.019 2.479 . . . . 10.0 115.536 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.2 92.38 0.76 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.989 1.716 . . . . 10.0 106.543 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -37.23 -49.01 0.91 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.272 1.829 . . . . 10.0 112.613 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.73 -38.12 4.21 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.11 1.364 . . . . 10.0 112.812 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.0 p -121.85 16.29 10.97 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.893 0.877 . . . . 10.0 111.069 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 48.23 37.84 9.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.382 1.073 . . . . 10.0 110.836 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.52 6.76 43.51 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 118.955 -0.914 . . . . 10.0 115.058 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -44.0 87.01 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.78 1.79 . . . . 10.0 110.643 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.81 30.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.816 1.198 . . . . 10.0 113.405 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -146.25 154.61 41.92 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.481 1.64 . . . . 10.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 155.77 33.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 125.771 1.629 . . . . 10.0 109.298 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.53 141.56 51.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.286 -0.635 . . . . 10.0 109.286 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.97 67.28 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.756 2.022 . . . . 10.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.457 -0.096 0 C-N-CA 125.906 1.682 . . . . 10.0 108.288 176.368 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.47 167.01 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.042 0.537 . . . . 10.0 111.969 -177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -71.03 66.3 0.38 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.435 1.894 . . . . 10.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -162.03 -41.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 130.221 3.409 . . . . 10.0 106.414 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.36 80.14 1.02 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.04 -1.096 . . . . 10.0 108.04 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.93 62.15 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.635 1.174 . . . . 10.0 111.402 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -55.73 -37.37 68.36 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.776 0.83 . . . . 10.0 111.683 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.14 139.24 45.53 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.975 1.31 . . . . 10.0 110.589 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.1 84.65 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.181 3.254 . . . . 10.0 110.146 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 134.88 57.47 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.409 1.883 . . . . 10.0 112.013 -174.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.13 126.11 34.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -112.84 124.5 52.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.487 1.115 . . . . 10.0 108.959 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.63 125.21 15.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.233 1.013 . . . . 10.0 110.584 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -81.1 89.04 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 109.688 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -49.5 -38.04 28.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.516 1.126 . . . . 10.0 111.016 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.07 -36.42 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.46 1.504 . . . . 10.0 111.655 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 p -117.52 23.92 11.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.078 0.551 . . . . 10.0 110.791 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.5 p80 46.03 42.35 9.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.64 1.576 . . . . 10.0 111.486 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.0 -3.72 27.46 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -77.84 -67.82 0.69 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 120.099 1.95 . . . . 10.0 110.196 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.65 -3.54 3.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.184 1.849 . . . . 10.0 110.496 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.49 140.23 30.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.008 1.904 . . . . 10.0 111.196 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -48.42 140.72 9.78 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.067 0.947 . . . . 10.0 111.625 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -36.28 133.41 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 125.165 3.91 . . . . 10.0 113.942 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.77 -45.72 1.64 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.236 0.922 . . . . 10.0 112.456 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 68.97 0.64 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.542 2.337 . . . . 10.0 108.503 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.55 151.76 28.42 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.178 0.991 . . . . 10.0 112.419 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.09 146.93 53.29 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.294 1.329 . . . . 10.0 108.786 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -83.06 140.38 32.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -57.71 123.26 15.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.547 0.739 . . . . 10.0 109.734 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -67.61 116.3 36.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.264 0.938 . . . . 10.0 108.981 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.64 -38.35 10.85 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 120.557 1.235 . . . . 10.0 110.777 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.22 -40.31 11.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.388 1.875 . . . . 10.0 113.134 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 p -121.3 27.68 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.821 0.849 . . . . 10.0 110.598 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 45.39 42.12 7.2 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.724 1.21 . . . . 10.0 112.788 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.46 58.29 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.328 -1.262 . . . . 10.0 116.196 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.6 p -81.31 -66.27 0.91 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.991 1.895 . . . . 10.0 112.02 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.43 -6.31 0.78 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.556 -1.135 . . . . 10.0 115.761 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.06 132.93 43.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.095 1.947 . . . . 10.0 111.67 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -75.99 138.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.1 114.69 23.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.7 mtp -77.49 73.72 4.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -68.71 62.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.292 1.437 . . . . 10.0 112.299 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.12 51.4 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.385 1.474 . . . . 10.0 110.489 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.23 -65.98 0.73 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.386 0.993 . . . . 10.0 113.332 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -100.91 -69.68 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.835 1.254 . . . . 10.0 112.122 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -74.52 68.69 1.63 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.573 -0.704 . . . . 10.0 111.213 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.24 59.24 0.75 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.21 1.004 . . . . 10.0 112.16 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.35 169.93 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 124.614 1.166 . . . . 10.0 110.7 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -146.84 159.52 43.41 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.621 0.6 . . . . 10.0 112.621 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.59 158.69 43.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.832 1.253 . . . . 10.0 108.572 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -53.55 134.44 40.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.062 0.545 . . . . 10.0 110.209 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.7 t -75.93 116.97 60.42 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.865 -0.588 . . . . 10.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.67 -39.01 7.2 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.169 1.913 . . . . 10.0 111.336 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -44.84 -43.41 8.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.997 1.719 . . . . 10.0 112.552 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.06 23.0 12.53 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.083 0.953 . . . . 10.0 111.699 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 44.21 44.68 6.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.781 1.232 . . . . 10.0 111.713 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -5.09 17.48 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -81.26 -8.32 59.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.308 2.054 . . . . 10.0 113.43 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.04 -7.63 3.05 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 121.459 -0.775 . . . . 10.0 113.192 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 133.61 55.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.747 2.019 . . . . 10.0 111.874 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.63 119.56 33.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.216 1.406 . . . . 10.0 108.854 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.31 81.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.79 1.636 . . . . 10.0 108.856 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -42.44 -49.95 5.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.415 1.486 . . . . 10.0 111.294 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -149.03 128.45 6.34 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.17 136.35 31.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.769 2.313 . . . . 10.0 114.848 -171.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.5 t -73.68 90.82 1.84 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.673 1.589 . . . . 10.0 106.831 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -39.41 -45.39 1.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.73 1.612 . . . . 10.0 112.685 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.12 -39.32 2.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.827 1.251 . . . . 10.0 112.731 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.8 24.63 8.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.886 0.875 . . . . 10.0 110.631 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 47.99 35.59 5.23 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.296 1.038 . . . . 10.0 110.849 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.52 21.0 53.5 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.973 0.749 . . . . 10.0 114.973 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.42 -40.46 57.7 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.881 1.34 . . . . 10.0 110.367 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.72 -13.73 14.87 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.471 1.51 . . . . 10.0 112.073 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.62 145.5 29.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.155 0.978 . . . . 10.0 109.686 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.49 138.14 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.98 124.28 33.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -68.76 73.27 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.076 1.35 . . . . 10.0 108.406 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.631 1.973 . . . . 10.0 109.662 -176.643 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.22 -14.87 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.044 0.538 . . . . 10.0 110.161 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 p -67.77 70.34 0.13 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.521 2.328 . . . . 10.0 110.343 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -163.97 -169.11 1.77 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.675 1.59 . . . . 10.0 107.708 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.75 138.04 57.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt -75.95 56.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.836 0.827 . . . . 10.0 112.115 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -158.33 43.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.093 1.757 . . . . 10.0 106.46 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.3 tt -53.02 116.45 9.27 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 123.787 0.835 . . . . 10.0 111.251 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.32 76.72 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.054 2.503 . . . . 10.0 107.619 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 m -74.79 64.1 1.23 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.927 1.291 . . . . 10.0 111.305 -173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.86 143.66 27.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.219 1.008 . . . . 10.0 109.755 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.69 132.78 54.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.229 1.812 . . . . 10.0 107.448 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.21 129.79 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -75.54 88.43 2.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -48.06 -39.48 20.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.831 1.252 . . . . 10.0 111.292 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -49.83 -33.44 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.143 1.377 . . . . 10.0 112.224 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.66 27.19 8.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.62 0.645 . . . . 10.0 110.656 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 44.69 41.97 5.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.47 1.508 . . . . 10.0 111.499 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 -3.52 30.95 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.131 -1.372 . . . . 10.0 116.044 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -80.9 -71.63 0.46 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 120.024 1.912 . . . . 10.0 110.661 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.43 -10.44 1.72 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.934 1.255 . . . . 10.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.63 137.81 33.64 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.222 2.011 . . . . 10.0 109.225 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 152.33 4.59 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 118.882 0.764 . . . . 10.0 112.071 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -46.82 141.77 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.122 3.214 . . . . 10.0 114.322 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.6 -58.32 3.78 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.783 0.706 . . . . 10.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 81.82 1.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.588 0.709 . . . . 10.0 109.852 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -56.49 157.32 9.91 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.636 1.174 . . . . 10.0 112.475 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.95 -174.72 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.328 2.019 . . . . 10.0 109.397 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -119.24 156.52 29.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -65.66 131.29 45.98 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.525 -1.359 . . . . 10.0 110.493 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -75.03 114.9 39.63 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.312 0.96 . . . . 10.0 109.389 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.1 -37.55 8.22 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.607 1.538 . . . . 10.0 110.558 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.96 -38.63 7.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.818 1.647 . . . . 10.0 112.964 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.3 p -119.06 20.45 12.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.797 0.839 . . . . 10.0 111.334 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 46.0 44.08 11.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.478 1.111 . . . . 10.0 111.483 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.13 -1.19 34.72 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.315 -1.269 . . . . 10.0 115.737 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.8 p -70.33 -63.2 1.13 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 120.336 2.068 . . . . 10.0 111.256 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.71 7.11 4.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.474 1.988 . . . . 10.0 111.529 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -134.7 146.93 49.93 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.426 1.613 . . . . 10.0 111.759 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 m -111.93 145.61 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.546 1.538 . . . . 10.0 108.336 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -107.91 113.33 26.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.072 -1.085 . . . . 10.0 108.072 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.7 tpp -75.15 73.95 2.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -70.76 60.98 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.655 1.582 . . . . 10.0 112.023 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -76.99 56.59 1.24 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.258 1.423 . . . . 10.0 110.861 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.68 -71.3 0.38 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.503 1.049 . . . . 10.0 112.847 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -98.63 -63.76 1.1 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.058 0.943 . . . . 10.0 112.025 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -77.49 60.73 2.14 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.895 0.878 . . . . 10.0 111.059 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.14 60.38 0.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.736 1.214 . . . . 10.0 113.096 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.29 -179.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.806 0.842 . . . . 10.0 110.013 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.6 160.08 40.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.46 166.6 24.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.513 1.125 . . . . 10.0 108.722 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 m -63.98 141.13 58.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.3 t -75.62 115.34 44.94 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 118.613 0.642 . . . . 10.0 109.707 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.45 -37.83 9.35 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.263 1.975 . . . . 10.0 111.052 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -45.38 -33.42 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.831 1.652 . . . . 10.0 112.538 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.07 21.79 6.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.9 0.88 . . . . 10.0 111.746 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.83 40.42 8.94 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.134 0.974 . . . . 10.0 112.263 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.29 53.62 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.114 0.805 . . . . 10.0 115.114 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -82.69 -7.77 59.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.966 1.383 . . . . 10.0 112.405 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.03 -6.49 2.97 Favored Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.465 -0.772 . . . . 10.0 113.041 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.56 127.04 52.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.184 1.793 . . . . 10.0 112.172 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.57 116.89 10.5 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.699 1.6 . . . . 10.0 107.482 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 mm -72.07 74.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 126.121 1.768 . . . . 10.0 109.291 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -42.47 -47.75 5.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.17 1.788 . . . . 10.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.22 94.96 5.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.87 1.268 . . . . 10.0 109.263 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.61 123.22 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 1 C-N-CA 125.573 4.182 . . . . 10.0 117.553 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.97 91.41 2.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.187 1.795 . . . . 10.0 107.142 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -36.98 -48.27 0.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.198 1.799 . . . . 10.0 112.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -43.37 -42.68 4.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.678 1.591 . . . . 10.0 112.639 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.28 16.87 14.81 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 123.756 0.823 . . . . 10.0 110.795 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 51.25 35.02 12.54 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.54 1.136 . . . . 10.0 110.27 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.64 14.25 57.45 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.688 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -75.05 -27.28 59.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.184 1.492 . . . . 10.0 111.627 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.56 -34.26 4.84 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.578 1.085 . . . . 10.0 113.718 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 144.37 50.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.123 0.969 . . . . 10.0 108.72 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.37 145.39 34.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.154 0.982 . . . . 10.0 109.412 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -80.47 138.69 36.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -67.79 72.09 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.034 1.334 . . . . 10.0 109.291 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 125.48 1.512 . . . . 10.0 110.625 -176.055 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 109.386 -1.486 . . . . 10.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.52 -22.33 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.5 p -71.0 69.1 0.46 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.991 2.116 . . . . 10.0 108.709 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -136.38 -149.69 0.34 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.435 1.094 . . . . 10.0 109.551 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.27 58.84 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.352 1.061 . . . . 10.0 111.981 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.0 pt -77.74 59.19 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.463 0.705 . . . . 10.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -77.75 64.95 3.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.46 0.704 . . . . 10.0 109.125 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.79 154.35 80.46 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 126.242 1.817 . . . . 10.0 107.368 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.49 75.26 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.8 2.334 . . . . 10.0 110.799 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 m -73.43 65.78 0.93 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.572 0.749 . . . . 10.0 110.683 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.51 120.93 15.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.643 -0.661 . . . . 10.0 110.214 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -129.56 150.39 50.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.16 0.984 . . . . 10.0 109.531 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 131.44 43.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.808 1.643 . . . . 10.0 112.412 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.3 t -76.99 101.13 5.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.195 -1.78 . . . . 10.0 106.195 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -48.8 -41.97 34.44 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.288 1.435 . . . . 10.0 111.518 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.5 t -52.23 -33.38 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.103 1.361 . . . . 10.0 111.89 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.76 19.54 14.43 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.404 0.547 . . . . 10.0 110.925 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.08 38.31 16.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.019 1.327 . . . . 10.0 111.242 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.34 60.19 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.593 -1.115 . . . . 10.0 115.382 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.6 p -79.28 -67.88 0.71 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.89 1.845 . . . . 10.0 110.909 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.11 -9.47 3.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.981 2.705 . . . . 10.0 110.028 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 126.63 30.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.209 1.003 . . . . 10.0 111.739 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -44.76 141.49 2.92 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.916 1.687 . . . . 10.0 111.258 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.13 145.35 65.2 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.641 2.227 . . . . 10.0 110.185 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.05 39.06 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.44 0.543 . . . . 10.0 113.118 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -137.87 169.77 17.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 150.68 75.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 118.933 0.788 . . . . 10.0 111.047 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.86 168.05 10.98 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.236 2.624 . . . . 10.0 108.506 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -105.37 126.09 51.72 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 122.191 -0.318 . . . . 10.0 110.647 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -50.13 121.92 6.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 10.0 110.573 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.85 115.8 26.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -70.21 -36.27 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.642 1.561 . . . . 10.0 110.754 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.14 -40.26 10.8 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.679 1.592 . . . . 10.0 112.907 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 p -115.73 18.14 15.86 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 10.0 111.32 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 47.79 42.0 15.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.249 1.02 . . . . 10.0 110.722 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.37 -2.95 8.81 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.385 -1.231 . . . . 10.0 115.518 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -45.41 82.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.324 2.062 . . . . 10.0 111.322 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.06 3.24 28.06 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.365 1.459 . . . . 10.0 111.262 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -135.12 143.11 46.39 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.074 1.437 . . . . 10.0 112.079 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 m -99.46 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 126.096 1.758 . . . . 10.0 107.679 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -126.68 118.7 25.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.01 -1.478 . . . . 10.0 107.01 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -107.77 135.62 48.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.698 1.199 . . . . 10.0 108.843 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -99.05 115.26 28.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.767 1.227 . . . . 10.0 108.234 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 58.05 3.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.585 -0.895 . . . . 10.0 108.585 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 -66.7 2.07 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -101.23 -76.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.841 1.256 . . . . 10.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.46 172.84 6.61 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.475 0.579 . . . . 10.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.34 152.24 40.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.784 -0.573 . . . . 10.0 109.718 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.43 156.87 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.419 1.088 . . . . 10.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 158.85 23.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.595 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -147.03 155.13 41.97 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.231 -1.396 . . . . 10.0 107.231 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -63.76 133.99 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.34 117.35 56.07 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 119.178 0.899 . . . . 10.0 109.087 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.26 -37.04 8.47 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.95 1.767 . . . . 10.0 111.422 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -39.25 25.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.779 1.231 . . . . 10.0 113.566 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -116.26 19.63 14.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.892 1.277 . . . . 10.0 110.892 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 46.59 44.59 13.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.631 1.172 . . . . 10.0 111.319 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.84 -8.18 6.39 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.451 0.94 . . . . 10.0 115.451 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -74.94 -17.65 60.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.775 1.787 . . . . 10.0 112.714 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.2 12.64 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.843 -0.536 . . . . 10.0 112.385 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -106.54 130.49 54.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.703 1.601 . . . . 10.0 112.069 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.6 mt -81.63 115.82 21.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -75.68 67.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.321 1.048 . . . . 10.0 108.192 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.91 -24.59 67.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.078 0.551 . . . . 10.0 109.575 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -118.35 80.18 15.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 128.396 2.678 . . . . 10.0 110.655 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.6 122.17 11.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.962 2.442 . . . . 10.0 115.191 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.43 89.42 0.69 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.367 -1.345 . . . . 10.0 107.367 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -39.26 -46.31 1.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.283 1.833 . . . . 10.0 112.848 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -45.59 -36.79 4.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.274 1.03 . . . . 10.0 112.555 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.1 26.07 6.58 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.822 0.849 . . . . 10.0 110.182 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 43.44 40.13 2.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.549 1.54 . . . . 10.0 112.117 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.97 37.32 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.198 -0.939 . . . . 10.0 115.245 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.42 -39.27 88.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.727 1.763 . . . . 10.0 109.547 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.26 -9.08 67.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.213 1.863 . . . . 10.0 114.333 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.74 44.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.865 1.332 . . . . 10.0 109.271 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.72 147.9 30.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.558 1.143 . . . . 10.0 110.419 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 79.88 1.99 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.351 1.06 . . . . 10.0 108.439 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -79.48 50.28 1.1 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.396 1.079 . . . . 10.0 110.764 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.455 -0.218 0 O-C-N 121.513 -0.742 . . . . 10.0 109.888 -179.418 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 109.999 -1.24 . . . . 10.0 109.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.8 m -46.48 -30.75 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.86 1.664 . . . . 10.0 113.836 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p -55.95 -38.95 71.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.179 0.991 . . . . 10.0 110.64 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -94.43 -50.9 5.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.303 1.041 . . . . 10.0 108.192 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.8 65.44 1.93 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.906 1.283 . . . . 10.0 109.1 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -58.11 -8.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.82 66.38 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.21 158.4 10.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.938 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -56.16 69.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 1 C-N-CA 125.321 4.014 . . . . 10.0 115.027 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -92.24 88.43 6.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.708 -1.96 . . . . 10.0 105.708 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.4 mt -96.59 132.62 42.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.549 1.14 . . . . 10.0 111.795 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -110.78 127.01 55.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.766 1.626 . . . . 10.0 107.566 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.4 127.11 30.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.795 1.238 . . . . 10.0 109.798 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.1 85.23 4.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.289 0.566 . . . . 10.0 110.041 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -46.77 -38.7 10.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.258 1.423 . . . . 10.0 111.708 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -49.16 -38.48 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.798 1.639 . . . . 10.0 111.712 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.14 19.52 17.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.147 0.579 . . . . 10.0 110.585 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 51.89 36.27 17.82 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.218 1.407 . . . . 10.0 109.772 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 3.66 42.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.43 1.014 . . . . 10.0 115.546 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -75.34 -66.3 0.78 Allowed 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.61 1.705 . . . . 10.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.89 -9.91 3.64 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.978 2.228 . . . . 10.0 109.82 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.18 139.65 46.46 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.355 1.578 . . . . 10.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -56.13 146.4 50.84 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.438 -0.791 . . . . 10.0 109.407 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -32.81 -66.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 1 C-N-CA 125.349 4.033 . . . . 10.0 115.68 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.29 44.5 3.06 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.583 -0.698 . . . . 10.0 113.074 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -158.13 158.65 35.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.673 1.236 . . . . 10.0 107.975 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 147.25 36.73 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.105 1.362 . . . . 10.0 108.662 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.401 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 29.8 Cg_endo -74.21 160.15 42.84 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.413 2.075 . . . . 10.0 107.247 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -105.32 126.18 51.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -36.75 116.92 0.46 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.949 1.3 . . . . 10.0 113.073 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.6 115.52 44.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.14 -31.75 18.26 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.649 1.566 . . . . 10.0 110.589 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -43.56 29.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.151 1.38 . . . . 10.0 112.062 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -108.04 11.55 27.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.081 0.953 . . . . 10.0 111.28 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 52.15 37.93 23.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.272 1.029 . . . . 10.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 -8.35 19.18 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.799 -0.563 . . . . 10.0 113.993 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 m -71.38 -8.7 55.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.989 1.394 . . . . 10.0 114.438 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.92 -18.78 11.35 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.064 0.847 . . . . 10.0 113.729 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -133.61 131.62 39.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.246 1.023 . . . . 10.0 109.566 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 m -73.8 150.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.337 1.455 . . . . 10.0 107.291 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.51 107.22 14.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.341 0.657 . . . . 10.0 109.889 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.32 114.87 22.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -97.95 133.12 42.87 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.578 1.151 . . . . 10.0 109.984 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.07 80.94 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.902 1.681 . . . . 10.0 107.606 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.37 -64.2 2.5 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.996 0.807 . . . . 10.0 111.704 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.71 -66.69 0.82 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.258 1.023 . . . . 10.0 109.416 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -59.92 155.33 16.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.981 0.512 . . . . 10.0 109.715 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.01 157.21 43.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.418 0.287 . . . . 10.0 110.83 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.92 148.57 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.429 1.092 . . . . 10.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.83 144.76 30.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.883 0.873 . . . . 10.0 112.177 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -140.15 143.81 36.36 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.302 1.441 . . . . 10.0 107.843 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -53.09 135.39 37.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.253 0.933 . . . . 10.0 111.489 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.2 t -79.53 116.89 64.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.97 -41.94 3.59 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.133 1.889 . . . . 10.0 111.259 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.2 -29.83 2.59 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.95 1.092 . . . . 10.0 113.95 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.2 p -127.46 29.95 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.759 0.824 . . . . 10.0 111.594 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 38.78 49.83 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.239 1.416 . . . . 10.0 111.945 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.54 -11.03 3.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.203 1.241 . . . . 10.0 116.203 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -74.08 -13.82 60.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.106 1.953 . . . . 10.0 113.574 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.35 7.2 86.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.559 -0.578 . . . . 10.0 114.339 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' PRO . 77.3 p -132.03 119.05 20.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.444 1.122 . . . . 10.0 110.565 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.03 150.19 43.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.002 1.321 . . . . 10.0 110.209 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -112.72 73.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 125.557 1.543 . . . . 10.0 109.961 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -68.45 -24.67 64.74 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.275 -0.891 . . . . 10.0 109.613 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -107.4 79.14 0.73 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.942 2.497 . . . . 10.0 110.323 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 118.09 5.06 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.296 2.664 . . . . 10.0 115.801 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.6 t -65.6 95.49 0.23 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.481 -1.674 . . . . 10.0 106.481 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -38.79 -48.81 1.56 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.869 1.668 . . . . 10.0 112.776 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -42.93 -39.89 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.725 1.21 . . . . 10.0 112.752 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.01 19.5 10.03 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.594 0.757 . . . . 10.0 111.047 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 46.38 41.93 9.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.653 1.181 . . . . 10.0 110.776 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.13 15.46 44.04 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.409 0.924 . . . . 10.0 115.409 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.83 -44.63 31.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.625 1.712 . . . . 10.0 109.009 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.75 -7.43 13.41 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.906 1.717 . . . . 10.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.62 152.85 32.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.881 -1.364 . . . . 10.0 109.688 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.08 146.45 13.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -98.59 137.69 36.86 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.344 -0.613 . . . . 10.0 109.344 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -78.26 59.98 2.41 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.064 -1.087 . . . . 10.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.31 1.044 . . . . 10.0 110.86 -178.97 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 109.905 -0.405 . . . . 10.0 109.905 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -138.16 144.22 40.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.844 1.257 . . . . 10.0 108.059 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.95 142.95 45.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.0 t -76.58 87.26 3.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -41.67 -41.86 2.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.567 1.947 . . . . 10.0 111.751 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -51.67 -45.69 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 10.0 111.443 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.79 18.49 18.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.768 0.713 . . . . 10.0 110.599 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.83 35.95 25.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.26 1.424 . . . . 10.0 110.166 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.86 3.06 58.77 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.144 -1.364 . . . . 10.0 115.02 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -80.05 -75.22 0.27 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.012 1.906 . . . . 10.0 110.388 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.89 -19.25 0.76 Allowed Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.628 1.585 . . . . 10.0 112.308 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.71 151.53 26.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.596 1.698 . . . . 10.0 111.087 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -52.82 151.59 8.13 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.182 0.901 . . . . 10.0 111.92 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -50.51 137.23 40.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.54 2.827 . . . . 10.0 112.06 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.82 -51.8 2.75 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.598 1.094 . . . . 10.0 111.1 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -68.56 70.42 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.235 2.614 . . . . 10.0 108.904 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -56.76 158.43 8.68 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.383 0.673 . . . . 10.0 112.656 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.59 145.21 60.08 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.69 1.593 . . . . 10.0 109.287 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -84.6 123.01 29.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -50.78 121.35 5.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.914 0.886 . . . . 10.0 109.624 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.92 116.9 33.7 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.898 -0.778 . . . . 10.0 108.898 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.27 -38.46 6.66 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.582 1.521 . . . . 10.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.58 -39.71 7.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.289 1.836 . . . . 10.0 113.272 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -115.4 17.0 16.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.926 0.89 . . . . 10.0 111.568 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 47.1 49.71 14.77 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.0 0.92 . . . . 10.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.67 2.92 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.779 1.18 . . . . 10.0 115.247 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -90.12 2.84 54.86 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.843 1.321 . . . . 10.0 113.107 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.99 -8.82 5.83 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.776 1.07 . . . . 10.0 115.776 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.98 130.75 52.99 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.068 1.434 . . . . 10.0 110.031 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 m -87.95 143.85 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.658 -1.608 . . . . 10.0 106.658 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -98.33 110.67 23.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.93 -1.137 . . . . 10.0 107.93 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.6 tpt -75.79 73.29 2.73 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -69.44 55.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.064 2.146 . . . . 10.0 112.981 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.27 64.29 4.13 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.764 1.226 . . . . 10.0 108.414 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 -126.91 31.88 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -53.59 -47.83 69.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.306 1.042 . . . . 10.0 113.284 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -79.67 58.17 2.69 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.983 0.513 . . . . 10.0 111.143 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 59.0 2.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.261 0.625 . . . . 10.0 112.527 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.65 175.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -115.42 171.12 7.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -141.63 154.64 45.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.827 -1.916 . . . . 10.0 105.827 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -65.65 136.08 55.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 39.1 t -71.04 116.57 47.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.848 0.749 . . . . 10.0 109.649 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -38.99 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.874 1.716 . . . . 10.0 111.251 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -47.21 -41.14 17.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.004 1.322 . . . . 10.0 113.101 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.3 p -116.02 20.63 14.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.139 0.976 . . . . 10.0 111.299 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 46.8 42.92 12.58 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.374 1.07 . . . . 10.0 111.6 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.95 -4.09 11.18 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.433 0.933 . . . . 10.0 115.433 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -78.86 -5.5 53.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.644 1.722 . . . . 10.0 113.041 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.94 5.64 5.77 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.39 0.995 . . . . 10.0 114.642 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 p -129.14 132.41 47.34 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.773 1.229 . . . . 10.0 111.322 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -104.56 120.26 40.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.391 1.077 . . . . 10.0 110.111 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -78.01 65.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.356 1.462 . . . . 10.0 107.429 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -56.83 -45.43 82.34 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.296 0.57 . . . . 10.0 109.479 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -114.02 100.03 51.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.981 1.712 . . . . 10.0 108.475 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.72 131.04 19.13 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.925 1.75 . . . . 10.0 112.34 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.47 100.21 0.48 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -40.73 -50.37 3.1 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.63 1.572 . . . . 10.0 112.805 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -45.21 -40.0 6.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.861 1.265 . . . . 10.0 112.973 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -118.45 19.78 13.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.286 0.634 . . . . 10.0 111.004 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 46.5 42.92 11.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.647 1.179 . . . . 10.0 110.827 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.73 29.3 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.236 -1.313 . . . . 10.0 116.279 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -65.99 -55.95 14.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.278 2.039 . . . . 10.0 110.293 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.69 -9.62 16.51 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.718 1.151 . . . . 10.0 114.415 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.73 156.36 41.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.34 -1.356 . . . . 10.0 107.34 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.14 166.51 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.155 0.582 . . . . 10.0 109.69 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.57 136.59 36.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.817 -1.92 . . . . 10.0 105.817 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -51.11 116.19 1.89 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.414 -0.588 . . . . 10.0 109.414 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 124.334 1.054 . . . . 10.0 108.247 -177.748 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 109.845 -0.428 . . . . 10.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -118.05 147.09 43.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.79 138.34 58.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.406 0.441 . . . . 10.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.03 100.09 4.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.057 -1.461 . . . . 10.0 107.057 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.16 -43.38 20.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.563 . . . . 10.0 111.577 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.7 -29.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.277 1.431 . . . . 10.0 112.445 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.31 19.84 8.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.816 0.846 . . . . 10.0 110.808 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 44.93 42.44 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.344 1.458 . . . . 10.0 111.314 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.29 -11.26 38.34 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.165 1.226 . . . . 10.0 116.165 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.8 p -70.32 -68.72 0.4 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 120.036 1.918 . . . . 10.0 110.816 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.74 -5.5 5.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.863 2.173 . . . . 10.0 109.205 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.54 131.32 35.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.519 1.16 . . . . 10.0 109.159 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -54.69 159.41 3.53 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -42.5 137.35 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.983 3.122 . . . . 10.0 114.68 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.41 10.92 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.789 1.185 . . . . 10.0 114.157 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 m -127.36 136.07 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.406 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -90.86 146.12 33.26 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 124.12 0.968 . . . . 10.0 110.319 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -68.75 158.21 58.75 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 106.839 -2.023 . . . . 10.0 106.839 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -89.96 114.22 26.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -48.07 124.13 7.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.381 1.072 . . . . 10.0 109.866 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.53 115.39 17.96 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.74 -36.94 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.815 1.676 . . . . 10.0 110.725 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.61 -39.93 8.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.682 1.593 . . . . 10.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 p -114.6 12.65 17.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.788 . . . . 10.0 111.667 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.89 41.93 23.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.024 0.93 . . . . 10.0 109.895 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.53 -7.81 8.18 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.246 -0.752 . . . . 10.0 114.846 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -68.14 -9.06 43.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.499 1.65 . . . . 10.0 113.898 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.25 54.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.356 0.979 . . . . 10.0 113.68 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.4 143.55 30.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.509 1.154 . . . . 10.0 110.404 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.34 152.03 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.1 1.76 . . . . 10.0 107.534 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -125.66 118.94 26.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 89.6 mtp -104.02 121.48 43.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.873 1.269 . . . . 10.0 108.505 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -95.28 112.18 23.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.568 1.147 . . . . 10.0 108.914 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.82 53.73 2.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.43 -71.25 0.35 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.341 0.972 . . . . 10.0 112.427 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -80.56 -68.49 0.68 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 10.0 110.099 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.94 174.31 7.23 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.269 0.628 . . . . 10.0 110.058 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.14 43.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.703 0.801 . . . . 10.0 109.443 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 164.58 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 124.644 1.177 . . . . 10.0 108.576 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.407 ' H ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -124.56 152.63 43.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.113 0.965 . . . . 10.0 111.621 -178.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.1 160.04 41.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -59.75 136.74 58.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.4 t -72.05 117.14 55.58 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.812 0.733 . . . . 10.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.09 -40.44 6.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.086 1.857 . . . . 10.0 111.357 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -45.85 -36.87 5.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.651 1.18 . . . . 10.0 113.013 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.4 p -121.43 21.49 10.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.877 0.871 . . . . 10.0 111.595 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 44.86 42.99 6.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.407 1.083 . . . . 10.0 111.705 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -4.76 9.13 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.699 1.04 . . . . 10.0 115.699 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -77.62 -7.8 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.425 1.612 . . . . 10.0 112.932 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.82 -2.21 2.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.105 0.86 . . . . 10.0 114.14 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 135.28 49.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.657 1.583 . . . . 10.0 109.876 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -101.88 119.79 39.35 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.773 1.229 . . . . 10.0 108.252 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.0 66.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 10.0 108.351 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -63.43 -35.51 80.68 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.786 -0.571 . . . . 10.0 110.22 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -109.64 77.05 0.96 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 127.795 2.438 . . . . 10.0 110.086 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.81 124.52 13.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.222 2.614 . . . . 10.0 115.591 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.99 94.89 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.495 1.518 . . . . 10.0 107.989 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -39.54 -47.83 1.95 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.476 1.51 . . . . 10.0 113.273 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -45.97 -43.29 13.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.972 0.909 . . . . 10.0 112.7 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.43 19.69 16.72 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 122.923 0.489 . . . . 10.0 110.461 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.08 40.85 18.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.436 1.094 . . . . 10.0 110.314 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.44 20.56 45.61 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.388 -0.673 . . . . 10.0 114.325 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -67.69 0.65 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.145 1.473 . . . . 10.0 107.371 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.92 -45.04 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.475 -0.65 . . . . 10.0 111.475 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.29 161.36 26.0 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.167 0.987 . . . . 10.0 110.237 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.7 149.78 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.226 1.011 . . . . 10.0 110.107 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.2 71.55 2.23 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.321 1.048 . . . . 10.0 109.371 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 67.14 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.906 2.083 . . . . 10.0 109.044 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.451 -0.422 0 C-N-CA 125.875 1.67 . . . . 10.0 111.724 -175.552 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.3 0.095 . . . . 10.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -129.82 156.26 44.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.731 1.612 . . . . 10.0 108.243 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.18 137.08 58.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.197 0.599 . . . . 10.0 109.783 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 t -76.6 81.63 3.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -46.18 -38.19 8.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.419 1.487 . . . . 10.0 111.502 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.04 -42.5 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.359 1.464 . . . . 10.0 111.776 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.8 p -110.36 20.19 18.03 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.511 0.724 . . . . 10.0 110.34 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 49.93 38.01 15.17 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.418 1.487 . . . . 10.0 110.27 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.84 0.54 14.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.544 -1.142 . . . . 10.0 115.384 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -73.77 -57.88 3.68 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 120.123 1.961 . . . . 10.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.85 5.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.433 1.968 . . . . 10.0 109.829 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 129.57 40.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.215 1.008 . . . . 10.0 112.172 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -42.2 145.59 0.76 Allowed Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.556 1.943 . . . . 10.0 111.729 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -39.13 132.08 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.725 2.95 . . . . 10.0 113.139 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.46 15.27 23.85 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.13 -0.817 . . . . 10.0 114.307 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -119.21 157.51 27.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.783 1.233 . . . . 10.0 107.717 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.99 152.63 43.77 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.1 1.36 . . . . 10.0 109.019 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.83 -177.9 4.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.149 1.899 . . . . 10.0 108.996 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -117.64 125.93 51.61 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -47.01 122.33 4.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.305 1.042 . . . . 10.0 110.897 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.61 115.79 27.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 -36.76 9.04 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.603 1.535 . . . . 10.0 110.887 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -46.32 -38.88 9.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.951 1.7 . . . . 10.0 112.985 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.21 19.99 13.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.089 0.956 . . . . 10.0 111.261 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 46.65 42.68 11.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.357 1.063 . . . . 10.0 111.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.41 -6.31 11.87 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.691 -1.061 . . . . 10.0 115.615 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.3 p -68.12 -44.48 76.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.073 1.936 . . . . 10.0 112.069 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.59 2.51 34.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.264 1.411 . . . . 10.0 111.136 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -128.82 130.07 46.46 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.714 1.257 . . . . 10.0 110.19 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.51 132.73 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -116.92 116.53 27.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.9 mmt -68.98 158.48 34.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -144.28 41.34 1.37 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.769 0.828 . . . . 10.0 109.854 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -163.69 0.59 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.015 1.726 . . . . 10.0 107.754 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.25 3.24 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.975 -0.85 . . . . 10.0 110.975 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -158.07 -60.74 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.295 0.547 . . . . 10.0 110.915 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -135.77 156.15 49.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.211 1.404 . . . . 10.0 107.404 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.7 63.03 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -78.34 172.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 123.412 0.685 . . . . 10.0 111.005 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.1 164.24 30.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.421 0.526 . . . . 10.0 112.421 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -144.6 161.69 38.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.718 1.207 . . . . 10.0 108.272 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -62.41 134.17 56.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.52 117.1 40.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 119.031 0.832 . . . . 10.0 109.748 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.88 -39.8 5.86 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.819 1.679 . . . . 10.0 111.241 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.88 -39.88 27.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.501 1.12 . . . . 10.0 113.635 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.8 p -113.12 16.23 19.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.196 0.998 . . . . 10.0 111.384 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 48.07 44.57 19.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 10.0 110.608 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.57 -2.36 16.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -78.63 -2.67 40.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.028 1.914 . . . . 10.0 113.343 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.54 -0.28 2.22 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.176 0.893 . . . . 10.0 114.279 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -125.71 128.59 48.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.628 1.571 . . . . 10.0 109.971 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.41 144.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.588 -1.264 . . . . 10.0 107.588 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mm -108.62 73.74 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.515 1.126 . . . . 10.0 109.334 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -66.14 -27.82 68.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.968 . . . . 10.0 108.719 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 80.23 0.42 Allowed Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 127.392 2.277 . . . . 10.0 110.061 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.36 121.69 9.01 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.292 2.661 . . . . 10.0 114.716 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.0 t -68.55 91.65 0.43 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.339 -1.726 . . . . 10.0 106.339 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -40.87 -44.19 2.23 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 125.347 1.459 . . . . 10.0 112.596 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -44.16 -37.22 3.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.08 0.952 . . . . 10.0 112.599 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -124.22 14.01 9.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.009 . . . . 10.0 111.243 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m80 45.73 43.24 9.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.46 1.104 . . . . 10.0 110.612 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.3 38.27 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.64 -37.82 59.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.011 1.906 . . . . 10.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.99 34.02 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.406 1.003 . . . . 10.0 114.925 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.77 155.37 45.61 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 119.162 1.481 . . . . 10.0 110.367 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.6 m -134.19 155.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 125.136 1.374 . . . . 10.0 108.676 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.91 148.33 23.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.533 0.733 . . . . 10.0 109.424 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -75.56 49.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.795 0.838 . . . . 10.0 110.623 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.452 -0.336 0 O-C-N 121.077 -1.014 . . . . 10.0 111.021 -177.329 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -134.02 146.12 50.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.627 1.171 . . . . 10.0 108.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.68 144.2 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.466 -0.568 . . . . 10.0 109.466 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.51 91.31 5.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -46.69 -38.9 10.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.415 1.486 . . . . 10.0 111.814 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.5 t -49.59 -43.01 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.392 1.477 . . . . 10.0 111.278 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 20.22 18.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.952 0.501 . . . . 10.0 110.688 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 52.84 38.56 27.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.152 1.381 . . . . 10.0 110.099 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.99 -3.11 47.6 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.411 -1.216 . . . . 10.0 115.167 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -78.0 -74.51 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.144 1.972 . . . . 10.0 111.36 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.9 -18.0 1.09 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.626 1.108 . . . . 10.0 111.847 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.73 140.9 31.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.662 1.731 . . . . 10.0 109.587 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 157.6 2.47 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.008 0.744 . . . . 10.0 113.008 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -41.67 136.72 2.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.643 3.562 . . . . 10.0 115.337 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -60.25 2.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.582 0.611 . . . . 10.0 112.227 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 m -70.91 79.69 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.327 0.584 . . . . 10.0 109.928 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.78 162.95 4.43 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.183 0.993 . . . . 10.0 111.865 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.55 153.54 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.86 1.707 . . . . 10.0 110.215 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -98.49 135.0 40.67 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.797 -0.445 . . . . 10.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -50.82 124.93 12.14 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.058 0.943 . . . . 10.0 110.738 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -68.19 115.85 33.22 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 118.597 0.635 . . . . 10.0 109.445 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.25 -34.75 12.39 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.43 1.42 . . . . 10.0 110.806 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -46.25 -38.26 8.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.624 1.569 . . . . 10.0 113.22 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.23 15.29 13.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.315 1.046 . . . . 10.0 110.718 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 50.0 40.59 21.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.973 0.909 . . . . 10.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.06 10.34 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.851 0.739 . . . . 10.0 114.654 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.4 m -64.29 -28.29 69.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.918 1.359 . . . . 10.0 113.339 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 -16.79 57.56 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.483 1.04 . . . . 10.0 114.776 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 146.75 52.47 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.946 1.373 . . . . 10.0 110.455 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.23 155.14 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.271 1.428 . . . . 10.0 107.146 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -126.54 114.71 18.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.2 mtp -76.53 73.17 3.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.87 60.69 0.17 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.144 1.378 . . . . 10.0 112.408 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 48.29 0.63 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.504 1.122 . . . . 10.0 110.797 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.2 -61.78 2.22 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.344 -0.847 . . . . 10.0 112.432 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -102.35 -72.66 0.68 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.981 0.89 . . . . 10.0 113.359 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -73.64 68.99 1.25 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.568 -0.708 . . . . 10.0 111.553 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 59.74 0.63 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.424 1.09 . . . . 10.0 111.35 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.0 m -78.6 151.96 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 C-N-CA 123.138 0.575 . . . . 10.0 111.295 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.1 150.88 24.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.414 1.086 . . . . 10.0 111.921 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -145.13 151.11 37.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -60.5 135.93 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.51 116.38 48.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.001 0.819 . . . . 10.0 109.29 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.02 -38.38 7.3 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.156 1.904 . . . . 10.0 111.33 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -45.3 -42.52 9.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.961 1.704 . . . . 10.0 112.258 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -115.21 20.79 14.69 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.195 0.998 . . . . 10.0 112.077 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 46.92 41.9 11.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.53 1.132 . . . . 10.0 111.354 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.22 -7.04 6.42 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.409 0.923 . . . . 10.0 115.409 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.34 -9.33 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.61 1.705 . . . . 10.0 113.443 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.02 3.33 10.63 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.568 -0.707 . . . . 10.0 112.941 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.78 133.11 47.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.078 1.751 . . . . 10.0 109.933 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.04 122.68 43.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.207 1.403 . . . . 10.0 109.905 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.5 mm -81.02 67.14 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.637 1.575 . . . . 10.0 107.092 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -57.56 -38.03 74.11 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.562 0.579 . . . . 10.0 112.562 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -125.98 84.25 61.56 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.283 1.433 . . . . 10.0 110.44 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.53 132.34 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.959 3.773 . . . . 10.0 115.914 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.1 t -74.62 95.15 2.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -37.4 -50.05 1.04 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.76 1.624 . . . . 10.0 113.009 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -45.13 -36.15 3.54 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.397 1.079 . . . . 10.0 113.508 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -122.59 15.55 10.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.477 0.711 . . . . 10.0 110.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 43.98 45.33 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.939 1.295 . . . . 10.0 111.15 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.78 -3.1 13.51 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 116.291 1.277 . . . . 10.0 116.291 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -66.84 -36.88 83.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.14 1.97 . . . . 10.0 111.132 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.48 56.17 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 123.99 0.805 . . . . 10.0 113.333 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -135.93 160.93 37.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.453 1.126 . . . . 10.0 110.14 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.71 157.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.344 1.457 . . . . 10.0 107.895 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.29 126.97 50.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.861 0.864 . . . . 10.0 109.096 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -77.09 62.93 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.454 -0.249 0 O-C-N 121.463 -0.773 . . . . 10.0 110.919 -177.317 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -109.0 128.36 54.89 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.226 1.811 . . . . 10.0 107.656 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 128.89 39.06 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.573 0.749 . . . . 10.0 109.84 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 t -79.48 88.99 5.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.032 -0.729 . . . . 10.0 109.032 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -49.3 -36.01 19.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.064 1.346 . . . . 10.0 111.418 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -49.47 -48.29 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.796 1.238 . . . . 10.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.1 p -103.21 23.45 12.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.411 0.624 . . . . 10.0 111.001 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 53.33 37.14 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.259 1.424 . . . . 10.0 110.604 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.45 47.37 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.592 -1.115 . . . . 10.0 115.109 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -84.52 -69.57 0.64 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.751 1.775 . . . . 10.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.58 -24.89 1.51 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.205 1.859 . . . . 10.0 109.994 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.99 131.86 40.95 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.804 0.802 . . . . 10.0 111.063 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.7 143.34 6.01 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.849 -0.596 . . . . 10.0 111.741 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -22.27 126.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 1 C-N-CA 127.321 5.347 . . . . 10.0 117.163 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.1 -48.25 2.39 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.848 0.737 . . . . 10.0 112.831 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.89 128.74 38.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.246 1.418 . . . . 10.0 109.772 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.56 152.47 63.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 122.032 -0.418 . . . . 10.0 111.481 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 179.28 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.072 1.848 . . . . 10.0 108.941 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -121.5 131.72 54.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -50.49 125.32 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.056 0.942 . . . . 10.0 112.088 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.36 116.08 45.6 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.5 -38.79 7.86 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.353 1.368 . . . . 10.0 110.589 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -45.2 -39.42 6.25 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.314 1.846 . . . . 10.0 113.06 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.37 30.68 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.744 0.818 . . . . 10.0 110.641 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 39.78 47.96 1.89 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.305 1.442 . . . . 10.0 113.261 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 -4.17 39.61 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 116.279 1.272 . . . . 10.0 116.279 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 p -84.14 -68.99 0.67 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.127 1.964 . . . . 10.0 111.939 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.19 -5.28 0.65 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.261 -1.299 . . . . 10.0 116.277 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 143.55 47.32 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.46 2.13 . . . . 10.0 112.459 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -99.4 130.38 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.611 1.564 . . . . 10.0 108.153 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -103.21 106.31 16.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.045 0.538 . . . . 10.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.3 tpp -77.44 72.76 4.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.4 65.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.38 2.272 . . . . 10.0 112.98 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -79.25 70.07 5.58 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -136.96 27.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.945 -1.262 . . . . 10.0 109.945 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -55.1 -34.93 64.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.074 0.95 . . . . 10.0 112.128 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -74.29 72.13 1.76 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.743 0.817 . . . . 10.0 110.164 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 58.5 0.51 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.544 1.138 . . . . 10.0 111.544 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 m -81.47 157.35 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.538 0.735 . . . . 10.0 109.791 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.25 164.97 29.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.227 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.69 153.38 42.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.043 1.337 . . . . 10.0 108.021 -175.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.7 m -60.44 136.4 58.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.74 116.77 51.39 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.42 -39.21 7.44 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.08 1.853 . . . . 10.0 112.116 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.42 -36.88 45.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.1 p -112.82 16.69 19.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.077 0.951 . . . . 10.0 111.28 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 47.77 42.9 16.43 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.987 1.315 . . . . 10.0 110.813 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.78 1.07 53.5 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -87.8 5.65 39.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.623 1.711 . . . . 10.0 113.583 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.42 -3.88 0.75 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.091 0.853 . . . . 10.0 115.009 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -121.81 125.96 47.7 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.417 1.487 . . . . 10.0 111.255 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.68 152.59 23.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.89 85.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -66.89 -23.05 65.96 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -111.62 68.3 0.75 Allowed Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 128.294 2.638 . . . . 10.0 109.973 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.31 133.74 27.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.269 2.646 . . . . 10.0 115.491 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.0 t -70.24 93.16 0.82 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.336 -1.357 . . . . 10.0 107.336 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -40.62 -45.4 2.33 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.693 1.597 . . . . 10.0 112.582 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -42.35 -40.01 2.35 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.348 1.459 . . . . 10.0 112.464 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -124.83 23.08 8.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.906 0.883 . . . . 10.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 46.22 40.96 8.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.987 1.315 . . . . 10.0 111.069 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.04 14.89 48.09 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 118.814 -0.992 . . . . 10.0 115.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.02 -23.57 44.24 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.726 1.763 . . . . 10.0 110.578 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.97 3.18 80.09 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.649 1.595 . . . . 10.0 114.38 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 153.1 31.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.304 1.052 . . . . 10.0 109.288 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.09 140.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 107.752 -1.203 . . . . 10.0 107.752 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -66.16 134.2 52.26 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.727 -0.608 . . . . 10.0 110.646 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -77.47 65.21 2.96 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.674 -0.862 . . . . 10.0 108.674 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.342 1.057 . . . . 10.0 109.045 -179.224 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 77' ' ' GLU . 62.3 mt . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -132.23 124.58 29.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.034 1.733 . . . . 10.0 108.15 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -62.43 135.05 57.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.291 0.636 . . . . 10.0 110.02 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 51.4 t -69.75 114.56 8.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -54.77 -42.78 72.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.228 0.611 . . . . 10.0 111.018 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -54.08 -49.59 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.346 1.058 . . . . 10.0 112.447 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 26.6 p -95.65 -0.44 51.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.609 0.64 . . . . 10.0 112.061 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 66.74 40.52 3.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.766 1.227 . . . . 10.0 109.437 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.39 -3.51 39.98 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.151 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.5 p -75.68 -69.22 0.5 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.073 1.937 . . . . 10.0 110.362 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.26 -8.47 4.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.08 2.752 . . . . 10.0 109.443 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.7 133.93 39.37 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.141 0.971 . . . . 10.0 110.728 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -44.91 142.6 2.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.258 1.423 . . . . 10.0 110.69 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.92 141.68 45.41 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.659 2.239 . . . . 10.0 110.906 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.75 21.04 34.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.642 0.639 . . . . 10.0 113.144 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -134.03 160.56 37.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -121.7 148.7 51.34 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.197 0.999 . . . . 10.0 111.825 -175.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.09 -179.05 5.09 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.15 2.566 . . . . 10.0 108.395 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -117.23 129.71 56.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -49.02 123.53 7.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.745 1.218 . . . . 10.0 110.845 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.2 t -65.68 115.83 26.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.85 -35.69 11.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.646 1.564 . . . . 10.0 111.092 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.71 -38.24 9.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.767 1.627 . . . . 10.0 112.997 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -117.45 15.59 14.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 111.333 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.7 40.91 21.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.18 0.992 . . . . 10.0 110.376 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.18 -11.79 7.88 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.628 0.632 . . . . 10.0 114.535 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -66.98 -11.85 58.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.997 1.398 . . . . 10.0 114.302 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.66 41.23 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.795 -0.566 . . . . 10.0 113.384 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 125.56 33.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.536 1.134 . . . . 10.0 109.163 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.32 131.3 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.72 111.5 21.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.0 mmm -74.24 72.35 1.75 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.003 1.321 . . . . 10.0 108.274 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -66.21 62.48 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.519 1.928 . . . . 10.0 112.704 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 51.86 1.01 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.648 1.179 . . . . 10.0 110.435 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.06 -67.28 0.48 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.27 0.938 . . . . 10.0 113.291 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -98.23 -72.51 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.76 1.224 . . . . 10.0 112.655 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -77.35 69.72 3.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.179 0.899 . . . . 10.0 110.881 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.8 59.68 0.9 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.805 0.842 . . . . 10.0 111.546 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.22 163.59 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.14 0.576 . . . . 10.0 110.246 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -125.04 171.17 10.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.23 154.04 45.58 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -62.21 133.52 55.31 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.37 117.16 56.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.849 0.75 . . . . 10.0 109.62 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.16 -36.38 5.76 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.166 1.911 . . . . 10.0 111.286 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -39.57 24.09 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.529 1.132 . . . . 10.0 112.543 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.7 p -117.62 20.12 13.61 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.249 1.019 . . . . 10.0 110.806 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 42.92 45.49 4.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.437 1.495 . . . . 10.0 112.177 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -9.2 5.36 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.237 0.855 . . . . 10.0 115.237 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -73.57 -8.44 55.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.257 1.529 . . . . 10.0 112.363 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 -13.06 0.55 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.533 1.063 . . . . 10.0 115.167 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.79 133.52 55.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.833 1.653 . . . . 10.0 110.904 -174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.0 116.91 28.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.17 66.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.633 1.573 . . . . 10.0 108.438 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -62.61 -34.08 76.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.255 0.55 . . . . 10.0 109.713 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -107.98 79.91 0.96 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.145 2.578 . . . . 10.0 109.69 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 125.79 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.477 2.118 . . . . 10.0 114.998 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.32 87.13 0.43 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -38.64 -44.7 1.01 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.218 1.807 . . . . 10.0 112.83 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -44.7 -41.42 6.76 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.801 1.24 . . . . 10.0 112.362 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.99 27.4 8.09 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.668 0.787 . . . . 10.0 109.963 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 45.62 37.72 3.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.937 1.695 . . . . 10.0 111.827 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.91 9.46 46.7 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 114.98 0.752 . . . . 10.0 114.98 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.66 -32.16 69.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.299 1.55 . . . . 10.0 109.563 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.44 -23.71 32.49 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.19 1.376 . . . . 10.0 113.525 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.32 151.5 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.267 1.034 . . . . 10.0 109.736 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.26 154.67 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.965 1.306 . . . . 10.0 107.662 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.487 ' HA ' HD23 ' A' ' 11' ' ' LEU . 35.0 tt0 -69.42 142.89 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.577 -0.702 . . . . 10.0 110.216 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -69.42 70.84 0.28 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.734 1.214 . . . . 10.0 109.515 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 125.771 1.628 . . . . 10.0 110.653 -176.211 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 77' ' ' GLU . 81.5 mt . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 111.555 0.206 . . . . 10.0 111.555 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -119.22 144.35 46.78 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.463 1.505 . . . . 10.0 109.929 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.78 135.74 56.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -77.98 87.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -46.46 -38.53 9.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.55 1.54 . . . . 10.0 111.312 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.69 -43.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.897 1.279 . . . . 10.0 111.029 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.64 13.99 29.06 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.845 0.458 . . . . 10.0 111.802 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 53.79 33.15 16.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 10.0 110.496 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.23 3.8 33.14 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.777 -1.013 . . . . 10.0 114.861 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 p -83.93 -24.55 30.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.602 1.701 . . . . 10.0 112.208 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.74 -9.99 74.73 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 119.029 -0.873 . . . . 10.0 110.927 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.6 139.11 33.98 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.862 1.331 . . . . 10.0 111.267 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -50.5 155.46 1.82 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.277 0.631 . . . . 10.0 111.56 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -28.53 121.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 125.308 4.005 . . . . 10.0 116.292 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.86 16.39 1.18 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.165 1.841 . . . . 10.0 116.021 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -93.08 119.51 32.39 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.193 1.496 . . . . 10.0 108.615 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.09 128.28 84.93 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.516 -0.754 . . . . 10.0 111.085 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 19.5 Cg_exo -68.31 -175.97 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.522 2.148 . . . . 10.0 111.618 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -122.33 120.64 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.774 1.63 . . . . 10.0 107.295 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -48.97 124.77 9.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.621 1.168 . . . . 10.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.2 117.32 48.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.62 -38.5 8.02 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.432 1.421 . . . . 10.0 110.898 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -40.1 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.962 1.705 . . . . 10.0 113.221 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.2 21.84 12.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.822 0.849 . . . . 10.0 111.174 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 45.52 43.63 9.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.354 1.062 . . . . 10.0 111.676 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.91 -4.03 25.13 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.422 -1.21 . . . . 10.0 115.987 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -68.53 -58.05 4.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.197 1.998 . . . . 10.0 111.609 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.77 3.31 7.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.233 1.873 . . . . 10.0 110.85 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 131.06 33.03 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.803 1.301 . . . . 10.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -87.09 157.92 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.684 1.193 . . . . 10.0 108.558 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -123.81 112.7 17.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.683 1.193 . . . . 10.0 108.132 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.28 73.08 3.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -68.68 64.41 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.04 1.336 . . . . 10.0 111.885 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.99 59.03 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.437 1.095 . . . . 10.0 110.439 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.69 -66.3 1.08 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.253 0.93 . . . . 10.0 113.028 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -109.68 -65.94 1.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.86 0.864 . . . . 10.0 112.743 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.77 68.49 1.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.911 -0.493 . . . . 10.0 111.324 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.26 63.96 1.06 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.605 1.162 . . . . 10.0 112.077 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.1 m -75.08 160.28 5.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 123.12 0.568 . . . . 10.0 111.707 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -117.91 152.46 35.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.935 0.894 . . . . 10.0 112.907 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -147.1 154.98 41.78 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.366 1.067 . . . . 10.0 108.564 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -60.7 139.38 57.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.37 116.72 57.27 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.54 -37.73 5.19 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.913 1.742 . . . . 10.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.53 -38.93 32.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.958 1.303 . . . . 10.0 113.37 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.4 p -115.7 23.21 12.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.507 1.123 . . . . 10.0 110.988 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 41.25 49.22 3.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.485 1.514 . . . . 10.0 111.987 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.45 -3.55 11.22 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.449 1.34 . . . . 10.0 116.449 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -73.81 -31.34 63.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.173 1.986 . . . . 10.0 112.318 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -6.86 83.16 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.572 -0.611 . . . . 10.0 111.572 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.6 p -116.65 122.87 45.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.708 1.203 . . . . 10.0 111.628 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.4 mt -91.23 171.61 9.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.695 -1.594 . . . . 10.0 106.695 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.53 126.59 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -67.52 -37.63 83.06 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.293 -1.003 . . . . 10.0 108.293 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -109.62 76.79 0.93 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.689 2.396 . . . . 10.0 108.855 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.75 157.06 61.71 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.894 2.396 . . . . 10.0 113.614 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.23 85.71 0.57 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.982 0.913 . . . . 10.0 109.307 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -36.94 -47.38 0.7 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.357 1.863 . . . . 10.0 112.606 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -40.9 -39.53 1.17 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.946 1.698 . . . . 10.0 112.597 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.2 p -127.21 25.1 6.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.823 0.849 . . . . 10.0 110.927 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 49.39 35.96 8.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.613 0.765 . . . . 10.0 110.237 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.6 21.85 29.98 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.78 -1.011 . . . . 10.0 114.64 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -27.52 60.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.397 1.599 . . . . 10.0 111.29 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.99 -8.79 65.44 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.63 1.11 . . . . 10.0 111.976 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -139.46 153.66 47.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.094 0.947 . . . . 10.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.36 173.71 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 127.027 2.131 . . . . 10.0 106.914 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 11' ' ' LEU . 34.5 tt0 -77.75 139.9 39.43 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.525 -0.734 . . . . 10.0 111.434 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -71.19 67.79 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.944 2.098 . . . . 10.0 108.109 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.942 1.697 . . . . 10.0 110.703 -175.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -139.53 150.77 45.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.397 1.479 . . . . 10.0 107.463 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -79.58 137.37 37.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.014 0.526 . . . . 10.0 109.587 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.36 89.22 3.18 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.474 -0.936 . . . . 10.0 108.474 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -44.18 -39.78 4.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.912 1.685 . . . . 10.0 112.153 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -49.25 -42.35 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.457 1.503 . . . . 10.0 111.83 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.1 p -108.32 18.72 20.73 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.828 0.851 . . . . 10.0 110.386 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 52.57 36.49 20.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.209 1.404 . . . . 10.0 110.086 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.95 -0.87 35.21 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.393 -1.226 . . . . 10.0 114.982 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -73.27 -67.22 0.6 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.066 1.933 . . . . 10.0 111.194 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.66 -17.36 3.27 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.267 1.889 . . . . 10.0 110.031 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.98 154.12 38.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.509 1.155 . . . . 10.0 108.92 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -54.99 167.9 0.58 Allowed Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 119.871 1.214 . . . . 10.0 113.38 -174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -39.99 122.98 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.899 3.066 . . . . 10.0 114.325 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.61 26.22 7.39 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.806 1.193 . . . . 10.0 114.461 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.0 m -113.92 145.94 40.78 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.269 -1.382 . . . . 10.0 107.269 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -92.26 151.05 41.23 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 117.947 0.339 . . . . 10.0 110.744 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.59 -179.37 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.235 1.957 . . . . 10.0 108.067 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -110.11 125.5 53.05 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -49.42 124.73 9.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.142 0.977 . . . . 10.0 110.343 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.47 116.72 39.98 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 -37.78 6.95 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.844 1.696 . . . . 10.0 110.915 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.58 -40.82 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.1 1.76 . . . . 10.0 112.957 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.8 16.64 18.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.034 0.934 . . . . 10.0 111.534 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.26 42.3 13.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.301 1.041 . . . . 10.0 110.594 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.18 -4.95 5.49 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.475 -1.181 . . . . 10.0 115.775 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.6 p -67.53 -36.32 80.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.452 2.126 . . . . 10.0 111.972 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.36 50.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.506 1.05 . . . . 10.0 112.651 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -134.02 150.17 51.22 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.993 1.397 . . . . 10.0 111.0 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.4 130.07 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -115.67 110.47 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.522 0.677 . . . . 10.0 109.796 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 62.3 mmm -73.25 79.96 1.32 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.106 1.362 . . . . 10.0 107.328 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.73 67.72 0.81 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.008 0.923 . . . . 10.0 110.012 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.37 70.3 0.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.725 1.21 . . . . 10.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 -63.63 2.07 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.421 1.01 . . . . 10.0 111.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.72 -35.84 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.364 0.666 . . . . 10.0 112.707 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -75.46 59.59 1.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.538 1.063 . . . . 10.0 109.991 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 128.58 36.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.741 0.816 . . . . 10.0 111.275 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.52 155.88 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 106.868 -1.53 . . . . 10.0 106.868 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.81 161.48 37.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.775 0.657 . . . . 10.0 112.775 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.63 163.86 31.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.631 1.172 . . . . 10.0 108.57 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -61.78 137.51 58.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -69.98 117.29 52.49 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.861 0.755 . . . . 10.0 109.148 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 -40.31 5.18 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.124 1.882 . . . . 10.0 111.479 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.09 -39.58 20.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.798 1.239 . . . . 10.0 113.284 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.4 p -116.08 21.73 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.102 0.961 . . . . 10.0 111.48 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 44.1 44.97 6.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.561 1.145 . . . . 10.0 111.517 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 -6.14 8.26 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.214 1.246 . . . . 10.0 116.214 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -76.69 -8.72 57.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.361 2.08 . . . . 10.0 112.672 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.08 6.12 23.87 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.496 -0.752 . . . . 10.0 112.449 -174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.87 131.28 38.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.748 1.219 . . . . 10.0 111.574 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.87 122.26 32.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.532 1.533 . . . . 10.0 107.699 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 mm -75.74 77.33 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 124.694 1.198 . . . . 10.0 108.815 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -37.2 -51.51 1.02 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.805 2.042 . . . . 10.0 111.792 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 119.01 10.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.854 1.662 . . . . 10.0 106.673 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 126.46 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.34 2.027 . . . . 10.0 113.782 -174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.65 94.63 0.8 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.597 1.159 . . . . 10.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -38.25 -48.98 1.35 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.346 1.458 . . . . 10.0 112.727 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -43.93 -38.23 3.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.7 p -122.2 11.7 10.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.438 0.695 . . . . 10.0 110.882 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 m80 45.83 45.79 11.71 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.791 1.236 . . . . 10.0 111.495 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.86 28.58 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.06 -0.855 . . . . 10.0 114.838 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -11.53 60.48 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.349 1.574 . . . . 10.0 110.567 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 -49.11 3.56 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.564 0.602 . . . . 10.0 112.333 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.59 168.2 9.64 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.158 0.983 . . . . 10.0 110.797 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.51 157.94 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.559 1.944 . . . . 10.0 106.383 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -99.3 132.78 44.38 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.077 -1.082 . . . . 10.0 108.077 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -68.98 76.13 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.149 1.379 . . . . 10.0 110.569 -174.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 111.587 0.217 . . . . 10.0 111.587 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -106.12 131.19 53.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.86 124.89 20.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.728 1.211 . . . . 10.0 109.699 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -78.99 87.23 4.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.23 -36.28 13.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.563 1.545 . . . . 10.0 111.549 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -49.75 -49.46 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.725 1.21 . . . . 10.0 110.303 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -99.86 19.2 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.116 0.484 . . . . 10.0 110.945 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 56.39 34.4 24.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.651 1.181 . . . . 10.0 109.687 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 -1.98 34.66 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.791 -1.005 . . . . 10.0 115.086 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -76.04 -67.4 0.68 Allowed 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.671 1.735 . . . . 10.0 110.67 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.37 -22.51 2.05 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.869 1.223 . . . . 10.0 111.804 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.85 147.75 23.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.963 1.382 . . . . 10.0 109.991 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 154.01 1.62 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -34.35 128.43 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 125.503 4.136 . . . . 10.0 115.902 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.49 -49.4 1.97 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.867 0.746 . . . . 10.0 113.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -75.31 69.25 2.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.471 1.109 . . . . 10.0 109.355 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.04 156.67 18.92 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.105 1.762 . . . . 10.0 110.328 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.63 176.64 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.283 1.988 . . . . 10.0 111.168 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -112.87 136.87 52.04 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -54.0 123.55 12.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.539 0.735 . . . . 10.0 111.176 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.62 119.32 70.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.982 -1.118 . . . . 10.0 107.982 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.67 -37.47 9.33 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.608 1.539 . . . . 10.0 111.399 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.55 -49.14 27.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.305 1.442 . . . . 10.0 112.61 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.08 11.85 37.8 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.618 0.767 . . . . 10.0 111.611 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 51.38 46.73 26.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.528 0.731 . . . . 10.0 109.306 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.47 -2.33 1.21 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.38 0.991 . . . . 10.0 114.703 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -90.46 11.72 20.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.736 1.268 . . . . 10.0 113.426 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -26.54 0.61 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 116.417 1.327 . . . . 10.0 116.417 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.75 136.1 53.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.657 1.229 . . . . 10.0 110.908 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 m -87.67 158.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -135.17 114.59 12.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 75.83 3.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -68.33 63.19 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.504 1.521 . . . . 10.0 113.426 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 52.79 0.99 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.586 0.754 . . . . 10.0 110.345 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.14 -68.44 0.34 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.353 0.978 . . . . 10.0 113.417 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -96.39 -71.47 0.67 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.909 1.283 . . . . 10.0 112.4 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -77.04 68.9 3.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.237 0.926 . . . . 10.0 110.94 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.8 0.96 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.211 1.004 . . . . 10.0 110.633 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.8 m -75.48 140.32 17.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.757 0.789 . . . . 10.0 112.691 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -91.77 154.44 18.93 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.504 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.27 152.04 42.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 m -65.5 131.88 47.52 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.52 117.43 55.14 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 119.087 0.858 . . . . 10.0 109.616 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.15 -38.44 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.754 1.636 . . . . 10.0 111.051 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.86 -37.54 2.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.408 1.483 . . . . 10.0 113.259 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 p -127.41 25.75 6.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.192 0.997 . . . . 10.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 41.94 48.5 3.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.813 1.245 . . . . 10.0 112.196 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.98 -8.77 7.44 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 115.564 0.985 . . . . 10.0 115.564 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -75.29 -8.87 57.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.792 1.796 . . . . 10.0 113.406 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.14 0.29 4.23 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.873 0.749 . . . . 10.0 114.588 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.48 129.46 51.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.144 1.377 . . . . 10.0 110.58 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.52 107.16 16.61 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.86 -1.904 . . . . 10.0 105.86 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.67 74.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.788 1.235 . . . . 10.0 108.68 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -40.42 -50.76 2.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.357 1.863 . . . . 10.0 112.501 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -142.87 99.99 5.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.875 1.67 . . . . 10.0 107.585 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.04 141.4 57.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.387 2.725 . . . . 10.0 116.113 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.9 t -77.76 93.81 4.37 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.357 1.463 . . . . 10.0 107.679 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -41.25 -45.59 2.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.956 1.703 . . . . 10.0 112.544 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -43.35 -38.8 2.84 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.171 1.788 . . . . 10.0 112.685 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.2 p -123.22 23.37 9.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.067 0.947 . . . . 10.0 110.653 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.0 39.01 5.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.312 1.445 . . . . 10.0 111.388 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.68 -2.59 39.22 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.578 -1.124 . . . . 10.0 115.75 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.32 -29.97 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 120.283 2.041 . . . . 10.0 111.906 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.95 7.84 60.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.829 1.204 . . . . 10.0 114.027 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.15 150.51 29.95 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.147 0.974 . . . . 10.0 109.331 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.05 132.13 60.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.31 101.57 12.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.393 0.677 . . . . 10.0 109.18 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -79.84 60.86 3.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.149 -0.685 . . . . 10.0 109.149 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.457 -0.105 0 C-N-CA 124.894 1.278 . . . . 10.0 108.613 -179.831 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--O 1.231 0.092 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.25 139.91 49.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.713 1.605 . . . . 10.0 107.922 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.46 140.32 48.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.26 93.95 4.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.065 -1.087 . . . . 10.0 108.065 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.56 -37.26 17.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.43 1.492 . . . . 10.0 111.628 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.08 -40.94 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.269 1.028 . . . . 10.0 110.9 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.5 p -106.05 20.31 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.573 0.624 . . . . 10.0 110.748 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.81 35.19 23.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.847 1.259 . . . . 10.0 110.197 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 7.86 67.44 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.206 -1.33 . . . . 10.0 114.848 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.1 p -85.5 -74.06 0.42 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.943 1.872 . . . . 10.0 110.401 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -20.15 1.04 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.982 1.753 . . . . 10.0 112.242 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.98 154.18 20.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.241 1.521 . . . . 10.0 110.584 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -49.63 148.51 5.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 118.41 0.55 . . . . 10.0 112.458 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.1 135.76 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 125.129 3.886 . . . . 10.0 114.692 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.73 -52.91 2.02 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.233 0.921 . . . . 10.0 112.653 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 m -73.6 79.77 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.881 0.872 . . . . 10.0 109.203 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.11 156.48 13.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.904 0.882 . . . . 10.0 111.369 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.89 168.39 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.78 2.32 . . . . 10.0 113.231 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -90.26 121.8 32.6 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -52.44 124.62 13.92 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.911 0.884 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.65 118.49 54.81 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 -37.61 9.95 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.567 1.512 . . . . 10.0 111.505 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -46.57 -47.59 19.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.084 1.354 . . . . 10.0 113.161 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.0 p -100.73 6.41 43.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.75 0.82 . . . . 10.0 111.139 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 54.31 39.56 30.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.702 -0.851 . . . . 10.0 108.702 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.66 13.57 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.731 0.681 . . . . 10.0 113.943 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -72.0 4.86 3.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.602 1.704 . . . . 10.0 115.602 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.05 -28.93 0.95 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 115.821 1.089 . . . . 10.0 115.821 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.65 154.46 46.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.22 1.01 . . . . 10.0 109.61 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.29 147.32 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.46 109.34 18.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.1 tpp -102.41 139.72 37.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.428 1.491 . . . . 10.0 109.331 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -90.65 107.77 19.38 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 58.88 1.36 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.294 0.569 . . . . 10.0 111.503 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.43 -44.19 2.18 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.124 -0.985 . . . . 10.0 111.624 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -114.02 -72.54 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.884 1.274 . . . . 10.0 111.672 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -102.54 163.06 12.44 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 124.845 1.258 . . . . 10.0 112.9 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.75 128.9 34.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.799 1.24 . . . . 10.0 109.924 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.57 148.63 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.68 1.192 . . . . 10.0 108.553 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.84 145.25 28.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.525 0.73 . . . . 10.0 111.778 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.28 142.48 41.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 m -57.63 135.21 56.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.397 0.544 . . . . 10.0 110.013 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.2 t -75.97 117.9 67.23 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.885 -0.783 . . . . 10.0 108.885 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 -37.85 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.25 1.967 . . . . 10.0 112.062 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -38.82 22.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.796 1.239 . . . . 10.0 113.143 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.3 p -115.43 21.42 14.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.849 1.26 . . . . 10.0 111.189 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 44.01 45.4 6.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.922 1.289 . . . . 10.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.49 -9.71 7.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.52 -1.156 . . . . 10.0 115.986 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -67.21 -45.41 76.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.32 2.06 . . . . 10.0 111.285 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.13 46.66 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.897 1.237 . . . . 10.0 110.523 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 p -114.05 131.37 56.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.97 1.708 . . . . 10.0 111.709 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.03 113.5 25.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.48 69.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 108.068 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -59.35 -44.08 92.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.034 0.445 . . . . 10.0 110.64 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -120.73 82.86 34.95 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 127.318 2.247 . . . . 10.0 109.421 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.12 139.95 69.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.855 3.036 . . . . 10.0 116.617 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.6 t -74.0 89.94 1.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -41.72 -43.33 2.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.138 1.375 . . . . 10.0 112.915 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -46.32 -43.85 16.26 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 10.0 112.31 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.6 p -112.86 24.49 12.35 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.308 0.643 . . . . 10.0 110.208 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.59 43.02 12.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.083 1.353 . . . . 10.0 111.047 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.63 7.39 27.62 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.777 -1.013 . . . . 10.0 115.349 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -59.4 3.22 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.597 1.698 . . . . 10.0 108.872 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.75 11.83 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.956 1.265 . . . . 10.0 114.056 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.47 153.06 40.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.9 -1.519 . . . . 10.0 106.9 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.35 161.58 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.204 1.001 . . . . 10.0 109.524 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.04 149.79 32.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.258 -0.645 . . . . 10.0 109.258 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ttp-105 -75.86 52.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.034 1.334 . . . . 10.0 108.448 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.452 -0.356 0 O-C-N 121.143 -0.973 . . . . 10.0 111.079 -176.741 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.49 -0.559 . . . . 10.0 109.49 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.97 150.32 42.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.938 2.095 . . . . 10.0 106.808 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.81 143.06 51.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.05 91.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.62 -37.29 12.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.49 1.516 . . . . 10.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.06 -48.73 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.572 1.149 . . . . 10.0 110.205 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.61 22.0 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.159 0.504 . . . . 10.0 111.006 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.31 35.37 22.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.9 1.28 . . . . 10.0 110.436 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.37 -0.76 46.64 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.628 -1.096 . . . . 10.0 114.84 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -77.7 -71.02 0.44 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.773 1.787 . . . . 10.0 110.571 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.77 -17.06 2.2 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.065 1.793 . . . . 10.0 110.766 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.28 135.83 33.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.799 1.299 . . . . 10.0 109.862 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -50.26 147.06 7.87 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 -175.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -22.54 126.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 1 C-N-CA 127.513 5.475 . . . . 10.0 117.913 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.48 -42.67 0.85 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.556 1.074 . . . . 10.0 113.801 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -72.44 82.82 1.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.693 1.197 . . . . 10.0 108.195 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.03 155.1 16.82 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 122.789 0.436 . . . . 10.0 111.711 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.88 152.63 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 107.804 -1.652 . . . . 10.0 107.804 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -89.52 118.89 29.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.136 -1.431 . . . . 10.0 107.136 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -50.51 123.16 8.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.806 0.842 . . . . 10.0 109.105 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.65 115.49 15.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.24 -35.59 8.36 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.572 1.515 . . . . 10.0 110.348 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.67 -39.46 11.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.565 1.546 . . . . 10.0 112.806 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.5 p -115.18 16.8 16.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.341 0.656 . . . . 10.0 111.632 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.13 48.39 15.82 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.44 1.096 . . . . 10.0 110.384 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.89 -47.91 2.27 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.207 -0.774 . . . . 10.0 113.239 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.6 -45.4 0.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.756 2.422 . . . . 10.0 115.971 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.13 5.28 43.86 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.425 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.83 152.1 50.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.683 1.741 . . . . 10.0 112.235 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.12 158.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.769 1.627 . . . . 10.0 107.72 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -113.83 105.41 13.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.893 0.877 . . . . 10.0 110.027 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 tpt -72.28 93.3 1.47 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.079 -1.823 . . . . 10.0 106.079 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -92.64 121.22 33.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.196 2.598 . . . . 10.0 109.588 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.37 55.25 0.74 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.83 -77.61 0.21 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.792 1.187 . . . . 10.0 112.301 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -81.52 -65.95 0.95 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.774 0.829 . . . . 10.0 109.932 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -83.9 162.96 20.33 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.65 154.16 20.07 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.18 165.99 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 107.84 -1.171 . . . . 10.0 107.84 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -123.71 137.66 54.66 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.617 0.767 . . . . 10.0 110.521 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 162.03 37.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.706 0.629 . . . . 10.0 109.513 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 m -55.49 137.18 49.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 10.0 110.84 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.21 116.28 45.27 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.8 -0.619 . . . . 10.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.35 -39.38 7.38 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.843 1.695 . . . . 10.0 111.159 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -35.63 5.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.832 1.253 . . . . 10.0 113.204 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.1 p -125.16 25.87 7.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.089 0.956 . . . . 10.0 111.058 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 41.49 45.35 2.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.184 1.394 . . . . 10.0 112.316 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.91 -7.04 3.29 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.625 1.01 . . . . 10.0 115.625 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -69.49 -28.44 66.06 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.508 1.654 . . . . 10.0 110.952 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -9.59 76.54 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.799 0.714 . . . . 10.0 112.315 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 p -116.06 131.81 56.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.954 1.701 . . . . 10.0 113.455 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.14 100.59 12.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.0 mt -82.93 71.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.87 -24.64 67.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.959 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -124.44 75.52 62.11 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.894 2.078 . . . . 10.0 110.999 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.92 133.5 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.223 3.282 . . . . 10.0 116.295 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.48 88.81 2.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.653 -1.24 . . . . 10.0 107.653 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -36.96 -47.84 0.73 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.156 1.782 . . . . 10.0 112.98 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.37 -43.71 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.518 1.527 . . . . 10.0 112.415 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.6 p -116.99 22.26 12.7 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.725 0.81 . . . . 10.0 110.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 47.0 40.95 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.867 1.267 . . . . 10.0 110.241 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.81 10.57 13.8 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.882 1.113 . . . . 10.0 115.882 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.3 82.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.784 1.792 . . . . 10.0 109.319 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.17 59.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.563 2.03 . . . . 10.0 113.544 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.91 155.39 41.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.036 0.934 . . . . 10.0 108.668 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.87 152.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 125.296 1.438 . . . . 10.0 108.402 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.73 138.33 58.44 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.849 0.46 . . . . 10.0 110.152 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -78.83 61.31 3.04 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.532 0.263 0 O-C-N 121.522 -0.736 . . . . 10.0 110.582 -178.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.379 -0.23 . . . . 10.0 110.379 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.33 145.49 47.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.217 1.407 . . . . 10.0 108.194 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -72.47 131.6 42.77 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.298 0.639 . . . . 10.0 110.145 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.94 86.21 4.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.591 0.71 . . . . 10.0 109.14 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -48.1 -35.82 12.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.307 1.443 . . . . 10.0 111.38 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.44 -45.43 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.009 1.324 . . . . 10.0 110.835 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -102.29 17.2 24.04 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.269 0.486 . . . . 10.0 111.087 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.47 34.43 23.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.365 1.066 . . . . 10.0 109.17 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 -4.21 20.94 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.552 -1.138 . . . . 10.0 115.583 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -71.77 -61.17 1.88 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.293 2.046 . . . . 10.0 110.589 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.34 -12.31 6.36 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.65 2.072 . . . . 10.0 109.215 -173.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 141.71 33.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.63 1.215 . . . . 10.0 109.247 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -51.26 152.28 4.36 Favored Pre-proline 0 CA--C 1.551 1.003 0 CA-C-N 119.031 0.832 . . . . 10.0 112.415 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.26 129.7 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.076 3.85 . . . . 10.0 116.205 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.46 12.73 3.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.105 1.336 . . . . 10.0 115.248 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.9 m -110.58 125.45 53.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.893 1.346 . . . . 10.0 107.59 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.52 144.36 98.61 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 122.935 0.494 . . . . 10.0 111.302 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.34 164.68 34.53 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 N-CA-C 106.829 -2.027 . . . . 10.0 106.829 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.54 115.62 27.73 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.609 -0.682 . . . . 10.0 109.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -48.42 124.14 7.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.413 1.085 . . . . 10.0 110.452 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -65.6 115.82 25.83 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -35.55 8.0 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.319 1.346 . . . . 10.0 110.1 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -39.27 7.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.613 1.565 . . . . 10.0 113.181 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.77 17.09 13.55 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.435 0.694 . . . . 10.0 111.22 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 47.95 48.85 17.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.036 0.934 . . . . 10.0 110.201 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.68 -46.71 2.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.408 -0.808 . . . . 10.0 113.271 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -29.94 -40.59 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.976 2.91 . . . . 10.0 116.5 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.68 0.16 52.69 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.65 1.119 . . . . 10.0 115.811 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.28 151.65 40.78 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.815 1.307 . . . . 10.0 109.609 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -113.75 133.56 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.889 1.676 . . . . 10.0 108.178 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -107.92 91.08 3.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.435 1.094 . . . . 10.0 109.065 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.0 mmm -81.82 57.7 3.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.994 0.739 . . . . 10.0 112.994 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 176.12 165.15 0.41 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.083 2.153 . . . . 10.0 108.864 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.9 147.15 9.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.259 1.024 . . . . 10.0 108.77 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.96 40.22 6.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.168 0.89 . . . . 10.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -174.24 -149.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.444 -2.428 . . . . 10.0 104.444 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.36 73.45 2.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.526 1.057 . . . . 10.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.6 68.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.834 1.654 . . . . 10.0 112.124 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.99 160.35 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 124.134 0.974 . . . . 10.0 109.785 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -146.34 160.83 41.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 123.438 0.461 . . . . 10.0 111.367 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 163.14 34.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.088 0.955 . . . . 10.0 108.621 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.6 m -55.8 137.95 48.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.042 0.937 . . . . 10.0 109.471 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.69 118.69 68.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 118.569 0.622 . . . . 10.0 109.471 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.99 -38.6 7.09 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.186 1.924 . . . . 10.0 111.387 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -47.52 -42.29 22.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.586 1.554 . . . . 10.0 112.838 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.7 p -112.82 20.89 16.05 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.314 1.046 . . . . 10.0 111.585 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 44.18 44.45 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.799 1.24 . . . . 10.0 111.176 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.26 -7.02 5.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.486 -1.174 . . . . 10.0 115.976 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -68.42 -39.32 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 120.288 2.044 . . . . 10.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.27 -19.21 46.52 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.326 0.965 . . . . 10.0 110.711 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 132.4 54.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.524 1.93 . . . . 10.0 111.712 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -92.45 120.05 32.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.869 1.268 . . . . 10.0 108.11 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.86 63.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.95 -35.23 79.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.141 0.576 . . . . 10.0 111.212 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -111.45 74.49 1.17 Allowed Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.268 2.227 . . . . 10.0 109.083 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.67 133.92 38.7 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.657 2.904 . . . . 10.0 116.632 -172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.2 90.66 2.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.494 1.518 . . . . 10.0 107.212 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -39.51 -46.88 1.79 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.433 1.493 . . . . 10.0 112.489 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.17 -44.68 5.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.588 1.155 . . . . 10.0 112.643 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -113.89 14.2 18.5 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.204 0.602 . . . . 10.0 111.072 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.92 36.02 20.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.757 0.823 . . . . 10.0 109.919 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.09 15.19 49.51 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.127 -0.818 . . . . 10.0 114.393 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -2.02 40.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.326 1.563 . . . . 10.0 111.895 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.09 -43.77 2.28 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.384 -0.823 . . . . 10.0 113.091 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 168.84 9.44 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.283 1.433 . . . . 10.0 110.851 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.15 144.16 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 125.721 1.608 . . . . 10.0 107.722 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -87.84 105.54 17.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -71.94 81.73 0.92 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 126.455 1.902 . . . . 10.0 109.837 -178.282 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -120.34 145.5 47.06 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.108 1.363 . . . . 10.0 110.041 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -54.09 134.79 43.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.187 0.995 . . . . 10.0 111.642 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -77.43 103.93 7.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -46.84 -42.85 17.95 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.212 1.405 . . . . 10.0 111.126 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.11 -38.62 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.524 1.13 . . . . 10.0 111.928 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -106.75 4.2 27.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.085 0.857 . . . . 10.0 111.812 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.93 33.54 12.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.733 0.813 . . . . 10.0 108.935 174.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.78 -11.82 44.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.326 -1.263 . . . . 10.0 114.628 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.4 p -71.5 -71.59 0.26 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.066 1.933 . . . . 10.0 111.213 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.31 -24.66 2.2 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.814 2.15 . . . . 10.0 109.458 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 150.27 43.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.747 0.774 . . . . 10.0 110.017 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.21 165.1 2.98 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 122.086 -0.384 . . . . 10.0 111.133 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -40.48 127.68 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.908 3.072 . . . . 10.0 114.956 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.7 19.86 5.26 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.938 1.256 . . . . 10.0 114.786 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -108.12 135.16 49.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.606 -1.628 . . . . 10.0 106.606 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -79.94 147.55 66.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 118.466 0.576 . . . . 10.0 111.161 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.63 -173.32 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.152 -1.903 . . . . 10.0 107.152 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -126.05 123.17 37.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -45.54 124.85 5.3 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.813 1.245 . . . . 10.0 111.922 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -68.89 117.53 52.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.32 -36.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.796 1.664 . . . . 10.0 110.756 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.54 -46.49 19.35 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.664 1.585 . . . . 10.0 112.363 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -105.44 14.93 27.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.796 0.839 . . . . 10.0 111.634 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 49.22 40.39 17.84 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.961 0.904 . . . . 10.0 110.68 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -5.37 7.07 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.854 -0.97 . . . . 10.0 115.412 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.0 p -69.48 -26.61 64.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 120.096 1.948 . . . . 10.0 112.804 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.43 71.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 133.2 35.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.463 1.131 . . . . 10.0 110.482 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.47 157.55 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.282 1.433 . . . . 10.0 107.99 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -108.38 117.78 35.05 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.951 -1.499 . . . . 10.0 106.951 172.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.36 92.21 2.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.699 -2.704 . . . . 10.0 103.699 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -65.73 40.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.574 1.694 . . . . 10.0 115.574 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -78.61 55.66 1.69 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.299 -1.501 . . . . 10.0 111.043 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 26.15 -92.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 128.046 2.736 . . . . 10.0 114.064 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -36.74 -44.96 0.5 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.603 1.961 . . . . 10.0 112.678 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -129.68 56.6 1.71 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.07 69.1 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.187 0.995 . . . . 10.0 111.376 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 169.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.602 1.161 . . . . 10.0 112.491 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -109.2 149.8 28.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.487 1.115 . . . . 10.0 111.415 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -141.58 151.51 43.24 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.568 1.547 . . . . 10.0 108.037 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 m -58.25 138.09 56.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.863 0.756 . . . . 10.0 109.957 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.76 117.75 63.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.874 0.761 . . . . 10.0 108.998 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.99 -41.66 3.8 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.795 1.664 . . . . 10.0 111.16 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -47.66 -42.03 23.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.864 1.265 . . . . 10.0 113.547 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.21 21.66 15.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.66 0.784 . . . . 10.0 111.456 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 45.96 46.74 12.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.619 1.167 . . . . 10.0 111.369 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.31 -6.81 9.61 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.652 1.021 . . . . 10.0 115.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -68.18 -25.57 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.866 1.833 . . . . 10.0 112.652 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 1.51 87.07 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.38 0.514 . . . . 10.0 112.601 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.5 p -118.12 125.7 50.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.463 1.505 . . . . 10.0 111.304 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.65 151.67 22.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.26 90.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -64.88 -27.46 68.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -106.77 69.57 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.946 2.498 . . . . 10.0 109.856 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.26 128.74 22.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.195 1.93 . . . . 10.0 113.457 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.3 91.73 0.17 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -33.3 -51.54 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.011 2.124 . . . . 10.0 113.894 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -44.54 -45.63 9.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.187 1.395 . . . . 10.0 112.624 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.9 p -111.45 15.79 21.08 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.112 0.565 . . . . 10.0 110.45 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 54.14 34.08 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.222 1.009 . . . . 10.0 110.382 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.21 15.21 60.59 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 119.39 -0.672 . . . . 10.0 113.938 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -77.35 -4.41 44.98 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.036 1.418 . . . . 10.0 111.765 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.51 -43.5 2.1 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.028 -1.045 . . . . 10.0 114.242 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -134.5 155.52 50.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.162 0.985 . . . . 10.0 110.235 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.66 158.41 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 C-N-CA 124.748 1.219 . . . . 10.0 109.922 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -69.6 139.51 53.65 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -74.0 55.97 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.533 1.533 . . . . 10.0 110.634 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.453 -0.32 0 O-C-N 121.273 -0.892 . . . . 10.0 110.929 -178.384 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 112.076 0.398 . . . . 10.0 112.076 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -128.67 150.54 50.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.779 1.232 . . . . 10.0 108.399 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.13 135.14 56.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.794 0.838 . . . . 10.0 111.2 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -80.02 87.49 5.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 10.0 108.167 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -48.67 -37.01 17.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 10.0 111.528 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -49.98 -53.52 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.657 1.183 . . . . 10.0 110.157 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -93.38 18.6 9.45 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.264 0.484 . . . . 10.0 111.255 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 54.24 35.92 23.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.986 0.914 . . . . 10.0 109.898 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.54 4.63 61.55 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.282 -1.288 . . . . 10.0 115.452 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -87.0 -81.34 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.811 1.805 . . . . 10.0 111.382 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.7 -8.39 0.07 OUTLIER Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.616 -1.102 . . . . 10.0 114.61 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.44 157.77 20.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.702 1.751 . . . . 10.0 109.961 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -49.95 163.65 0.4 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.89 1.07 . . . . 10.0 113.89 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.23 135.99 24.87 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.107 2.538 . . . . 10.0 112.733 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 -57.7 2.65 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.992 -0.338 . . . . 10.0 112.417 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.1 m -72.68 64.67 0.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.804 1.242 . . . . 10.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 159.57 27.31 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.759 0.823 . . . . 10.0 112.331 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.57 176.06 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 10.0 110.946 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -117.74 124.76 49.24 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -44.3 124.0 3.78 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 10.0 111.807 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.67 116.71 40.44 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -38.06 7.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.63 1.554 . . . . 10.0 110.952 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -42.65 12.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.776 1.63 . . . . 10.0 112.861 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.0 p -112.18 18.17 18.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.813 0.845 . . . . 10.0 111.454 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.67 41.56 13.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.949 0.9 . . . . 10.0 111.172 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.17 0.08 55.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.283 -1.287 . . . . 10.0 115.801 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.7 p -69.56 -61.08 1.93 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 120.461 2.13 . . . . 10.0 111.321 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.31 10.34 7.37 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.115 2.293 . . . . 10.0 110.86 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 151.18 47.95 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.127 1.464 . . . . 10.0 110.48 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.44 144.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.342 1.457 . . . . 10.0 108.042 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -106.34 110.09 22.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.632 -0.877 . . . . 10.0 108.632 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.8 ttm -77.65 90.34 3.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.111 -1.07 . . . . 10.0 108.111 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -73.37 69.22 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.327 0.651 . . . . 10.0 110.517 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 45.44 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.45 -73.0 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.069 1.318 . . . . 10.0 115.059 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.74 -42.64 73.66 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.777 0.831 . . . . 10.0 110.438 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -120.48 170.64 9.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.705 1.202 . . . . 10.0 107.886 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 63.98 1.11 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.113 0.565 . . . . 10.0 109.694 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.65 176.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 110.465 -0.198 . . . . 10.0 110.465 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.44 159.27 41.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.526 0.33 . . . . 10.0 111.363 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.84 164.85 28.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.678 1.191 . . . . 10.0 108.429 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 m -63.87 140.76 58.9 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.64 116.0 45.4 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 118.849 0.75 . . . . 10.0 109.587 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.42 -38.81 7.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.043 1.829 . . . . 10.0 111.274 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.14 -34.22 5.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.245 . . . . 10.0 113.287 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.9 p -123.86 21.83 9.02 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.006 0.922 . . . . 10.0 111.189 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 45.5 42.21 7.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 10.0 111.928 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.38 -1.57 19.36 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.263 0.865 . . . . 10.0 115.263 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -79.32 -4.48 51.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.277 1.538 . . . . 10.0 111.744 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.59 -12.57 0.71 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.426 1.013 . . . . 10.0 113.978 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -122.03 132.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 10.0 111.094 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.13 106.03 7.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.895 -2.261 . . . . 10.0 104.895 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.14 77.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.259 1.423 . . . . 10.0 108.054 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -43.06 2.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.579 1.952 . . . . 10.0 111.022 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -145.2 144.99 25.15 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 104.441 -2.429 . . . . 10.0 104.441 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.0 125.39 3.11 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.187 1.925 . . . . 10.0 112.15 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -71.03 85.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -39.88 -46.03 1.92 Allowed 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 125.899 1.68 . . . . 10.0 113.172 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -42.61 -40.2 2.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.525 1.13 . . . . 10.0 112.683 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.16 18.73 12.31 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.539 0.736 . . . . 10.0 111.256 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 45.74 42.53 8.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.487 1.115 . . . . 10.0 109.537 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 51.96 25.41 16.62 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.528 1.537 . . . . 10.0 116.328 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -79.04 -38.88 35.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.588 1.694 . . . . 10.0 108.754 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.27 -0.91 55.96 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.095 1.807 . . . . 10.0 113.791 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 151.4 44.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.83 142.65 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.045 0.938 . . . . 10.0 110.47 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -77.53 78.29 4.05 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -76.19 60.27 1.46 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.452 1.101 . . . . 10.0 111.537 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 10.0 108.657 177.766 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 121.804 0.811 . . . . 10.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.81 127.62 33.41 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.437 1.895 . . . . 10.0 110.422 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.56 126.65 28.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.601 0.76 . . . . 10.0 110.593 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.19 89.84 3.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.28 -38.54 19.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.302 1.441 . . . . 10.0 111.319 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -50.27 -41.81 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.776 1.23 . . . . 10.0 111.618 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.4 p -107.56 19.28 20.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.916 0.486 . . . . 10.0 110.662 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.38 38.74 18.76 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.059 1.344 . . . . 10.0 110.163 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.63 24.16 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.445 -1.197 . . . . 10.0 115.561 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -72.7 -66.24 0.69 Allowed 'General case' 0 C--N 1.341 0.207 0 CA-C-N 120.098 1.949 . . . . 10.0 111.057 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.15 -8.13 4.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.226 2.346 . . . . 10.0 110.183 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.39 138.87 40.67 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.902 1.351 . . . . 10.0 111.031 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -51.76 144.45 18.92 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.817 0.735 . . . . 10.0 110.695 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -49.26 -37.0 38.97 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.298 2.665 . . . . 10.0 113.792 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.41 12.23 68.84 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.017 -1.435 . . . . 10.0 115.113 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -155.66 147.1 22.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.126 2.463 . . . . 10.0 110.938 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.77 157.73 66.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.823 -0.608 . . . . 10.0 109.495 176.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.62 169.64 19.45 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.281 1.987 . . . . 10.0 108.057 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -101.41 115.78 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 119.127 -0.463 . . . . 10.0 110.207 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -42.92 122.23 2.34 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.561 1.144 . . . . 10.0 111.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -65.61 115.57 23.49 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.66 -36.09 6.94 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.823 1.682 . . . . 10.0 110.709 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.38 -39.83 7.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.681 1.593 . . . . 10.0 112.883 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.3 p -114.86 12.48 16.92 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.094 0.958 . . . . 10.0 111.751 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.77 42.46 23.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.013 0.925 . . . . 10.0 109.995 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.08 -8.44 8.36 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 114.805 0.682 . . . . 10.0 114.805 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -68.27 -8.61 40.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.425 1.612 . . . . 10.0 114.045 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 14.66 55.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.602 1.096 . . . . 10.0 113.769 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -145.04 142.29 29.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.145 0.972 . . . . 10.0 110.088 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.11 133.15 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.625 1.57 . . . . 10.0 106.93 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.54 109.61 22.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.03 0.532 . . . . 10.0 110.428 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.99 88.5 0.4 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.331 1.052 . . . . 10.0 108.59 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -73.89 62.3 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.67 0.788 . . . . 10.0 110.238 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 43.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.632 1.173 . . . . 10.0 112.729 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.17 -64.45 1.3 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.684 -0.635 . . . . 10.0 112.391 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.99 -78.23 0.37 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.122 0.969 . . . . 10.0 113.09 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -84.11 98.15 9.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.536 0.734 . . . . 10.0 111.455 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 58.84 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.375 0.67 . . . . 10.0 111.266 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.02 162.36 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 O-C-N 121.878 -0.514 . . . . 10.0 110.05 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.39 171.97 7.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.812 1.041 . . . . 10.0 113.812 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 153.13 47.37 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.645 -1.983 . . . . 10.0 105.645 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 m -58.86 135.76 57.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.85 116.99 49.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.908 0.776 . . . . 10.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.15 -38.05 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.027 1.818 . . . . 10.0 111.367 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.41 -39.49 22.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.599 1.16 . . . . 10.0 113.174 -177.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.49 18.66 15.85 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.094 . . . . 10.0 111.47 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 47.01 43.51 13.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.341 1.056 . . . . 10.0 111.113 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.34 6.43 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.44 0.936 . . . . 10.0 115.44 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -74.54 -7.38 52.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.918 1.859 . . . . 10.0 112.737 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.39 1.21 7.26 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.403 -0.811 . . . . 10.0 113.216 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -133.18 132.91 42.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.17 1.388 . . . . 10.0 109.783 -174.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.74 118.58 27.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.875 1.27 . . . . 10.0 108.323 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -78.4 61.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.976 1.31 . . . . 10.0 108.435 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.74 -34.4 77.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.588 0.709 . . . . 10.0 109.752 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.79 78.14 1.18 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.011 2.924 . . . . 10.0 109.108 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.07 136.65 35.39 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.296 2.664 . . . . 10.0 116.342 -173.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.8 t -74.15 87.95 1.94 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.466 -1.679 . . . . 10.0 106.466 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.96 -40.79 4.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.97 1.308 . . . . 10.0 111.859 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -46.45 -38.66 9.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.932 0.893 . . . . 10.0 112.123 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.6 p -122.26 22.93 9.99 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.534 0.734 . . . . 10.0 110.477 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 45.87 39.81 5.88 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 10.0 110.949 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.07 17.7 31.13 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.249 0.86 . . . . 10.0 115.249 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -36.73 64.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.151 1.475 . . . . 10.0 110.328 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.04 -23.85 17.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.557 1.075 . . . . 10.0 112.031 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.73 159.17 44.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.141 0.97 . . . . 10.0 110.321 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.48 145.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 124.952 1.301 . . . . 10.0 109.865 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -69.77 139.45 53.27 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.905 -0.497 . . . . 10.0 109.876 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -64.61 71.37 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.093 1.757 . . . . 10.0 109.862 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 125.576 1.55 . . . . 10.0 110.633 -176.917 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -120.16 156.4 31.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.873 1.669 . . . . 10.0 110.383 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.66 129.13 19.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 112.081 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -77.24 89.59 3.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -49.09 -38.02 23.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.784 1.233 . . . . 10.0 111.313 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.8 -31.43 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.249 1.42 . . . . 10.0 112.221 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -123.24 22.52 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 10.0 110.13 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 45.01 41.71 5.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.589 1.556 . . . . 10.0 111.238 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.53 -4.44 27.65 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.803 1.081 . . . . 10.0 115.803 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -73.17 -68.95 0.45 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.742 1.771 . . . . 10.0 109.164 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.13 -6.52 4.35 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.58 2.038 . . . . 10.0 109.105 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 128.12 34.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.924 1.362 . . . . 10.0 109.673 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 156.42 2.6 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -38.76 133.59 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.408 3.406 . . . . 10.0 114.794 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.58 19.52 9.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.968 1.27 . . . . 10.0 114.498 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -126.11 140.9 52.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.68 153.44 42.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 122.809 0.444 . . . . 10.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.97 168.67 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 107.768 -1.666 . . . . 10.0 107.768 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.98 119.29 33.24 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -51.15 124.37 11.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.893 0.877 . . . . 10.0 109.362 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -64.23 115.18 17.52 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 118.702 0.683 . . . . 10.0 109.397 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.0 -35.85 8.4 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.632 1.555 . . . . 10.0 110.587 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -45.37 -38.34 5.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 10.0 113.056 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.35 13.95 13.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.241 1.016 . . . . 10.0 111.471 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.3 41.89 21.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.886 0.874 . . . . 10.0 110.195 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.8 -8.08 8.27 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 119.233 -0.76 . . . . 10.0 114.979 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -65.39 -15.7 62.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.563 1.682 . . . . 10.0 113.955 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 4.61 68.47 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.864 0.745 . . . . 10.0 113.651 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.97 156.74 44.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.94 1.37 . . . . 10.0 110.611 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.99 141.64 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 126.451 1.9 . . . . 10.0 107.391 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -124.55 115.47 20.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.16 165.43 24.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.427 1.091 . . . . 10.0 108.399 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -131.33 46.06 2.72 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.274 0.63 . . . . 10.0 112.434 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -78.74 64.0 3.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.874 0.845 . . . . 10.0 109.399 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 37.03 -104.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.439 2.447 . . . . 10.0 113.18 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -47.82 -35.19 9.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.251 1.42 . . . . 10.0 113.591 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -124.43 57.87 1.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.025 0.375 . . . . 10.0 111.227 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.99 66.48 0.38 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.443 1.097 . . . . 10.0 110.589 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.74 167.01 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.49 1.116 . . . . 10.0 112.885 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -126.44 156.86 39.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.063 0.945 . . . . 10.0 111.474 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.18 162.39 35.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.502 1.121 . . . . 10.0 108.94 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 m -62.4 140.99 58.56 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.777 0.831 . . . . 10.0 108.968 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.9 117.48 61.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 118.752 0.706 . . . . 10.0 109.605 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.31 -40.49 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.079 1.853 . . . . 10.0 111.46 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -44.73 -40.11 5.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.992 1.317 . . . . 10.0 112.625 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.59 22.54 11.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 10.0 112.05 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 44.39 43.11 5.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.535 1.134 . . . . 10.0 111.641 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.56 -6.16 6.42 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.757 1.063 . . . . 10.0 115.757 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -78.8 -2.73 40.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.674 1.737 . . . . 10.0 112.775 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.8 -8.97 0.73 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.205 0.907 . . . . 10.0 114.671 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -125.1 135.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.684 1.593 . . . . 10.0 110.655 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.6 mt -97.77 120.58 38.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.883 1.273 . . . . 10.0 108.073 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.5 mm -78.13 63.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.536 1.135 . . . . 10.0 108.23 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -69.36 -26.23 64.57 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.663 -0.648 . . . . 10.0 110.69 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -111.28 72.85 0.93 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 127.253 2.221 . . . . 10.0 109.46 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -62.99 129.42 25.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.019 2.479 . . . . 10.0 115.536 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.2 92.38 0.76 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.989 1.716 . . . . 10.0 106.543 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -37.23 -49.01 0.91 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.272 1.829 . . . . 10.0 112.613 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.73 -38.12 4.21 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.11 1.364 . . . . 10.0 112.812 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.0 p -121.85 16.29 10.97 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.893 0.877 . . . . 10.0 111.069 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 48.23 37.84 9.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.382 1.073 . . . . 10.0 110.836 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.52 6.76 43.51 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 118.955 -0.914 . . . . 10.0 115.058 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -44.0 87.01 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.78 1.79 . . . . 10.0 110.643 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.81 30.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.816 1.198 . . . . 10.0 113.405 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -146.25 154.61 41.92 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.481 1.64 . . . . 10.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 155.77 33.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 125.771 1.629 . . . . 10.0 109.298 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.53 141.56 51.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.286 -0.635 . . . . 10.0 109.286 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.97 67.28 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.756 2.022 . . . . 10.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.457 -0.096 0 C-N-CA 125.906 1.682 . . . . 10.0 108.288 176.368 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 mt . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -112.84 124.5 52.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.487 1.115 . . . . 10.0 108.959 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.63 125.21 15.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.233 1.013 . . . . 10.0 110.584 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -81.1 89.04 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 109.688 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -49.5 -38.04 28.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.516 1.126 . . . . 10.0 111.016 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.07 -36.42 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.46 1.504 . . . . 10.0 111.655 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 p -117.52 23.92 11.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.078 0.551 . . . . 10.0 110.791 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.5 p80 46.03 42.35 9.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.64 1.576 . . . . 10.0 111.486 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.0 -3.72 27.46 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -77.84 -67.82 0.69 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 120.099 1.95 . . . . 10.0 110.196 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.65 -3.54 3.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.184 1.849 . . . . 10.0 110.496 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.49 140.23 30.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.008 1.904 . . . . 10.0 111.196 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -48.42 140.72 9.78 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.067 0.947 . . . . 10.0 111.625 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -36.28 133.41 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 125.165 3.91 . . . . 10.0 113.942 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.77 -45.72 1.64 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.236 0.922 . . . . 10.0 112.456 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 68.97 0.64 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.542 2.337 . . . . 10.0 108.503 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.55 151.76 28.42 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.178 0.991 . . . . 10.0 112.419 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.09 146.93 53.29 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.294 1.329 . . . . 10.0 108.786 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -83.06 140.38 32.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -57.71 123.26 15.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.547 0.739 . . . . 10.0 109.734 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -67.61 116.3 36.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.264 0.938 . . . . 10.0 108.981 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.64 -38.35 10.85 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 120.557 1.235 . . . . 10.0 110.777 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.22 -40.31 11.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.388 1.875 . . . . 10.0 113.134 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 p -121.3 27.68 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.821 0.849 . . . . 10.0 110.598 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 45.39 42.12 7.2 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.724 1.21 . . . . 10.0 112.788 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.46 58.29 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.328 -1.262 . . . . 10.0 116.196 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.6 p -81.31 -66.27 0.91 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.991 1.895 . . . . 10.0 112.02 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.43 -6.31 0.78 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.556 -1.135 . . . . 10.0 115.761 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.06 132.93 43.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.095 1.947 . . . . 10.0 111.67 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -75.99 138.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.1 114.69 23.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.7 mtp -77.49 73.72 4.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -68.71 62.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.292 1.437 . . . . 10.0 112.299 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.12 51.4 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.385 1.474 . . . . 10.0 110.489 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.23 -65.98 0.73 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.386 0.993 . . . . 10.0 113.332 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -100.91 -69.68 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.835 1.254 . . . . 10.0 112.122 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -74.52 68.69 1.63 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.573 -0.704 . . . . 10.0 111.213 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.24 59.24 0.75 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.21 1.004 . . . . 10.0 112.16 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.35 169.93 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 124.614 1.166 . . . . 10.0 110.7 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -146.84 159.52 43.41 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.621 0.6 . . . . 10.0 112.621 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.59 158.69 43.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.832 1.253 . . . . 10.0 108.572 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -53.55 134.44 40.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.062 0.545 . . . . 10.0 110.209 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.7 t -75.93 116.97 60.42 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.865 -0.588 . . . . 10.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.67 -39.01 7.2 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.169 1.913 . . . . 10.0 111.336 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -44.84 -43.41 8.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.997 1.719 . . . . 10.0 112.552 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.06 23.0 12.53 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.083 0.953 . . . . 10.0 111.699 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 44.21 44.68 6.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.781 1.232 . . . . 10.0 111.713 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -5.09 17.48 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -81.26 -8.32 59.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.308 2.054 . . . . 10.0 113.43 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.04 -7.63 3.05 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 121.459 -0.775 . . . . 10.0 113.192 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 133.61 55.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.747 2.019 . . . . 10.0 111.874 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.63 119.56 33.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.216 1.406 . . . . 10.0 108.854 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.31 81.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.79 1.636 . . . . 10.0 108.856 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -42.44 -49.95 5.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.415 1.486 . . . . 10.0 111.294 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -149.03 128.45 6.34 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.17 136.35 31.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.769 2.313 . . . . 10.0 114.848 -171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.5 t -73.68 90.82 1.84 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.673 1.589 . . . . 10.0 106.831 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -39.41 -45.39 1.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.73 1.612 . . . . 10.0 112.685 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.12 -39.32 2.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.827 1.251 . . . . 10.0 112.731 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.8 24.63 8.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.886 0.875 . . . . 10.0 110.631 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 47.99 35.59 5.23 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.296 1.038 . . . . 10.0 110.849 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.52 21.0 53.5 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.973 0.749 . . . . 10.0 114.973 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.42 -40.46 57.7 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.881 1.34 . . . . 10.0 110.367 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.72 -13.73 14.87 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.471 1.51 . . . . 10.0 112.073 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.62 145.5 29.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.155 0.978 . . . . 10.0 109.686 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.49 138.14 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.98 124.28 33.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -68.76 73.27 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.076 1.35 . . . . 10.0 108.406 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.631 1.973 . . . . 10.0 109.662 -176.643 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.755 -0.461 . . . . 10.0 109.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.69 132.78 54.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.229 1.812 . . . . 10.0 107.448 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.21 129.79 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -75.54 88.43 2.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -48.06 -39.48 20.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.831 1.252 . . . . 10.0 111.292 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -49.83 -33.44 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.143 1.377 . . . . 10.0 112.224 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.66 27.19 8.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.62 0.645 . . . . 10.0 110.656 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 44.69 41.97 5.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.47 1.508 . . . . 10.0 111.499 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 -3.52 30.95 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.131 -1.372 . . . . 10.0 116.044 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -80.9 -71.63 0.46 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 120.024 1.912 . . . . 10.0 110.661 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.43 -10.44 1.72 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.934 1.255 . . . . 10.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.63 137.81 33.64 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.222 2.011 . . . . 10.0 109.225 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 152.33 4.59 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 118.882 0.764 . . . . 10.0 112.071 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -46.82 141.77 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.122 3.214 . . . . 10.0 114.322 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.6 -58.32 3.78 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.783 0.706 . . . . 10.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 81.82 1.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.588 0.709 . . . . 10.0 109.852 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -56.49 157.32 9.91 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.636 1.174 . . . . 10.0 112.475 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.95 -174.72 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.328 2.019 . . . . 10.0 109.397 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -119.24 156.52 29.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -65.66 131.29 45.98 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.525 -1.359 . . . . 10.0 110.493 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -75.03 114.9 39.63 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.312 0.96 . . . . 10.0 109.389 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.1 -37.55 8.22 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.607 1.538 . . . . 10.0 110.558 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.96 -38.63 7.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.818 1.647 . . . . 10.0 112.964 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.3 p -119.06 20.45 12.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.797 0.839 . . . . 10.0 111.334 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 46.0 44.08 11.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.478 1.111 . . . . 10.0 111.483 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.13 -1.19 34.72 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.315 -1.269 . . . . 10.0 115.737 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.8 p -70.33 -63.2 1.13 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 120.336 2.068 . . . . 10.0 111.256 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.71 7.11 4.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.474 1.988 . . . . 10.0 111.529 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -134.7 146.93 49.93 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.426 1.613 . . . . 10.0 111.759 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 m -111.93 145.61 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.546 1.538 . . . . 10.0 108.336 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -107.91 113.33 26.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.072 -1.085 . . . . 10.0 108.072 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.7 tpp -75.15 73.95 2.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -70.76 60.98 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.655 1.582 . . . . 10.0 112.023 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -76.99 56.59 1.24 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.258 1.423 . . . . 10.0 110.861 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.68 -71.3 0.38 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.503 1.049 . . . . 10.0 112.847 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -98.63 -63.76 1.1 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.058 0.943 . . . . 10.0 112.025 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -77.49 60.73 2.14 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.895 0.878 . . . . 10.0 111.059 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.14 60.38 0.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.736 1.214 . . . . 10.0 113.096 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.29 -179.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.806 0.842 . . . . 10.0 110.013 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.6 160.08 40.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.46 166.6 24.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.513 1.125 . . . . 10.0 108.722 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 m -63.98 141.13 58.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.3 t -75.62 115.34 44.94 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 118.613 0.642 . . . . 10.0 109.707 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.45 -37.83 9.35 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.263 1.975 . . . . 10.0 111.052 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -45.38 -33.42 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.831 1.652 . . . . 10.0 112.538 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.07 21.79 6.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.9 0.88 . . . . 10.0 111.746 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.83 40.42 8.94 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.134 0.974 . . . . 10.0 112.263 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.29 53.62 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.114 0.805 . . . . 10.0 115.114 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -82.69 -7.77 59.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.966 1.383 . . . . 10.0 112.405 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.03 -6.49 2.97 Favored Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.465 -0.772 . . . . 10.0 113.041 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.56 127.04 52.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.184 1.793 . . . . 10.0 112.172 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.57 116.89 10.5 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.699 1.6 . . . . 10.0 107.482 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 mm -72.07 74.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 126.121 1.768 . . . . 10.0 109.291 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -42.47 -47.75 5.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.17 1.788 . . . . 10.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.22 94.96 5.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.87 1.268 . . . . 10.0 109.263 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.61 123.22 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 1 C-N-CA 125.573 4.182 . . . . 10.0 117.553 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.97 91.41 2.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.187 1.795 . . . . 10.0 107.142 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -36.98 -48.27 0.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.198 1.799 . . . . 10.0 112.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -43.37 -42.68 4.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.678 1.591 . . . . 10.0 112.639 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.28 16.87 14.81 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 123.756 0.823 . . . . 10.0 110.795 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 51.25 35.02 12.54 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.54 1.136 . . . . 10.0 110.27 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.64 14.25 57.45 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.688 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -75.05 -27.28 59.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.184 1.492 . . . . 10.0 111.627 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.56 -34.26 4.84 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.578 1.085 . . . . 10.0 113.718 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 144.37 50.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.123 0.969 . . . . 10.0 108.72 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.37 145.39 34.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.154 0.982 . . . . 10.0 109.412 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -80.47 138.69 36.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -67.79 72.09 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.034 1.334 . . . . 10.0 109.291 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 125.48 1.512 . . . . 10.0 110.625 -176.055 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 110.214 -0.291 . . . . 10.0 110.214 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -129.56 150.39 50.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.16 0.984 . . . . 10.0 109.531 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 131.44 43.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.808 1.643 . . . . 10.0 112.412 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.3 t -76.99 101.13 5.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.195 -1.78 . . . . 10.0 106.195 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -48.8 -41.97 34.44 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.288 1.435 . . . . 10.0 111.518 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.5 t -52.23 -33.38 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.103 1.361 . . . . 10.0 111.89 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.76 19.54 14.43 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.404 0.547 . . . . 10.0 110.925 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.08 38.31 16.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.019 1.327 . . . . 10.0 111.242 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.34 60.19 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.593 -1.115 . . . . 10.0 115.382 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.6 p -79.28 -67.88 0.71 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.89 1.845 . . . . 10.0 110.909 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.11 -9.47 3.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.981 2.705 . . . . 10.0 110.028 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 126.63 30.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.209 1.003 . . . . 10.0 111.739 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -44.76 141.49 2.92 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.916 1.687 . . . . 10.0 111.258 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.13 145.35 65.2 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.641 2.227 . . . . 10.0 110.185 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.05 39.06 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.44 0.543 . . . . 10.0 113.118 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -137.87 169.77 17.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 150.68 75.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 118.933 0.788 . . . . 10.0 111.047 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.86 168.05 10.98 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.236 2.624 . . . . 10.0 108.506 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -105.37 126.09 51.72 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 122.191 -0.318 . . . . 10.0 110.647 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -50.13 121.92 6.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 10.0 110.573 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.85 115.8 26.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -70.21 -36.27 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.642 1.561 . . . . 10.0 110.754 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.14 -40.26 10.8 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.679 1.592 . . . . 10.0 112.907 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 p -115.73 18.14 15.86 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 10.0 111.32 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 47.79 42.0 15.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.249 1.02 . . . . 10.0 110.722 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.37 -2.95 8.81 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.385 -1.231 . . . . 10.0 115.518 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -45.41 82.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.324 2.062 . . . . 10.0 111.322 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.06 3.24 28.06 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.365 1.459 . . . . 10.0 111.262 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -135.12 143.11 46.39 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.074 1.437 . . . . 10.0 112.079 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 m -99.46 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 126.096 1.758 . . . . 10.0 107.679 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -126.68 118.7 25.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.01 -1.478 . . . . 10.0 107.01 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -107.77 135.62 48.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.698 1.199 . . . . 10.0 108.843 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -99.05 115.26 28.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.767 1.227 . . . . 10.0 108.234 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 58.05 3.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.585 -0.895 . . . . 10.0 108.585 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 -66.7 2.07 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -101.23 -76.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.841 1.256 . . . . 10.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.46 172.84 6.61 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.475 0.579 . . . . 10.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.34 152.24 40.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.784 -0.573 . . . . 10.0 109.718 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.43 156.87 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.419 1.088 . . . . 10.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 158.85 23.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.595 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -147.03 155.13 41.97 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.231 -1.396 . . . . 10.0 107.231 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -63.76 133.99 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.34 117.35 56.07 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 119.178 0.899 . . . . 10.0 109.087 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.26 -37.04 8.47 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.95 1.767 . . . . 10.0 111.422 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -39.25 25.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.779 1.231 . . . . 10.0 113.566 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -116.26 19.63 14.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.892 1.277 . . . . 10.0 110.892 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 46.59 44.59 13.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.631 1.172 . . . . 10.0 111.319 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.84 -8.18 6.39 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.451 0.94 . . . . 10.0 115.451 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -74.94 -17.65 60.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.775 1.787 . . . . 10.0 112.714 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.2 12.64 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.843 -0.536 . . . . 10.0 112.385 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -106.54 130.49 54.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.703 1.601 . . . . 10.0 112.069 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.6 mt -81.63 115.82 21.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -75.68 67.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.321 1.048 . . . . 10.0 108.192 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.91 -24.59 67.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.078 0.551 . . . . 10.0 109.575 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -118.35 80.18 15.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 128.396 2.678 . . . . 10.0 110.655 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.6 122.17 11.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.962 2.442 . . . . 10.0 115.191 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.43 89.42 0.69 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.367 -1.345 . . . . 10.0 107.367 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -39.26 -46.31 1.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.283 1.833 . . . . 10.0 112.848 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -45.59 -36.79 4.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.274 1.03 . . . . 10.0 112.555 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.1 26.07 6.58 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.822 0.849 . . . . 10.0 110.182 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 43.44 40.13 2.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.549 1.54 . . . . 10.0 112.117 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.97 37.32 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.198 -0.939 . . . . 10.0 115.245 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.42 -39.27 88.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.727 1.763 . . . . 10.0 109.547 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.26 -9.08 67.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.213 1.863 . . . . 10.0 114.333 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.74 44.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.865 1.332 . . . . 10.0 109.271 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.72 147.9 30.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.558 1.143 . . . . 10.0 110.419 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 79.88 1.99 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.351 1.06 . . . . 10.0 108.439 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -79.48 50.28 1.1 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.396 1.079 . . . . 10.0 110.764 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.455 -0.218 0 O-C-N 121.513 -0.742 . . . . 10.0 109.888 -179.418 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -110.78 127.01 55.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.766 1.626 . . . . 10.0 107.566 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.4 127.11 30.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.795 1.238 . . . . 10.0 109.798 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.1 85.23 4.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.289 0.566 . . . . 10.0 110.041 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -46.77 -38.7 10.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.258 1.423 . . . . 10.0 111.708 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -49.16 -38.48 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.798 1.639 . . . . 10.0 111.712 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.14 19.52 17.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.147 0.579 . . . . 10.0 110.585 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 51.89 36.27 17.82 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.218 1.407 . . . . 10.0 109.772 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 3.66 42.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.43 1.014 . . . . 10.0 115.546 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -75.34 -66.3 0.78 Allowed 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.61 1.705 . . . . 10.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.89 -9.91 3.64 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.978 2.228 . . . . 10.0 109.82 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.18 139.65 46.46 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.355 1.578 . . . . 10.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -56.13 146.4 50.84 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.438 -0.791 . . . . 10.0 109.407 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -32.81 -66.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 1 C-N-CA 125.349 4.033 . . . . 10.0 115.68 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.29 44.5 3.06 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.583 -0.698 . . . . 10.0 113.074 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -158.13 158.65 35.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.673 1.236 . . . . 10.0 107.975 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 147.25 36.73 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.105 1.362 . . . . 10.0 108.662 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.401 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 29.8 Cg_endo -74.21 160.15 42.84 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.413 2.075 . . . . 10.0 107.247 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -105.32 126.18 51.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -36.75 116.92 0.46 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.949 1.3 . . . . 10.0 113.073 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.6 115.52 44.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.14 -31.75 18.26 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.649 1.566 . . . . 10.0 110.589 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -43.56 29.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.151 1.38 . . . . 10.0 112.062 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -108.04 11.55 27.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.081 0.953 . . . . 10.0 111.28 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 52.15 37.93 23.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.272 1.029 . . . . 10.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 -8.35 19.18 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.799 -0.563 . . . . 10.0 113.993 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 m -71.38 -8.7 55.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.989 1.394 . . . . 10.0 114.438 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.92 -18.78 11.35 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.064 0.847 . . . . 10.0 113.729 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -133.61 131.62 39.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.246 1.023 . . . . 10.0 109.566 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 m -73.8 150.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.337 1.455 . . . . 10.0 107.291 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.51 107.22 14.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.341 0.657 . . . . 10.0 109.889 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.32 114.87 22.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -97.95 133.12 42.87 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.578 1.151 . . . . 10.0 109.984 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.07 80.94 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.902 1.681 . . . . 10.0 107.606 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.37 -64.2 2.5 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.996 0.807 . . . . 10.0 111.704 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.71 -66.69 0.82 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.258 1.023 . . . . 10.0 109.416 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -59.92 155.33 16.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.981 0.512 . . . . 10.0 109.715 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.01 157.21 43.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.418 0.287 . . . . 10.0 110.83 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.92 148.57 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.429 1.092 . . . . 10.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.83 144.76 30.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.883 0.873 . . . . 10.0 112.177 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -140.15 143.81 36.36 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.302 1.441 . . . . 10.0 107.843 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -53.09 135.39 37.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.253 0.933 . . . . 10.0 111.489 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.2 t -79.53 116.89 64.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.97 -41.94 3.59 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.133 1.889 . . . . 10.0 111.259 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.2 -29.83 2.59 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.95 1.092 . . . . 10.0 113.95 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.2 p -127.46 29.95 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.759 0.824 . . . . 10.0 111.594 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 38.78 49.83 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.239 1.416 . . . . 10.0 111.945 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.54 -11.03 3.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.203 1.241 . . . . 10.0 116.203 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -74.08 -13.82 60.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.106 1.953 . . . . 10.0 113.574 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.35 7.2 86.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.559 -0.578 . . . . 10.0 114.339 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' PRO . 77.3 p -132.03 119.05 20.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.444 1.122 . . . . 10.0 110.565 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.03 150.19 43.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.002 1.321 . . . . 10.0 110.209 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -112.72 73.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 125.557 1.543 . . . . 10.0 109.961 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -68.45 -24.67 64.74 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.275 -0.891 . . . . 10.0 109.613 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -107.4 79.14 0.73 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.942 2.497 . . . . 10.0 110.323 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 118.09 5.06 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.296 2.664 . . . . 10.0 115.801 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.6 t -65.6 95.49 0.23 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.481 -1.674 . . . . 10.0 106.481 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -38.79 -48.81 1.56 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.869 1.668 . . . . 10.0 112.776 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -42.93 -39.89 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.725 1.21 . . . . 10.0 112.752 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.01 19.5 10.03 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.594 0.757 . . . . 10.0 111.047 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 46.38 41.93 9.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.653 1.181 . . . . 10.0 110.776 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.13 15.46 44.04 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.409 0.924 . . . . 10.0 115.409 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.83 -44.63 31.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.625 1.712 . . . . 10.0 109.009 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.75 -7.43 13.41 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.906 1.717 . . . . 10.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.62 152.85 32.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.881 -1.364 . . . . 10.0 109.688 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.08 146.45 13.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -98.59 137.69 36.86 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.344 -0.613 . . . . 10.0 109.344 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -78.26 59.98 2.41 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.064 -1.087 . . . . 10.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.31 1.044 . . . . 10.0 110.86 -178.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.457 0 N-CA-C 108.519 -1.833 . . . . 10.0 108.519 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -54.78 -23.68 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.504 1.122 . . . . 10.0 111.825 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -65.81 -35.9 81.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.906 2.082 . . . . 10.0 110.974 176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -93.91 -49.61 5.73 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 124.378 1.071 . . . . 10.0 108.496 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.29 65.71 1.65 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.564 1.546 . . . . 10.0 108.292 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.5 pt -70.02 73.09 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.182 0.993 . . . . 10.0 112.142 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 55.36 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.08 2.152 . . . . 10.0 113.484 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.58 86.77 52.0 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.713 -1.588 . . . . 10.0 106.713 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -42.62 138.56 3.5 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.355 3.37 . . . . 10.0 115.297 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.57 146.27 14.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.358 -1.719 . . . . 10.0 106.358 176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -89.59 147.7 23.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.907 0.483 . . . . 10.0 109.905 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -138.16 144.22 40.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.844 1.257 . . . . 10.0 108.059 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.95 142.95 45.87 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.0 t -76.58 87.26 3.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -41.67 -41.86 2.37 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.567 1.947 . . . . 10.0 111.751 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 t -51.67 -45.69 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.15 1.38 . . . . 10.0 111.443 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -99.79 18.49 18.11 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.768 0.713 . . . . 10.0 110.599 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.83 35.95 25.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.26 1.424 . . . . 10.0 110.166 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.86 3.06 58.77 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.144 -1.364 . . . . 10.0 115.02 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.3 p -80.05 -75.22 0.27 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.012 1.906 . . . . 10.0 110.388 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.89 -19.25 0.76 Allowed Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.628 1.585 . . . . 10.0 112.308 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.71 151.53 26.17 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.596 1.698 . . . . 10.0 111.087 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -52.82 151.59 8.13 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.182 0.901 . . . . 10.0 111.92 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -50.51 137.23 40.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.54 2.827 . . . . 10.0 112.06 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.82 -51.8 2.75 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.598 1.094 . . . . 10.0 111.1 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -68.56 70.42 0.18 Allowed 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.235 2.614 . . . . 10.0 108.904 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -56.76 158.43 8.68 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 123.383 0.673 . . . . 10.0 112.656 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -54.59 145.21 60.08 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.69 1.593 . . . . 10.0 109.287 176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -84.6 123.01 29.85 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -50.78 121.35 5.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.914 0.886 . . . . 10.0 109.624 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.92 116.9 33.7 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 108.898 -0.778 . . . . 10.0 108.898 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.27 -38.46 6.66 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.582 1.521 . . . . 10.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.58 -39.71 7.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.289 1.836 . . . . 10.0 113.272 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -115.4 17.0 16.66 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.926 0.89 . . . . 10.0 111.568 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 47.1 49.71 14.77 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.0 0.92 . . . . 10.0 110.034 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.67 2.92 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.779 1.18 . . . . 10.0 115.247 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -90.12 2.84 54.86 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.843 1.321 . . . . 10.0 113.107 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.99 -8.82 5.83 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 115.776 1.07 . . . . 10.0 115.776 176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.98 130.75 52.99 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 119.068 1.434 . . . . 10.0 110.031 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 m -87.95 143.85 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.658 -1.608 . . . . 10.0 106.658 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -98.33 110.67 23.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.93 -1.137 . . . . 10.0 107.93 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.6 tpt -75.79 73.29 2.73 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -69.44 55.94 0.11 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.064 2.146 . . . . 10.0 112.981 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.27 64.29 4.13 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.764 1.226 . . . . 10.0 108.414 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.19 -126.91 31.88 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 109.895 -1.282 . . . . 10.0 109.895 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -53.59 -47.83 69.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.306 1.042 . . . . 10.0 113.284 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -79.67 58.17 2.69 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.983 0.513 . . . . 10.0 111.143 -173.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 59.0 2.38 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.261 0.625 . . . . 10.0 112.527 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.8 m -86.65 175.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -115.42 171.12 7.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 -176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -141.63 154.64 45.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.827 -1.916 . . . . 10.0 105.827 175.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.9 m -65.65 136.08 55.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 39.1 t -71.04 116.57 47.95 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 118.848 0.749 . . . . 10.0 109.649 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -38.99 4.25 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.874 1.716 . . . . 10.0 111.251 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -47.21 -41.14 17.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.004 1.322 . . . . 10.0 113.101 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.3 p -116.02 20.63 14.31 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.139 0.976 . . . . 10.0 111.299 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 46.8 42.92 12.58 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.374 1.07 . . . . 10.0 111.6 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.95 -4.09 11.18 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.433 0.933 . . . . 10.0 115.433 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -78.86 -5.5 53.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.644 1.722 . . . . 10.0 113.041 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.94 5.64 5.77 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.39 0.995 . . . . 10.0 114.642 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.0 p -129.14 132.41 47.34 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.773 1.229 . . . . 10.0 111.322 -173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -104.56 120.26 40.89 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.391 1.077 . . . . 10.0 110.111 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 29.0 mm -78.01 65.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.356 1.462 . . . . 10.0 107.429 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -56.83 -45.43 82.34 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.296 0.57 . . . . 10.0 109.479 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -114.02 100.03 51.67 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.981 1.712 . . . . 10.0 108.475 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -70.72 131.04 19.13 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.925 1.75 . . . . 10.0 112.34 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.1 t -65.47 100.21 0.48 Allowed 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.707 -1.22 . . . . 10.0 107.707 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -40.73 -50.37 3.1 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.63 1.572 . . . . 10.0 112.805 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -45.21 -40.0 6.87 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.861 1.265 . . . . 10.0 112.973 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -118.45 19.78 13.24 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.286 0.634 . . . . 10.0 111.004 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 46.5 42.92 11.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.647 1.179 . . . . 10.0 110.827 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.23 -3.73 29.3 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.236 -1.313 . . . . 10.0 116.279 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -65.99 -55.95 14.12 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.278 2.039 . . . . 10.0 110.293 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.69 -9.62 16.51 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.718 1.151 . . . . 10.0 114.415 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.73 156.36 41.72 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.34 -1.356 . . . . 10.0 107.34 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 m -146.14 166.51 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.155 0.582 . . . . 10.0 109.69 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.57 136.59 36.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.817 -1.92 . . . . 10.0 105.817 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttp-105 -51.11 116.19 1.89 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.414 -0.588 . . . . 10.0 109.414 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 124.334 1.054 . . . . 10.0 108.247 -177.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.788 0 N-CA-C 111.011 -0.836 . . . . 10.0 111.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.8 t -59.72 -42.69 89.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.607 0.763 . . . . 10.0 109.955 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -166.83 -166.64 0.85 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -167.92 -159.16 0.28 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.418 1.887 . . . . 10.0 107.074 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -75.67 65.92 1.92 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.555 -0.716 . . . . 10.0 109.936 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.15 62.0 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.942 0.897 . . . . 10.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.15 62.03 2.79 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.077 -1.014 . . . . 10.0 108.516 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.4 mm -78.72 135.94 59.45 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 105.722 -1.955 . . . . 10.0 105.722 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.11 91.08 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.544 2.163 . . . . 10.0 108.609 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 62.51 0.25 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.558 1.943 . . . . 10.0 112.469 -173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.9 mt -68.28 109.9 3.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.998 -0.438 . . . . 10.0 109.845 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -118.05 147.09 43.59 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -61.79 138.34 58.32 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.406 0.441 . . . . 10.0 110.703 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.03 100.09 4.8 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.057 -1.461 . . . . 10.0 107.057 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -47.16 -43.38 20.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.606 1.563 . . . . 10.0 111.577 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.7 -29.39 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.277 1.431 . . . . 10.0 112.445 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.6 p -125.31 19.84 8.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.816 0.846 . . . . 10.0 110.808 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 44.93 42.44 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.344 1.458 . . . . 10.0 111.314 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.29 -11.26 38.34 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 116.165 1.226 . . . . 10.0 116.165 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.8 p -70.32 -68.72 0.4 Allowed 'General case' 0 C--N 1.34 0.173 0 CA-C-N 120.036 1.918 . . . . 10.0 110.816 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.74 -5.5 5.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 126.863 2.173 . . . . 10.0 109.205 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.54 131.32 35.99 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.519 1.16 . . . . 10.0 109.159 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -54.69 159.41 3.53 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -42.5 137.35 3.87 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.983 3.122 . . . . 10.0 114.68 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.97 19.41 10.92 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.789 1.185 . . . . 10.0 114.157 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 m -127.36 136.07 51.39 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' H ' ' NE2' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -90.86 146.12 33.26 Favored Pre-proline 0 C--O 1.237 0.427 0 C-N-CA 124.12 0.968 . . . . 10.0 110.319 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -68.75 158.21 58.75 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 106.839 -2.023 . . . . 10.0 106.839 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -89.96 114.22 26.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -48.07 124.13 7.21 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.381 1.072 . . . . 10.0 109.866 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.7 t -63.53 115.39 17.96 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -70.74 -36.94 7.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.815 1.676 . . . . 10.0 110.725 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.61 -39.93 8.3 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.682 1.593 . . . . 10.0 112.846 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 p -114.6 12.65 17.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.788 . . . . 10.0 111.667 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.89 41.93 23.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.024 0.93 . . . . 10.0 109.895 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.53 -7.81 8.18 Favored Glycine 0 CA--C 1.538 1.491 0 CA-C-O 119.246 -0.752 . . . . 10.0 114.846 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -68.14 -9.06 43.71 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.499 1.65 . . . . 10.0 113.898 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.08 11.25 54.67 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.356 0.979 . . . . 10.0 113.68 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -145.4 143.55 30.16 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.509 1.154 . . . . 10.0 110.404 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -100.34 152.03 4.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.1 1.76 . . . . 10.0 107.534 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -125.66 118.94 26.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 89.6 mtp -104.02 121.48 43.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.873 1.269 . . . . 10.0 108.505 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -95.28 112.18 23.92 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.568 1.147 . . . . 10.0 108.914 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.82 53.73 2.88 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.43 -71.25 0.35 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.341 0.972 . . . . 10.0 112.427 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -80.56 -68.49 0.68 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.77 0.828 . . . . 10.0 110.099 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.94 174.31 7.23 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.269 0.628 . . . . 10.0 110.058 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.81 156.14 43.38 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.703 0.801 . . . . 10.0 109.443 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.48 164.58 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 C-N-CA 124.644 1.177 . . . . 10.0 108.576 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' H ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -124.56 152.63 43.26 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.113 0.965 . . . . 10.0 111.621 -178.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -142.1 160.04 41.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 m -59.75 136.74 58.09 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.4 t -72.05 117.14 55.58 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.812 0.733 . . . . 10.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.09 -40.44 6.36 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.086 1.857 . . . . 10.0 111.357 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -45.85 -36.87 5.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.651 1.18 . . . . 10.0 113.013 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.4 p -121.43 21.49 10.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.877 0.871 . . . . 10.0 111.595 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 44.86 42.99 6.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.407 1.083 . . . . 10.0 111.705 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.9 -4.76 9.13 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.699 1.04 . . . . 10.0 115.699 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -77.62 -7.8 56.93 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.425 1.612 . . . . 10.0 112.932 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.82 -2.21 2.81 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.105 0.86 . . . . 10.0 114.14 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -128.16 135.28 49.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.657 1.583 . . . . 10.0 109.876 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.2 mt -101.88 119.79 39.35 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.773 1.229 . . . . 10.0 108.252 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.0 66.47 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.234 1.014 . . . . 10.0 108.351 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -63.43 -35.51 80.68 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.786 -0.571 . . . . 10.0 110.22 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -109.64 77.05 0.96 Allowed Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 127.795 2.438 . . . . 10.0 110.086 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.81 124.52 13.74 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.222 2.614 . . . . 10.0 115.591 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.99 94.89 0.9 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.495 1.518 . . . . 10.0 107.989 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -39.54 -47.83 1.95 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.476 1.51 . . . . 10.0 113.273 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -45.97 -43.29 13.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.972 0.909 . . . . 10.0 112.7 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -113.43 19.69 16.72 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 122.923 0.489 . . . . 10.0 110.461 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.08 40.85 18.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.436 1.094 . . . . 10.0 110.314 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.44 20.56 45.61 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.388 -0.673 . . . . 10.0 114.325 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.81 -67.69 0.65 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.145 1.473 . . . . 10.0 107.371 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.92 -45.04 0.79 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.475 -0.65 . . . . 10.0 111.475 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.29 161.36 26.0 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.167 0.987 . . . . 10.0 110.237 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.7 149.78 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.226 1.011 . . . . 10.0 110.107 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.2 71.55 2.23 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.321 1.048 . . . . 10.0 109.371 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.94 67.14 0.39 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.906 2.083 . . . . 10.0 109.044 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.451 -0.422 0 C-N-CA 125.875 1.67 . . . . 10.0 111.724 -175.552 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 108.93 -1.668 . . . . 10.0 108.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.25 -49.78 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.6 p -78.35 68.35 4.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -49.7 -37.37 28.71 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.922 1.289 . . . . 10.0 111.856 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -73.23 63.7 0.74 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.951 1.3 . . . . 10.0 110.279 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.0 pt -73.53 53.93 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.56 1.144 . . . . 10.0 111.986 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -98.36 36.56 1.59 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.586 1.154 . . . . 10.0 108.747 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -157.15 155.65 28.29 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 128.627 2.771 . . . . 10.0 104.591 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.38 74.76 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.977 3.118 . . . . 10.0 111.072 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 m -78.23 67.32 4.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.177 1.391 . . . . 10.0 108.391 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 55.4 mt -101.72 142.3 33.26 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.938 1.295 . . . . 10.0 110.903 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -129.82 156.26 44.65 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.731 1.612 . . . . 10.0 108.243 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -61.18 137.08 58.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.197 0.599 . . . . 10.0 109.783 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 t -76.6 81.63 3.26 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -46.18 -38.19 8.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.419 1.487 . . . . 10.0 111.502 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.0 t -48.04 -42.5 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.359 1.464 . . . . 10.0 111.776 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.8 p -110.36 20.19 18.03 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.511 0.724 . . . . 10.0 110.34 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 49.93 38.01 15.17 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.418 1.487 . . . . 10.0 110.27 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.84 0.54 14.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.544 -1.142 . . . . 10.0 115.384 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -73.77 -57.88 3.68 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 120.123 1.961 . . . . 10.0 109.793 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.62 -11.85 5.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.433 1.968 . . . . 10.0 109.829 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.16 129.57 40.25 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.215 1.008 . . . . 10.0 112.172 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -42.2 145.59 0.76 Allowed Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 126.556 1.943 . . . . 10.0 111.729 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -39.13 132.08 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.725 2.95 . . . . 10.0 113.139 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 58.46 15.27 23.85 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.13 -0.817 . . . . 10.0 114.307 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 m -119.21 157.51 27.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.783 1.233 . . . . 10.0 107.717 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.99 152.63 43.77 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.1 1.36 . . . . 10.0 109.019 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.83 -177.9 4.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.149 1.899 . . . . 10.0 108.996 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -117.64 125.93 51.61 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.836 -0.802 . . . . 10.0 108.836 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -47.01 122.33 4.33 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.305 1.042 . . . . 10.0 110.897 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -66.61 115.79 27.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.22 -36.76 9.04 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.603 1.535 . . . . 10.0 110.887 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -46.32 -38.88 9.3 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.951 1.7 . . . . 10.0 112.985 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 p -118.21 19.99 13.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.089 0.956 . . . . 10.0 111.261 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 46.65 42.68 11.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.357 1.063 . . . . 10.0 111.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.41 -6.31 11.87 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.691 -1.061 . . . . 10.0 115.615 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.3 p -68.12 -44.48 76.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.073 1.936 . . . . 10.0 112.069 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.59 2.51 34.97 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.264 1.411 . . . . 10.0 111.136 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -128.82 130.07 46.46 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.714 1.257 . . . . 10.0 110.19 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.51 132.73 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 106.909 -1.515 . . . . 10.0 106.909 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -116.92 116.53 27.58 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 11.9 mmt -68.98 158.48 34.65 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 175.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -144.28 41.34 1.37 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.769 0.828 . . . . 10.0 109.854 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.63 -163.69 0.59 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.015 1.726 . . . . 10.0 107.754 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.25 3.24 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.975 -0.85 . . . . 10.0 110.975 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -158.07 -60.74 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 117.295 0.547 . . . . 10.0 110.915 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -135.77 156.15 49.26 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.211 1.404 . . . . 10.0 107.404 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.7 63.03 1.55 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.116 0.413 . . . . 10.0 112.116 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -78.34 172.56 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 C-N-CA 123.412 0.685 . . . . 10.0 111.005 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -139.1 164.24 30.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 112.421 0.526 . . . . 10.0 112.421 -176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -144.6 161.69 38.5 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.718 1.207 . . . . 10.0 108.272 175.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -62.41 134.17 56.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.67 -1.233 . . . . 10.0 107.67 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.5 t -66.52 117.1 40.85 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 119.031 0.832 . . . . 10.0 109.748 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -69.88 -39.8 5.86 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.819 1.679 . . . . 10.0 111.241 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.88 -39.88 27.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.501 1.12 . . . . 10.0 113.635 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 20.8 p -113.12 16.23 19.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.196 0.998 . . . . 10.0 111.384 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 48.07 44.57 19.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 10.0 110.608 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.57 -2.36 16.45 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 115.627 1.011 . . . . 10.0 115.627 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -78.63 -2.67 40.14 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 120.028 1.914 . . . . 10.0 113.343 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.54 -0.28 2.22 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.176 0.893 . . . . 10.0 114.279 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -125.71 128.59 48.01 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.628 1.571 . . . . 10.0 109.971 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.41 144.68 25.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.588 -1.264 . . . . 10.0 107.588 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mm -108.62 73.74 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 124.515 1.126 . . . . 10.0 109.334 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -66.14 -27.82 68.32 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.152 -0.968 . . . . 10.0 108.719 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -104.16 80.23 0.42 Allowed Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 127.392 2.277 . . . . 10.0 110.061 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.36 121.69 9.01 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.292 2.661 . . . . 10.0 114.716 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 27.0 t -68.55 91.65 0.43 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 106.339 -1.726 . . . . 10.0 106.339 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -40.87 -44.19 2.23 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 125.347 1.459 . . . . 10.0 112.596 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -44.16 -37.22 3.01 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.08 0.952 . . . . 10.0 112.599 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -124.22 14.01 9.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.224 1.009 . . . . 10.0 111.243 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m80 45.73 43.24 9.46 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.46 1.104 . . . . 10.0 110.612 -175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.3 38.27 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.64 -37.82 59.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.011 1.906 . . . . 10.0 110.79 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.33 7.99 34.02 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.406 1.003 . . . . 10.0 114.925 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.77 155.37 45.61 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-N 119.162 1.481 . . . . 10.0 110.367 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.6 m -134.19 155.72 39.73 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 C-N-CA 125.136 1.374 . . . . 10.0 108.676 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -88.91 148.33 23.89 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.533 0.733 . . . . 10.0 109.424 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -75.56 49.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.795 0.838 . . . . 10.0 110.623 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.452 -0.336 0 O-C-N 121.077 -1.014 . . . . 10.0 111.021 -177.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 N-CA-C 109.143 -1.583 . . . . 10.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t -54.42 -34.82 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -63.08 -33.09 74.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.816 2.046 . . . . 10.0 112.302 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -85.25 -41.28 15.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.353 1.061 . . . . 10.0 109.44 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -56.8 145.69 28.55 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.02 0.928 . . . . 10.0 109.495 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt -71.22 66.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.782 0.833 . . . . 10.0 113.018 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -79.11 56.86 2.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.139 0.975 . . . . 10.0 109.644 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 pt -70.7 132.3 87.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.397 -0.811 . . . . 10.0 108.908 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -45.85 103.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.118 3.212 . . . . 10.0 112.965 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 m -134.05 129.21 35.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.4 mt -76.28 136.32 39.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 118.305 0.502 . . . . 10.0 109.667 -179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -134.02 146.12 50.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.627 1.171 . . . . 10.0 108.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -68.68 144.2 54.51 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.466 -0.568 . . . . 10.0 109.466 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.51 91.31 5.74 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -46.69 -38.9 10.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.415 1.486 . . . . 10.0 111.814 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.5 t -49.59 -43.01 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.392 1.477 . . . . 10.0 111.278 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.6 p -108.09 20.22 18.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.952 0.501 . . . . 10.0 110.688 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 52.84 38.56 27.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.152 1.381 . . . . 10.0 110.099 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.99 -3.11 47.6 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.411 -1.216 . . . . 10.0 115.167 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -78.0 -74.51 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 120.144 1.972 . . . . 10.0 111.36 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.9 -18.0 1.09 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.626 1.108 . . . . 10.0 111.847 -177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.73 140.9 31.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.662 1.731 . . . . 10.0 109.587 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.57 157.6 2.47 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 113.008 0.744 . . . . 10.0 113.008 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -41.67 136.72 2.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 124.643 3.562 . . . . 10.0 115.337 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.72 -60.25 2.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.582 0.611 . . . . 10.0 112.227 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.3 m -70.91 79.69 0.64 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.327 0.584 . . . . 10.0 109.928 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -57.78 162.95 4.43 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.183 0.993 . . . . 10.0 111.865 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.55 153.54 34.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.86 1.707 . . . . 10.0 110.215 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -98.49 135.0 40.67 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.797 -0.445 . . . . 10.0 109.797 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -50.82 124.93 12.14 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.058 0.943 . . . . 10.0 110.738 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -68.19 115.85 33.22 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 118.597 0.635 . . . . 10.0 109.445 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.25 -34.75 12.39 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.43 1.42 . . . . 10.0 110.806 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -46.25 -38.26 8.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.624 1.569 . . . . 10.0 113.22 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.23 15.29 13.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.315 1.046 . . . . 10.0 110.718 177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 50.0 40.59 21.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.973 0.909 . . . . 10.0 110.443 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.36 -8.06 10.34 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 123.851 0.739 . . . . 10.0 114.654 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.4 m -64.29 -28.29 69.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.918 1.359 . . . . 10.0 113.339 -176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 -16.79 57.56 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.483 1.04 . . . . 10.0 114.776 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.97 146.75 52.47 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.946 1.373 . . . . 10.0 110.455 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.23 155.14 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.271 1.428 . . . . 10.0 107.146 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -126.54 114.71 18.47 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.2 mtp -76.53 73.17 3.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.87 60.69 0.17 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.144 1.378 . . . . 10.0 112.408 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 48.29 0.63 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.504 1.122 . . . . 10.0 110.797 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.2 -61.78 2.22 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 121.344 -0.847 . . . . 10.0 112.432 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -102.35 -72.66 0.68 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.981 0.89 . . . . 10.0 113.359 -175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -73.64 68.99 1.25 Allowed 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.568 -0.708 . . . . 10.0 111.553 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.56 59.74 0.63 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.424 1.09 . . . . 10.0 111.35 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.0 m -78.6 151.96 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.123 0 C-N-CA 123.138 0.575 . . . . 10.0 111.295 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -105.1 150.88 24.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.414 1.086 . . . . 10.0 111.921 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -145.13 151.11 37.96 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 m -60.5 135.93 57.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.26 -1.015 . . . . 10.0 108.26 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.51 116.38 48.88 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.001 0.819 . . . . 10.0 109.29 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.02 -38.38 7.3 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.156 1.904 . . . . 10.0 111.33 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -45.3 -42.52 9.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.961 1.704 . . . . 10.0 112.258 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.6 p -115.21 20.79 14.69 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.195 0.998 . . . . 10.0 112.077 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 46.92 41.9 11.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.53 1.132 . . . . 10.0 111.354 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.22 -7.04 6.42 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.409 0.923 . . . . 10.0 115.409 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.34 -9.33 58.56 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.61 1.705 . . . . 10.0 113.443 -177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.02 3.33 10.63 Favored Glycine 0 CA--C 1.537 1.424 0 O-C-N 121.568 -0.707 . . . . 10.0 112.941 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.78 133.11 47.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.078 1.751 . . . . 10.0 109.933 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.3 mt -100.04 122.68 43.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.207 1.403 . . . . 10.0 109.905 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.5 mm -81.02 67.14 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.637 1.575 . . . . 10.0 107.092 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -57.56 -38.03 74.11 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.562 0.579 . . . . 10.0 112.562 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 p-10 -125.98 84.25 61.56 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.283 1.433 . . . . 10.0 110.44 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -49.53 132.34 29.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 124.959 3.773 . . . . 10.0 115.914 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.1 t -74.62 95.15 2.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -37.4 -50.05 1.04 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.76 1.624 . . . . 10.0 113.009 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -45.13 -36.15 3.54 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.397 1.079 . . . . 10.0 113.508 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.6 p -122.59 15.55 10.3 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.477 0.711 . . . . 10.0 110.951 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 43.98 45.33 6.51 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.939 1.295 . . . . 10.0 111.15 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 70.78 -3.1 13.51 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 116.291 1.277 . . . . 10.0 116.291 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -66.84 -36.88 83.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.14 1.97 . . . . 10.0 111.132 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.25 -9.48 56.17 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 123.99 0.805 . . . . 10.0 113.333 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.8 ptt85 -135.93 160.93 37.08 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.453 1.126 . . . . 10.0 110.14 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.71 157.93 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 125.344 1.457 . . . . 10.0 107.895 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -103.29 126.97 50.73 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.861 0.864 . . . . 10.0 109.096 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -77.09 62.93 2.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.454 -0.249 0 O-C-N 121.463 -0.773 . . . . 10.0 110.919 -177.317 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 109.192 -1.563 . . . . 10.0 109.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 34.6 m -67.46 152.53 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 117.193 0.497 . . . . 10.0 109.921 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t -64.85 154.32 37.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.029 0.442 . . . . 10.0 110.069 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -65.49 -28.26 69.07 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.08 57.76 2.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.801 -0.562 . . . . 10.0 111.476 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.6 pt -66.11 -15.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 120.892 0.377 . . . . 10.0 111.351 175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -76.56 51.76 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.342 1.857 . . . . 10.0 108.851 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -55.48 138.11 68.81 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 123.078 0.551 . . . . 10.0 110.222 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.59 51.79 3.09 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.301 2.668 . . . . 10.0 112.88 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 m -81.11 55.82 2.63 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.1 mt -140.02 137.13 34.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.361 1.464 . . . . 10.0 108.687 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -109.0 128.36 54.89 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.226 1.811 . . . . 10.0 107.656 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.05 128.89 39.06 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.573 0.749 . . . . 10.0 109.84 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.2 t -79.48 88.99 5.03 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.032 -0.729 . . . . 10.0 109.032 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -49.3 -36.01 19.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.064 1.346 . . . . 10.0 111.418 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -49.47 -48.29 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.796 1.238 . . . . 10.0 110.402 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 16.1 p -103.21 23.45 12.39 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.411 0.624 . . . . 10.0 111.001 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 53.33 37.14 24.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.259 1.424 . . . . 10.0 110.604 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.45 47.37 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.592 -1.115 . . . . 10.0 115.109 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.0 p -84.52 -69.57 0.64 Allowed 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.751 1.775 . . . . 10.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.58 -24.89 1.51 Allowed Glycine 0 CA--C 1.53 1.005 0 C-N-CA 126.205 1.859 . . . . 10.0 109.994 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.99 131.86 40.95 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.804 0.802 . . . . 10.0 111.063 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.7 143.34 6.01 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.849 -0.596 . . . . 10.0 111.741 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -22.27 126.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 1 C-N-CA 127.321 5.347 . . . . 10.0 117.163 -176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.1 -48.25 2.39 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.848 0.737 . . . . 10.0 112.831 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.89 128.74 38.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.246 1.418 . . . . 10.0 109.772 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.56 152.47 63.75 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 122.032 -0.418 . . . . 10.0 111.481 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 179.28 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.072 1.848 . . . . 10.0 108.941 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -121.5 131.72 54.31 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -50.49 125.32 12.57 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.056 0.942 . . . . 10.0 112.088 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.36 116.08 45.6 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.5 -38.79 7.86 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.353 1.368 . . . . 10.0 110.589 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -45.2 -39.42 6.25 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.314 1.846 . . . . 10.0 113.06 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.37 30.68 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.744 0.818 . . . . 10.0 110.641 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 39.78 47.96 1.89 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.305 1.442 . . . . 10.0 113.261 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.87 -4.17 39.61 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 116.279 1.272 . . . . 10.0 116.279 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.7 p -84.14 -68.99 0.67 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.127 1.964 . . . . 10.0 111.939 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.19 -5.28 0.65 Allowed Glycine 0 CA--C 1.53 1.019 0 CA-C-O 118.261 -1.299 . . . . 10.0 116.277 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.67 143.55 47.32 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.46 2.13 . . . . 10.0 112.459 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -99.4 130.38 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.611 1.564 . . . . 10.0 108.153 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -103.21 106.31 16.79 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.045 0.538 . . . . 10.0 109.728 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.3 tpp -77.44 72.76 4.0 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -62.4 65.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.38 2.272 . . . . 10.0 112.98 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -79.25 70.07 5.58 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -136.96 27.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.945 -1.262 . . . . 10.0 109.945 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -55.1 -34.93 64.1 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.074 0.95 . . . . 10.0 112.128 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -74.29 72.13 1.76 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.743 0.817 . . . . 10.0 110.164 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.16 58.5 0.51 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.544 1.138 . . . . 10.0 111.544 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 m -81.47 157.35 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 C-N-CA 123.538 0.735 . . . . 10.0 109.791 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -145.25 164.97 29.74 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 116.224 -0.444 . . . . 10.0 111.227 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.69 153.38 42.41 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.043 1.337 . . . . 10.0 108.021 -175.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.7 m -60.44 136.4 58.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.602 -0.518 . . . . 10.0 109.602 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -71.74 116.77 51.39 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.42 -39.21 7.44 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.08 1.853 . . . . 10.0 112.116 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -51.42 -36.88 45.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.609 0.966 . . . . 10.0 113.609 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.1 p -112.82 16.69 19.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.077 0.951 . . . . 10.0 111.28 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 47.77 42.9 16.43 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.987 1.315 . . . . 10.0 110.813 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.78 1.07 53.5 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -87.8 5.65 39.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.623 1.711 . . . . 10.0 113.583 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.42 -3.88 0.75 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.091 0.853 . . . . 10.0 115.009 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -121.81 125.96 47.7 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.417 1.487 . . . . 10.0 111.255 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.68 152.59 23.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.89 85.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -66.89 -23.05 65.96 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.933 -0.395 . . . . 10.0 109.933 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -111.62 68.3 0.75 Allowed Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 128.294 2.638 . . . . 10.0 109.973 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.31 133.74 27.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.269 2.646 . . . . 10.0 115.491 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.0 t -70.24 93.16 0.82 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.336 -1.357 . . . . 10.0 107.336 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -40.62 -45.4 2.33 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.693 1.597 . . . . 10.0 112.582 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -42.35 -40.01 2.35 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.348 1.459 . . . . 10.0 112.464 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -124.83 23.08 8.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.906 0.883 . . . . 10.0 110.591 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 46.22 40.96 8.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.987 1.315 . . . . 10.0 111.069 -177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.04 14.89 48.09 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-O 118.814 -0.992 . . . . 10.0 115.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.02 -23.57 44.24 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.726 1.763 . . . . 10.0 110.578 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.97 3.18 80.09 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.649 1.595 . . . . 10.0 114.38 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.08 153.1 31.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.304 1.052 . . . . 10.0 109.288 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.09 140.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 107.752 -1.203 . . . . 10.0 107.752 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -66.16 134.2 52.26 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.727 -0.608 . . . . 10.0 110.646 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.0 ttm105 -77.47 65.21 2.96 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.674 -0.862 . . . . 10.0 108.674 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.342 1.057 . . . . 10.0 109.045 -179.224 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.856 0 N-CA-C 110.114 -1.194 . . . . 10.0 110.114 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.15 174.57 7.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 C-N-CA 125.32 1.448 . . . . 10.0 107.952 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.9 p -74.6 61.12 0.94 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.26 1.024 . . . . 10.0 111.433 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -94.37 -44.32 7.97 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.625 1.17 . . . . 10.0 108.124 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -78.08 51.02 0.94 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.305 0.642 . . . . 10.0 111.475 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.37 61.62 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 121.764 0.792 . . . . 10.0 109.871 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -79.73 71.98 6.41 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 94.4 mt -42.56 135.19 2.66 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 125.455 1.502 . . . . 10.0 108.669 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -70.1 62.19 1.95 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.831 3.02 . . . . 10.0 113.878 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.5 m -142.41 54.62 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 105.038 -2.208 . . . . 10.0 105.038 174.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 77' ' ' GLU . 62.3 mt -141.43 155.43 45.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.815 1.646 . . . . 10.0 108.11 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -132.23 124.58 29.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.034 1.733 . . . . 10.0 108.15 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -62.43 135.05 57.25 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.291 0.636 . . . . 10.0 110.02 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 51.4 t -69.75 114.56 8.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -54.77 -42.78 72.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.228 0.611 . . . . 10.0 111.018 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -54.08 -49.59 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.346 1.058 . . . . 10.0 112.447 -178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 26.6 p -95.65 -0.44 51.72 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.609 0.64 . . . . 10.0 112.061 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 66.74 40.52 3.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.766 1.227 . . . . 10.0 109.437 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.39 -3.51 39.98 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.151 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.5 p -75.68 -69.22 0.5 Allowed 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.073 1.937 . . . . 10.0 110.362 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.26 -8.47 4.72 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 128.08 2.752 . . . . 10.0 109.443 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.7 133.93 39.37 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.141 0.971 . . . . 10.0 110.728 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -44.91 142.6 2.59 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.258 1.423 . . . . 10.0 110.69 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -51.92 141.68 45.41 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.659 2.239 . . . . 10.0 110.906 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.75 21.04 34.78 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.642 0.639 . . . . 10.0 113.144 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.8 m -134.03 160.56 37.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -121.7 148.7 51.34 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.197 0.999 . . . . 10.0 111.825 -175.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.09 -179.05 5.09 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.15 2.566 . . . . 10.0 108.395 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -117.23 129.71 56.1 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.7 m -49.02 123.53 7.3 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.745 1.218 . . . . 10.0 110.845 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.2 t -65.68 115.83 26.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.85 -35.69 11.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.646 1.564 . . . . 10.0 111.092 -177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.71 -38.24 9.6 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.767 1.627 . . . . 10.0 112.997 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 p -117.45 15.59 14.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 111.333 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.7 40.91 21.05 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.18 0.992 . . . . 10.0 110.376 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.18 -11.79 7.88 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 123.628 0.632 . . . . 10.0 114.535 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -66.98 -11.85 58.02 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.997 1.398 . . . . 10.0 114.302 -176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.66 41.23 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.795 -0.566 . . . . 10.0 113.384 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 125.56 33.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.536 1.134 . . . . 10.0 109.163 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -77.32 131.3 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.72 111.5 21.9 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 79.0 mmm -74.24 72.35 1.75 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.003 1.321 . . . . 10.0 108.274 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -66.21 62.48 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.519 1.928 . . . . 10.0 112.704 -177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.0 51.86 1.01 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.648 1.179 . . . . 10.0 110.435 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.06 -67.28 0.48 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.27 0.938 . . . . 10.0 113.291 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -98.23 -72.51 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.76 1.224 . . . . 10.0 112.655 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -77.35 69.72 3.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.179 0.899 . . . . 10.0 110.881 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.8 59.68 0.9 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.805 0.842 . . . . 10.0 111.546 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.0 m -82.22 163.59 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.14 0.576 . . . . 10.0 110.246 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -125.04 171.17 10.46 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.519 1.303 . . . . 10.0 114.519 -175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -141.23 154.04 45.58 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.9 -1.889 . . . . 10.0 105.9 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -62.21 133.52 55.31 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -72.37 117.16 56.33 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.849 0.75 . . . . 10.0 109.62 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.16 -36.38 5.76 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.166 1.911 . . . . 10.0 111.286 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -48.56 -39.57 24.09 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.529 1.132 . . . . 10.0 112.543 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 23.7 p -117.62 20.12 13.61 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 124.249 1.019 . . . . 10.0 110.806 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 42.92 45.49 4.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.437 1.495 . . . . 10.0 112.177 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.94 -9.2 5.36 Favored Glycine 0 CA--C 1.538 1.505 0 N-CA-C 115.237 0.855 . . . . 10.0 115.237 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -73.57 -8.44 55.97 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.257 1.529 . . . . 10.0 112.363 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 -13.06 0.55 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.533 1.063 . . . . 10.0 115.167 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.79 133.52 55.95 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.833 1.653 . . . . 10.0 110.904 -174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.0 116.91 28.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.17 66.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.633 1.573 . . . . 10.0 108.438 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -62.61 -34.08 76.29 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.255 0.55 . . . . 10.0 109.713 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -107.98 79.91 0.96 Allowed Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 128.145 2.578 . . . . 10.0 109.69 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 125.79 14.41 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.477 2.118 . . . . 10.0 114.998 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.32 87.13 0.43 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -38.64 -44.7 1.01 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.218 1.807 . . . . 10.0 112.83 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -44.7 -41.42 6.76 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.801 1.24 . . . . 10.0 112.362 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.99 27.4 8.09 Favored 'General case' 0 CA--C 1.528 0.135 0 C-N-CA 123.668 0.787 . . . . 10.0 109.963 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 45.62 37.72 3.45 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.937 1.695 . . . . 10.0 111.827 -179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.91 9.46 46.7 Favored Glycine 0 CA--C 1.534 1.272 0 N-CA-C 114.98 0.752 . . . . 10.0 114.98 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -70.66 -32.16 69.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.299 1.55 . . . . 10.0 109.563 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.44 -23.71 32.49 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.19 1.376 . . . . 10.0 113.525 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.32 151.5 47.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.267 1.034 . . . . 10.0 109.736 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.26 154.67 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.965 1.306 . . . . 10.0 107.662 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.487 ' HA ' HD23 ' A' ' 11' ' ' LEU . 35.0 tt0 -69.42 142.89 53.76 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.577 -0.702 . . . . 10.0 110.216 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -69.42 70.84 0.28 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.734 1.214 . . . . 10.0 109.515 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.447 -0.61 0 C-N-CA 125.771 1.628 . . . . 10.0 110.653 -176.211 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.814 0 N-CA-C 110.501 -1.04 . . . . 10.0 110.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.0 m -54.52 71.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.312 2.245 . . . . 10.0 113.877 -178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -145.55 -78.57 0.18 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.497 1.919 . . . . 10.0 107.312 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -141.22 -56.36 0.49 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.73 2.412 . . . . 10.0 106.126 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -74.88 72.55 2.09 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.12 63.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.785 1.634 . . . . 10.0 111.639 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.8 mtm105 -76.55 59.18 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.991 1.316 . . . . 10.0 111.811 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 ' N ' ' CD ' ' A' ' 9' ' ' PRO 0.278 9.3 mm -60.33 -49.4 90.66 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 121.106 -0.237 . . . . 10.0 110.77 174.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 8' ' ' ILE . 18.3 Cg_exo -67.88 175.24 6.63 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 124.471 3.448 . . . . 10.0 109.761 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -59.73 59.82 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.386 2.674 . . . . 10.0 114.346 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 77' ' ' GLU . 81.5 mt -132.54 145.75 51.38 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.655 1.182 . . . . 10.0 111.555 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -119.22 144.35 46.78 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.463 1.505 . . . . 10.0 109.929 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.78 135.74 56.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.6 t -77.98 87.34 4.15 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -46.46 -38.53 9.29 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.55 1.54 . . . . 10.0 111.312 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.69 -43.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.897 1.279 . . . . 10.0 111.029 177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.4 p -105.64 13.99 29.06 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 122.845 0.458 . . . . 10.0 111.802 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 53.79 33.15 16.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 10.0 110.496 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.23 3.8 33.14 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.777 -1.013 . . . . 10.0 114.861 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.5 p -83.93 -24.55 30.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.602 1.701 . . . . 10.0 112.208 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.74 -9.99 74.73 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 119.029 -0.873 . . . . 10.0 110.927 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -97.6 139.11 33.98 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.862 1.331 . . . . 10.0 111.267 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -50.5 155.46 1.82 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.277 0.631 . . . . 10.0 111.56 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -28.53 121.82 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 1 C-N-CA 125.308 4.005 . . . . 10.0 116.292 -176.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.86 16.39 1.18 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.165 1.841 . . . . 10.0 116.021 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.4 m -93.08 119.51 32.39 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.193 1.496 . . . . 10.0 108.615 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 0.0 OUTLIER -59.09 128.28 84.93 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 118.516 -0.754 . . . . 10.0 111.085 -178.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 19.5 Cg_exo -68.31 -175.97 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.522 2.148 . . . . 10.0 111.618 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -122.33 120.64 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.774 1.63 . . . . 10.0 107.295 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -48.97 124.77 9.24 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.621 1.168 . . . . 10.0 111.442 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.2 117.32 48.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.62 -38.5 8.02 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.432 1.421 . . . . 10.0 110.898 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -40.1 11.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.962 1.705 . . . . 10.0 113.221 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -117.2 21.84 12.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.822 0.849 . . . . 10.0 111.174 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 45.52 43.63 9.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.354 1.062 . . . . 10.0 111.676 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.91 -4.03 25.13 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.422 -1.21 . . . . 10.0 115.987 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.9 p -68.53 -58.05 4.88 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.197 1.998 . . . . 10.0 111.609 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.77 3.31 7.74 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.233 1.873 . . . . 10.0 110.85 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.7 131.06 33.03 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.803 1.301 . . . . 10.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.9 m -87.09 157.92 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.684 1.193 . . . . 10.0 108.558 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -123.81 112.7 17.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.683 1.193 . . . . 10.0 108.132 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.28 73.08 3.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -68.68 64.41 0.11 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.04 1.336 . . . . 10.0 111.885 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.99 59.03 2.07 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.437 1.095 . . . . 10.0 110.439 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.69 -66.3 1.08 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.253 0.93 . . . . 10.0 113.028 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -109.68 -65.94 1.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.86 0.864 . . . . 10.0 112.743 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -73.77 68.49 1.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.911 -0.493 . . . . 10.0 111.324 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.26 63.96 1.06 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.605 1.162 . . . . 10.0 112.077 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.1 m -75.08 160.28 5.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 C-N-CA 123.12 0.568 . . . . 10.0 111.707 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -117.91 152.46 35.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.935 0.894 . . . . 10.0 112.907 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -147.1 154.98 41.78 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.366 1.067 . . . . 10.0 108.564 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.0 m -60.7 139.38 57.89 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 174.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.8 t -75.37 116.72 57.27 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.906 -0.776 . . . . 10.0 108.906 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.54 -37.73 5.19 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.913 1.742 . . . . 10.0 110.891 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -49.53 -38.93 32.56 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.958 1.303 . . . . 10.0 113.37 -176.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.4 p -115.7 23.21 12.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.507 1.123 . . . . 10.0 110.988 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 41.25 49.22 3.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.485 1.514 . . . . 10.0 111.987 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.45 -3.55 11.22 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 116.449 1.34 . . . . 10.0 116.449 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -73.81 -31.34 63.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.173 1.986 . . . . 10.0 112.318 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.57 -6.86 83.16 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 111.572 -0.611 . . . . 10.0 111.572 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.6 p -116.65 122.87 45.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.708 1.203 . . . . 10.0 111.628 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.4 mt -91.23 171.61 9.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.695 -1.594 . . . . 10.0 106.695 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.53 126.59 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -67.52 -37.63 83.06 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.293 -1.003 . . . . 10.0 108.293 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -109.62 76.79 0.93 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.689 2.396 . . . . 10.0 108.855 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.75 157.06 61.71 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.894 2.396 . . . . 10.0 113.614 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.23 85.71 0.57 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.982 0.913 . . . . 10.0 109.307 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.7 p-10 -36.94 -47.38 0.7 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.357 1.863 . . . . 10.0 112.606 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -40.9 -39.53 1.17 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.946 1.698 . . . . 10.0 112.597 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.2 p -127.21 25.1 6.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.823 0.849 . . . . 10.0 110.927 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 49.39 35.96 8.91 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.613 0.765 . . . . 10.0 110.237 -176.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.6 21.85 29.98 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.78 -1.011 . . . . 10.0 114.64 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -27.52 60.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.397 1.599 . . . . 10.0 111.29 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.99 -8.79 65.44 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.63 1.11 . . . . 10.0 111.976 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -139.46 153.66 47.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.094 0.947 . . . . 10.0 111.125 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 m -127.36 173.71 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 127.027 2.131 . . . . 10.0 106.914 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HA ' HD23 ' A' ' 11' ' ' LEU . 34.5 tt0 -77.75 139.9 39.43 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.525 -0.734 . . . . 10.0 111.434 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -71.19 67.79 0.47 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.944 2.098 . . . . 10.0 108.109 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.942 1.697 . . . . 10.0 110.703 -175.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 108.668 -1.773 . . . . 10.0 108.668 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -56.17 -29.14 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.407 0.683 . . . . 10.0 110.365 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 p -55.24 -35.62 65.15 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.817 1.647 . . . . 10.0 110.922 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.83 -51.09 5.25 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -76.81 60.23 1.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.95 0.9 . . . . 10.0 111.061 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 pt -78.71 64.08 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -75.55 61.12 1.28 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.523 1.129 . . . . 10.0 110.632 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 pt -138.21 154.51 74.01 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 126.679 1.992 . . . . 10.0 107.187 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.32 73.26 0.83 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 124.533 3.489 . . . . 10.0 109.803 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 m -71.0 112.06 6.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.597 1.159 . . . . 10.0 109.853 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.61 149.31 34.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -139.53 150.77 45.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.397 1.479 . . . . 10.0 107.463 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -79.58 137.37 37.11 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.014 0.526 . . . . 10.0 109.587 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -76.36 89.22 3.18 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.474 -0.936 . . . . 10.0 108.474 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -44.18 -39.78 4.6 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.912 1.685 . . . . 10.0 112.153 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -49.25 -42.35 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.457 1.503 . . . . 10.0 111.83 178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.1 p -108.32 18.72 20.73 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.828 0.851 . . . . 10.0 110.386 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 52.57 36.49 20.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.209 1.404 . . . . 10.0 110.086 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.95 -0.87 35.21 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.393 -1.226 . . . . 10.0 114.982 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.5 p -73.27 -67.22 0.6 Allowed 'General case' 0 C--N 1.34 0.187 0 CA-C-N 120.066 1.933 . . . . 10.0 111.194 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.66 -17.36 3.27 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.267 1.889 . . . . 10.0 110.031 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.98 154.12 38.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.509 1.155 . . . . 10.0 108.92 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 pttm -54.99 167.9 0.58 Allowed Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 119.871 1.214 . . . . 10.0 113.38 -174.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -39.99 122.98 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.899 3.066 . . . . 10.0 114.325 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.61 26.22 7.39 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.806 1.193 . . . . 10.0 114.461 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.0 m -113.92 145.94 40.78 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.269 -1.382 . . . . 10.0 107.269 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -92.26 151.05 41.23 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 117.947 0.339 . . . . 10.0 110.744 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.59 -179.37 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.235 1.957 . . . . 10.0 108.067 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -110.11 125.5 53.05 Favored 'General case' 0 C--O 1.226 -0.149 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -49.42 124.73 9.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.142 0.977 . . . . 10.0 110.343 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -67.47 116.72 39.98 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.52 -37.78 6.95 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.844 1.696 . . . . 10.0 110.915 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -45.58 -40.82 9.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.1 1.76 . . . . 10.0 112.957 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.7 p -113.8 16.64 18.43 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.034 0.934 . . . . 10.0 111.534 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.26 42.3 13.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.301 1.041 . . . . 10.0 110.594 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.18 -4.95 5.49 Favored Glycine 0 CA--C 1.537 1.419 0 CA-C-O 118.475 -1.181 . . . . 10.0 115.775 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.6 p -67.53 -36.32 80.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.452 2.126 . . . . 10.0 111.972 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.93 5.36 50.56 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.506 1.05 . . . . 10.0 112.651 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -134.02 150.17 51.22 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.993 1.397 . . . . 10.0 111.0 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.4 130.07 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -115.67 110.47 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.522 0.677 . . . . 10.0 109.796 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 62.3 mmm -73.25 79.96 1.32 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.106 1.362 . . . . 10.0 107.328 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -72.73 67.72 0.81 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.008 0.923 . . . . 10.0 110.012 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -72.37 70.3 0.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.725 1.21 . . . . 10.0 110.798 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 -63.63 2.07 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.421 1.01 . . . . 10.0 111.957 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -146.72 -35.84 0.25 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.364 0.666 . . . . 10.0 112.707 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -75.46 59.59 1.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.538 1.063 . . . . 10.0 109.991 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.27 128.58 36.42 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.741 0.816 . . . . 10.0 111.275 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.52 155.88 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 106.868 -1.53 . . . . 10.0 106.868 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.81 161.48 37.46 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 112.775 0.657 . . . . 10.0 112.775 -173.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.63 163.86 31.77 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.631 1.172 . . . . 10.0 108.57 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 m -61.78 137.51 58.25 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.1 t -69.98 117.29 52.49 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.861 0.755 . . . . 10.0 109.148 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 -40.31 5.18 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.124 1.882 . . . . 10.0 111.479 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.09 -39.58 20.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.798 1.239 . . . . 10.0 113.284 -177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.4 p -116.08 21.73 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.102 0.961 . . . . 10.0 111.48 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 44.1 44.97 6.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.561 1.145 . . . . 10.0 111.517 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 -6.14 8.26 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.214 1.246 . . . . 10.0 116.214 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.0 mtm-85 -76.69 -8.72 57.81 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.361 2.08 . . . . 10.0 112.672 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.08 6.12 23.87 Favored Glycine 0 CA--C 1.536 1.349 0 O-C-N 121.496 -0.752 . . . . 10.0 112.449 -174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.87 131.28 38.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.748 1.219 . . . . 10.0 111.574 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.87 122.26 32.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.532 1.533 . . . . 10.0 107.699 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 34.8 mm -75.74 77.33 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 124.694 1.198 . . . . 10.0 108.815 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -37.2 -51.51 1.02 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.805 2.042 . . . . 10.0 111.792 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.24 119.01 10.18 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.854 1.662 . . . . 10.0 106.673 -178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.43 126.46 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.34 2.027 . . . . 10.0 113.782 -174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.65 94.63 0.8 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.597 1.159 . . . . 10.0 109.14 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -38.25 -48.98 1.35 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.346 1.458 . . . . 10.0 112.727 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -43.93 -38.23 3.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 24.7 p -122.2 11.7 10.17 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.438 0.695 . . . . 10.0 110.882 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.1 m80 45.83 45.79 11.71 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.791 1.236 . . . . 10.0 111.495 -175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.41 7.86 28.58 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 119.06 -0.855 . . . . 10.0 114.838 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.49 -11.53 60.48 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.349 1.574 . . . . 10.0 110.567 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 -49.11 3.56 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.564 0.602 . . . . 10.0 112.333 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.59 168.2 9.64 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.158 0.983 . . . . 10.0 110.797 177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.51 157.94 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 126.559 1.944 . . . . 10.0 106.383 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -99.3 132.78 44.38 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.077 -1.082 . . . . 10.0 108.077 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -68.98 76.13 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.329 -1.36 . . . . 10.0 107.329 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.149 1.379 . . . . 10.0 110.569 -174.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.513 0 N-CA-C 108.856 -1.698 . . . . 10.0 108.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.82 -26.75 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.488 0.715 . . . . 10.0 111.257 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -68.01 -42.43 80.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.681 1.993 . . . . 10.0 110.897 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -79.76 -38.1 33.95 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.535 1.134 . . . . 10.0 110.472 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -72.25 68.85 0.76 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.228 1.011 . . . . 10.0 109.831 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.6 pt -67.49 66.11 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.756 1.622 . . . . 10.0 112.597 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.8 ptt-85 -74.31 60.07 0.81 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.294 1.838 . . . . 10.0 110.604 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.9 mm -56.4 121.23 41.53 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.168 -0.92 . . . . 10.0 108.544 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.35 74.65 1.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.598 2.865 . . . . 10.0 110.217 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -79.72 62.8 4.09 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.45 1.5 . . . . 10.0 108.181 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.0 mt -79.12 121.08 24.56 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.473 0.709 . . . . 10.0 111.587 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -106.12 131.19 53.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -56.86 124.89 20.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.728 1.211 . . . . 10.0 109.699 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -78.99 87.23 4.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.451 -0.574 . . . . 10.0 109.451 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.23 -36.28 13.58 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.563 1.545 . . . . 10.0 111.549 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.7 t -49.75 -49.46 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.725 1.21 . . . . 10.0 110.303 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.5 p -99.86 19.2 16.52 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.116 0.484 . . . . 10.0 110.945 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 56.39 34.4 24.11 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.651 1.181 . . . . 10.0 109.687 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.7 -1.98 34.66 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.791 -1.005 . . . . 10.0 115.086 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.3 p -76.04 -67.4 0.68 Allowed 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.671 1.735 . . . . 10.0 110.67 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.37 -22.51 2.05 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.869 1.223 . . . . 10.0 111.804 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.85 147.75 23.59 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.963 1.382 . . . . 10.0 109.991 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 154.01 1.62 Allowed Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 113.446 0.906 . . . . 10.0 113.446 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -34.35 128.43 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 125.503 4.136 . . . . 10.0 115.902 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.49 -49.4 1.97 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.867 0.746 . . . . 10.0 113.132 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -75.31 69.25 2.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.471 1.109 . . . . 10.0 109.355 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.04 156.67 18.92 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.105 1.762 . . . . 10.0 110.328 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -65.63 176.64 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.283 1.988 . . . . 10.0 111.168 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -112.87 136.87 52.04 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.3 m -54.0 123.55 12.92 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.539 0.735 . . . . 10.0 111.176 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.0 t -69.62 119.32 70.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.982 -1.118 . . . . 10.0 107.982 176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.67 -37.47 9.33 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 121.608 1.539 . . . . 10.0 111.399 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.55 -49.14 27.17 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.305 1.442 . . . . 10.0 112.61 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.8 p -99.08 11.85 37.8 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.618 0.767 . . . . 10.0 111.611 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 51.38 46.73 26.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.528 0.731 . . . . 10.0 109.306 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.47 -2.33 1.21 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.38 0.991 . . . . 10.0 114.703 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -90.46 11.72 20.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.736 1.268 . . . . 10.0 113.426 -174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.6 -26.54 0.61 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 116.417 1.327 . . . . 10.0 116.417 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.75 136.1 53.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.657 1.229 . . . . 10.0 110.908 -177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 m -87.67 158.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.768 -1.938 . . . . 10.0 105.768 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -135.17 114.59 12.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.784 -0.45 . . . . 10.0 109.784 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.36 75.83 3.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -68.33 63.19 0.1 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.504 1.521 . . . . 10.0 113.426 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.44 52.79 0.99 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.586 0.754 . . . . 10.0 110.345 176.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.14 -68.44 0.34 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.353 0.978 . . . . 10.0 113.417 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -96.39 -71.47 0.67 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.909 1.283 . . . . 10.0 112.4 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -77.04 68.9 3.26 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 119.237 0.926 . . . . 10.0 110.94 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.8 0.96 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.211 1.004 . . . . 10.0 110.633 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.8 m -75.48 140.32 17.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 121.757 0.789 . . . . 10.0 112.691 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -91.77 154.44 18.93 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.037 -0.983 . . . . 10.0 111.504 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.27 152.04 42.63 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 173.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.7 m -65.5 131.88 47.52 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.52 117.43 55.14 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 119.087 0.858 . . . . 10.0 109.616 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.15 -38.44 6.95 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.754 1.636 . . . . 10.0 111.051 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.86 -37.54 2.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.408 1.483 . . . . 10.0 113.259 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 p -127.41 25.75 6.07 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.192 0.997 . . . . 10.0 110.887 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 41.94 48.5 3.93 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.813 1.245 . . . . 10.0 112.196 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.98 -8.77 7.44 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 115.564 0.985 . . . . 10.0 115.564 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -75.29 -8.87 57.82 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.792 1.796 . . . . 10.0 113.406 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.14 0.29 4.23 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.873 0.749 . . . . 10.0 114.588 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.48 129.46 51.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.144 1.377 . . . . 10.0 110.58 -174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -84.52 107.16 16.61 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.86 -1.904 . . . . 10.0 105.86 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.67 74.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.788 1.235 . . . . 10.0 108.68 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -40.42 -50.76 2.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.357 1.863 . . . . 10.0 112.501 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -142.87 99.99 5.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.875 1.67 . . . . 10.0 107.585 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.04 141.4 57.77 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.387 2.725 . . . . 10.0 116.113 -171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.9 t -77.76 93.81 4.37 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.357 1.463 . . . . 10.0 107.679 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -41.25 -45.59 2.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.956 1.703 . . . . 10.0 112.544 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -43.35 -38.8 2.84 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.171 1.788 . . . . 10.0 112.685 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.2 p -123.22 23.37 9.15 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.067 0.947 . . . . 10.0 110.653 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.0 39.01 5.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.312 1.445 . . . . 10.0 111.388 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.68 -2.59 39.22 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-O 118.578 -1.124 . . . . 10.0 115.75 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.32 -29.97 63.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 120.283 2.041 . . . . 10.0 111.906 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.95 7.84 60.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.829 1.204 . . . . 10.0 114.027 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.15 150.51 29.95 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.147 0.974 . . . . 10.0 109.331 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.1 m -111.05 132.13 60.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 109.05 -0.722 . . . . 10.0 109.05 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -84.31 101.57 12.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.393 0.677 . . . . 10.0 109.18 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -79.84 60.86 3.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.149 -0.685 . . . . 10.0 109.149 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.457 -0.105 0 C-N-CA 124.894 1.278 . . . . 10.0 108.613 -179.831 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.595 -1.002 . . . . 10.0 110.595 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -50.2 -33.19 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.838 1.255 . . . . 10.0 111.326 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -50.05 -32.72 16.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.815 2.046 . . . . 10.0 112.078 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -66.2 -29.01 69.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.764 -0.585 . . . . 10.0 111.344 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -78.17 56.13 1.61 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.474 0.709 . . . . 10.0 111.424 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.21 -17.68 16.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.941 0.897 . . . . 10.0 112.282 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -56.11 -30.32 61.9 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 125.008 1.323 . . . . 10.0 110.781 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.2 tt -125.13 85.01 58.6 Favored Pre-proline 0 N--CA 1.452 -0.338 0 N-CA-C 105.876 -1.898 . . . . 10.0 105.876 177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.04 179.38 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.332 2.021 . . . . 10.0 112.239 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -163.53 160.24 22.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 105.503 -2.036 . . . . 10.0 105.503 175.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 75.5 mt -109.51 144.44 37.78 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -131.25 139.91 49.73 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.713 1.605 . . . . 10.0 107.922 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -72.46 140.32 48.21 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.26 93.95 4.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.065 -1.087 . . . . 10.0 108.065 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -48.56 -37.26 17.4 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.43 1.492 . . . . 10.0 111.628 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.0 t -53.08 -40.94 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.269 1.028 . . . . 10.0 110.9 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.5 p -106.05 20.31 19.15 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.573 0.624 . . . . 10.0 110.748 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.81 35.19 23.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.847 1.259 . . . . 10.0 110.197 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 7.86 67.44 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 118.206 -1.33 . . . . 10.0 114.848 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.1 p -85.5 -74.06 0.42 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.943 1.872 . . . . 10.0 110.401 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.46 -20.15 1.04 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.982 1.753 . . . . 10.0 112.242 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.98 154.18 20.7 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.241 1.521 . . . . 10.0 110.584 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -49.63 148.51 5.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 118.41 0.55 . . . . 10.0 112.458 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -40.1 135.76 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 125.129 3.886 . . . . 10.0 114.692 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.73 -52.91 2.02 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.233 0.921 . . . . 10.0 112.653 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.6 m -73.6 79.77 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.881 0.872 . . . . 10.0 109.203 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.11 156.48 13.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.904 0.882 . . . . 10.0 111.369 -178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.89 168.39 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.78 2.32 . . . . 10.0 113.231 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -90.26 121.8 32.6 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 m -52.44 124.62 13.92 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.911 0.884 . . . . 10.0 110.223 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.65 118.49 54.81 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 108.728 -0.842 . . . . 10.0 108.728 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.33 -37.61 9.95 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.567 1.512 . . . . 10.0 111.505 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -46.57 -47.59 19.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.084 1.354 . . . . 10.0 113.161 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.0 p -100.73 6.41 43.92 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.75 0.82 . . . . 10.0 111.139 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 54.31 39.56 30.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.702 -0.851 . . . . 10.0 108.702 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.37 -9.66 13.57 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.731 0.681 . . . . 10.0 113.943 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -72.0 4.86 3.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.602 1.704 . . . . 10.0 115.602 -175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.05 -28.93 0.95 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 115.821 1.089 . . . . 10.0 115.821 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.65 154.46 46.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.22 1.01 . . . . 10.0 109.61 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 m -102.29 147.32 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -113.46 109.34 18.52 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.1 tpp -102.41 139.72 37.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.428 1.491 . . . . 10.0 109.331 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.0 ttp85 -90.65 107.77 19.38 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 58.88 1.36 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.294 0.569 . . . . 10.0 111.503 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.43 -44.19 2.18 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 121.124 -0.985 . . . . 10.0 111.624 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -114.02 -72.54 0.7 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.884 1.274 . . . . 10.0 111.672 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -102.54 163.06 12.44 Favored 'General case' 0 N--CA 1.458 -0.053 0 C-N-CA 124.845 1.258 . . . . 10.0 112.9 -172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.75 128.9 34.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.799 1.24 . . . . 10.0 109.924 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -134.57 148.63 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 124.68 1.192 . . . . 10.0 108.553 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -100.84 145.25 28.8 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.525 0.73 . . . . 10.0 111.778 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -137.28 142.48 41.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.2 m -57.63 135.21 56.68 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.397 0.544 . . . . 10.0 110.013 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.2 t -75.97 117.9 67.23 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 108.885 -0.783 . . . . 10.0 108.885 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.38 -37.85 7.17 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.25 1.967 . . . . 10.0 112.062 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -48.73 -38.82 22.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.796 1.239 . . . . 10.0 113.143 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.3 p -115.43 21.42 14.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.849 1.26 . . . . 10.0 111.189 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 44.01 45.4 6.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.922 1.289 . . . . 10.0 111.355 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.49 -9.71 7.51 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.52 -1.156 . . . . 10.0 115.986 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.8 mtm-85 -67.21 -45.41 76.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 120.32 2.06 . . . . 10.0 111.285 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.56 -14.13 46.66 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.897 1.237 . . . . 10.0 110.523 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 p -114.05 131.37 56.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.97 1.708 . . . . 10.0 111.709 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.03 113.5 25.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.48 69.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 108.068 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.7 tptp -59.35 -44.08 92.73 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.034 0.445 . . . . 10.0 110.64 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -120.73 82.86 34.95 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 127.318 2.247 . . . . 10.0 109.421 -176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -64.12 139.95 69.32 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.855 3.036 . . . . 10.0 116.617 -173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 41.6 t -74.0 89.94 1.95 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -41.72 -43.33 2.84 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.138 1.375 . . . . 10.0 112.915 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -46.32 -43.85 16.26 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.192 0.997 . . . . 10.0 112.31 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.6 p -112.86 24.49 12.35 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.308 0.643 . . . . 10.0 110.208 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 46.59 43.02 12.04 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.083 1.353 . . . . 10.0 111.047 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.63 7.39 27.62 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 118.777 -1.013 . . . . 10.0 115.349 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.34 -59.4 3.22 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 119.597 1.698 . . . . 10.0 108.872 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.75 11.83 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.956 1.265 . . . . 10.0 114.056 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.47 153.06 40.75 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.9 -1.519 . . . . 10.0 106.9 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.35 161.58 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 124.204 1.001 . . . . 10.0 109.524 -176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.04 149.79 32.07 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.258 -0.645 . . . . 10.0 109.258 177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ttp-105 -75.86 52.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.034 1.334 . . . . 10.0 108.448 174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.452 -0.356 0 O-C-N 121.143 -0.973 . . . . 10.0 111.079 -176.741 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 109.657 -1.377 . . . . 10.0 109.657 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.6 m -43.39 -44.55 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.707 1.203 . . . . 10.0 112.209 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -52.18 -36.46 51.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.339 1.856 . . . . 10.0 112.581 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -91.06 -34.07 15.24 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.214 1.006 . . . . 10.0 110.028 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.29 -41.8 94.15 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.057 0.456 . . . . 10.0 111.969 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.7 pt -61.4 125.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -76.7 57.98 1.34 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.029 0.532 . . . . 10.0 111.806 -174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.61 129.2 24.45 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 104.55 -2.389 . . . . 10.0 104.55 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -42.0 115.94 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.538 2.825 . . . . 10.0 110.948 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -68.99 59.74 0.1 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.595 1.558 . . . . 10.0 114.044 -172.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt -138.43 161.62 36.52 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.741 1.616 . . . . 10.0 109.49 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.97 150.32 42.94 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.938 2.095 . . . . 10.0 106.808 176.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -70.81 143.06 51.26 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.869 -0.789 . . . . 10.0 108.869 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.2 t -79.05 91.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.62 -37.29 12.35 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.49 1.516 . . . . 10.0 111.44 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -50.06 -48.73 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.572 1.149 . . . . 10.0 110.205 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.3 p -101.61 22.0 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.159 0.504 . . . . 10.0 111.006 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 54.31 35.37 22.7 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.9 1.28 . . . . 10.0 110.436 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.37 -0.76 46.64 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 118.628 -1.096 . . . . 10.0 114.84 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.5 p -77.7 -71.02 0.44 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.773 1.787 . . . . 10.0 110.571 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.77 -17.06 2.2 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.065 1.793 . . . . 10.0 110.766 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.28 135.83 33.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.799 1.299 . . . . 10.0 109.862 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . 0.275 0.0 OUTLIER -50.26 147.06 7.87 Favored Pre-proline 0 CA--C 1.551 0.983 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 -175.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -22.54 126.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 1 C-N-CA 127.513 5.475 . . . . 10.0 117.913 -175.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.48 -42.67 0.85 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.556 1.074 . . . . 10.0 113.801 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -72.44 82.82 1.08 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.693 1.197 . . . . 10.0 108.195 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -57.03 155.1 16.82 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 122.789 0.436 . . . . 10.0 111.711 -177.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.88 152.63 69.03 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 107.804 -1.652 . . . . 10.0 107.804 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -89.52 118.89 29.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.136 -1.431 . . . . 10.0 107.136 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -50.51 123.16 8.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.806 0.842 . . . . 10.0 109.105 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.3 t -61.65 115.49 15.44 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -71.24 -35.59 8.36 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 121.572 1.515 . . . . 10.0 110.348 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.67 -39.46 11.44 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.565 1.546 . . . . 10.0 112.806 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.5 p -115.18 16.8 16.89 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.341 0.656 . . . . 10.0 111.632 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.13 48.39 15.82 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.44 1.096 . . . . 10.0 110.384 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.89 -47.91 2.27 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.207 -0.774 . . . . 10.0 113.239 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -30.6 -45.4 0.07 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.756 2.422 . . . . 10.0 115.971 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 104.13 5.28 43.86 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.493 -1.171 . . . . 10.0 114.425 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.83 152.1 50.54 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.683 1.741 . . . . 10.0 112.235 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.12 158.84 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.769 1.627 . . . . 10.0 107.72 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -113.83 105.41 13.24 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.893 0.877 . . . . 10.0 110.027 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 tpt -72.28 93.3 1.47 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.079 -1.823 . . . . 10.0 106.079 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -92.64 121.22 33.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.196 2.598 . . . . 10.0 109.588 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.37 55.25 0.74 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 176.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.83 -77.61 0.21 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 124.792 1.187 . . . . 10.0 112.301 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -81.52 -65.95 0.95 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.774 0.829 . . . . 10.0 109.932 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -83.9 162.96 20.33 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.65 154.16 20.07 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 109.132 -0.692 . . . . 10.0 109.132 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.18 165.99 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 107.84 -1.171 . . . . 10.0 107.84 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -123.71 137.66 54.66 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 123.617 0.767 . . . . 10.0 110.521 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 162.03 37.65 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 123.706 0.629 . . . . 10.0 109.513 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 m -55.49 137.18 49.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.453 1.101 . . . . 10.0 110.84 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.21 116.28 45.27 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.8 -0.619 . . . . 10.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.35 -39.38 7.38 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.843 1.695 . . . . 10.0 111.159 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -46.16 -35.63 5.23 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.832 1.253 . . . . 10.0 113.204 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 22.1 p -125.16 25.87 7.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.089 0.956 . . . . 10.0 111.058 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 41.49 45.35 2.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.184 1.394 . . . . 10.0 112.316 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.91 -7.04 3.29 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 115.625 1.01 . . . . 10.0 115.625 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtp-105 -69.49 -28.44 66.06 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 119.508 1.654 . . . . 10.0 110.952 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -9.59 76.54 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.799 0.714 . . . . 10.0 112.315 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 20.6 p -116.06 131.81 56.83 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.954 1.701 . . . . 10.0 113.455 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.2 mt -95.14 100.59 12.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.0 mt -82.93 71.58 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.87 -24.64 67.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.959 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -124.44 75.52 62.11 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.894 2.078 . . . . 10.0 110.999 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.92 133.5 55.06 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.223 3.282 . . . . 10.0 116.295 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.48 88.81 2.13 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.653 -1.24 . . . . 10.0 107.653 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.0 p-10 -36.96 -47.84 0.73 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.156 1.782 . . . . 10.0 112.98 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -43.37 -43.71 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.518 1.527 . . . . 10.0 112.415 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.6 p -116.99 22.26 12.7 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.725 0.81 . . . . 10.0 110.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 47.0 40.95 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.867 1.267 . . . . 10.0 110.241 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.81 10.57 13.8 Favored Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.882 1.113 . . . . 10.0 115.882 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -37.3 82.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.784 1.792 . . . . 10.0 109.319 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.61 10.17 59.37 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 126.563 2.03 . . . . 10.0 113.544 177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.91 155.39 41.53 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.036 0.934 . . . . 10.0 108.668 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.87 152.31 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 125.296 1.438 . . . . 10.0 108.402 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.73 138.33 58.44 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.849 0.46 . . . . 10.0 110.152 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.8 ttp-105 -78.83 61.31 3.04 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 176.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.532 0.263 0 O-C-N 121.522 -0.736 . . . . 10.0 110.582 -178.144 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.596 0 N-CA-C 108.639 -1.784 . . . . 10.0 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.1 t -54.87 -31.57 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.094 0.958 . . . . 10.0 109.282 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.2 p -46.18 -38.09 7.86 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.069 1.748 . . . . 10.0 111.58 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -67.42 -30.34 70.06 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.94 0.337 . . . . 10.0 111.856 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -85.39 -41.28 15.59 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.315 1.046 . . . . 10.0 112.531 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.1 pt -75.91 69.92 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.517 0.675 . . . . 10.0 109.373 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 -76.62 58.07 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.572 1.149 . . . . 10.0 111.106 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -77.08 134.57 67.63 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 105.79 -1.93 . . . . 10.0 105.79 174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.68 51.57 1.91 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.221 2.614 . . . . 10.0 112.834 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.5 73.71 5.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.174 -1.417 . . . . 10.0 107.174 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.6 mt -69.15 123.26 20.64 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.549 -0.719 . . . . 10.0 110.379 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -121.33 145.49 47.83 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.217 1.407 . . . . 10.0 108.194 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -72.47 131.6 42.77 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.298 0.639 . . . . 10.0 110.145 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.5 t -77.94 86.21 4.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.591 0.71 . . . . 10.0 109.14 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -48.1 -35.82 12.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.307 1.443 . . . . 10.0 111.38 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.44 -45.43 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.009 1.324 . . . . 10.0 110.835 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.3 p -102.29 17.2 24.04 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.269 0.486 . . . . 10.0 111.087 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 55.47 34.43 23.0 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.365 1.066 . . . . 10.0 109.17 177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 -4.21 20.94 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.552 -1.138 . . . . 10.0 115.583 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.8 p -71.77 -61.17 1.88 Allowed 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.293 2.046 . . . . 10.0 110.589 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.34 -12.31 6.36 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.65 2.072 . . . . 10.0 109.215 -173.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 141.71 33.66 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.63 1.215 . . . . 10.0 109.247 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -51.26 152.28 4.36 Favored Pre-proline 0 CA--C 1.551 1.003 0 CA-C-N 119.031 0.832 . . . . 10.0 112.415 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -33.26 129.7 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 125.076 3.85 . . . . 10.0 116.205 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 54.46 12.73 3.47 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.105 1.336 . . . . 10.0 115.248 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.9 m -110.58 125.45 53.4 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.893 1.346 . . . . 10.0 107.59 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -66.52 144.36 98.61 Favored Pre-proline 0 N--CA 1.449 -0.494 0 C-N-CA 122.935 0.494 . . . . 10.0 111.302 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.34 164.68 34.53 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 N-CA-C 106.829 -2.027 . . . . 10.0 106.829 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.54 115.62 27.73 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.609 -0.682 . . . . 10.0 109.691 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -48.42 124.14 7.62 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.413 1.085 . . . . 10.0 110.452 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.0 t -65.6 115.82 25.83 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.383 -0.599 . . . . 10.0 109.383 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.46 -35.55 8.0 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 121.319 1.346 . . . . 10.0 110.1 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.4 m -45.48 -39.27 7.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.613 1.565 . . . . 10.0 113.181 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.77 17.09 13.55 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.435 0.694 . . . . 10.0 111.22 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 47.95 48.85 17.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.036 0.934 . . . . 10.0 110.201 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.68 -46.71 2.35 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 121.408 -0.808 . . . . 10.0 113.271 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -29.94 -40.59 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.976 2.91 . . . . 10.0 116.5 -177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.68 0.16 52.69 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.65 1.119 . . . . 10.0 115.811 174.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.28 151.65 40.78 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.815 1.307 . . . . 10.0 109.609 -178.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -113.75 133.56 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 125.889 1.676 . . . . 10.0 108.178 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -107.92 91.08 3.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.435 1.094 . . . . 10.0 109.065 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.0 mmm -81.82 57.7 3.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.994 0.739 . . . . 10.0 112.994 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 176.12 165.15 0.41 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 127.083 2.153 . . . . 10.0 108.864 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -163.9 147.15 9.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.259 1.024 . . . . 10.0 108.77 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.96 40.22 6.82 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.168 0.89 . . . . 10.0 111.546 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -174.24 -149.43 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.444 -2.428 . . . . 10.0 104.444 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -75.36 73.45 2.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 119.526 1.057 . . . . 10.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.6 68.6 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.834 1.654 . . . . 10.0 112.124 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 m -79.99 160.35 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 124.134 0.974 . . . . 10.0 109.785 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -146.34 160.83 41.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 123.438 0.461 . . . . 10.0 111.367 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 163.14 34.28 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.088 0.955 . . . . 10.0 108.621 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.6 m -55.8 137.95 48.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.042 0.937 . . . . 10.0 109.471 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.69 118.69 68.82 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 118.569 0.622 . . . . 10.0 109.471 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.99 -38.6 7.09 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.186 1.924 . . . . 10.0 111.387 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -47.52 -42.29 22.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.586 1.554 . . . . 10.0 112.838 -177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.7 p -112.82 20.89 16.05 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.314 1.046 . . . . 10.0 111.585 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 44.18 44.45 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.799 1.24 . . . . 10.0 111.176 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.26 -7.02 5.0 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.486 -1.174 . . . . 10.0 115.976 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -68.42 -39.32 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 120.288 2.044 . . . . 10.0 110.916 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.27 -19.21 46.52 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.326 0.965 . . . . 10.0 110.711 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.0 p -111.3 132.4 54.41 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.524 1.93 . . . . 10.0 111.712 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -92.45 120.05 32.56 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.869 1.268 . . . . 10.0 108.11 175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.4 mm -79.86 63.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.809 -1.182 . . . . 10.0 107.809 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.95 -35.23 79.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.141 0.576 . . . . 10.0 111.212 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -111.45 74.49 1.17 Allowed Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.268 2.227 . . . . 10.0 109.083 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.67 133.92 38.7 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.657 2.904 . . . . 10.0 116.632 -172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.0 t -74.2 90.66 2.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.494 1.518 . . . . 10.0 107.212 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -39.51 -46.88 1.79 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.433 1.493 . . . . 10.0 112.489 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.17 -44.68 5.24 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.588 1.155 . . . . 10.0 112.643 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -113.89 14.2 18.5 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.204 0.602 . . . . 10.0 111.072 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 52.92 36.02 20.68 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.757 0.823 . . . . 10.0 109.919 -176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.09 15.19 49.51 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 119.127 -0.818 . . . . 10.0 114.393 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.57 -2.02 40.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.326 1.563 . . . . 10.0 111.895 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.09 -43.77 2.28 Favored Glycine 0 CA--C 1.531 1.089 0 O-C-N 121.384 -0.823 . . . . 10.0 113.091 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 168.84 9.44 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.283 1.433 . . . . 10.0 110.851 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.0 m -134.15 144.16 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 125.721 1.608 . . . . 10.0 107.722 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -87.84 105.54 17.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -71.94 81.73 0.92 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.446 -0.645 0 C-N-CA 126.455 1.902 . . . . 10.0 109.837 -178.282 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 111.987 -0.445 . . . . 10.0 111.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -74.07 144.75 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 t -53.46 -21.29 5.92 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.743 1.016 . . . . 10.0 113.743 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -63.78 -27.1 68.96 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.597 0.759 . . . . 10.0 110.383 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -75.83 66.16 2.05 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.178 0.991 . . . . 10.0 109.1 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.45 66.8 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.817 1.247 . . . . 10.0 112.994 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -75.55 62.41 1.41 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.394 -0.816 . . . . 10.0 109.39 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.6 mt -130.65 121.81 19.35 Favored Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 125.663 1.585 . . . . 10.0 106.771 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.77 72.75 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.571 3.514 . . . . 10.0 112.394 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -72.95 146.74 45.85 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.976 1.311 . . . . 10.0 110.691 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.5 mt -95.44 127.67 41.67 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.878 -1.156 . . . . 10.0 107.878 177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -120.34 145.5 47.06 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.108 1.363 . . . . 10.0 110.041 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mp0 -54.09 134.79 43.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.187 0.995 . . . . 10.0 111.642 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.0 t -77.43 103.93 7.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.555 -2.017 . . . . 10.0 105.555 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -46.84 -42.85 17.95 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 125.212 1.405 . . . . 10.0 111.126 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.11 -38.62 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.524 1.13 . . . . 10.0 111.928 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 p -106.75 4.2 27.41 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.085 0.857 . . . . 10.0 111.812 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 63.93 33.54 12.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.733 0.813 . . . . 10.0 108.935 174.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.78 -11.82 44.94 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.326 -1.263 . . . . 10.0 114.628 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.4 p -71.5 -71.59 0.26 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 120.066 1.933 . . . . 10.0 111.213 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 143.31 -24.66 2.2 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.814 2.15 . . . . 10.0 109.458 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 150.27 43.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.747 0.774 . . . . 10.0 110.017 178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -58.21 165.1 2.98 Favored Pre-proline 0 CA--C 1.553 1.069 0 O-C-N 122.086 -0.384 . . . . 10.0 111.133 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -40.48 127.68 2.35 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.908 3.072 . . . . 10.0 114.956 -176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 51.7 19.86 5.26 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.938 1.256 . . . . 10.0 114.786 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.0 m -108.12 135.16 49.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.606 -1.628 . . . . 10.0 106.606 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -79.94 147.55 66.29 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 118.466 0.576 . . . . 10.0 111.161 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -74.63 -173.32 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 N-CA-C 107.152 -1.903 . . . . 10.0 107.152 172.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 -126.05 123.17 37.8 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -45.54 124.85 5.3 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.813 1.245 . . . . 10.0 111.922 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -68.89 117.53 52.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.32 -36.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.796 1.664 . . . . 10.0 110.756 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.54 -46.49 19.35 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.664 1.585 . . . . 10.0 112.363 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 p -105.44 14.93 27.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.796 0.839 . . . . 10.0 111.634 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 49.22 40.39 17.84 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.961 0.904 . . . . 10.0 110.68 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 70.37 -5.37 7.07 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.854 -0.97 . . . . 10.0 115.412 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.0 p -69.48 -26.61 64.65 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 120.096 1.948 . . . . 10.0 112.804 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.43 71.03 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 -173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 133.2 35.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.463 1.131 . . . . 10.0 110.482 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 m -87.47 157.55 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.282 1.433 . . . . 10.0 107.99 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -108.38 117.78 35.05 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 106.951 -1.499 . . . . 10.0 106.951 172.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -75.36 92.21 2.78 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.699 -2.704 . . . . 10.0 103.699 173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -65.73 40.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.574 1.694 . . . . 10.0 115.574 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -78.61 55.66 1.69 Allowed 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.299 -1.501 . . . . 10.0 111.043 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 26.15 -92.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.946 0 C-N-CA 128.046 2.736 . . . . 10.0 114.064 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -36.74 -44.96 0.5 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 126.603 1.961 . . . . 10.0 112.678 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -129.68 56.6 1.71 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.07 69.1 0.33 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.187 0.995 . . . . 10.0 111.376 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.7 m -86.03 169.78 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.602 1.161 . . . . 10.0 112.491 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -109.2 149.8 28.84 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.487 1.115 . . . . 10.0 111.415 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -141.58 151.51 43.24 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.568 1.547 . . . . 10.0 108.037 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 m -58.25 138.09 56.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.863 0.756 . . . . 10.0 109.957 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.9 t -73.76 117.75 63.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 118.874 0.761 . . . . 10.0 108.998 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -69.99 -41.66 3.8 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.795 1.664 . . . . 10.0 111.16 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -47.66 -42.03 23.67 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.864 1.265 . . . . 10.0 113.547 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.21 21.66 15.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.66 0.784 . . . . 10.0 111.456 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 45.96 46.74 12.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.619 1.167 . . . . 10.0 111.369 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.31 -6.81 9.61 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.652 1.021 . . . . 10.0 115.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -68.18 -25.57 65.31 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.866 1.833 . . . . 10.0 112.652 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.75 1.51 87.07 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.38 0.514 . . . . 10.0 112.601 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.5 p -118.12 125.7 50.77 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.463 1.505 . . . . 10.0 111.304 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -88.65 151.67 22.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -133.26 90.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -64.88 -27.46 68.87 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.349 -0.612 . . . . 10.0 109.349 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -106.77 69.57 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.946 2.498 . . . . 10.0 109.856 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.26 128.74 22.26 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.195 1.93 . . . . 10.0 113.457 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -66.3 91.73 0.17 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -33.3 -51.54 0.34 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.011 2.124 . . . . 10.0 113.894 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -44.54 -45.63 9.46 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.187 1.395 . . . . 10.0 112.624 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.9 p -111.45 15.79 21.08 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.112 0.565 . . . . 10.0 110.45 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 54.14 34.08 19.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.222 1.009 . . . . 10.0 110.382 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.21 15.21 60.59 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 119.39 -0.672 . . . . 10.0 113.938 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -77.35 -4.41 44.98 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.036 1.418 . . . . 10.0 111.765 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.51 -43.5 2.1 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.028 -1.045 . . . . 10.0 114.242 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -134.5 155.52 50.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.162 0.985 . . . . 10.0 110.235 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.66 158.41 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.055 0 C-N-CA 124.748 1.219 . . . . 10.0 109.922 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -69.6 139.51 53.65 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -74.0 55.97 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.533 1.533 . . . . 10.0 110.634 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.453 -0.32 0 O-C-N 121.273 -0.892 . . . . 10.0 110.929 -178.384 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.58 0 N-CA-C 109.603 -1.399 . . . . 10.0 109.603 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -61.31 -31.7 51.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -159.86 -176.35 5.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 176.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -84.85 -34.22 22.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -75.05 47.91 0.37 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.28 55.51 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 42.1 mmt-85 4.63 39.9 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.588 1 C-N-CA 132.389 4.276 . . . . 10.0 118.603 -171.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.6 mt -95.19 130.26 32.98 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 105.933 -1.877 . . . . 10.0 105.933 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -44.98 97.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.646 3.564 . . . . 10.0 114.763 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -154.02 59.6 0.72 Allowed 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 106.148 -1.797 . . . . 10.0 106.148 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.2 mt -69.46 119.49 13.81 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.201 -0.909 . . . . 10.0 112.076 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -128.67 150.54 50.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.779 1.232 . . . . 10.0 108.399 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -64.13 135.14 56.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.794 0.838 . . . . 10.0 111.2 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -80.02 87.49 5.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.167 -1.049 . . . . 10.0 108.167 175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -48.67 -37.01 17.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.305 1.442 . . . . 10.0 111.528 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -49.98 -53.52 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.657 1.183 . . . . 10.0 110.157 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -93.38 18.6 9.45 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.264 0.484 . . . . 10.0 111.255 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 54.24 35.92 23.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.986 0.914 . . . . 10.0 109.898 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.54 4.63 61.55 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.282 -1.288 . . . . 10.0 115.452 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -87.0 -81.34 0.23 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.811 1.805 . . . . 10.0 111.382 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.7 -8.39 0.07 OUTLIER Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.616 -1.102 . . . . 10.0 114.61 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.44 157.77 20.66 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.702 1.751 . . . . 10.0 109.961 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -49.95 163.65 0.4 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.89 1.07 . . . . 10.0 113.89 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -48.23 135.99 24.87 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.107 2.538 . . . . 10.0 112.733 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.88 -57.7 2.65 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.992 -0.338 . . . . 10.0 112.417 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.1 m -72.68 64.67 0.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.804 1.242 . . . . 10.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 159.57 27.31 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.759 0.823 . . . . 10.0 112.331 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -60.57 176.06 0.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.011 2.474 . . . . 10.0 110.946 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -117.74 124.76 49.24 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 m -44.3 124.0 3.78 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.053 1.341 . . . . 10.0 111.807 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.67 116.71 40.44 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -38.06 7.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.63 1.554 . . . . 10.0 110.952 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.88 -42.65 12.83 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.776 1.63 . . . . 10.0 112.861 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.0 p -112.18 18.17 18.88 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.813 0.845 . . . . 10.0 111.454 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 47.67 41.56 13.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.949 0.9 . . . . 10.0 111.172 -179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.17 0.08 55.4 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.283 -1.287 . . . . 10.0 115.801 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.7 p -69.56 -61.08 1.93 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 120.461 2.13 . . . . 10.0 111.321 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.31 10.34 7.37 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.115 2.293 . . . . 10.0 110.86 -174.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 151.18 47.95 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 119.127 1.464 . . . . 10.0 110.48 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 m -124.44 144.87 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 125.342 1.457 . . . . 10.0 108.042 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -106.34 110.09 22.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.632 -0.877 . . . . 10.0 108.632 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 32.8 ttm -77.65 90.34 3.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.111 -1.07 . . . . 10.0 108.111 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -73.37 69.22 1.14 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.327 0.651 . . . . 10.0 110.517 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.63 45.44 0.19 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.45 -73.0 0.01 OUTLIER Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.069 1.318 . . . . 10.0 115.059 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -69.74 -42.64 73.66 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.777 0.831 . . . . 10.0 110.438 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -120.48 170.64 9.19 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.705 1.202 . . . . 10.0 107.886 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.92 63.98 1.11 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.113 0.565 . . . . 10.0 109.694 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.65 176.96 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.05 0 N-CA-C 110.465 -0.198 . . . . 10.0 110.465 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -134.44 159.27 41.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.526 0.33 . . . . 10.0 111.363 -177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.84 164.85 28.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.678 1.191 . . . . 10.0 108.429 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.9 m -63.87 140.76 58.9 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.533 -0.914 . . . . 10.0 108.533 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.6 t -72.64 116.0 45.4 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 118.849 0.75 . . . . 10.0 109.587 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.42 -38.81 7.99 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.043 1.829 . . . . 10.0 111.274 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.14 -34.22 5.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.811 1.245 . . . . 10.0 113.287 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 17.9 p -123.86 21.83 9.02 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.006 0.922 . . . . 10.0 111.189 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 45.5 42.21 7.64 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 10.0 111.928 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.38 -1.57 19.36 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 115.263 0.865 . . . . 10.0 115.263 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -79.32 -4.48 51.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.277 1.538 . . . . 10.0 111.744 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.59 -12.57 0.71 Allowed Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.426 1.013 . . . . 10.0 113.978 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.3 p -122.03 132.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 10.0 111.094 -173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.13 106.03 7.51 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.895 -2.261 . . . . 10.0 104.895 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.14 77.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 125.259 1.423 . . . . 10.0 108.054 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.48 -43.06 2.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.579 1.952 . . . . 10.0 111.022 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -145.2 144.99 25.15 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 104.441 -2.429 . . . . 10.0 104.441 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -85.0 125.39 3.11 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.187 1.925 . . . . 10.0 112.15 -177.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -71.03 85.02 0.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 171.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -39.88 -46.03 1.92 Allowed 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 125.899 1.68 . . . . 10.0 113.172 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -42.61 -40.2 2.62 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.525 1.13 . . . . 10.0 112.683 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.16 18.73 12.31 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.539 0.736 . . . . 10.0 111.256 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 45.74 42.53 8.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.487 1.115 . . . . 10.0 109.537 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 51.96 25.41 16.62 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.528 1.537 . . . . 10.0 116.328 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -79.04 -38.88 35.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.588 1.694 . . . . 10.0 108.754 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.27 -0.91 55.96 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.095 1.807 . . . . 10.0 113.791 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 151.4 44.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.021 -1.474 . . . . 10.0 107.021 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.7 m -135.83 142.65 38.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 C-N-CA 124.045 0.938 . . . . 10.0 110.47 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -77.53 78.29 4.05 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -76.19 60.27 1.46 Allowed 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.452 1.101 . . . . 10.0 111.537 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.623 1.169 . . . . 10.0 108.657 177.766 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.0 m -40.95 -48.02 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.987 1.315 . . . . 10.0 112.615 -177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 p -52.03 -43.69 63.85 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.599 1.56 . . . . 10.0 111.821 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -74.97 -42.09 58.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -55.32 -41.25 72.15 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 pt -74.09 56.34 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.7 0.762 . . . . 10.0 111.88 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -56.47 -38.35 71.57 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.13 -0.981 . . . . 10.0 112.229 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.51 ' H ' ' CD ' ' A' ' 9' ' ' PRO 0.255 0.2 OUTLIER -117.96 -48.45 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.637 1.975 . . . . 10.0 116.168 -178.514 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.51 ' CD ' ' H ' ' A' ' 8' ' ' ILE . 87.3 Cg_exo -54.38 74.54 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.497 1 C-N-CA 126.712 4.941 . . . . 10.0 117.209 -175.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 m -152.5 114.84 4.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.45 99.84 12.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 121.804 0.811 . . . . 10.0 111.185 -175.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -75.81 127.62 33.41 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.437 1.895 . . . . 10.0 110.422 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -59.56 126.65 28.46 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.601 0.76 . . . . 10.0 110.593 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.19 89.84 3.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.163 -0.68 . . . . 10.0 109.163 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -48.28 -38.54 19.04 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.302 1.441 . . . . 10.0 111.319 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.8 t -50.27 -41.81 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.776 1.23 . . . . 10.0 111.618 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.4 p -107.56 19.28 20.42 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.916 0.486 . . . . 10.0 110.662 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.38 38.74 18.76 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.059 1.344 . . . . 10.0 110.163 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.21 -4.63 24.16 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.445 -1.197 . . . . 10.0 115.561 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.7 p -72.7 -66.24 0.69 Allowed 'General case' 0 C--N 1.341 0.207 0 CA-C-N 120.098 1.949 . . . . 10.0 111.057 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.15 -8.13 4.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 127.226 2.346 . . . . 10.0 110.183 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.39 138.87 40.67 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.902 1.351 . . . . 10.0 111.031 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -51.76 144.45 18.92 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 118.817 0.735 . . . . 10.0 110.695 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -49.26 -37.0 38.97 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.298 2.665 . . . . 10.0 113.792 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.41 12.23 68.84 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.017 -1.435 . . . . 10.0 115.113 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.6 m -155.66 147.1 22.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 121.126 2.463 . . . . 10.0 110.938 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.77 157.73 66.38 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.823 -0.608 . . . . 10.0 109.495 176.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.62 169.64 19.45 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.281 1.987 . . . . 10.0 108.057 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -101.41 115.78 31.28 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 119.127 -0.463 . . . . 10.0 110.207 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 m -42.92 122.23 2.34 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.561 1.144 . . . . 10.0 111.188 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -65.61 115.57 23.49 Favored Pre-proline 0 C--O 1.235 0.297 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.66 -36.09 6.94 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.823 1.682 . . . . 10.0 110.709 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.38 -39.83 7.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.681 1.593 . . . . 10.0 112.883 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.3 p -114.86 12.48 16.92 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.094 0.958 . . . . 10.0 111.751 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.77 42.46 23.78 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.013 0.925 . . . . 10.0 109.995 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.08 -8.44 8.36 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 114.805 0.682 . . . . 10.0 114.805 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 m -68.27 -8.61 40.98 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.425 1.612 . . . . 10.0 114.045 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.53 14.66 55.37 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.602 1.096 . . . . 10.0 113.769 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -145.04 142.29 29.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 118.145 0.972 . . . . 10.0 110.088 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.11 133.15 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 125.625 1.57 . . . . 10.0 106.93 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.54 109.61 22.33 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.03 0.532 . . . . 10.0 110.428 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.99 88.5 0.4 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.331 1.052 . . . . 10.0 108.59 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -73.89 62.3 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.67 0.788 . . . . 10.0 110.238 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.04 43.76 0.29 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.632 1.173 . . . . 10.0 112.729 -177.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.17 -64.45 1.3 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.684 -0.635 . . . . 10.0 112.391 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -89.99 -78.23 0.37 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.122 0.969 . . . . 10.0 113.09 -176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -84.11 98.15 9.73 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.536 0.734 . . . . 10.0 111.455 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.41 58.84 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.375 0.67 . . . . 10.0 111.266 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.02 162.36 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 O-C-N 121.878 -0.514 . . . . 10.0 110.05 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -116.39 171.97 7.5 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 113.812 1.041 . . . . 10.0 113.812 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.55 153.13 47.37 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.645 -1.983 . . . . 10.0 105.645 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 m -58.86 135.76 57.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.85 116.99 49.36 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.908 0.776 . . . . 10.0 109.15 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.15 -38.05 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.027 1.818 . . . . 10.0 111.367 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -48.41 -39.49 22.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.599 1.16 . . . . 10.0 113.174 -177.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.6 p -115.49 18.66 15.85 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.436 1.094 . . . . 10.0 111.47 178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 47.01 43.51 13.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.341 1.056 . . . . 10.0 111.113 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.97 -8.34 6.43 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 115.44 0.936 . . . . 10.0 115.44 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -74.54 -7.38 52.89 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.918 1.859 . . . . 10.0 112.737 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.39 1.21 7.26 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 121.403 -0.811 . . . . 10.0 113.216 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -133.18 132.91 42.12 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.17 1.388 . . . . 10.0 109.783 -174.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.74 118.58 27.35 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.875 1.27 . . . . 10.0 108.323 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.9 mm -78.4 61.41 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.976 1.31 . . . . 10.0 108.435 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -63.74 -34.4 77.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.588 0.709 . . . . 10.0 109.752 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -109.79 78.14 1.18 Allowed Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 129.011 2.924 . . . . 10.0 109.108 -178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -69.07 136.65 35.39 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.296 2.664 . . . . 10.0 116.342 -173.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.8 t -74.15 87.95 1.94 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.466 -1.679 . . . . 10.0 106.466 172.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.96 -40.79 4.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.97 1.308 . . . . 10.0 111.859 -178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -46.45 -38.66 9.43 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.932 0.893 . . . . 10.0 112.123 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.6 p -122.26 22.93 9.99 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.534 0.734 . . . . 10.0 110.477 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 45.87 39.81 5.88 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.507 1.123 . . . . 10.0 110.949 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.07 17.7 31.13 Favored Glycine 0 CA--C 1.536 1.348 0 N-CA-C 115.249 0.86 . . . . 10.0 115.249 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.18 -36.73 64.05 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.151 1.475 . . . . 10.0 110.328 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.04 -23.85 17.93 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.557 1.075 . . . . 10.0 112.031 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -147.73 159.17 44.1 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.141 0.97 . . . . 10.0 110.321 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.48 145.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 124.952 1.301 . . . . 10.0 109.865 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -69.77 139.45 53.27 Favored 'General case' 0 C--O 1.234 0.282 0 O-C-N 121.905 -0.497 . . . . 10.0 109.876 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.5 ttp85 -64.61 71.37 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.093 1.757 . . . . 10.0 109.862 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 125.576 1.55 . . . . 10.0 110.633 -176.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 108.546 -1.822 . . . . 10.0 108.546 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.95 -31.93 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.026 0.53 . . . . 10.0 110.198 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 p -48.82 -33.67 10.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.763 2.025 . . . . 10.0 111.737 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -67.17 -30.87 70.95 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.862 0.465 . . . . 10.0 111.027 178.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -89.56 -56.58 3.2 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.389 1.09 . . . . 10.0 111.374 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 pt -76.47 71.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.542 -1.208 . . . . 10.0 110.379 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -72.68 58.47 0.44 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 10.0 111.578 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.91 138.64 61.5 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.05 76.32 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.691 2.927 . . . . 10.0 109.685 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m -87.41 101.85 13.98 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.062 1.745 . . . . 10.0 108.982 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.25 120.1 23.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -120.16 156.4 31.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.873 1.669 . . . . 10.0 110.383 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.66 129.13 19.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 112.081 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.5 t -77.24 89.59 3.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -49.09 -38.02 23.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.784 1.233 . . . . 10.0 111.313 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.2 t -50.8 -31.43 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.249 1.42 . . . . 10.0 112.221 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.9 p -123.24 22.52 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.61 0.764 . . . . 10.0 110.13 175.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 45.01 41.71 5.65 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.589 1.556 . . . . 10.0 111.238 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.53 -4.44 27.65 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 115.803 1.081 . . . . 10.0 115.803 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.8 p -73.17 -68.95 0.45 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.742 1.771 . . . . 10.0 109.164 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.13 -6.52 4.35 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 126.58 2.038 . . . . 10.0 109.105 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 128.12 34.54 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.924 1.362 . . . . 10.0 109.673 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 156.42 2.6 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.974 0.731 . . . . 10.0 112.974 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -38.76 133.59 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 124.408 3.406 . . . . 10.0 114.794 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.58 19.52 9.62 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.968 1.27 . . . . 10.0 114.498 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -126.11 140.9 52.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -92.68 153.44 42.32 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 122.809 0.444 . . . . 10.0 110.326 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.97 168.67 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 107.768 -1.666 . . . . 10.0 107.768 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -94.98 119.29 33.24 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.7 m -51.15 124.37 11.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.893 0.877 . . . . 10.0 109.362 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -64.23 115.18 17.52 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-N 118.702 0.683 . . . . 10.0 109.397 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.0 -35.85 8.4 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.632 1.555 . . . . 10.0 110.587 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 m -45.37 -38.34 5.79 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 10.0 113.056 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 p -118.35 13.95 13.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.241 1.016 . . . . 10.0 111.471 178.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 49.3 41.89 21.02 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.886 0.874 . . . . 10.0 110.195 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.8 -8.08 8.27 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 119.233 -0.76 . . . . 10.0 114.979 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -65.39 -15.7 62.86 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.563 1.682 . . . . 10.0 113.955 -177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 4.61 68.47 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.864 0.745 . . . . 10.0 113.651 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -144.97 156.74 44.13 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.94 1.37 . . . . 10.0 110.611 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.99 141.64 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 126.451 1.9 . . . . 10.0 107.391 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -124.55 115.47 20.91 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.125 -0.695 . . . . 10.0 109.125 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 85.9 mtp -76.16 165.43 24.91 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.427 1.091 . . . . 10.0 108.399 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -131.33 46.06 2.72 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.274 0.63 . . . . 10.0 112.434 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -78.74 64.0 3.63 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.874 0.845 . . . . 10.0 109.399 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 37.03 -104.42 0.03 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.439 2.447 . . . . 10.0 113.18 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -47.82 -35.19 9.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.251 1.42 . . . . 10.0 113.591 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -124.43 57.87 1.23 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 118.025 0.375 . . . . 10.0 111.227 -175.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.99 66.48 0.38 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.443 1.097 . . . . 10.0 110.589 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.9 m -83.74 167.01 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 C-N-CA 124.49 1.116 . . . . 10.0 112.885 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -126.44 156.86 39.96 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.063 0.945 . . . . 10.0 111.474 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.18 162.39 35.73 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.502 1.121 . . . . 10.0 108.94 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 m -62.4 140.99 58.56 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.777 0.831 . . . . 10.0 108.968 175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.9 117.48 61.51 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 118.752 0.706 . . . . 10.0 109.605 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -69.31 -40.49 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.079 1.853 . . . . 10.0 111.46 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -44.73 -40.11 5.73 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.992 1.317 . . . . 10.0 112.625 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.59 22.54 11.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.716 0.806 . . . . 10.0 112.05 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.7 mm-40 44.39 43.11 5.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.535 1.134 . . . . 10.0 111.641 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.56 -6.16 6.42 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 115.757 1.063 . . . . 10.0 115.757 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -78.8 -2.73 40.97 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.674 1.737 . . . . 10.0 112.775 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 65.8 -8.97 0.73 Allowed Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.205 0.907 . . . . 10.0 114.671 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -125.1 135.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.684 1.593 . . . . 10.0 110.655 -174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 65.6 mt -97.77 120.58 38.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.883 1.273 . . . . 10.0 108.073 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.5 mm -78.13 63.12 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.536 1.135 . . . . 10.0 108.23 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -69.36 -26.23 64.57 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.663 -0.648 . . . . 10.0 110.69 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -111.28 72.85 0.93 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 127.253 2.221 . . . . 10.0 109.46 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -62.99 129.42 25.83 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.019 2.479 . . . . 10.0 115.536 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.2 92.38 0.76 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.989 1.716 . . . . 10.0 106.543 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -37.23 -49.01 0.91 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.272 1.829 . . . . 10.0 112.613 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -44.73 -38.12 4.21 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.11 1.364 . . . . 10.0 112.812 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.0 p -121.85 16.29 10.97 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.893 0.877 . . . . 10.0 111.069 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 48.23 37.84 9.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.382 1.073 . . . . 10.0 110.836 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.52 6.76 43.51 Favored Glycine 0 CA--C 1.537 1.421 0 CA-C-O 118.955 -0.914 . . . . 10.0 115.058 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.8 -44.0 87.01 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.78 1.79 . . . . 10.0 110.643 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.81 30.04 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.816 1.198 . . . . 10.0 113.405 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -146.25 154.61 41.92 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.481 1.64 . . . . 10.0 110.983 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.94 155.77 33.51 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 C-N-CA 125.771 1.629 . . . . 10.0 109.298 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.53 141.56 51.9 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.286 -0.635 . . . . 10.0 109.286 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.97 67.28 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.756 2.022 . . . . 10.0 112.268 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 N--CA 1.457 -0.096 0 C-N-CA 125.906 1.682 . . . . 10.0 108.288 176.368 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 111.774 -0.53 . . . . 10.0 111.774 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.2 m -70.47 167.01 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.042 0.537 . . . . 10.0 111.969 -177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.5 p -71.03 66.3 0.38 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.435 1.894 . . . . 10.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -162.03 -41.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 130.221 3.409 . . . . 10.0 106.414 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -72.36 80.14 1.02 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.04 -1.096 . . . . 10.0 108.04 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.7 pt -72.93 62.15 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.635 1.174 . . . . 10.0 111.402 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -55.73 -37.37 68.36 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.776 0.83 . . . . 10.0 111.683 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.5 pt -53.14 139.24 45.53 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.975 1.31 . . . . 10.0 110.589 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.1 84.65 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.181 3.254 . . . . 10.0 110.146 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 134.88 57.47 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.409 1.883 . . . . 10.0 112.013 -174.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 mt -88.13 126.11 34.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.074 -1.084 . . . . 10.0 108.074 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -112.84 124.5 52.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.487 1.115 . . . . 10.0 108.959 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -52.63 125.21 15.83 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.233 1.013 . . . . 10.0 110.584 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -81.1 89.04 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.295 0.569 . . . . 10.0 109.688 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -49.5 -38.04 28.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.516 1.126 . . . . 10.0 111.016 177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.07 -36.42 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.46 1.504 . . . . 10.0 111.655 177.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.5 p -117.52 23.92 11.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.078 0.551 . . . . 10.0 110.791 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.5 p80 46.03 42.35 9.4 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.64 1.576 . . . . 10.0 111.486 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.0 -3.72 27.46 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 115.647 1.019 . . . . 10.0 115.647 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -77.84 -67.82 0.69 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 120.099 1.95 . . . . 10.0 110.196 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.65 -3.54 3.54 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.184 1.849 . . . . 10.0 110.496 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.49 140.23 30.84 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 120.008 1.904 . . . . 10.0 111.196 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -48.42 140.72 9.78 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.067 0.947 . . . . 10.0 111.625 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -36.28 133.41 0.32 Allowed 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 125.165 3.91 . . . . 10.0 113.942 177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.77 -45.72 1.64 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.236 0.922 . . . . 10.0 112.456 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -71.75 68.97 0.64 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 127.542 2.337 . . . . 10.0 108.503 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.55 151.76 28.42 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.178 0.991 . . . . 10.0 112.419 -174.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.09 146.93 53.29 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.294 1.329 . . . . 10.0 108.786 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -83.06 140.38 32.7 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 -178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -57.71 123.26 15.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.547 0.739 . . . . 10.0 109.734 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -67.61 116.3 36.11 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 119.264 0.938 . . . . 10.0 108.981 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.64 -38.35 10.85 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 CA-C-N 120.557 1.235 . . . . 10.0 110.777 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -46.22 -40.31 11.16 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.388 1.875 . . . . 10.0 113.134 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 p -121.3 27.68 8.21 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.821 0.849 . . . . 10.0 110.598 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 45.39 42.12 7.2 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.724 1.21 . . . . 10.0 112.788 175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.12 -4.46 58.29 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.328 -1.262 . . . . 10.0 116.196 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.6 p -81.31 -66.27 0.91 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.991 1.895 . . . . 10.0 112.02 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.43 -6.31 0.78 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.556 -1.135 . . . . 10.0 115.761 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.06 132.93 43.8 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 120.095 1.947 . . . . 10.0 111.67 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 m -75.99 138.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -118.1 114.69 23.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 19.7 mtp -77.49 73.72 4.06 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -68.71 62.86 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.292 1.437 . . . . 10.0 112.299 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.12 51.4 0.99 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.385 1.474 . . . . 10.0 110.489 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.23 -65.98 0.73 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.386 0.993 . . . . 10.0 113.332 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -100.91 -69.68 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.835 1.254 . . . . 10.0 112.122 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -74.52 68.69 1.63 Allowed 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.573 -0.704 . . . . 10.0 111.213 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.24 59.24 0.75 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.21 1.004 . . . . 10.0 112.16 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -77.35 169.93 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 124.614 1.166 . . . . 10.0 110.7 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -146.84 159.52 43.41 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.621 0.6 . . . . 10.0 112.621 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.59 158.69 43.47 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.832 1.253 . . . . 10.0 108.572 178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -53.55 134.44 40.97 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.062 0.545 . . . . 10.0 110.209 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.7 t -75.93 116.97 60.42 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.865 -0.588 . . . . 10.0 109.438 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.67 -39.01 7.2 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.169 1.913 . . . . 10.0 111.336 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -44.84 -43.41 8.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.997 1.719 . . . . 10.0 112.552 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.8 p -116.06 23.0 12.53 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.083 0.953 . . . . 10.0 111.699 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 44.21 44.68 6.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.781 1.232 . . . . 10.0 111.713 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.53 -5.09 17.48 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.211 1.244 . . . . 10.0 116.211 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.7 mtm-85 -81.26 -8.32 59.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 120.308 2.054 . . . . 10.0 113.43 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.04 -7.63 3.05 Favored Glycine 0 CA--C 1.542 1.736 0 O-C-N 121.459 -0.775 . . . . 10.0 113.192 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -120.76 133.61 55.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.747 2.019 . . . . 10.0 111.874 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.63 119.56 33.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.216 1.406 . . . . 10.0 108.854 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -70.31 81.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.79 1.636 . . . . 10.0 108.856 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -42.44 -49.95 5.22 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.415 1.486 . . . . 10.0 111.294 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -149.03 128.45 6.34 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.17 136.35 31.7 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.769 2.313 . . . . 10.0 114.848 -171.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.5 t -73.68 90.82 1.84 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.673 1.589 . . . . 10.0 106.831 174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -39.41 -45.39 1.49 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.73 1.612 . . . . 10.0 112.685 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -43.12 -39.32 2.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.827 1.251 . . . . 10.0 112.731 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.8 24.63 8.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.886 0.875 . . . . 10.0 110.631 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 47.99 35.59 5.23 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.296 1.038 . . . . 10.0 110.849 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.52 21.0 53.5 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.973 0.749 . . . . 10.0 114.973 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -75.42 -40.46 57.7 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.881 1.34 . . . . 10.0 110.367 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 116.72 -13.73 14.87 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.471 1.51 . . . . 10.0 112.073 -177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.62 145.5 29.0 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.155 0.978 . . . . 10.0 109.686 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.9 m -94.49 138.14 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -87.98 124.28 33.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.7 ttp85 -68.76 73.27 0.25 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.076 1.35 . . . . 10.0 108.406 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 126.631 1.973 . . . . 10.0 109.662 -176.643 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 109.286 -1.526 . . . . 10.0 109.286 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.22 -14.87 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.044 0.538 . . . . 10.0 110.161 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.6 p -67.77 70.34 0.13 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.521 2.328 . . . . 10.0 110.343 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -163.97 -169.11 1.77 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.675 1.59 . . . . 10.0 107.708 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -59.75 138.04 57.88 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.066 -0.716 . . . . 10.0 109.066 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.4 pt -75.95 56.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.836 0.827 . . . . 10.0 112.115 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -158.33 43.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.093 1.757 . . . . 10.0 106.46 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.3 tt -53.02 116.45 9.27 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 123.787 0.835 . . . . 10.0 111.251 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.32 76.72 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.054 2.503 . . . . 10.0 107.619 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 m -74.79 64.1 1.23 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.927 1.291 . . . . 10.0 111.305 -173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.86 143.66 27.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.219 1.008 . . . . 10.0 109.755 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -122.69 132.78 54.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.229 1.812 . . . . 10.0 107.448 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.21 129.79 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -75.54 88.43 2.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -48.06 -39.48 20.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.831 1.252 . . . . 10.0 111.292 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.3 t -49.83 -33.44 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.143 1.377 . . . . 10.0 112.224 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.66 27.19 8.68 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.62 0.645 . . . . 10.0 110.656 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 23.2 p80 44.69 41.97 5.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.47 1.508 . . . . 10.0 111.499 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.3 -3.52 30.95 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.131 -1.372 . . . . 10.0 116.044 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.7 p -80.9 -71.63 0.46 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 120.024 1.912 . . . . 10.0 110.661 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.43 -10.44 1.72 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.934 1.255 . . . . 10.0 111.795 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.63 137.81 33.64 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.222 2.011 . . . . 10.0 109.225 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.41 152.33 4.59 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-N 118.882 0.764 . . . . 10.0 112.071 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -46.82 141.77 11.3 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.122 3.214 . . . . 10.0 114.322 -175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.6 -58.32 3.78 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 123.783 0.706 . . . . 10.0 111.441 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 81.82 1.12 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.588 0.709 . . . . 10.0 109.852 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -56.49 157.32 9.91 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.636 1.174 . . . . 10.0 112.475 -176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.95 -174.72 1.63 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.328 2.019 . . . . 10.0 109.397 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -119.24 156.52 29.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.762 -0.829 . . . . 10.0 108.762 175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.5 m -65.66 131.29 45.98 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.525 -1.359 . . . . 10.0 110.493 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.2 t -75.03 114.9 39.63 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.312 0.96 . . . . 10.0 109.389 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.1 -37.55 8.22 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.607 1.538 . . . . 10.0 110.558 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 m -45.96 -38.63 7.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.818 1.647 . . . . 10.0 112.964 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.3 p -119.06 20.45 12.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.797 0.839 . . . . 10.0 111.334 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 46.0 44.08 11.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.478 1.111 . . . . 10.0 111.483 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.13 -1.19 34.72 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.315 -1.269 . . . . 10.0 115.737 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.8 p -70.33 -63.2 1.13 Allowed 'General case' 0 C--N 1.34 0.18 0 CA-C-N 120.336 2.068 . . . . 10.0 111.256 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 128.71 7.11 4.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.474 1.988 . . . . 10.0 111.529 -175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -134.7 146.93 49.93 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.426 1.613 . . . . 10.0 111.759 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 m -111.93 145.61 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 C-N-CA 125.546 1.538 . . . . 10.0 108.336 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -107.91 113.33 26.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.072 -1.085 . . . . 10.0 108.072 175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.7 tpp -75.15 73.95 2.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -70.76 60.98 0.24 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.655 1.582 . . . . 10.0 112.023 -177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -76.99 56.59 1.24 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.258 1.423 . . . . 10.0 110.861 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.68 -71.3 0.38 Allowed Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.503 1.049 . . . . 10.0 112.847 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -98.63 -63.76 1.1 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 124.058 0.943 . . . . 10.0 112.025 -175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -77.49 60.73 2.14 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.895 0.878 . . . . 10.0 111.059 -174.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.14 60.38 0.57 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.736 1.214 . . . . 10.0 113.096 -176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.29 -179.74 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.806 0.842 . . . . 10.0 110.013 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -139.6 160.08 40.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.972 0.36 . . . . 10.0 111.972 -176.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.46 166.6 24.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.513 1.125 . . . . 10.0 108.722 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.7 m -63.98 141.13 58.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.3 t -75.62 115.34 44.94 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 118.613 0.642 . . . . 10.0 109.707 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.45 -37.83 9.35 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.263 1.975 . . . . 10.0 111.052 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -45.38 -33.42 2.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.831 1.652 . . . . 10.0 112.538 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.7 p -127.07 21.79 6.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.9 0.88 . . . . 10.0 111.746 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 46.83 40.42 8.94 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.134 0.974 . . . . 10.0 112.263 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.53 3.29 53.62 Favored Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.114 0.805 . . . . 10.0 115.114 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -82.69 -7.77 59.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.966 1.383 . . . . 10.0 112.405 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 68.03 -6.49 2.97 Favored Glycine 0 CA--C 1.541 1.663 0 O-C-N 121.465 -0.772 . . . . 10.0 113.041 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.56 127.04 52.61 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.184 1.793 . . . . 10.0 112.172 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.57 116.89 10.5 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 125.699 1.6 . . . . 10.0 107.482 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 mm -72.07 74.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 126.121 1.768 . . . . 10.0 109.291 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -42.47 -47.75 5.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.17 1.788 . . . . 10.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.22 94.96 5.17 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.87 1.268 . . . . 10.0 109.263 -176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -42.61 123.22 2.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 1 C-N-CA 125.573 4.182 . . . . 10.0 117.553 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 39.4 t -73.97 91.41 2.02 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.187 1.795 . . . . 10.0 107.142 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -36.98 -48.27 0.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.198 1.799 . . . . 10.0 112.805 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -43.37 -42.68 4.74 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.678 1.591 . . . . 10.0 112.639 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 27.8 p -117.28 16.87 14.81 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 123.756 0.823 . . . . 10.0 110.795 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 51.25 35.02 12.54 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.54 1.136 . . . . 10.0 110.27 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.64 14.25 57.45 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.688 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -75.05 -27.28 59.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.184 1.492 . . . . 10.0 111.627 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.56 -34.26 4.84 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.578 1.085 . . . . 10.0 113.718 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.61 144.37 50.32 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.123 0.969 . . . . 10.0 108.72 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.6 m -127.37 145.39 34.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.154 0.982 . . . . 10.0 109.412 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -80.47 138.69 36.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -67.79 72.09 0.15 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.034 1.334 . . . . 10.0 109.291 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 125.48 1.512 . . . . 10.0 110.625 -176.055 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 109.386 -1.486 . . . . 10.0 109.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.52 -22.33 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 109.411 -0.588 . . . . 10.0 109.411 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.5 p -71.0 69.1 0.46 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.991 2.116 . . . . 10.0 108.709 176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -136.38 -149.69 0.34 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.435 1.094 . . . . 10.0 109.551 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.27 58.84 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.352 1.061 . . . . 10.0 111.981 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.0 pt -77.74 59.19 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.463 0.705 . . . . 10.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -77.75 64.95 3.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.46 0.704 . . . . 10.0 109.125 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.79 154.35 80.46 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 126.242 1.817 . . . . 10.0 107.368 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.49 75.26 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.8 2.334 . . . . 10.0 110.799 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 m -73.43 65.78 0.93 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.572 0.749 . . . . 10.0 110.683 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.51 120.93 15.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.643 -0.661 . . . . 10.0 110.214 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -129.56 150.39 50.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.16 0.984 . . . . 10.0 109.531 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.74 131.44 43.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.808 1.643 . . . . 10.0 112.412 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.3 t -76.99 101.13 5.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.195 -1.78 . . . . 10.0 106.195 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -48.8 -41.97 34.44 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.288 1.435 . . . . 10.0 111.518 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.5 t -52.23 -33.38 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.103 1.361 . . . . 10.0 111.89 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.76 19.54 14.43 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.404 0.547 . . . . 10.0 110.925 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 50.08 38.31 16.48 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.019 1.327 . . . . 10.0 111.242 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.34 60.19 Favored Glycine 0 CA--C 1.534 1.252 0 CA-C-O 118.593 -1.115 . . . . 10.0 115.382 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.6 p -79.28 -67.88 0.71 Allowed 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.89 1.845 . . . . 10.0 110.909 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.11 -9.47 3.57 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 127.981 2.705 . . . . 10.0 110.028 -173.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 126.63 30.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.209 1.003 . . . . 10.0 111.739 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -44.76 141.49 2.92 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.916 1.687 . . . . 10.0 111.258 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.13 145.35 65.2 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.641 2.227 . . . . 10.0 110.185 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.22 23.05 39.06 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 123.44 0.543 . . . . 10.0 113.118 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -137.87 169.77 17.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 106.317 -1.735 . . . . 10.0 106.317 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.3 150.68 75.9 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 118.933 0.788 . . . . 10.0 111.047 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -84.86 168.05 10.98 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.236 2.624 . . . . 10.0 108.506 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -105.37 126.09 51.72 Favored 'General case' 0 N--CA 1.462 0.172 0 O-C-N 122.191 -0.318 . . . . 10.0 110.647 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -50.13 121.92 6.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.802 0.841 . . . . 10.0 110.573 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.85 115.8 26.28 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -70.21 -36.27 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.642 1.561 . . . . 10.0 110.754 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.2 m -46.14 -40.26 10.8 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.679 1.592 . . . . 10.0 112.907 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.6 p -115.73 18.14 15.86 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.581 0.752 . . . . 10.0 111.32 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 47.79 42.0 15.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.249 1.02 . . . . 10.0 110.722 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.37 -2.95 8.81 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 118.385 -1.231 . . . . 10.0 115.518 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -45.41 82.39 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.324 2.062 . . . . 10.0 111.322 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.06 3.24 28.06 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.365 1.459 . . . . 10.0 111.262 -175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -135.12 143.11 46.39 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.074 1.437 . . . . 10.0 112.079 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 m -99.46 168.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 126.096 1.758 . . . . 10.0 107.679 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -126.68 118.7 25.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.01 -1.478 . . . . 10.0 107.01 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -107.77 135.62 48.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.698 1.199 . . . . 10.0 108.843 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -99.05 115.26 28.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.767 1.227 . . . . 10.0 108.234 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 58.05 3.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.585 -0.895 . . . . 10.0 108.585 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 -66.7 2.07 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -101.23 -76.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.841 1.256 . . . . 10.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -69.46 172.84 6.61 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.475 0.579 . . . . 10.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -144.34 152.24 40.46 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.784 -0.573 . . . . 10.0 109.718 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.43 156.87 8.25 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 C-N-CA 124.419 1.088 . . . . 10.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.51 158.85 23.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.578 -0.737 . . . . 10.0 110.595 178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -147.03 155.13 41.97 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 107.231 -1.396 . . . . 10.0 107.231 173.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -63.76 133.99 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.34 117.35 56.07 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 119.178 0.899 . . . . 10.0 109.087 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.26 -37.04 8.47 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.95 1.767 . . . . 10.0 111.422 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -48.95 -39.25 25.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.779 1.231 . . . . 10.0 113.566 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.0 p -116.26 19.63 14.74 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.892 1.277 . . . . 10.0 110.892 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 46.59 44.59 13.62 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.631 1.172 . . . . 10.0 111.319 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.84 -8.18 6.39 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 115.451 0.94 . . . . 10.0 115.451 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -74.94 -17.65 60.52 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.775 1.787 . . . . 10.0 112.714 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.2 12.64 Favored Glycine 0 CA--C 1.532 1.15 0 O-C-N 121.843 -0.536 . . . . 10.0 112.385 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -106.54 130.49 54.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.703 1.601 . . . . 10.0 112.069 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.6 mt -81.63 115.82 21.08 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.3 mm -75.68 67.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.321 1.048 . . . . 10.0 108.192 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -64.91 -24.59 67.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.078 0.551 . . . . 10.0 109.575 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -118.35 80.18 15.88 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 128.396 2.678 . . . . 10.0 110.655 -178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -59.6 122.17 11.04 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.962 2.442 . . . . 10.0 115.191 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.9 t -70.43 89.42 0.69 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.367 -1.345 . . . . 10.0 107.367 172.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -39.26 -46.31 1.52 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.283 1.833 . . . . 10.0 112.848 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -45.59 -36.79 4.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.274 1.03 . . . . 10.0 112.555 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.1 26.07 6.58 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.822 0.849 . . . . 10.0 110.182 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 43.44 40.13 2.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.549 1.54 . . . . 10.0 112.117 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.97 37.32 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.198 -0.939 . . . . 10.0 115.245 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.42 -39.27 88.85 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.727 1.763 . . . . 10.0 109.547 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.26 -9.08 67.35 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.213 1.863 . . . . 10.0 114.333 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 157.74 44.92 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.865 1.332 . . . . 10.0 109.271 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.72 147.9 30.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.558 1.143 . . . . 10.0 110.419 -177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -74.61 79.88 1.99 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.351 1.06 . . . . 10.0 108.439 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -79.48 50.28 1.1 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.396 1.079 . . . . 10.0 110.764 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.9 m . . . . . 0 N--CA 1.455 -0.218 0 O-C-N 121.513 -0.742 . . . . 10.0 109.888 -179.418 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 109.999 -1.24 . . . . 10.0 109.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.8 m -46.48 -30.75 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.86 1.664 . . . . 10.0 113.836 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 p -55.95 -38.95 71.03 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.179 0.991 . . . . 10.0 110.64 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -94.43 -50.9 5.01 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.303 1.041 . . . . 10.0 108.192 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.8 65.44 1.93 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.906 1.283 . . . . 10.0 109.1 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -58.11 -8.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.255 1.576 . . . . 10.0 115.255 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -76.82 66.38 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.235 -1.024 . . . . 10.0 108.235 173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.1 pt -57.21 158.4 10.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.064 -0.97 . . . . 10.0 109.938 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -56.16 69.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 1 C-N-CA 125.321 4.014 . . . . 10.0 115.027 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -92.24 88.43 6.47 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.708 -1.96 . . . . 10.0 105.708 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.4 mt -96.59 132.62 42.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.549 1.14 . . . . 10.0 111.795 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -110.78 127.01 55.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.766 1.626 . . . . 10.0 107.566 176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -57.4 127.11 30.33 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.795 1.238 . . . . 10.0 109.798 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.1 85.23 4.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.289 0.566 . . . . 10.0 110.041 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -46.77 -38.7 10.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.258 1.423 . . . . 10.0 111.708 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -49.16 -38.48 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.798 1.639 . . . . 10.0 111.712 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.14 19.52 17.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.147 0.579 . . . . 10.0 110.585 176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 51.89 36.27 17.82 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.218 1.407 . . . . 10.0 109.772 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 3.66 42.3 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.43 1.014 . . . . 10.0 115.546 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.9 p -75.34 -66.3 0.78 Allowed 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.61 1.705 . . . . 10.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.89 -9.91 3.64 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.978 2.228 . . . . 10.0 109.82 -175.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.18 139.65 46.46 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.355 1.578 . . . . 10.0 110.839 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -56.13 146.4 50.84 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 118.438 -0.791 . . . . 10.0 109.407 176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -32.81 -66.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 1 C-N-CA 125.349 4.033 . . . . 10.0 115.68 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -81.29 44.5 3.06 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 121.583 -0.698 . . . . 10.0 113.074 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.6 m -158.13 158.65 35.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.673 1.236 . . . . 10.0 107.975 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.71 147.25 36.73 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 125.105 1.362 . . . . 10.0 108.662 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.401 ' HB2' ' HB ' ' A' ' 61' ' ' THR . 29.8 Cg_endo -74.21 160.15 42.84 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.413 2.075 . . . . 10.0 107.247 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -105.32 126.18 51.81 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.667 -0.682 . . . . 10.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -36.75 116.92 0.46 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.949 1.3 . . . . 10.0 113.073 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.1 t -74.6 115.52 44.6 Favored Pre-proline 0 N--CA 1.449 -0.503 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.14 -31.75 18.26 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.649 1.566 . . . . 10.0 110.589 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.96 -43.56 29.49 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.151 1.38 . . . . 10.0 112.062 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.7 p -108.04 11.55 27.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.081 0.953 . . . . 10.0 111.28 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 52.15 37.93 23.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.272 1.029 . . . . 10.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.38 -8.35 19.18 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.799 -0.563 . . . . 10.0 113.993 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 m -71.38 -8.7 55.49 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.989 1.394 . . . . 10.0 114.438 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.92 -18.78 11.35 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.064 0.847 . . . . 10.0 113.729 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -133.61 131.62 39.84 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.246 1.023 . . . . 10.0 109.566 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 m -73.8 150.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.337 1.455 . . . . 10.0 107.291 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -117.51 107.22 14.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.341 0.657 . . . . 10.0 109.889 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.9 mmt -85.32 114.87 22.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.287 -1.005 . . . . 10.0 108.287 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -97.95 133.12 42.87 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.578 1.151 . . . . 10.0 109.984 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.07 80.94 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.902 1.681 . . . . 10.0 107.606 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.37 -64.2 2.5 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.996 0.807 . . . . 10.0 111.704 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -128.71 -66.69 0.82 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.258 1.023 . . . . 10.0 109.416 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -59.92 155.33 16.76 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.981 0.512 . . . . 10.0 109.715 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.01 157.21 43.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.418 0.287 . . . . 10.0 110.83 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 m -135.92 148.57 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.207 0 C-N-CA 124.429 1.092 . . . . 10.0 109.339 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -102.83 144.76 30.74 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.883 0.873 . . . . 10.0 112.177 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -140.15 143.81 36.36 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.302 1.441 . . . . 10.0 107.843 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 m -53.09 135.39 37.53 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.253 0.933 . . . . 10.0 111.489 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.2 t -79.53 116.89 64.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.97 -41.94 3.59 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.133 1.889 . . . . 10.0 111.259 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -47.2 -29.83 2.59 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.95 1.092 . . . . 10.0 113.95 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.2 p -127.46 29.95 5.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.759 0.824 . . . . 10.0 111.594 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 38.78 49.83 1.56 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.239 1.416 . . . . 10.0 111.945 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.54 -11.03 3.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 116.203 1.241 . . . . 10.0 116.203 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -74.08 -13.82 60.9 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 120.106 1.953 . . . . 10.0 113.574 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.35 7.2 86.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.559 -0.578 . . . . 10.0 114.339 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' PRO . 77.3 p -132.03 119.05 20.5 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.444 1.122 . . . . 10.0 110.565 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.03 150.19 43.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.002 1.321 . . . . 10.0 110.209 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -112.72 73.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 C-N-CA 125.557 1.543 . . . . 10.0 109.961 -177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -68.45 -24.67 64.74 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.275 -0.891 . . . . 10.0 109.613 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -107.4 79.14 0.73 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.942 2.497 . . . . 10.0 110.323 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.05 118.09 5.06 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.296 2.664 . . . . 10.0 115.801 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.6 t -65.6 95.49 0.23 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.481 -1.674 . . . . 10.0 106.481 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -38.79 -48.81 1.56 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.869 1.668 . . . . 10.0 112.776 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -42.93 -39.89 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.725 1.21 . . . . 10.0 112.752 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.4 p -123.01 19.5 10.03 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.594 0.757 . . . . 10.0 111.047 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 46.38 41.93 9.9 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.653 1.181 . . . . 10.0 110.776 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 61.13 15.46 44.04 Favored Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.409 0.924 . . . . 10.0 115.409 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.83 -44.63 31.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.625 1.712 . . . . 10.0 109.009 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.75 -7.43 13.41 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.906 1.717 . . . . 10.0 112.346 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.62 152.85 32.28 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 120.881 -1.364 . . . . 10.0 109.688 -178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.4 m -108.08 146.45 13.99 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -98.59 137.69 36.86 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.344 -0.613 . . . . 10.0 109.344 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -78.26 59.98 2.41 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.064 -1.087 . . . . 10.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.455 -0.222 0 C-N-CA 124.31 1.044 . . . . 10.0 110.86 -178.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_